https://www.pharmasalmanac.com/articles/what-makes-a-great-liquid-oral-dose-cdmo 2026-07-22 14:08:44.27409+00 https://www.pharmasalmanac.com/articles/stem-cell-therapies-close-to-transforming-promise-into-real-patient-outcomes 2026-07-22 09:00:31.214432+00 https://www.pharmasalmanac.com/articles/five-exosome-biotechs-to-watch-july-2025 2026-07-21 20:11:01.738753+00 https://www.pharmasalmanac.com/articles/from-screening-to-design-can-production-cell-lines-become-programmable-platforms 2026-07-20 09:01:21.872973+00 https://www.pharmasalmanac.com/articles/testing-and-correcting-gender-bias-in-healthcare-ai 2026-07-17 15:23:58.724804+00 https://www.pharmasalmanac.com/articles/basket-vs-umbrella-clinical-trials-which-precision-oncology-trial-design-is-better 2026-07-17 09:00:58.306203+00 https://www.pharmasalmanac.com/articles/developing-cell-and-gene-therapies-for-rare-oncology-applications 2026-07-16 17:58:03.999805+00 https://www.pharmasalmanac.com/articles/sustainability-by-design-in-drug-delivery-devices 2026-07-16 09:00:24.654187+00 https://www.pharmasalmanac.com/articles/high-concentration-biologics-are-redefining-subcutaneous-delivery 2026-07-15 13:06:38.928888+00 https://www.pharmasalmanac.com/articles/intracellular-delivery-reaching-targets-beyond-the-cell-surface 2026-07-14 09:00:17.287514+00 https://www.pharmasalmanac.com/articles/repairing-more-tissue-than-you-edit-what-in-vivo-selection-could-mean-for-gene-therapy 2026-07-13 09:00:17.637997+00 https://www.pharmasalmanac.com/articles/offshoring-vs-reshoring-vs-half-shoring-which-manufacturing-strategy-is-best-for-pharma 2026-07-10 09:01:14.544163+00 https://www.pharmasalmanac.com/articles/the-formulation-science-behind-extended-drug-release 2026-07-09 09:01:10.385614+00 https://www.pharmasalmanac.com/articles/moving-beyond-tumor-origin-the-rise-of-tissue-agnostic-oncology 2026-07-08 09:00:17.768321+00 https://www.pharmasalmanac.com/articles/designing-formulations-around-devices-rather-than-vice-versa 2026-07-07 09:00:09.249625+00 https://www.pharmasalmanac.com/articles/do-you-expect-continued-movement-away-from-one-stop-shop-outsourcing-toward-deeper-modality-specific-expertise 2026-07-07 00:50:04.694378+00 https://www.pharmasalmanac.com/articles/beyond-lipid-nanoparticles-the-search-for-next-generation-delivery-platforms 2026-07-06 09:01:00.653634+00 https://www.pharmasalmanac.com/articles/designing-drugs-against-moving-proteins-drug-discovery-enters-the-era-of-protein-conformational-ensembles 2026-07-06 09:01:00.653634+00 https://www.pharmasalmanac.com/articles/adaptive-trials-vs-traditional-randomized-controlled-trials-which-clinical-trial-design-is-better 2026-07-03 09:00:09.485309+00 https://www.pharmasalmanac.com/articles/how-much-of-your-last-years-research-budget-felt-wasted-the-hidden-cost-of-experimental-inconsistencies 2026-07-02 12:13:34.008079+00 https://www.pharmasalmanac.com/articles/basket-trials-and-the-future-of-rare-cancer-research 2026-07-02 09:00:09.515018+00 https://www.pharmasalmanac.com/articles/data-centric-organoid-services-for-predictive-drug-response-and-next-generation-oncology-research 2026-07-01 14:02:18.83912+00 https://www.pharmasalmanac.com/articles/the-long-view-how-extended-duration-therapies-are-reshaping-patient-care 2026-07-01 09:00:50.403805+00 https://www.pharmasalmanac.com/articles/austinpx-expands-kinetisol-technology-commercial-access-through-thermo-fisher-scientific-collaboration 2026-06-30 16:11:52.325376+00 https://www.pharmasalmanac.com/articles/aiming-for-more-than-single-base-corrections-the-technologies-opening-the-genome-to-therapeutic-cargo 2026-06-29 09:01:43.188838+00 https://www.pharmasalmanac.com/articles/advancing-deep-brain-stimulation-through-better-targeting-and-smarter-devices 2026-06-26 09:00:50.1732+00 https://www.pharmasalmanac.com/articles/site-based-vs-decentralized-vs-hybrid-clinical-trials-which-model-is-best-for-modern-clinical-research 2026-06-26 09:00:50.1732+00 https://www.pharmasalmanac.com/articles/why-successful-scale-up-and-transfer-capabilities-increasingly-determine-outsourcing-success 2026-06-25 09:00:50.479005+00 https://www.pharmasalmanac.com/articles/advancing-equity-in-rare-disease-trials-global-realities-local-solutions 2026-06-23 17:26:48.538296+00 https://www.pharmasalmanac.com/articles/data-integrity-drivers-challenges-and-key-program-elements 2026-06-23 09:01:08.579663+00 https://www.pharmasalmanac.com/articles/more-than-capacity-what-the-latest-us-cdmo-expansion-wave-reveals-about-specialized-manufacturing-demand 2026-06-22 13:42:47.594946+00 https://www.pharmasalmanac.com/articles/building-better-rna-medicines-through-smarter-lnp-formulation-strategy 2026-06-22 09:00:16.185686+00 https://www.pharmasalmanac.com/articles/editing-the-microbiome-in-place-from-engineered-probiotics-to-programmable-ecological-therapies 2026-06-22 09:00:16.185686+00 https://www.pharmasalmanac.com/articles/building-bioreactors-for-living-architecture-the-manufacturing-challenge-for-clinical-grade-organoids 2026-06-22 09:00:16.185686+00 https://www.pharmasalmanac.com/articles/designing-for-change-adaptive-clinical-trials-and-the-evolving-path-to-regulatory-acceptance 2026-06-19 09:00:22.73323+00 https://www.pharmasalmanac.com/articles/depot-injection-vs-implantable-drug-delivery-which-long-acting-delivery-strategy-is-better 2026-06-19 09:00:22.73323+00 https://www.pharmasalmanac.com/articles/regulatory-innovation-for-a-more-personalized-era-of-medicine 2026-06-18 09:00:01.796725+00 https://www.pharmasalmanac.com/articles/building-resilient-development-models-how-mid-size-pharma-can-scale-without-losing-control 2026-06-17 21:31:44.136373+00 https://www.pharmasalmanac.com/articles/outsourcing-fragmentation-and-the-new-supply-chain-resilience-challenge 2026-06-17 21:25:32.224233+00 https://www.pharmasalmanac.com/articles/10x-genomics-and-cleveland-clinic-collaborate-in-diagnostic-applications-of-single-cell-and-spatial-technologies-in-bladder-cancer 2026-06-17 13:53:27.179613+00 https://www.pharmasalmanac.com/articles/insilico-completes-first-in-human-dosing-in-phase-i-clinical-study-of-ai-driven-nlrp3-inhibitor-ism8969 2026-06-17 13:43:17.436143+00 https://www.pharmasalmanac.com/articles/accelerated-pathways-are-they-delivering-on-their-promise 2026-06-17 09:00:37.38468+00 https://www.pharmasalmanac.com/articles/bridging-the-gap-addressing-unmet-needs-in-cardiology-neuroscience-and-respiratory-trials 2026-06-16 20:12:50.820074+00 https://www.pharmasalmanac.com/articles/rethinking-clinical-evidence-requirements-in-rare-diseases 2026-06-16 13:45:08.890359+00 https://www.pharmasalmanac.com/articles/protein-misfolding-as-a-therapeutic-axis-in-neurodegenerative-disease 2026-06-15 14:35:06.986483+00 https://www.pharmasalmanac.com/articles/cell-free-biomanufacturing-and-the-future-of-flexible-biologics-production 2026-06-15 09:00:48.491797+00 https://www.pharmasalmanac.com/articles/lipid-nanoparticles-vs-viral-vectors-for-gene-delivery-which-platform-is-better 2026-06-12 09:00:48.61891+00 https://www.pharmasalmanac.com/articles/the-hidden-operational-costs-of-multi-vendor-outsourcing-models 2026-06-11 09:00:48.356593+00 https://www.pharmasalmanac.com/articles/enhancing-quality-and-environmental-monitoring-efficiency-through-paperless-sampling 2026-06-10 19:34:05.138437+00 https://www.pharmasalmanac.com/articles/how-is-the-increasing-complexity-of-modalities-reshaping-cdmo-differentiation-and-specialization-strategies 2026-06-10 16:08:43.033296+00 https://www.pharmasalmanac.com/articles/beyond-amyloid-building-the-next-alzheimers-disease-therapeutic-ecosystem 2026-06-10 12:12:11.32919+00 https://www.pharmasalmanac.com/articles/enabling-the-commercialization-of-peptide-therapeutics-with-manufacturing-advances 2026-06-09 19:41:55.9103+00 https://www.pharmasalmanac.com/articles/exponential-advances-in-protein-engineering 2026-06-08 09:00:48.917895+00 https://www.pharmasalmanac.com/articles/molecular-tags-dna-barcodes-and-the-future-of-pharmaceutical-supply-chain-authentication 2026-06-08 09:00:48.917895+00 https://www.pharmasalmanac.com/articles/lyophilized-vs-liquid-drug-formulations-which-formulation-strategy-is-better 2026-06-05 09:00:49.807572+00 https://www.pharmasalmanac.com/articles/validating-and-governing-ai-in-gmp-manufacturing 2026-06-04 09:00:11.638012+00 https://www.pharmasalmanac.com/articles/data-integrity-in-the-age-of-ai-assisted-manufacturing 2026-06-03 09:00:11.457032+00 https://www.pharmasalmanac.com/articles/why-bispecific-antibody-architecture-is-a-cmc-decision 2026-06-02 09:00:11.427828+00 https://www.pharmasalmanac.com/articles/dark-proteins-step-into-the-light 2026-06-01 15:44:22.302889+00 https://www.pharmasalmanac.com/articles/the-stepwise-future-of-continuous-viral-vector-manufacturing 2026-06-01 09:00:11.34023+00 https://www.pharmasalmanac.com/articles/aav-vs-lentiviral-vectors-which-viral-vector-is-better-for-gene-therapy 2026-05-29 09:00:11.892403+00 https://www.pharmasalmanac.com/articles/impurities-sequence-fidelity-and-structural-variants-in-nucleic-acid-therapeutics 2026-05-26 09:00:33.362597+00 https://www.pharmasalmanac.com/articles/the-gutbrain-axis-and-the-future-of-microbiome-directed-mental-health-strategies 2026-05-25 09:00:33.51188+00 https://www.pharmasalmanac.com/articles/beyond-cleaning-could-self-healing-materials-redefine-bioprocess-surfaces 2026-05-25 09:00:33.51188+00 https://www.pharmasalmanac.com/articles/the-cmc-challenge-for-psychedelic-drugs 2026-05-22 09:00:33.80087+00 https://www.pharmasalmanac.com/articles/sterile-filtration-vs-terminal-sterilization-which-sterility-strategy-is-best-for-injectable-drugs 2026-05-22 09:00:33.80087+00 https://www.pharmasalmanac.com/articles/re-engineering-adcs-for-autoimmune-and-inflammatory-disease 2026-05-21 09:00:33.457397+00 https://www.pharmasalmanac.com/articles/why-adc-conjugation-strategy-is-now-a-cmc-decision 2026-05-20 09:00:33.493158+00 https://www.pharmasalmanac.com/articles/peptide-manufacturing-enters-the-industrial-era 2026-05-18 09:00:33.454945+00 https://www.pharmasalmanac.com/articles/rethinking-fermentation-halophiles-and-the-next-generation-of-industrial-biotechnology 2026-05-18 09:00:33.454945+00 https://www.pharmasalmanac.com/articles/the-resurgence-of-peptide-drugs-in-the-age-of-precision-medicine 2026-05-15 09:00:33.310316+00 https://www.pharmasalmanac.com/articles/in-vitro-vs-in-vivo-potency-assays-which-approach-is-best-for-biopharmaceutical-product-characterization 2026-05-15 09:00:33.310316+00 https://www.pharmasalmanac.com/articles/greener-pathways-for-peptide-and-oligonucleotide-manufacturing 2026-05-14 09:00:33.481481+00 https://www.pharmasalmanac.com/articles/rebuilding-the-psychiatric-drug-discovery-pipeline 2026-05-13 09:00:33.548877+00 https://www.pharmasalmanac.com/articles/the-solubility-company-and-persist-ai-unveil-strategic-partnership-to-bridge-the-data-gap-in-ai-driven-drug-formulation 2026-05-13 09:00:33.548877+00 https://www.pharmasalmanac.com/articles/beyond-symptoms-the-search-for-objective-biomarkers-in-psychiatric-disorders 2026-05-12 09:00:33.478136+00 https://www.pharmasalmanac.com/articles/from-mabs-to-adcs-rethinking-the-platform-manufacturing-model 2026-05-11 09:00:33.220048+00 https://www.pharmasalmanac.com/articles/synthetic-chromosome-therapeutics-expanding-genomic-medicine-beyond-the-limits-of-gene-therapy 2026-05-11 09:00:33.220048+00 https://www.pharmasalmanac.com/articles/lab-thread-introduces-unified-lab-software-platform-to-streamline-biological-research 2026-05-08 13:04:16.219506+00 https://www.pharmasalmanac.com/articles/linker-chemistry-as-the-hidden-determinant-of-adc-success 2026-05-08 09:00:33.477531+00 https://www.pharmasalmanac.com/articles/single-use-vs-stainless-steel-bioreactors-which-manufacturing-platform-is-better-for-biopharmaceutical-production 2026-05-08 09:00:33.477531+00 https://www.pharmasalmanac.com/articles/sustainable-clean-in-place-rethinking-legacy-chemistry-in-modern-biomanufacturing 2026-05-07 14:46:30.068949+00 https://www.pharmasalmanac.com/articles/how-are-companies-distinguishing-between-moonshot-automation-and-validated-digital-tools-that-can-be-deployed-today 2026-05-07 13:41:27.370753+00 https://www.pharmasalmanac.com/articles/scaling-oligonucleotide-manufacturing-when-chemistry-becomes-the-constraint 2026-05-07 09:00:06.368673+00 https://www.pharmasalmanac.com/articles/psychedelic-therapeutics-at-an-inflection-point-translating-clinical-signals-into-scalable-medicines 2026-05-06 09:00:06.301988+00 https://www.pharmasalmanac.com/articles/expanding-the-reach-of-oligonucleotide-drugs-through-delivery-innovation 2026-05-05 09:00:06.206088+00 https://www.pharmasalmanac.com/articles/engineering-antibodies-for-precision-payload-delivery 2026-05-04 09:00:06.653369+00 https://www.pharmasalmanac.com/articles/pharmacy-on-demand-can-medicines-be-manufactured-at-the-point-of-need 2026-05-04 09:00:06.653369+00 https://www.pharmasalmanac.com/articles/beyond-cytotoxins-expanding-the-payload-landscape-for-antibody-based-conjugates 2026-05-01 15:08:25.682409+00 https://www.pharmasalmanac.com/articles/crispr-vs-base-editing-vs-prime-editing-which-genome-editing-technology-is-best 2026-05-01 09:00:06.296376+00 https://www.pharmasalmanac.com/articles/product-carbon-footprint-enabling-product-level-decarbonization-in-biopharma 2026-04-30 15:08:49.140721+00 https://www.pharmasalmanac.com/articles/prion-like-signaling-systems-a-frontier-for-synthetic-biological-control 2026-04-27 09:00:06.390749+00 https://www.pharmasalmanac.com/articles/connecting-your-lab-with-an-integrated-digital-thread 2026-04-27 09:00:06.390749+00 https://www.pharmasalmanac.com/articles/zymo-research-launches-fecal-microbiome-discovery-grant-to-enable-the-next-breakthroughs-in-human-health 2026-04-24 18:19:50.500215+00 https://www.pharmasalmanac.com/articles/next-generation-therapies-for-neurological-diseases 2026-04-24 13:02:52.201779+00 https://www.pharmasalmanac.com/articles/nk-cell-therapy-vs-t-cell-therapy-which-cell-therapy-platform-is-better-for-cancer-treatment 2026-04-24 09:00:06.358757+00 https://www.pharmasalmanac.com/articles/which-digital-technologies-have-delivered-tangible-operational-value-over-the-past-1218-months-and-which-remain-over-hyped 2026-04-23 10:49:16.313835+00 https://www.pharmasalmanac.com/articles/rewriting-gene-expression-without-rewriting-dna-the-emerging-field-of-epigenetic-editing 2026-04-23 09:00:06.25654+00 https://www.pharmasalmanac.com/articles/therapeutic-bioelectricity-rewiring-physiology-through-bioelectronic-medicine 2026-04-22 09:00:06.804799+00 https://www.pharmasalmanac.com/articles/oncolytic-viruses-at-a-turning-point-advancing-olvi-vec-for-advanced-ovarian-cancer 2026-04-21 11:14:01.582724+00 https://www.pharmasalmanac.com/articles/enzyme-instructed-self-assembly-therapeutics-when-disease-biology-builds-the-drug 2026-04-21 09:00:06.249107+00 https://www.pharmasalmanac.com/articles/rarecyte-expands-clinical-scale-spatial-proteomics-portfolio-with-new-orion-systems-and-leadership-appointment 2026-04-20 18:04:11.468279+00 https://www.pharmasalmanac.com/articles/rewriting-the-genetic-code-designing-biologics-with-noncanonical-amino-acids 2026-04-20 09:00:06.452485+00 https://www.pharmasalmanac.com/articles/batch-vs-fed-batch-vs-continuous-bioprocessing-which-manufacturing-strategy-is-best-for-modern-biologics 2026-04-17 09:00:06.682175+00 https://www.pharmasalmanac.com/articles/introducing-cpc-biotech-one-brand-uniting-critical-fluid-management-components 2026-04-16 21:38:50.737235+00 https://www.pharmasalmanac.com/articles/the-intersection-of-pharmaceutical-tariffs-outsourcing-and-investment-balance-is-key 2026-04-16 14:24:19.095681+00 https://www.pharmasalmanac.com/articles/real-time-insight-in-biologic-manufacturing-why-pat-matters-for-commercial-scale-up 2026-04-16 09:00:06.739321+00 https://www.pharmasalmanac.com/articles/from-analytical-visibility-to-real-time-control-in-biologics-purification 2026-04-15 09:00:06.399665+00 https://www.pharmasalmanac.com/articles/targeting-rna-in-the-nervous-system-the-rise-of-antisense-and-rna-therapeutics 2026-04-15 09:00:06.399665+00 https://www.pharmasalmanac.com/articles/proving-a-robust-and-accelerated-human-vaccine-platform-provided-the-foundation-for-a-uniquely-capable-biologics-cdmo 2026-04-14 09:00:49.317975+00 https://www.pharmasalmanac.com/articles/precision-neurology-how-biomarkers-are-redefining-clinical-trial-design 2026-04-13 09:00:49.270313+00 https://www.pharmasalmanac.com/articles/cho-vs-hek293-which-expression-system-is-better-for-biopharmaceutical-production 2026-04-10 09:00:49.341898+00 https://www.pharmasalmanac.com/articles/navigating-global-regulatory-expectations-in-outsourced-manufacturing 2026-04-10 09:00:49.341898+00 https://www.pharmasalmanac.com/articles/drevidence-appoints-david-pennington-as-chief-executive-officer 2026-04-09 13:11:47.245229+00 https://www.pharmasalmanac.com/articles/accelerating-and-simplifying-the-use-of-complex-and-comprehensive-real-world-data 2026-04-09 09:01:49.260678+00 https://www.pharmasalmanac.com/articles/where-drugs-meet-devices-the-next-phase-of-combination-product-innovation 2026-04-08 09:00:49.370966+00 https://www.pharmasalmanac.com/articles/oral-delivery-of-monoclonal-antibodies-the-pursuit-continues 2026-04-07 09:00:49.546307+00 https://www.pharmasalmanac.com/articles/deeper-process-visibility-advanced-monitoring-technologies-for-modern-biologics-manufacturing 2026-04-06 09:00:49.456303+00 https://www.pharmasalmanac.com/articles/aav-vs-non-viral-gene-delivery-which-is-better-for-in-vivo-gene-therapy 2026-04-03 18:12:21.750695+00 https://www.pharmasalmanac.com/articles/transferring-cytoplasmic-contents-and-organelles-between-living-cells 2026-04-03 12:43:38.39815+00 https://www.pharmasalmanac.com/articles/producing-therapies-for-the-brain-manufacturing-and-formulation-challenges-for-cns-biologics 2026-04-03 09:00:49.634917+00 https://www.pharmasalmanac.com/articles/opening-the-bloodbrain-barrier-device-based-strategies-for-cns-drug-delivery 2026-04-02 09:00:49.4726+00 https://www.pharmasalmanac.com/articles/quotient-sciences-and-intrepid-labs-form-strategic-partnership-to-accelerate-ai-guided-formulation-development 2026-04-01 15:37:18.220934+00 https://www.pharmasalmanac.com/articles/quotient-sciences-and-biorasi-partner-to-accelerate-early-phase-clinical-trials-to-patient-proof-of-concept 2026-04-01 15:37:09.409129+00 https://www.pharmasalmanac.com/articles/lindus-health-and-quotient-sciences-partner-to-accelerate-drug-development-from-first-in-human-to-pivotal-trials 2026-04-01 15:36:55.479824+00 https://www.pharmasalmanac.com/articles/quotient-sciences-extends-commercial-manufacturing-partnership-for-ultra-rare-disease-treatment 2026-04-01 15:36:47.260797+00 https://www.pharmasalmanac.com/articles/rois-cdmo-closes-on-the-acquisition-of-us-injectable-manufacturing-facility 2026-04-01 14:27:38.053325+00 https://www.pharmasalmanac.com/articles/can-lab-management-software-help-solve-the-reproducibility-crisis 2026-04-01 12:21:40.160028+00 https://www.pharmasalmanac.com/articles/engineering-biologics-and-nanomedicines-to-traverse-the-bloodbrain-barrier 2026-04-01 09:00:49.538756+00 https://www.pharmasalmanac.com/articles/samsung-biologics-completes-acquisition-of-gsks-manufacturing-facility-in-rockville-maryland 2026-03-31 14:11:10.850009+00 https://www.pharmasalmanac.com/articles/predicting-contamination-before-it-happens-simulation-in-sterile-manufacturing 2026-03-26 09:00:49.691722+00 https://www.pharmasalmanac.com/articles/designing-sterile-fill-finish-systems-for-the-realities-of-advanced-therapies 2026-03-25 09:00:50.619924+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-acquires-kws-biotest 2026-03-24 22:21:39.384706+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-makes-investments-in-high-throughput-screening-infrastructure 2026-03-24 22:21:22.477041+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-to-acquire-mpi-research 2026-03-24 22:21:10.873542+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-announces-executive-management-appointments 2026-03-24 22:20:56.375548+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-makes-expansions-to-global-biologics-infrastructure 2026-03-24 22:20:26.318785+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-and-pathoquest-expand-strategic-biologics-partnership 2026-03-24 22:19:59.771562+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-announces-extended-relationship-with-the-michael-j.-fox-foundation 2026-03-24 22:19:38.390032+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-announces-updates-to-microbial-solutions-product-portfolio 2026-03-24 22:19:21.397811+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-joins-dementia-consortium-reaffirms-commitment-to-neuroscience-research 2026-03-24 22:19:03.467855+00 https://www.pharmasalmanac.com/articles/charles-river-laboratories-completes-the-acquisition-of-hemacare-corporation 2026-03-24 22:18:44.6487+00 https://www.pharmasalmanac.com/articles/castle-creek-pharmaceutical-holdings-announces-agreement-to-acquire-fibrocell 2026-03-24 22:15:06.044958+00 https://www.pharmasalmanac.com/articles/castle-creek-pharmaceuticals-announces-data-validating-first-investigators-global-assessment-scale-for-epidermolysis-bullosa-simplex-clinical-research 2026-03-24 22:14:14.34816+00 https://www.pharmasalmanac.com/articles/castle-creek-pharmaceuticals-receives-fda-fast-track-designation-for-diacerein-1-ointment-for-treatment-of-epidermolysis-bullosa-simplex 2026-03-24 22:14:03.276042+00 https://www.pharmasalmanac.com/articles/bioduro-sundia-appoints-alan-findlater-as-chief-commercial-officer-to-drive-strategic-growth-and-enhance-market-position 2026-03-24 21:55:32.596782+00 https://www.pharmasalmanac.com/articles/bayer-announces-publication-of-larotrectinib-data-in-the-new-england-journal-of-medicine 2026-03-24 21:47:06.341141+00 https://www.pharmasalmanac.com/articles/bayer-appoints-sebastian-guth-to-lead-pharmaceuticals-business-in-the-americas 2026-03-24 21:46:45.035622+00 https://www.pharmasalmanac.com/articles/synthetic-cells-rewriting-the-rules-of-biopharma-engineering 2026-03-24 09:00:49.534019+00 https://www.pharmasalmanac.com/articles/accelerating-adc-analytical-method-development-through-platform-innovation 2026-03-23 12:05:07.615788+00 https://www.pharmasalmanac.com/articles/long-acting-drug-delivery-for-chronic-metabolic-and-renal-conditions 2026-03-23 09:00:02.953472+00 https://www.pharmasalmanac.com/articles/the-fragile-backbone-of-sterile-manufacturing-container-closures-filtration-and-supply-chain-resilience 2026-03-20 09:00:02.455611+00 https://www.pharmasalmanac.com/articles/digital-patient-and-clinician-platforms-are-transforming-clinical-research-and-patient-outcomes 2026-03-19 09:00:02.764075+00 https://www.pharmasalmanac.com/articles/europes-innovation-engine-how-publicprivate-partnerships-are-transforming-biomedical-research 2026-03-18 09:00:02.759055+00 https://www.pharmasalmanac.com/articles/digitalization-and-automation-reshape-aseptic-fillfinish-operations 2026-03-17 09:00:02.829485+00 https://www.pharmasalmanac.com/articles/lab-thread-launches-free-version-of-unified-lab-software-platform-to-accelerate-academic-research 2026-03-16 14:29:24.534284+00 https://www.pharmasalmanac.com/articles/cardiorenalmetabolic-syndrome-redefining-chronic-disease-through-integrated-treatment 2026-03-16 09:00:22.532772+00 https://www.pharmasalmanac.com/articles/designing-flexible-fill-finish-platforms-for-small-batch-precision-medicines 2026-03-12 09:00:22.532046+00 https://www.pharmasalmanac.com/articles/from-formulation-tool-to-manufacturing-strategy-the-evolving-role-of-spray-drying 2026-03-11 13:28:38.748036+00 https://www.pharmasalmanac.com/articles/the-expanding-therapeutic-landscape-in-chronic-kidney-disease 2026-03-11 09:00:22.540164+00 https://www.pharmasalmanac.com/articles/human-factors-in-aseptic-processing-training-behavior-and-risk-reduction 2026-03-09 09:00:22.769406+00 https://www.pharmasalmanac.com/articles/what-emerging-technologies-or-scientific-breakthroughs-do-you-believe-will-most-reshape-biopharma-in-the-next-10-years 2026-03-06 20:02:16.944715+00 https://www.pharmasalmanac.com/articles/what-does-a-true-strategic-partnership-between-sponsors-and-cdmos-look-like-in-todays-environment 2026-03-06 20:01:43.081586+00 https://www.pharmasalmanac.com/articles/rabs-or-isolators-aligning-barrier-technology-with-your-contamination-control-strategy 2026-03-06 10:00:13.683496+00 https://www.pharmasalmanac.com/articles/a-continent-of-innovation-regions-what-europes-cluster-diversity-means-for-the-future-of-biotechnology 2026-03-05 10:00:13.274034+00 https://www.pharmasalmanac.com/articles/building-for-growth-infrastructure-governance-talent-and-clinical-integration-in-european-biotech-clusters 2026-03-05 10:00:13.274034+00 https://www.pharmasalmanac.com/articles/codis-unlocks-commercial-scale-amorphous-solid-dispersions-manufacturing-with-gea-psd4-solvent-spray-dryer-investment 2026-03-04 14:40:11.414837+00 https://www.pharmasalmanac.com/articles/breaking-down-barriers-in-cardiology-trials-to-expand-access-to-at-risk-populations 2026-03-04 10:00:10.581742+00 https://www.pharmasalmanac.com/articles/inside-europes-biotech-innovation-engines-scale-research-capacity-and-commercialization 2026-03-03 10:00:10.891214+00 https://www.pharmasalmanac.com/articles/innovations-in-early-phase-clinical-trials-pioneering-the-future-of-medicine 2026-03-02 10:00:35.834722+00 https://www.pharmasalmanac.com/articles/europes-polycentric-biotech-landscape-four-models-of-cluster-formation 2026-03-01 10:00:35.274022+00 https://www.pharmasalmanac.com/articles/univar-solutions-selected-as-ingredion-pharma-solutions-distributor-in-united-states-and-canada 2026-02-25 19:40:56.225797+00 https://www.pharmasalmanac.com/articles/flamma-usa-successfully-passes-fda-inspection 2026-02-25 19:31:52.614394+00 https://www.pharmasalmanac.com/articles/disamr-acquires-amr-insights-to-build-the-leading-global-hub-for-antimicrobial-resistance-amr-innovation 2026-02-24 14:42:36.377518+00 https://www.pharmasalmanac.com/articles/how-fully-owned-locally-led-site-networks-deliver-quality-speed-and-scalability-in-the-era-of-ich-e6r3 2026-02-23 10:00:14.434268+00 https://www.pharmasalmanac.com/articles/allogeneic-car-cell-therapies-the-rise-of-off-the-shelf-immunotherapy 2026-02-19 19:01:23.316178+00 https://www.pharmasalmanac.com/articles/key-trends-shaping-the-pharmaceutical-industry-at-pharmap-2026 2026-02-19 14:47:24.812419+00 https://www.pharmasalmanac.com/articles/modern-mes-drives-high-throughput-high-quality-cdmo-manufacturing 2026-02-13 15:32:55.798111+00 https://www.pharmasalmanac.com/articles/when-commercial-manufacturing-serves-dozens-not-thousands 2026-02-13 10:00:14.607661+00 https://www.pharmasalmanac.com/articles/rois-appoints-kimberlee-steele-as-chief-commercial-officer 2026-02-12 17:29:29.733189+00 https://www.pharmasalmanac.com/articles/automation-as-a-strategic-enabler-in-small-molecule-drug-development-and-manufacturing 2026-02-12 10:00:14.666038+00 https://www.pharmasalmanac.com/articles/when-review-stops-at-the-door-the-fda-mrna-influenza-vaccines-and-the-future-of-regulatory-consistency 2026-02-11 20:52:18.447353+00 https://www.pharmasalmanac.com/articles/experic-announces-the-appointment-of-matthew-mollan-phd-as-chief-executive-officer 2026-02-11 18:59:05.251445+00 https://www.pharmasalmanac.com/articles/kincell-bio-announces-partnership-with-regcell-to-advance-treg-cell-therapies-into-clinical-trials-for-autoimmune-diseases 2026-02-11 18:57:37.920263+00 https://www.pharmasalmanac.com/articles/how-rare-is-too-rare-redefining-viability-for-ultra-rare-disease-therapeutics 2026-02-11 10:00:14.757227+00 https://www.pharmasalmanac.com/articles/fewer-bigger-smarter-how-pharma-ma-evolved-in-2025-and-what-comes-next 2026-02-10 19:25:30.137209+00 https://www.pharmasalmanac.com/articles/scarcity-by-design-the-manufacturing-reality-of-aav-gene-therapies-for-rare-indications 2026-02-10 10:00:16.307628+00 https://www.pharmasalmanac.com/articles/editing-risk-gene-targets-for-lifelong-cardiovascular-disease-prevention 2026-02-09 14:47:36.73955+00 https://www.pharmasalmanac.com/articles/state-of-the-industry-2026-virtual-panel-drug-product 2026-02-09 14:40:01.60509+00 https://www.pharmasalmanac.com/articles/a-look-at-insect-cell-expression-for-viral-vector-and-virus-like-particle-production 2026-02-09 14:39:26.764562+00 https://www.pharmasalmanac.com/articles/promise-vs-practice-adaptive-control-systems-in-cell-and-gene-therapy-bioreactors 2026-02-09 10:00:03.638949+00 https://www.pharmasalmanac.com/articles/state-of-the-industry-2026-virtual-panel-small-molecules 2026-02-09 10:00:03.638949+00 https://www.pharmasalmanac.com/articles/a-release-by-exception-model-for-cell-therapy-quality-decisions 2026-02-06 10:00:03.333161+00 https://www.pharmasalmanac.com/articles/experience-and-flexibility-ensure-accelerated-development-and-security-of-supply 2026-02-05 17:31:32.903762+00 https://www.pharmasalmanac.com/articles/revolutionizing-cell-culture-bioprocesses-with-real-time-glucose-measurement 2026-02-05 12:25:19.861318+00 https://www.pharmasalmanac.com/articles/innovations-in-baculovirus-insect-cell-expression-systems 2026-02-05 11:25:14.615321+00 https://www.pharmasalmanac.com/articles/precision-antiplatelet-therapy-aligning-genetics-biology-and-clinical-judgment 2026-02-05 10:00:25.746667+00 https://www.pharmasalmanac.com/articles/hybrid-by-design-automation-limits-in-cell-therapy-manufacturing 2026-02-04 10:00:25.633169+00 https://www.pharmasalmanac.com/articles/regulatory-flexibility-clarified-why-execution-not-easing-defines-the-next-phase-of-cgt-manufacturing 2026-02-03 20:38:05.670431+00 https://www.pharmasalmanac.com/articles/when-process-defines-the-product-managing-comparability-in-cell-and-gene-therapy-manufacturing 2026-02-02 10:00:25.261148+00 https://www.pharmasalmanac.com/articles/state-of-the-industry-2026-virtual-panel-advanced-therapies-pt-2 2026-02-02 10:00:25.261148+00 https://www.pharmasalmanac.com/articles/state-of-the-industry-2026-virtual-panel-advanced-therapies-pt-1 2026-02-02 10:00:25.261148+00 https://www.pharmasalmanac.com/articles/redefining-cardiovascular-disease-treatment-through-innovation-and-prevention 2026-02-02 10:00:25.261148+00 https://www.pharmasalmanac.com/articles/re-imagining-process-understanding-in-mammalian-systems 2026-01-27 17:23:44.073058+00 https://www.pharmasalmanac.com/articles/seamless-technology-transfer-accelerating-biologics-from-drug-substance-to-drug-product 2026-01-26 14:40:44.613648+00 https://www.pharmasalmanac.com/articles/state-of-the-industry-2026-virtual-panel-biologics 2026-01-26 14:35:32.79882+00 https://www.pharmasalmanac.com/articles/redrawing-the-lines-of-federal-science-the-nihs-shift-away-from-human-fetal-tissue-research 2026-01-23 21:51:19.029502+00 https://www.pharmasalmanac.com/articles/lab-thread-announces-beta-release-of-unified-lab-software-platform 2026-01-23 16:57:21.946217+00 https://www.pharmasalmanac.com/articles/transforming-effective-patient-recruitment-within-the-changing-healthcare-landscape 2026-01-22 10:00:29.738018+00 https://www.pharmasalmanac.com/articles/how-drug-delivery-choices-shape-regulatory-review-risk 2026-01-21 15:54:15.302073+00 https://www.pharmasalmanac.com/articles/when-signals-fade-what-the-acetaminophenautism-debate-teaches-about-evidence-design-and-causality 2026-01-19 22:08:29.792139+00 https://www.pharmasalmanac.com/articles/new-ferring-and-ache-laboratorios-farmaceuticos-facility-opens-to-optimise-drug-delivery-using-nanotechnology 2026-01-19 12:14:39.803026+00 https://www.pharmasalmanac.com/articles/grunenthal-group-receives-fdas-expedited-access-pathway-designation-for-vivo 2026-01-19 12:13:52.647631+00 https://www.pharmasalmanac.com/articles/centogene-announces-agreement-with-aldeyra-therapeutics-for-the-advancement-of-novel-therapeutics-for-patients-with-sjogren-larsson-syndrome 2026-01-19 12:12:30.938591+00 https://www.pharmasalmanac.com/articles/aldeyra-therapeutics-announces-first-patient-enrolled-in-sjogren-larsson-syndrome-pivotal-phase-3-clinical-trial 2026-01-19 12:12:10.43283+00 https://www.pharmasalmanac.com/articles/kyowa-kirin-announces-fda-approval-of-poteligeo-mogamulizumab-kpkc-for-the-treatment-of-mycosis-fungoides-and-sezary-syndrome 2026-01-19 12:11:39.961671+00 https://www.pharmasalmanac.com/articles/kaleo-confirms-us-availability-of-auvi-q-epinephrine-injection-usp-auto-injector-for-back-to-school-season 2026-01-19 12:10:31.886409+00 https://www.pharmasalmanac.com/articles/crb-opens-second-office-in-europe-hires-bernd-muller 2026-01-19 12:09:54.852594+00 https://www.pharmasalmanac.com/articles/grunenthal-acquires-global-rights-for-qutenza 2026-01-19 12:09:31.475073+00 https://www.pharmasalmanac.com/articles/abbvies-mavyret-glecaprevirpibrentasvir-shows-high-virologic-cure-rates-in-treatment-naive-hepatitis-c-patients-with-compensated-cirrhosis 2026-01-19 12:09:03.267006+00 https://www.pharmasalmanac.com/articles/entrinsic-health-solutions-and-nestle-health-science-enter-global-partnership-for-novel-amino-acid-product-enterade 2026-01-19 12:08:22.221423+00 https://www.pharmasalmanac.com/articles/prometic-to-initiate-pbi-4050-pivotal-phase-3-clinical-trial-in-alstrom-syndrome 2026-01-19 12:07:26.169202+00 https://www.pharmasalmanac.com/articles/biotechpharma-uab-is-changing-its-management-structure-and-appoints-giedrius-zunda-as-chief-executive-officer 2026-01-19 12:07:08.379795+00 https://www.pharmasalmanac.com/articles/nestle-enters-into-exclusive-negotiations-to-sell-nestle-skin-health-to-a-consortium-led-by-eqt-and-adia 2026-01-19 12:06:38.733105+00 https://www.pharmasalmanac.com/articles/schrodinger-announces-close-of-latest-financing-raising-a-total-of-110-million 2026-01-19 12:06:16.321769+00 https://www.pharmasalmanac.com/articles/lsne-completes-acquisition-of-sterile-injectables-manufacturing-facility-located-in-leon-spain 2026-01-19 12:05:50.750111+00 https://www.pharmasalmanac.com/articles/fda-approves-otezla-apremilast-for-the-treatment-of-oral-ulcers-associated-with-behcets-disease 2026-01-19 12:05:20.591323+00 https://www.pharmasalmanac.com/articles/alize-pharma-3-raises-67-million-75-million-in-series-a-from-an-international-syndicate 2026-01-19 12:04:48.08199+00 https://www.pharmasalmanac.com/articles/clearside-biomedical-provides-new-drug-application-update-for-xipere-triamcinolone-acetonide-suprachoroidal-injectable-suspension 2026-01-19 12:04:12.454233+00 https://www.pharmasalmanac.com/articles/mercks-ervebo-ebola-zaire-vaccine-rvsvdg-zebov-gp-live-granted-conditional-approval-in-the-european-union 2026-01-19 12:01:50.89783+00 https://www.pharmasalmanac.com/articles/schrodinger-taps-google-clouds-high-performance-compute-hpc-solution-to-bolster-its-drug-discovery-efforts 2026-01-19 12:01:16.568836+00 https://www.pharmasalmanac.com/articles/novartis-investigational-oral-therapy-iptacopan-lnp023-shows-benefit-as-monotherapy-in-treatment-naive-patients-with-rare-and-life-threatening-blood-dis-1623905300107 2026-01-19 11:57:47.485188+00 https://www.pharmasalmanac.com/articles/x4-pharmaceuticals-announces-presentation-of-positive-data-from-ongoing-phase-1b-clinical-trial-of-mavorixafor-in-waldenstroms-macroglobulinemia-at-eha-2021 2026-01-19 11:41:44.708725+00 https://www.pharmasalmanac.com/articles/dfe-pharma-harro-hofliger-and-sterling-partner-in-into-to-provide-formulation-services-for-respiratory-products 2026-01-19 11:37:17.291617+00 https://www.pharmasalmanac.com/articles/duration-is-the-new-potency-why-exposure-control-is-replacing-peak-concentration 2026-01-16 15:44:39.252293+00 https://www.pharmasalmanac.com/articles/real-time-release-testing-the-next-leap-in-pharmaceutical-manufacturing 2026-01-15 15:43:46.880662+00 https://www.pharmasalmanac.com/articles/where-capital-meets-cmc-the-emerging-role-of-cdmos-in-investor-risk-assessment 2026-01-15 15:29:18.384409+00 https://www.pharmasalmanac.com/articles/vetter-reaches-key-launch-milestones-for-the-v-ovs-next-tamper-evident-syringe-closure-system 2026-01-15 13:25:53.952822+00 https://www.pharmasalmanac.com/articles/why-autoinjectors-fail-after-phase-iii-and-why-its-not-a-device-problem 2026-01-14 14:12:14.619903+00 https://www.pharmasalmanac.com/articles/when-fewer-shots-on-goal-change-the-science-how-capital-discipline-is-reshaping-rd-strategy 2026-01-13 20:27:46.539671+00 https://www.pharmasalmanac.com/articles/when-drug-delivery-fails-at-tech-transfer 2026-01-13 16:48:03.144835+00 https://www.pharmasalmanac.com/articles/oral-biologics-and-the-anatomy-of-a-persistent-challenge 2026-01-12 19:22:18.643033+00 https://www.pharmasalmanac.com/articles/greener-on-paper-riskier-in-practice-the-reality-of-sustainable-pharma-packaging 2026-01-12 12:10:25.15085+00 https://www.pharmasalmanac.com/articles/inspection-ready-or-inspection-exposed-clinical-packaging-under-regulatory-scrutiny 2026-01-10 14:15:34.845762+00 https://www.pharmasalmanac.com/articles/blinding-reconsidered-why-trial-integrity-depends-on-more-than-a-checkbox 2026-01-10 14:13:05.703999+00 https://www.pharmasalmanac.com/articles/the-rebirth-of-antibiotic-rd-new-momentum-for-an-old-crisis 2026-01-09 15:55:54.610287+00 https://www.pharmasalmanac.com/articles/risk-sharing-rewritten-how-biopharma-partnerships-are-redesigning-incentives-beyond-the-deal 2026-01-09 13:50:26.146143+00 https://www.pharmasalmanac.com/articles/smart-packaging-and-connected-devices-hype-evidence-and-regulatory-reality 2026-01-08 21:22:34.342077+00 https://www.pharmasalmanac.com/articles/bioethics-not-just-essential-but-value-adding 2026-01-08 19:31:25.004625+00 https://www.pharmasalmanac.com/articles/structured-deals-on-the-rise-milestones-options-and-risk-sharing-in-biopharma-licensing 2026-01-08 14:33:29.361625+00 https://www.pharmasalmanac.com/articles/amgen-to-present-at-the-44th-annual-jp-morgan-healthcare-conference 2026-01-07 22:36:50.974362+00 https://www.pharmasalmanac.com/articles/looking-back-over-the-last-30-years-what-advance-has-had-the-greatest-impact-on-the-industry-and-why 2026-01-07 17:14:25.672115+00 https://www.pharmasalmanac.com/articles/sano-womens-health-reports-positive-nonclinical-efd-safety-results-for-rvvc-drug-product 2026-01-07 15:19:55.692377+00 https://www.pharmasalmanac.com/articles/from-afterthought-to-attribute-how-containerclosure-integrity-is-engineered-measured-and-maintained 2026-01-06 21:49:02.154161+00 https://www.pharmasalmanac.com/articles/the-economics-of-big-science-and-why-it-matters-for-drug-development 2026-01-06 21:16:58.839512+00 https://www.pharmasalmanac.com/articles/ernexa-therapeutics-announces-successful-pre-ind-fda-meeting-and-continues-progress-toward-first-in-human-trial-in-ovarian-cancer 2026-01-06 20:09:55.548747+00 https://www.pharmasalmanac.com/articles/selective-capital-stronger-science-the-emerging-biotech-funding-model 2026-01-06 17:32:32.70655+00 https://www.pharmasalmanac.com/articles/packaging-as-a-quality-attribute-why-containerclosure-systems-are-no-longer-an-afterthought 2026-01-06 14:33:42.366157+00 https://www.pharmasalmanac.com/articles/minimizing-non-enrolling-clinical-trial-sites 2026-01-06 10:00:12.296573+00 https://www.pharmasalmanac.com/articles/how-are-capital-constraints-impacting-ma-and-strategic-partnerships-in-the-cdmo-and-pharma-sectors 2026-01-05 18:11:13.054644+00 https://www.pharmasalmanac.com/articles/accelerating-clinical-trials-with-local-and-global-support 2025-12-18 10:00:03.366453+00 https://www.pharmasalmanac.com/articles/smarter-polymerases-cleaner-transcripts-better-rna 2025-12-15 18:42:10.540972+00 https://www.pharmasalmanac.com/articles/using-real-world-data-to-close-treatment-gaps-in-alzheimers-disease-and-related-dementias 2025-12-11 19:43:04.989132+00 https://www.pharmasalmanac.com/articles/bridging-the-gap-advancing-access-to-new-medications-for-older-adults-in-long-term-care 2025-12-11 19:23:09.433577+00 https://www.pharmasalmanac.com/articles/in-vivo-car-t-arrives-early-signals-from-a-new-generation-of-cell-therapies 2025-12-10 21:16:20.625502+00 https://www.pharmasalmanac.com/articles/digital-and-in-silico-transformation-in-biologics-formulation 2025-12-09 14:45:57.026064+00 https://www.pharmasalmanac.com/articles/guardrails-for-vaccine-innovation-are-under-threat 2025-12-08 15:55:55.356492+00 https://www.pharmasalmanac.com/articles/cdc-rewrites-its-vaccineautism-guidance-contradicting-decades-of-science 2025-12-08 15:55:45.841868+00 https://www.pharmasalmanac.com/articles/how-are-glp-1-therapies-reshaping-the-pharmaceutical-market-and-whats-next 2025-12-04 20:52:54.676579+00 https://www.pharmasalmanac.com/articles/roundtable-why-the-future-of-pharma-is-continuous 2025-12-02 12:57:29.729954+00 https://www.pharmasalmanac.com/articles/delivering-cdmo-excellence-quality-and-value-through-dedication 2025-12-02 11:32:53.558423+00 https://www.pharmasalmanac.com/articles/meeting-patient-site-and-sponsor-needs-with-home-trial-services 2025-12-02 10:00:13.425232+00 https://www.pharmasalmanac.com/articles/what-is-driving-renewed-interest-in-small-molecule-therapeutics-and-how-is-it-shaping-investment 2025-12-01 21:01:41.52318+00 https://www.pharmasalmanac.com/articles/vector-biomed-expands-lentiverse-platform-and-unveils-new-brand-identity 2025-12-01 19:50:01.437235+00 https://www.pharmasalmanac.com/articles/building-better-pharmaceutical-facilities-a-coatings-playbook-for-general-contractors 2025-12-01 17:27:05.351074+00 https://www.pharmasalmanac.com/articles/circular-genomics-announces-closure-of-15-million-series-a-financing-to-advance-first-in-class-circular-rna-platform 2025-12-01 14:13:45.668665+00 https://www.pharmasalmanac.com/articles/microsize-and-schedio-group-to-acquire-lonzas-micro-macinazione-site-in-switzerland 2025-11-24 17:44:22.367821+00 https://www.pharmasalmanac.com/articles/the-unraveling-how-mass-deportation-policies-may-trigger-a-nationwide-healthcare-crisis 2025-11-24 14:01:26.240111+00 https://www.pharmasalmanac.com/articles/the-hidden-cost-of-clinical-delays 2025-11-24 12:39:33.057888+00 https://www.pharmasalmanac.com/articles/integrated-capabilities-enable-faster-development-of-effective-crispr-therapies 2025-11-21 13:22:55.568653+00 https://www.pharmasalmanac.com/articles/a-universal-strategy-for-rare-diseases-researchers-unveil-a-mutation-agnostic-editor 2025-11-19 18:04:09.471611+00 https://www.pharmasalmanac.com/articles/the-rise-of-truly-virtual-pharma-generative-ai-ecosystems-for-end-to-end-drug-design 2025-11-19 17:06:24.463616+00 https://www.pharmasalmanac.com/articles/europes-pharma-overhaul-how-the-new-incentive-model-will-reshape-global-innovation-strategy 2025-11-19 17:05:08.362862+00 https://www.pharmasalmanac.com/articles/rising-biotech-innovation-outside-the-us-china-leading-the-surge 2025-11-17 18:26:39.641048+00 https://www.pharmasalmanac.com/articles/expanding-lnp-applications-beyond-mrna-vaccines 2025-11-17 10:00:18.603063+00 https://www.pharmasalmanac.com/articles/biosimilars-at-a-crossroads-will-the-fdas-new-framework-deliver-competition 2025-11-14 14:48:43.548843+00 https://www.pharmasalmanac.com/articles/efficiency-by-design-meeting-the-evolving-challenges-of-a-maturing-global-biologics-market 2025-11-13 15:24:47.050008+00 https://www.pharmasalmanac.com/articles/growing-importance-of-mass-spectrometry-from-drug-discovery-through-commercialization-and-life-cycle-management 2025-11-12 14:39:46.650943+00 https://www.pharmasalmanac.com/articles/what-economic-or-market-trends-are-having-the-biggest-impact-on-cdmo-capacity-and-pipelines-in-2025-and-what-will-2026-bring 2025-11-12 14:38:35.663812+00 https://www.pharmasalmanac.com/articles/what-do-you-consider-to-be-the-most-important-new-tools-or-technology-platforms-currently-being-developed 2025-11-12 14:38:04.32665+00 https://www.pharmasalmanac.com/articles/what-do-you-see-as-the-biggest-threat-to-the-cdmo-industry-in-2026-or-beyond 2025-11-12 14:37:45.447714+00 https://www.pharmasalmanac.com/articles/inovio-announces-pricing-of-25-million-public-offering 2025-11-11 21:22:20.936071+00 https://www.pharmasalmanac.com/articles/technologies-enabling-personalized-and-patient-specific-oral-solid-dosage-drugs 2025-11-11 15:55:21.272398+00 https://www.pharmasalmanac.com/articles/mrna-therapeutics-are-just-getting-started-charting-a-post-pandemic-path-forward 2025-11-10 10:00:02.211422+00 https://www.pharmasalmanac.com/articles/right-sized-cro-support-for-right-sized-sponsors 2025-11-06 10:00:41.471749+00 https://www.pharmasalmanac.com/articles/touchlight-expands-mbdna-portfolio-with-new-circular-dna-architectures-for-advanced-therapies 2025-11-05 19:43:39.309274+00 https://www.pharmasalmanac.com/articles/amyris-launches-new-brand-and-website-to-align-with-strategic-growth-pillars 2025-11-04 19:20:39.579075+00 https://www.pharmasalmanac.com/articles/pioneering-biocompatible-lubricants-for-next-generation-medical-devices 2025-11-04 17:51:34.853584+00 https://www.pharmasalmanac.com/articles/beyond-borders-a-disciplined-approach-to-successful-global-expansion 2025-11-04 15:24:54.342785+00 https://www.pharmasalmanac.com/articles/the-pragmatic-playbook-for-ai-in-biologics-rd 2025-11-03 22:33:58.73416+00 https://www.pharmasalmanac.com/articles/carsgen-announces-positive-clinical-data-for-allogeneic-car-t-products-ct0596-and-ct1190b 2025-11-03 20:07:21.311571+00 https://www.pharmasalmanac.com/articles/neurosense-to-host-investor-webinar-on-december-8-2025 2025-11-03 19:57:29.482836+00 https://www.pharmasalmanac.com/articles/circular-biomanufacturing-closing-the-loop-in-pharma-and-biopharma-production 2025-11-03 16:50:27.512576+00 https://www.pharmasalmanac.com/articles/raising-the-bar-in-analytical-excellence-samsung-biologics-approach-to-assay-performance-monitoring 2025-10-28 19:04:55.238115+00 https://www.pharmasalmanac.com/articles/biocina-announces-appointment-of-dr-thomas-broudy-as-chief-executive-officer 2025-10-28 18:05:06.772166+00 https://www.pharmasalmanac.com/articles/ajinomoto-bio-pharma-services-and-olon-spa-form-strategic-partnership-to-advance-large-scale-peptide-and-protein-manufacturing 2025-10-28 17:56:40.841833+00 https://www.pharmasalmanac.com/articles/building-the-right-team-and-resource-model-to-support-quality-system-and-validation-activities 2025-10-27 14:05:53.092297+00 https://www.pharmasalmanac.com/articles/seran-bioscience-expands-commercial-manufacturing-with-new-100000-sq-ft-campus-in-bend-oregon 2025-10-23 19:21:24.367497+00 https://www.pharmasalmanac.com/articles/biocatalysis-comes-of-age-redefining-small-molecule-api-synthesis 2025-10-23 13:35:52.937527+00 https://www.pharmasalmanac.com/articles/overcoming-challenges-to-continuous-processing-with-solids 2025-10-22 17:46:52.114478+00 https://www.pharmasalmanac.com/articles/codis-appoints-steven-facer-as-senior-vp-sales-and-marketing-to-support-the-haverhill-uk-facility 2025-10-20 20:24:47.626003+00 https://www.pharmasalmanac.com/articles/pharmacogenomics-converting-potential-into-benefits-for-patients-and-drug-developers 2025-10-20 19:50:04.967739+00 https://www.pharmasalmanac.com/articles/foundational-models-in-biological-design-part-3-translational-and-regulatory-outlook 2025-10-20 14:13:45.044503+00 https://www.pharmasalmanac.com/articles/foundational-models-in-biological-design-part-2-designing-for-manufacturability 2025-10-20 14:13:36.951018+00 https://www.pharmasalmanac.com/articles/foundational-models-in-biological-design-part-1-multimodal-and-controllable 2025-10-20 14:13:00.234654+00 https://www.pharmasalmanac.com/articles/abbvie-completes-acquisition-of-gilgamesh-pharmaceuticals-bretisilocin 2025-10-17 13:42:39.625848+00 https://www.pharmasalmanac.com/articles/codis-raises-growth-capital-to-expand-commercial-manufacturing-welcomes-1315-capital 2025-10-17 13:36:39.540395+00 https://www.pharmasalmanac.com/articles/eclinical-solutions-and-zs-announce-strategic-partnership-to-deliver-a-new-industry-standard-for-rbqm 2025-10-17 13:32:08.217181+00 https://www.pharmasalmanac.com/articles/how-organoids-are-continuing-to-transform-the-path-from-bench-to-bedside 2025-10-16 21:32:05.783123+00 https://www.pharmasalmanac.com/articles/what-are-the-keys-to-making-rare-disease-drug-development-sustainable 2025-10-16 15:36:34.525187+00 https://www.pharmasalmanac.com/articles/enabling-the-reshoring-of-pharma-manufacturing-with-integrated-continuous-manufacturing 2025-10-15 16:31:01.255728+00 https://www.pharmasalmanac.com/articles/bio-x-cell-unveils-new-brand-identity-reinforcing-global-leadership-in-functional-antibody-solutions 2025-10-14 15:31:18.015089+00 https://www.pharmasalmanac.com/articles/codis-launches-as-global-cdmo-for-commercial-spray-drying-and-amorphous-solid-dispersions 2025-10-14 15:27:02.583672+00 https://www.pharmasalmanac.com/articles/rovi-cdmo-business-unit-rebrands-as-rois-and-expands-with-new-phoenix-arizona-injectable-manufacturing-facility 2025-10-14 14:23:26.051021+00 https://www.pharmasalmanac.com/articles/bridging-boundaries-in-the-glp-1-era-pharma-nutra-and-food-solutions 2025-10-14 12:34:39.88617+00 https://www.pharmasalmanac.com/articles/samsung-biologics-introduces-optimized-manufacturing-framework-exellens 2025-10-10 15:16:49.518581+00 https://www.pharmasalmanac.com/articles/the-next-diagnostic-revolution-faster-smarter-more-personalized-care 2025-10-09 14:08:17.223759+00 https://www.pharmasalmanac.com/articles/peacekeepers-of-immunity-the-nobel-winning-discovery-that-redefined-immunity 2025-10-07 17:30:15.983848+00 https://www.pharmasalmanac.com/articles/kincell-bio-announces-collaboration-to-advance-moonlight-bios-lead-cell-therapy-candidate-to-clinical-study 2025-10-07 13:16:04.922217+00 https://www.pharmasalmanac.com/articles/kincell-bio-announces-strategic-collaboration-with-major-academic-medical-center-to-advance-cell-and-gene-therapy-innovation 2025-10-07 13:13:41.705102+00 https://www.pharmasalmanac.com/articles/fda-lifts-clinical-hold-on-nuz-001 2025-10-06 16:54:19.116034+00 https://www.pharmasalmanac.com/articles/matica-biotechnology-emerges-as-the-go-to-cdmo-for-cell-gene-therapy-in-2025 2025-10-06 16:48:01.737369+00 https://www.pharmasalmanac.com/articles/europe-signs-a-joint-procurement-contract-with-hipra-for-covid-19-lp81-vaccine 2025-10-06 14:09:25.103497+00 https://www.pharmasalmanac.com/articles/the-2025-measles-crisis-and-the-fight-for-public-health-trust 2025-10-03 17:56:26.088857+00 https://www.pharmasalmanac.com/articles/rigel-pharmaceuticals-inc-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 2025-10-03 13:34:22.450719+00 https://www.pharmasalmanac.com/articles/inovio-reports-inducement-grant-under-inducement-plan 2025-10-03 13:31:19.435601+00 https://www.pharmasalmanac.com/articles/advantages-of-integrated-continuous-manufacturing-throughout-the-drug-life-cycle 2025-10-02 20:42:36.021716+00 https://www.pharmasalmanac.com/articles/rezon-bio-launches-as-a-european-biologics-cdmo-combining-cost-efficiency-and-digital-innovation 2025-10-01 15:09:54.022813+00 https://www.pharmasalmanac.com/articles/made-scientific-and-syenex-forge-technology-partnership-to-transform-t-cell-therapy-manufacturing 2025-10-01 15:08:33.13625+00 https://www.pharmasalmanac.com/articles/pointclickcare-secures-triple-win-at-the-mcknights-excellence-in-technology-awards 2025-10-01 15:08:22.55786+00 https://www.pharmasalmanac.com/articles/arzeda-to-lead-major-nsf-funded-initiative-advancing-electricity-driven-cell-free-biomanufacturing-through-ai-designed-enzymes 2025-09-30 14:26:27.540106+00 https://www.pharmasalmanac.com/articles/us-fda-approves-tremfya-uselkumab-for-the-treatment-of-pediatric-plaque-psoriasis-and-active-psoriatic-arthritis 2025-09-29 18:19:10.840715+00 https://www.pharmasalmanac.com/articles/amgen-announces-650m-expansion-of-us-manufacturing-creating-hundreds-of-new-jobs 2025-09-29 18:11:55.364373+00 https://www.pharmasalmanac.com/articles/how-are-companies-meaningfully-incorporating-patient-voices-into-drug-development-decisions 2025-09-29 16:19:35.126089+00 https://www.pharmasalmanac.com/articles/navigating-duty-to-warn-challenges-in-biotech-clinical-trials 2025-09-25 13:31:13.786198+00 https://www.pharmasalmanac.com/articles/hipra-receives-european-commission-approval-for-the-commercialization-of-its-covid-19-vaccine-adapted-to-the-lp81-variant 2025-09-25 12:42:21.003085+00 https://www.pharmasalmanac.com/articles/tegmine-therapeutics-enters-collaboration-with-boehringer-ingelheim-to-advance-novel-2-factor-antibody-system-for-cancer 2025-09-23 18:51:53.148914+00 https://www.pharmasalmanac.com/articles/silence-at-the-fda-biotechs-report-delays-denied-meeting-requests-amid-staff-cuts 2025-09-23 18:39:55.272638+00 https://www.pharmasalmanac.com/articles/optimizing-charge-and-n-glycan-profiles-for-cho-derived-fusion-proteins 2025-09-23 14:36:08.962374+00 https://www.pharmasalmanac.com/articles/improved-efficacy-and-safety-driving-resurging-interest-in-adcs 2025-09-22 19:03:01.033726+00 https://www.pharmasalmanac.com/articles/mavrix-bio-receives-fda-fast-track-designation-for-mvx-220-for-treatment-of-angelman-syndrome 2025-09-22 19:00:40.791391+00 https://www.pharmasalmanac.com/articles/cleveland-clinic-to-present-final-phase-1-results-for-anixa-biosciences-breast-cancer-vaccine-at-2025-san-antonio-symposium 2025-09-22 18:52:04.658181+00 https://www.pharmasalmanac.com/articles/european-commission-approves-serviers-voranigo-as-the-first-targeted-therapy-for-grade-2-idh-mutant-glioma-in-the-eu 2025-09-22 18:51:56.53111+00 https://www.pharmasalmanac.com/articles/ecolab-strengthens-pharmaceutical-operations-through-smarter-cleaning-strategies 2025-09-22 17:49:39.28172+00 https://www.pharmasalmanac.com/articles/project-insulin-rebuilding-insulin-access-for-patients-not-profit 2025-09-16 19:20:31.534913+00 https://www.pharmasalmanac.com/articles/adaptive-biomaterials-and-the-future-of-therapeutic-production 2025-09-15 17:03:21.73106+00 https://www.pharmasalmanac.com/articles/integrated-mrnalnp-manufacturing-as-a-platform-for-innovation 2025-09-15 12:50:21.041426+00 https://www.pharmasalmanac.com/articles/ovarian-cancer-at-an-inflection-point-quantifying-the-burden-closing-gaps-and-accelerating-next-generation-therapies 2025-09-11 17:15:33.665762+00 https://www.pharmasalmanac.com/articles/what-role-is-precision-medicine-playing-in-transforming-cancer-treatment-and-how-are-developers-adapting 2025-09-08 12:57:55.30617+00 https://www.pharmasalmanac.com/articles/building-a-better-cell-therapy-cdmo 2025-09-05 17:44:39.780105+00 https://www.pharmasalmanac.com/articles/hipra-biotech-services-end-to-end-biologics-offering 2025-09-03 14:01:39.568578+00 https://www.pharmasalmanac.com/articles/curida-launches-unified-brand-and-website-on-its-10th-anniversary-signaling-a-new-era-for-the-european-cdmo 2025-09-03 12:40:40.717593+00 https://www.pharmasalmanac.com/articles/what-are-the-biggest-roadblocks-still-standing-in-the-way-of-cell-and-gene-therapy-commercialization 2025-09-02 14:20:09.651421+00 https://www.pharmasalmanac.com/articles/transformative-advances-in-viral-vector-manufacturing-unlocking-commercial-scalability-consistency-and-cost-effectiveness 2025-09-02 13:51:28.706929+00 https://www.pharmasalmanac.com/articles/australia-life-sciences-new-frontier 2025-08-28 16:20:44.667504+00 https://www.pharmasalmanac.com/articles/expanding-sterile-fill-finish-for-the-next-era-of-biologics 2025-08-27 19:44:54.757446+00 https://www.pharmasalmanac.com/articles/understanding-sponsor-expectations-navigating-market-dynamics-from-a-site-perspective 2025-08-26 19:04:00.096068+00 https://www.pharmasalmanac.com/articles/integrated-to-accelerate-seamless-end-to-end-biomanufacturing 2025-08-26 19:03:50.943085+00 https://www.pharmasalmanac.com/articles/the-fdas-expert-panels-shortcut-or-subversion-of-science 2025-08-26 18:25:30.478927+00 https://www.pharmasalmanac.com/articles/next-gen-biopharma-the-startups-leading-the-charge 2025-08-26 18:24:59.419954+00 https://www.pharmasalmanac.com/articles/advancing-drug-product-quality-through-automated-visual-inspection-and-future-ready-infrastructure 2025-08-26 14:12:53.960003+00 https://www.pharmasalmanac.com/articles/why-fill-finish-strategy-can-make-or-break-your-drug-program 2025-08-25 01:06:03.766599+00 https://www.pharmasalmanac.com/articles/how-kincell-bio-is-supporting-tomorrows-cell-therapy-innovators 2025-08-22 17:22:20.912258+00 https://www.pharmasalmanac.com/articles/organoids-adcs-and-more-on-the-horizon-at-samsung-biologics 2025-08-22 17:12:13.808211+00 https://www.pharmasalmanac.com/articles/co-founders-of-biotech-avidicure-talk-new-antibody-modality-starting-from-scratch-and-50m-launch 2025-08-22 17:09:06.494801+00 https://www.pharmasalmanac.com/articles/exploring-australias-burgeoning-life-sciences-market-with-biocina 2025-08-22 16:35:01.124181+00 https://www.pharmasalmanac.com/articles/body-image-glp-1s-and-pharmas-role 2025-08-21 21:15:59.413106+00 https://www.pharmasalmanac.com/articles/flexible-fillfinish-solutions-to-bridge-the-clinical-to-commercial-gap 2025-08-21 12:58:54.651296+00 https://www.pharmasalmanac.com/articles/reunion-neuroscience-announces-positive-topline-results-from-reconnect-phase-2-clinical-trial-of-re104-for-postpartum-depression 2025-08-19 20:16:52.778344+00 https://www.pharmasalmanac.com/articles/the-therapeutic-winter-and-why-urgent-innovation-in-pediatric-oncology-is-being-left-behind 2025-08-18 19:10:28.184702+00 https://www.pharmasalmanac.com/articles/the-strategic-case-for-investing-in-pediatric-oncology-beyond-altruism 2025-08-18 19:10:19.021538+00 https://www.pharmasalmanac.com/articles/the-mental-health-gender-gap-why-women-bear-the-burden 2025-08-18 19:09:59.210134+00 https://www.pharmasalmanac.com/articles/build-backwards-a-framework-for-rare-disease-gene-therapy-development 2025-08-14 13:42:41.105935+00 https://www.pharmasalmanac.com/articles/cdmo-advisor-is-connecting-innovators-with-manufacturers 2025-08-12 20:39:07.110932+00 https://www.pharmasalmanac.com/articles/decoding-the-gender-imbalance-how-sex-hormones-and-immunity-collide-in-autoimmune-disease 2025-08-12 20:11:48.84446+00 https://www.pharmasalmanac.com/articles/3p-innovations-unique-automation-solutions 2025-08-11 20:19:02.257443+00 https://www.pharmasalmanac.com/articles/10-womens-health-biotechs-to-watch-beyond-the-biology-toward-equity 2025-08-11 20:05:16.335074+00 https://www.pharmasalmanac.com/articles/sever-pharma-solutions-expands-partnership-with-silo-pharma-on-novel-ketamine-based-implant-for-chronic-pain-and-fibromyalgia 2025-08-11 19:22:18.909077+00 https://www.pharmasalmanac.com/articles/probio-launches-gmp-aav-manufacturing-services-at-hopewell-facility-to-advance-gene-therapy-development-and-manufacturing 2025-08-11 19:16:50.057188+00 https://www.pharmasalmanac.com/articles/innovation-worth-watching-how-ignota-labs-leverages-ai-to-rescue-promising-but-failing-drugs 2025-08-11 16:25:27.72254+00 https://www.pharmasalmanac.com/articles/in-vivo-car-t-technology-poised-to-expand-access-and-indications 2025-08-11 16:25:11.523082+00 https://www.pharmasalmanac.com/articles/bridging-the-gap-in-pediatric-cancer-accessa-call-to-investors-and-pharma-leaders 2025-08-08 21:28:29.898227+00 https://www.pharmasalmanac.com/articles/ideology-over-evidence-rfk-jr-just-set-vaccine-science-back-a-decade 2025-08-06 17:20:06.133928+00 https://www.pharmasalmanac.com/articles/novel-integration-of-process-analytical-technologies-for-continuous-biomanufacturing 2025-08-06 16:51:15.199773+00 https://www.pharmasalmanac.com/articles/pain-misdiagnosis-and-autoimmune-disease-untangling-complexity-and-bias 2025-08-06 11:41:11.262014+00 https://www.pharmasalmanac.com/articles/gene-therapy-at-a-crossroads-what-the-sarepta-crisis-reveals-and-what-comes-next 2025-08-05 14:54:53.072768+00 https://www.pharmasalmanac.com/articles/from-preclinical-to-commercialization-a-crdo-approach-to-accelerating-biologic-development 2025-08-04 13:27:47.311203+00 https://www.pharmasalmanac.com/articles/formulation-and-analytics-platforms-transforming-drug-product-development 2025-07-31 17:43:51.624904+00 https://www.pharmasalmanac.com/articles/glycocaging-a-smart-chemistry-platform-for-safer-smarter-ibd-treatments 2025-07-31 17:43:37.76152+00 https://www.pharmasalmanac.com/articles/built-for-speed-and-scale-how-cdmo-cell-line-platforms-are-reshaping-biologic-development 2025-07-31 17:43:25.746061+00 https://www.pharmasalmanac.com/articles/exosomes-a-promising-natural-nanoparticle-delivery-system 2025-07-31 17:43:15.170599+00 https://www.pharmasalmanac.com/articles/why-nih-grant-review-efficiency-may-endanger-public-health-research 2025-07-31 17:21:03.950343+00 https://www.pharmasalmanac.com/articles/backbone-of-innovation-how-cdmo-vector-platforms-are-accelerating-gene-therapy-development 2025-07-31 17:20:40.925123+00 https://www.pharmasalmanac.com/articles/enabling-growth-in-the-next-generation-of-biomanufacturing-regional-hubs 2025-07-31 17:20:19.01119+00 https://www.pharmasalmanac.com/articles/unlocking-oral-rna-therapeutics-overcoming-barriers-to-gut-stable-delivery 2025-07-31 17:19:48.888861+00 https://www.pharmasalmanac.com/articles/leveraging-the-therapeutic-potential-of-single-stranded-dna 2025-07-31 17:19:35.230405+00 https://www.pharmasalmanac.com/articles/innovation-worth-watching-trilobio-and-the-automation-of-experimental-discovery 2025-07-31 17:19:22.494968+00 https://www.pharmasalmanac.com/articles/what-progress-has-the-industry-made-in-advancing-women-in-leadership-rd-and-clinical-roles 2025-07-31 15:35:00.128672+00 https://www.pharmasalmanac.com/articles/de-risking-cell-and-gene-therapies-with-innovative-solutions-a-review-for-leveraging-a-proven-workhorse-technology-in-new-ways 2025-07-31 11:56:23.698354+00 https://www.pharmasalmanac.com/articles/simtra-biopharma-solutions-announces-strategic-purchase-to-expand-us-manufacturing-capacity-for-injectable-medicines 2025-07-25 20:20:26.22563+00 https://www.pharmasalmanac.com/articles/why-remarketing-belongs-in-every-cdmos-marketing-plan 2025-07-24 17:52:13.855824+00 https://www.pharmasalmanac.com/articles/pharma-and-biopharma-outsourcing-association-on-advocating-for-cdmos 2025-07-24 15:26:20.656046+00 https://www.pharmasalmanac.com/articles/datahow-is-advancing-bioprocess-development-with-ai-driven-solutions 2025-07-24 15:23:03.925192+00 https://www.pharmasalmanac.com/articles/eldon-james-corporation-on-advancing-single-use-solutions-for-life-sciences-and-healthcare 2025-07-24 15:19:38.900975+00 https://www.pharmasalmanac.com/articles/leriglitazone-marketing-authorization-application-submitted-for-treatment-of-cerebral-adrenoleukodystrophy-has-been-validated 2025-07-23 14:13:36.393642+00 https://www.pharmasalmanac.com/articles/bridging-innovation-and-manufacturing-for-conventional-and-complex-injectables 2025-07-22 18:34:28.452689+00 https://www.pharmasalmanac.com/articles/bringing-conventional-and-complex-injectable-products-to-market-with-greater-efficiency 2025-07-22 18:15:33.8939+00 https://www.pharmasalmanac.com/articles/from-paper-to-performance-a-journey-toward-smart-manufacturing-and-quality-excellence 2025-07-22 14:41:49.257597+00 https://www.pharmasalmanac.com/articles/strengthening-solid-dose-manufacturing-through-equipment-and-training-support 2025-07-21 16:42:07.436154+00 https://www.pharmasalmanac.com/articles/ampersand-capital-partners-invests-in-curtec-a-global-leader-in-pharma-specialty-chemicals-bulk-packaging 2025-07-21 13:58:36.151195+00 https://www.pharmasalmanac.com/articles/why-clinical-trial-platforms-must-evolve-from-tools-to-strategy 2025-07-18 15:32:06.705509+00 https://www.pharmasalmanac.com/articles/compressing-analytical-timelines-without-cutting-corners 2025-07-16 21:48:00.2477+00 https://www.pharmasalmanac.com/articles/building-clinical-supply-agility-in-a-changing-trial-landscape 2025-07-16 21:45:04.137139+00 https://www.pharmasalmanac.com/articles/advancing-biologics-development-with-next-generation-cell-line-development 2025-07-15 13:45:56.051623+00 https://www.pharmasalmanac.com/articles/australia-as-a-strategic-gateway-the-economic-and-regulatory-advantages-of-clinical-manufacturing-down-under 2025-07-14 20:57:03.037642+00 https://www.pharmasalmanac.com/articles/how-kymanox-is-guiding-life-science-innovation-from-lab-to-launch 2025-07-10 17:28:10.95058+00 https://www.pharmasalmanac.com/articles/from-prefilled-syringes-to-on-body-devices-how-optimized-biologics-formulations-improve-patient-adherence 2025-07-08 17:03:03.023637+00 https://www.pharmasalmanac.com/articles/breaking-through-the-noise-in-viral-vector-cdmo-marketing 2025-07-07 23:44:15.130291+00 https://www.pharmasalmanac.com/articles/apprenticeio-is-driving-the-future-of-pharma-manufacturing-with-embedded-ai 2025-07-07 22:06:11.066112+00 https://www.pharmasalmanac.com/articles/future-proofing-a-volatile-supply-chain-through-modular-biomanufacturing 2025-07-07 15:38:04.581076+00 https://www.pharmasalmanac.com/articles/single-use-support-on-protecting-high-value-drug-substances 2025-07-07 15:37:04.200808+00 https://www.pharmasalmanac.com/articles/tcp-analytical-backed-by-riverarch-audax-hillman-lacy-diversified-and-ppm-america-acquires-alconox-llc 2025-07-03 17:32:29.428429+00 https://www.pharmasalmanac.com/articles/alconox-delivers-eco-friendly-cleaning-for-pharma-and-biotech 2025-07-02 21:05:22.864951+00 https://www.pharmasalmanac.com/articles/how-diant-pharma-is-transforming-nanoparticle-manufacturing 2025-07-02 20:09:10.973185+00 https://www.pharmasalmanac.com/articles/what-are-the-most-significant-manufacturing-hurdles-in-biopharma-and-how-can-they-be-addressed 2025-07-02 16:52:43.157269+00 https://www.pharmasalmanac.com/articles/extending-the-reach-the-next-generation-of-long-acting-injectable-depots-for-biologics 2025-07-02 13:51:33.417341+00 https://www.pharmasalmanac.com/articles/unlocking-agility-and-efficiency-in-biomanufacturing-the-standardized-modular-kojox-platform 2025-07-02 12:50:04.281296+00 https://www.pharmasalmanac.com/articles/sever-pharma-solutions-announces-commercialization-of-new-aseptic-fill-and-finish-line-for-prefilled-syringes-in-malmo-sweden 2025-06-30 18:57:31.910898+00 https://www.pharmasalmanac.com/articles/the-importance-of-a-robust-formulation-for-long-term-drug-development-success 2025-06-30 18:45:30.056748+00 https://www.pharmasalmanac.com/articles/how-is-the-shift-toward-digital-health-solutions-transforming-the-pharmaceutical-industry-and-what-challenges-remain 2025-06-30 18:32:23.840294+00 https://www.pharmasalmanac.com/articles/probio-opens-flagship-us-plasmid-viral-vector-manufacturing-facility-to-advance-cell-and-gene-therapy 2025-06-30 14:02:35.303334+00 https://www.pharmasalmanac.com/articles/all-that-glitters-is-not-gold-standard-science 2025-06-27 17:48:27.404992+00 https://www.pharmasalmanac.com/articles/labviva-automates-chemical-supply-chain-for-the-life-sciences-industry 2025-06-26 21:23:03.281072+00 https://www.pharmasalmanac.com/articles/so-you-want-leads-eh 2025-06-26 17:41:16.818812+00 https://www.pharmasalmanac.com/articles/new-government-genetic-screening-plan-welcome-but-leaves-unanswered-questions-says-leading-biotech 2025-06-26 16:45:36.488448+00 https://www.pharmasalmanac.com/articles/human-digital-twins-in-biopharma-the-future-is-already-here 2025-06-26 15:59:00.637596+00 https://www.pharmasalmanac.com/articles/how-is-the-pharmaceutical-industry-addressing-global-health-inequities 2025-06-25 18:12:57.016387+00 https://www.pharmasalmanac.com/articles/building-guardrails-not-just-pills-rethinking-pain-management-without-abuse 2025-06-24 18:35:22.058937+00 https://www.pharmasalmanac.com/articles/enhanced-genomics-and-the-alborada-drug-discovery-institute-partner-to-accelerate-alzheimers-drug-discovery 2025-06-24 14:15:07.390758+00 https://www.pharmasalmanac.com/articles/what-are-the-key-ethical-and-regulatory-considerations-as-gene-editing-technologies-advance-toward-widespread-clinical-use 2025-06-23 21:09:13.11649+00 https://www.pharmasalmanac.com/articles/engineered-bacteria-as-precision-therapeutics-for-cancer-and-beyond 2025-06-23 18:36:25.919135+00 https://www.pharmasalmanac.com/articles/rethinking-inhalation-drug-development 2025-06-23 14:05:19.531162+00 https://www.pharmasalmanac.com/articles/brenus-pharma-and-insphero-have-developed-3d-tumor-spheroids-mimicking-in-vivo-human-colorectal-cancer-conditions 2025-06-23 13:55:56.823025+00 https://www.pharmasalmanac.com/articles/qureights-synthetic-study-arms-validate-clinical-efficacy-in-pioneering-rare-lung-disease-treatment 2025-06-17 18:41:43.979839+00 https://www.pharmasalmanac.com/articles/engineering-from-within-via-in-situ-programming-and-regeneration 2025-06-17 18:31:02.871665+00 https://www.pharmasalmanac.com/articles/bio-rad-extends-anti-idiotypic-antibody-and-spycatcher-reagent-ranges-for-bioanalysis-and-antibody-drug-development-inbox 2025-06-17 18:24:32.524338+00 https://www.pharmasalmanac.com/articles/delfin-enhances-pharmaceutical-manufacturing-with-advanced-containment-and-conveying-systems 2025-06-17 16:26:34.603421+00 https://www.pharmasalmanac.com/articles/kent-elastomer-advances-tubing-solutions-for-next-generation-drug-manufacturing 2025-06-17 16:24:42.958915+00 https://www.pharmasalmanac.com/articles/sphere-bio-expands-operations-in-china 2025-06-17 15:10:43.659193+00 https://www.pharmasalmanac.com/articles/verder-scientifics-multi-brand-approach-to-pharmaceutical-innovation 2025-06-16 18:51:20.234414+00 https://www.pharmasalmanac.com/articles/packaging-precision-multivac-usas-approach-to-safe-scalable-pharma-solutions 2025-06-16 18:50:38.402938+00 https://www.pharmasalmanac.com/articles/stonhards-flooring-solutions-built-for-pharma-precision 2025-06-16 18:49:05.415745+00 https://www.pharmasalmanac.com/articles/how-piab-is-automating-the-future-of-pharma-manufacturing 2025-06-16 18:47:34.782278+00 https://www.pharmasalmanac.com/articles/empowering-lgbtq-voices-in-life-sciences-a-conversation-with-outbio-greater-new-york 2025-06-16 18:46:36.387707+00 https://www.pharmasalmanac.com/articles/pioneering-heat-transfer-solutions-with-exergy 2025-06-16 18:45:11.665735+00 https://www.pharmasalmanac.com/articles/addressing-drug-delivery-challenges-at-the-nanoscale 2025-06-16 16:58:18.659288+00 https://www.pharmasalmanac.com/articles/what-biotech-and-pharma-buyers-actually-care-about-and-how-to-market-accordingly 2025-06-16 14:06:54.338447+00 https://www.pharmasalmanac.com/articles/elvis-has-entered-orbit-pioneering-imaging-system-to-enhance-space-biology-and-life-detection-beyond-earth 2025-06-13 19:31:29.353476+00 https://www.pharmasalmanac.com/articles/five-biotechs-approaching-critical-milestones-in-2025 2025-06-13 17:28:13.272978+00 https://www.pharmasalmanac.com/articles/staying-the-course-sustaining-equity-in-clinical-trials-amid-headwinds 2025-06-12 15:40:58.87614+00 https://www.pharmasalmanac.com/articles/redefining-access-embedding-diversity-into-the-clinical-research-ecosystem 2025-06-12 15:40:04.457606+00 https://www.pharmasalmanac.com/articles/five-small-biotechs-to-watch-june-2025 2025-06-11 16:59:52.416179+00 https://www.pharmasalmanac.com/articles/intelligent-gxp-manufacturing-with-aizon 2025-06-10 21:33:46.971717+00 https://www.pharmasalmanac.com/articles/rare-disease-biotech-announces-hugely-significant-milestone-with-selection-of-candidate-drug 2025-06-10 16:47:34.940562+00 https://www.pharmasalmanac.com/articles/sano-womens-health-raises-funds-to-advance-phase-2-clinical-trials-for-novel-rvvc-treatment 2025-06-06 19:25:53.051006+00 https://www.pharmasalmanac.com/articles/the-business-case-for-gender-inclusive-pharma-why-equity-drives-innovation-performance-and-profit 2025-06-04 21:23:48.714811+00 https://www.pharmasalmanac.com/articles/beyond-the-proteasome-unlocking-new-frontiers-with-autacs-and-lytacs 2025-06-04 15:50:56.446262+00 https://www.pharmasalmanac.com/articles/continuous-biomanufacturing-with-pak-biosolutions 2025-05-30 20:45:51.492802+00 https://www.pharmasalmanac.com/articles/at-cs-analytical-packaging-is-everything 2025-05-30 20:34:46.280386+00 https://www.pharmasalmanac.com/articles/loma-systems-advancements-in-detection-inspection 2025-05-30 20:26:39.858269+00 https://www.pharmasalmanac.com/articles/inclusive-trials-are-better-trials-why-womens-health-cant-be-a-footnote-anymore 2025-05-30 17:57:03.684068+00 https://www.pharmasalmanac.com/articles/family-owned-air-sampling-tech-with-global-impact 2025-05-29 19:58:25.134768+00 https://www.pharmasalmanac.com/articles/sex-differences-gender-biases-what-are-we-really-studying-in-preclinical-research 2025-05-29 18:24:39.246784+00 https://www.pharmasalmanac.com/articles/therapeutic-nanobodies-and-intrabodies-rewriting-the-rules-of-target-engagement 2025-05-29 17:14:10.243475+00 https://www.pharmasalmanac.com/articles/designer-control-dreadds-and-the-next-generation-of-targeted-neuromodulation 2025-05-29 17:12:17.952754+00 https://www.pharmasalmanac.com/articles/verdot-is-engineering-excellence 2025-05-28 21:30:21.789024+00 https://www.pharmasalmanac.com/articles/the-other-data-gap-reimagining-clinical-research-to-include-pregnant-and-lactating-women 2025-05-23 19:01:48.057883+00 https://www.pharmasalmanac.com/articles/prioritizing-data-security-through-digital-transformation-in-biomanufacturing 2025-05-23 14:34:18.285174+00 https://www.pharmasalmanac.com/articles/flexible-cdmo-solutions-reducing-risk-and-accelerating-time-to-market 2025-05-23 14:32:42.741495+00 https://www.pharmasalmanac.com/articles/achieving-gender-equity-without-saying-gender-or-women 2025-05-22 15:27:15.855313+00 https://www.pharmasalmanac.com/articles/foxx-life-sciences-single-use-bioprocess-lab-solutions 2025-05-21 18:50:30.54765+00 https://www.pharmasalmanac.com/articles/stevanato-groups-evolution 2025-05-20 15:12:05.738593+00 https://www.pharmasalmanac.com/articles/closing-the-gender-gap-in-digital-health-and-wearable-technologies 2025-05-19 18:58:31.660584+00 https://www.pharmasalmanac.com/articles/a-firsthand-look-at-lisures-m-tech-transfer-platform 2025-05-19 17:59:34.623386+00 https://www.pharmasalmanac.com/articles/breaking-the-biopharma-glass-ceiling-why-female-leadership-still-lags 2025-05-19 15:38:38.169032+00 https://www.pharmasalmanac.com/articles/title-intelligent-manufacturing-how-smart-pat-and-genai-can-transform-biopharmaceutical-manufacturing 2025-05-16 20:37:14.061026+00 https://www.pharmasalmanac.com/articles/lasts-tailor-made-solutions-for-sterilization-and-decontamination 2025-05-16 15:09:14.159369+00 https://www.pharmasalmanac.com/articles/partners-for-life-driving-excellence-through-trust-and-collaboration 2025-05-16 14:29:07.028876+00 https://www.pharmasalmanac.com/articles/wexlers-push-for-sustainability-in-packaging 2025-05-15 18:37:01.490928+00 https://www.pharmasalmanac.com/articles/half-the-data-half-the-science-the-cost-of-ignoring-sex-differences-in-preclinical-research 2025-05-15 15:21:33.926021+00 https://www.pharmasalmanac.com/articles/syntegon-delivers-record-results-in-2024 2025-05-15 13:39:00.640365+00 https://www.pharmasalmanac.com/articles/the-future-of-cold-storage-innovations-in-energy-efficiency 2025-05-14 17:21:46.364783+00 https://www.pharmasalmanac.com/articles/accelerating-biomanufacturing-facility-readiness-a-scalable-validation-model-for-multiproduct-facilities 2025-05-13 20:17:13.830128+00 https://www.pharmasalmanac.com/articles/natures-nanocarriers-the-evolving-role-of-exosomes-in-targeted-drug-delivery 2025-05-13 18:43:34.072995+00 https://www.pharmasalmanac.com/articles/recipharm-and-plg-announce-strategic-partnership-to-accelerate-development-projects 2025-05-13 14:52:43.449212+00 https://www.pharmasalmanac.com/articles/steri-teks-next-gen-sterilization-techniques 2025-05-12 17:33:55.308828+00 https://www.pharmasalmanac.com/articles/understanding-the-drug-supply-chain-security-act 2025-05-08 15:01:07.143154+00 https://www.pharmasalmanac.com/articles/how-simtra-helps-clients-overcome-challenges-in-biologics-manufacturing 2025-05-07 14:53:33.053928+00 https://www.pharmasalmanac.com/articles/wired-for-healing-the-future-of-brainmachine-interfaces 2025-05-07 14:41:25.853821+00 https://www.pharmasalmanac.com/articles/sanisures-legacy-of-innovation 2025-05-06 17:41:19.591812+00 https://www.pharmasalmanac.com/articles/gene-therapy-at-a-crossroads-rethinking-aav-amid-industry-resets 2025-05-06 11:30:46.58739+00 https://www.pharmasalmanac.com/articles/pharmas-almanac-thats-nice-at-interphex-2025 2025-05-05 17:45:42.30848+00 https://www.pharmasalmanac.com/articles/bringing-clinical-trial-enrollment-to-the-point-of-diagnosis 2025-05-05 13:42:26.505596+00 https://www.pharmasalmanac.com/articles/five-small-biotechs-to-watch-may-2025 2025-05-05 12:26:49.026386+00 https://www.pharmasalmanac.com/articles/examining-evolving-clean-room-requirements-with-michael-orourke 2025-05-02 14:00:33.711777+00 https://www.pharmasalmanac.com/articles/what-do-you-see-as-the-next-big-modality-in-biologics-and-what-factors-are-driving-innovation-in-this-space 2025-05-01 16:34:23.323448+00 https://www.pharmasalmanac.com/articles/anticipating-the-next-decade-of-gene-therapy 2025-05-01 13:40:44.786712+00 https://www.pharmasalmanac.com/articles/cutting-public-rd-would-slash-us-gdp-innovation-and-industry-growth-new-report-warns 2025-04-30 16:37:21.005327+00 https://www.pharmasalmanac.com/articles/controlling-the-cost-of-ownership-with-modular-facility-construction 2025-04-29 20:09:22.949356+00 https://www.pharmasalmanac.com/articles/engineering-the-future-of-biopharmaceutical-manufacturing-with-intelligent-automation-and-digitalization 2025-04-28 14:28:54.238996+00 https://www.pharmasalmanac.com/articles/a-reversal-isnt-a-rescue-womens-health-still-needs-defending 2025-04-25 17:39:41.127552+00 https://www.pharmasalmanac.com/articles/accelerating-time-to-market-with-rapid-testing-solutions 2025-04-25 17:05:32.111111+00 https://www.pharmasalmanac.com/articles/unlocking-the-power-of-real-world-data-in-long-term-care 2025-04-25 14:36:41.861998+00 https://www.pharmasalmanac.com/articles/crispr-edited-pig-organs-and-the-promise-of-xenotransplantation 2025-04-25 12:58:27.182136+00 https://www.pharmasalmanac.com/articles/truth-about-synthetic-food-dyes-and-why-theyre-finally-getting-the-boot 2025-04-24 17:53:29.966388+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-to-acquire-us-based-aseptic-fill-finish-cdmo-ajinomoto-althea 2025-04-24 14:44:10.620525+00 https://www.pharmasalmanac.com/articles/singing-the-body-electric-exploring-bioelectronic-medicine 2025-04-23 11:39:33.939935+00 https://www.pharmasalmanac.com/articles/chilling-new-attacks-on-scientific-integrity 2025-04-21 14:39:25.025252+00 https://www.pharmasalmanac.com/articles/rewriting-the-script-the-past-present-and-future-of-rna-editing-therapeutics 2025-04-18 21:04:13.599262+00 https://www.pharmasalmanac.com/articles/tailor-made-automation-solutions-for-systems-and-complete-process-plants-from-field-level-to-erp-system 2025-04-18 14:14:51.555551+00 https://www.pharmasalmanac.com/articles/nelson-labs-celebrates-40-years-of-excellence-in-science-and-service 2025-04-17 20:38:18.660837+00 https://www.pharmasalmanac.com/articles/manufacturing-nanomaterials-in-space-to-treat-disease-on-earth 2025-04-17 19:33:41.573482+00 https://www.pharmasalmanac.com/articles/four-decades-of-innovation-an-interview-with-joseph-carleone 2025-04-16 16:38:32.67884+00 https://www.pharmasalmanac.com/articles/from-chemo-to-advanced-therapies-new-frontiers-in-oncology 2025-04-15 17:49:52.819559+00 https://www.pharmasalmanac.com/articles/strategic-biomanufacturing-partner-for-multispecific-antibodies 2025-04-15 17:16:25.264515+00 https://www.pharmasalmanac.com/articles/reprogramming-the-rules-how-ai-is-transforming-de-novo-protein-design-in-drug-development 2025-04-15 16:46:15.902062+00 https://www.pharmasalmanac.com/articles/leveraging-advanced-gmp-release-and-stability-testing-methods-to-accelerate-new-drug-development 2025-04-15 12:56:21.73718+00 https://www.pharmasalmanac.com/articles/the-gender-bias-built-into-ai-and-its-threat-to-womens-health 2025-04-14 19:25:01.68957+00 https://www.pharmasalmanac.com/articles/gene-therapy-at-30-milestones-setbacks-and-a-path-forward 2025-04-14 15:44:41.939649+00 https://www.pharmasalmanac.com/articles/the-end-of-an-era-what-the-fdas-move-away-from-animal-testing-means-for-biopharma 2025-04-14 14:00:38.951304+00 https://www.pharmasalmanac.com/articles/beyond-the-binary-including-trans-and-non-binary-individuals-in-clinical-research 2025-04-11 20:03:40.477395+00 https://www.pharmasalmanac.com/articles/breaking-new-ground-30-years-of-first-in-class-drug-innovation 2025-04-09 16:24:29.939943+00 https://www.pharmasalmanac.com/articles/fighting-for-diversity-and-equity-in-pharma-and-biopharma 2025-04-09 15:01:45.076683+00 https://www.pharmasalmanac.com/articles/iff-pharma-solutions-launches-low-nitrite-methocel-hpmc-for-nitrosamine-mitigation 2025-04-08 20:38:59.30508+00 https://www.pharmasalmanac.com/articles/maternal-mandate-elevating-innovation-equity-and-investment-in-womens-health 2025-04-08 17:55:26.349383+00 https://www.pharmasalmanac.com/articles/innovating-to-target-the-microbiome-for-human-health 2025-04-08 16:18:15.280124+00 https://www.pharmasalmanac.com/articles/unparalleled-expertise-and-transparency-drive-a-unique-development-manufacturing-and-clinical-supply-experience 2025-04-05 12:56:44.852264+00 https://www.pharmasalmanac.com/articles/spintronics-and-the-future-of-drug-design 2025-04-05 12:51:15.439787+00 https://www.pharmasalmanac.com/articles/unlocking-the-potential-of-psychedelics-for-postpartum-depression 2025-04-04 15:40:39.066157+00 https://www.pharmasalmanac.com/articles/from-space-to-sight-leveraging-microgravity-to-enhance-artificial-retina-technology 2025-04-04 13:58:04.178413+00 https://www.pharmasalmanac.com/articles/dna-nanobots-precision-machines-at-the-molecular-frontier 2025-04-04 13:54:02.664697+00 https://www.pharmasalmanac.com/articles/public-statement-on-supporting-science-for-the-benefit-of-all-citizens 2025-03-31 18:02:39.995436+00 https://www.pharmasalmanac.com/articles/five-small-biotechs-to-watch-april-2025 2025-03-31 17:23:17.977485+00 https://www.pharmasalmanac.com/articles/building-resilient-pharma-supply-chains-in-an-uncertain-world 2025-03-31 17:22:07.509294+00 https://www.pharmasalmanac.com/articles/working-toward-a-future-without-neglected-tropical-diseases 2025-03-28 12:47:22.542781+00 https://www.pharmasalmanac.com/articles/how-can-the-industry-balance-the-need-for-faster-drug-approvals-with-the-necessity-of-ensuring-patient-safety-and-efficacy 2025-03-28 12:21:33.24411+00 https://www.pharmasalmanac.com/articles/what-new-opportunities-are-emerging-for-mrna-technology-and-how-is-the-portfolio-of-applications-expanding-beyond-vaccines 2025-03-27 17:28:48.648569+00 https://www.pharmasalmanac.com/articles/expanding-the-frontiers-of-cell-therapy-veterinary-applications-and-translational-insights 2025-03-26 19:49:25.329452+00 https://www.pharmasalmanac.com/articles/is-mrna-a-gene-therapy-unpacking-the-evolving-regulatory-debate 2025-03-26 19:49:13.111588+00 https://www.pharmasalmanac.com/articles/bioduro-opens-shanghai-laboratory-for-highly-potent-compound-synthesis 2025-03-25 13:23:24.852644+00 https://www.pharmasalmanac.com/articles/verista-to-showcase-countq-tray-inspection-systems-at-interphex-2025 2025-03-24 19:34:08.219788+00 https://www.pharmasalmanac.com/articles/diabetes-patients-look-forward-to-lower-priced-insulin 2025-03-24 17:14:50.558322+00 https://www.pharmasalmanac.com/articles/unilevers-indian-subsidiary-to-acquire-gsks-consumer-nutrition-brands-in-india 2025-03-24 17:14:33.007097+00 https://www.pharmasalmanac.com/articles/cilag-gmbh-to-collaborate-with-argenx-on-new-treatment-for-aml-mds 2025-03-24 17:14:12.069511+00 https://www.pharmasalmanac.com/articles/first-treatment-for-primary-hemophagocytic-lymphohistiocytosis-approved-by-fda 2025-03-24 17:13:56.138233+00 https://www.pharmasalmanac.com/articles/novartis-promacta-gets-expanded-use-approval-from-the-fda 2025-03-24 17:13:38.932294+00 https://www.pharmasalmanac.com/articles/novartis-grabs-attention-for-its-development-pipeline 2025-03-24 17:13:21.583233+00 https://www.pharmasalmanac.com/articles/eli-lilly-dicerna-to-collaborate-on-rnai-drug-development 2025-03-24 17:13:04.667066+00 https://www.pharmasalmanac.com/articles/genentech-gets-fda-approval-for-flu-medicine 2025-03-24 17:12:47.300322+00 https://www.pharmasalmanac.com/articles/precision-biosciences-aims-for-significant-funding-support-based-on-its-arcus-gene-editing-tech 2025-03-24 17:11:53.725461+00 https://www.pharmasalmanac.com/articles/innovative-tech-might-make-infrared-vision-possible 2025-03-24 17:11:36.982757+00 https://www.pharmasalmanac.com/articles/new-collaboration-targets-parkinsons-disease 2025-03-24 17:11:17.610108+00 https://www.pharmasalmanac.com/articles/cancer-vaccine-company-snapped-up-by-merck 2025-03-24 17:11:01.708822+00 https://www.pharmasalmanac.com/articles/will-car-t-therapies-be-covered-by-medicare 2025-03-24 17:10:45.037096+00 https://www.pharmasalmanac.com/articles/promising-treatment-for-brain-cancer 2025-03-24 17:10:28.618724+00 https://www.pharmasalmanac.com/articles/mercks-keytruda-to-get-accelerated-fda-evaluation-for-treatment-of-head-and-neck-cancer 2025-03-24 17:10:11.410511+00 https://www.pharmasalmanac.com/articles/trump-signs-executive-order-launching-the-american-ai-initiative 2025-03-24 17:09:54.475398+00 https://www.pharmasalmanac.com/articles/an-innovative-approach-to-oral-insulin 2025-03-24 17:09:36.87609+00 https://www.pharmasalmanac.com/articles/alexion-acquires-minority-stake-in-caelum-biosciences 2025-03-24 17:09:18.111849+00 https://www.pharmasalmanac.com/articles/novo-nordisk-to-use-priority-voucher-for-diabetes-drug 2025-03-24 17:09:02.182057+00 https://www.pharmasalmanac.com/articles/massachusetts-is-looking-for-ways-to-help-patients-receive-expensive-gene-therapy 2025-03-24 17:08:45.555272+00 https://www.pharmasalmanac.com/articles/company-developing-tech-to-identify-allosteric-mutations-raises-big-funds 2025-03-24 17:08:20.282855+00 https://www.pharmasalmanac.com/articles/researchers-identify-potential-approach-for-treating-the-toughest-breast-cancer 2025-03-24 17:08:03.258237+00 https://www.pharmasalmanac.com/articles/fda-approves-parkinsons-drug 2025-03-24 17:07:46.154415+00 https://www.pharmasalmanac.com/articles/gene-amplification-controls-obesity-in-mice 2025-03-24 17:07:26.521208+00 https://www.pharmasalmanac.com/articles/abbvie-exercises-option-to-license-parkinsons-tech-from-bioarctic 2025-03-24 17:06:50.444416+00 https://www.pharmasalmanac.com/articles/single-gene-identified-as-culprit-in-early-onset-dementia 2025-03-24 17:06:32.128712+00 https://www.pharmasalmanac.com/articles/mallinckrodt-spins-off-its-generics-business 2025-03-24 17:06:15.22709+00 https://www.pharmasalmanac.com/articles/gsk-acquires-oncology-company-tesaro 2025-03-24 17:05:58.498424+00 https://www.pharmasalmanac.com/articles/european-commission-approved-tecentriq/avastin-combination-therapy-for-lung-cancer 2025-03-24 17:04:48.931538+00 https://www.pharmasalmanac.com/articles/successful-funding-round-could-lead-to-commercialization-of-bio-integrative-bone-pin 2025-03-24 17:04:23.03966+00 https://www.pharmasalmanac.com/articles/takeda-collaborates-on-gene-therapy-development 2025-03-24 17:03:50.573797+00 https://www.pharmasalmanac.com/articles/new-tech-could-provide-early-detection-of-tumors 2025-03-24 17:03:22.169248+00 https://www.pharmasalmanac.com/articles/ech-monitoring-chest-patch-shows-promise-for-atrial-fibrillation-diagnosis 2025-03-24 17:03:06.136732+00 https://www.pharmasalmanac.com/articles/roche-gets-new-eu-approval-for-mabthera 2025-03-24 17:02:47.024963+00 https://www.pharmasalmanac.com/articles/descovy-shown-to-be-as-effective-and-safer-than-truvada-as-a-preventive-hiv-treatment 2025-03-24 17:02:04.756039+00 https://www.pharmasalmanac.com/articles/gsk-and-pfizers-combined-consumer-healthcare-business-will-focus-on-the-u.s.-and-china 2025-03-24 17:01:45.802539+00 https://www.pharmasalmanac.com/articles/treatment-for-deadly-fungal-infection-may-be-on-the-way 2025-03-24 17:01:28.957294+00 https://www.pharmasalmanac.com/articles/no-international-ebola-crisis-declared-yet 2025-03-24 17:01:08.139706+00 https://www.pharmasalmanac.com/articles/lung-cancer-drug-demonstrates-improved-survival-in-animal-models 2025-03-24 17:00:49.439965+00 https://www.pharmasalmanac.com/articles/fda-approves-first-anticoagulant-blood-thinner-for-use-in-children 2025-03-24 17:00:12.477613+00 https://www.pharmasalmanac.com/articles/philogen-raises-70-million 2025-03-24 16:59:54.163043+00 https://www.pharmasalmanac.com/articles/changes-coming-to-gilead-under-new-top-exec 2025-03-24 16:59:31.827252+00 https://www.pharmasalmanac.com/articles/fda-will-use-real-time-oncology-review-for-prostate-cancer-drug 2025-03-24 16:59:13.733063+00 https://www.pharmasalmanac.com/articles/crispr-used-to-correct-genes-in-mouse-fetuses-that-cause-lung-disease 2025-03-24 16:58:55.999915+00 https://www.pharmasalmanac.com/articles/genetechs-antibody-drug-conjugate-receives-fda-approval 2025-03-24 16:57:12.433274+00 https://www.pharmasalmanac.com/articles/cell-therapy-might-restore-sense-of-smell 2025-03-24 16:56:56.270385+00 https://www.pharmasalmanac.com/articles/thrive-earlier-detection-gets-funding-from-third-rock-to-develop-cancer-detection-tech 2025-03-24 16:56:37.600187+00 https://www.pharmasalmanac.com/articles/crispr-tech-is-going-gold 2025-03-24 16:56:20.691506+00 https://www.pharmasalmanac.com/articles/research-group-developing-lentiviral-vectors-for-treatment-of-hemophilia 2025-03-24 16:55:59.239209+00 https://www.pharmasalmanac.com/articles/public-private-neuromodulation-research-project-gets-boost-from-abbott 2025-03-24 16:55:36.468011+00 https://www.pharmasalmanac.com/articles/numerous-biosimilar-launches-coming-soon-in-united-states 2025-03-24 16:54:56.217955+00 https://www.pharmasalmanac.com/articles/cellarity-founded-to-identify-new-drugs-that-target-specific-cellular-behaviors 2025-03-24 16:54:38.984309+00 https://www.pharmasalmanac.com/articles/artificial-intelligence-expected-to-improve-pharma-rd 2025-03-24 16:54:24.277321+00 https://www.pharmasalmanac.com/articles/draft-icer-report-questions-cost-effectiveness-of-new-migraine-drugs 2025-03-24 16:53:52.063016+00 https://www.pharmasalmanac.com/articles/genfit-gets-new-ceo-as-it-moves-to-approval-and-commercialization-stage 2025-03-24 16:53:34.981666+00 https://www.pharmasalmanac.com/articles/suny-researchers-developing-device-to-restore-vision-to-amd-sufferers 2025-03-24 16:53:20.457069+00 https://www.pharmasalmanac.com/articles/biotech-company-stealth-biotherapeutics-files-for-ipo 2025-03-24 16:53:05.074005+00 https://www.pharmasalmanac.com/articles/new-insights-into-virus-evasion-tactics 2025-03-24 16:52:46.944087+00 https://www.pharmasalmanac.com/articles/scientists-edit-stem-cell-derived-neurons-using-crispr 2025-03-24 16:52:29.717626+00 https://www.pharmasalmanac.com/articles/adapted-pig-organs-could-transform-transplant-surgery 2025-03-24 16:52:12.837519+00 https://www.pharmasalmanac.com/articles/recovering-from-cancer-treatment-may-get-easier 2025-03-24 16:51:56.735374+00 https://www.pharmasalmanac.com/articles/asthma-patients-in-europe-will-have-access-to-a-self-administered-syringe 2025-03-24 16:51:39.105234+00 https://www.pharmasalmanac.com/articles/biomarin-going-for-2020-approval-of-its-hemophilia-a-gene-therapy 2025-03-24 16:50:55.502302+00 https://www.pharmasalmanac.com/articles/gsk-grows-oncology-pipeline-under-csos-leadership 2025-03-24 16:50:35.9513+00 https://www.pharmasalmanac.com/articles/u.s.-fda-approved-new-antibacterial-for-urinary-tract-and-abdominal-infections 2025-03-24 16:50:18.791144+00 https://www.pharmasalmanac.com/articles/new-alzheimers-test-could-be-on-the-horizon 2025-03-24 16:49:58.41775+00 https://www.pharmasalmanac.com/articles/hiv-vaccine-to-be-tested-in-the-u.s.-and-europe 2025-03-24 16:49:30.698124+00 https://www.pharmasalmanac.com/articles/eli-lilly-looking-to-boost-sales-of-migraine-med-with-new-data-on-emergency-room-visits 2025-03-24 16:49:13.03313+00 https://www.pharmasalmanac.com/articles/morphosys-gets-milestone-payment-from-gsk-for-otilimab 2025-03-24 16:48:56.068084+00 https://www.pharmasalmanac.com/articles/new-drug-for-duchenne-muscular-dystrophy-dmd-shows-promise 2025-03-24 16:48:36.854128+00 https://www.pharmasalmanac.com/articles/promoting-t-cell-survival 2025-03-24 16:48:21.456378+00 https://www.pharmasalmanac.com/articles/melintas-antibiotic-baxdela-gets-priority-review-from-fda-for-capb 2025-03-24 16:47:55.970082+00 https://www.pharmasalmanac.com/articles/ai-based-blackthorn-therapeutics-raises-additional-75-million 2025-03-24 16:47:35.804296+00 https://www.pharmasalmanac.com/articles/fecal-transplant-associated-with-one-patient-death 2025-03-24 16:47:17.274217+00 https://www.pharmasalmanac.com/articles/brain-organoids-could-speed-drug-development-for-neurological-diseases 2025-03-24 16:46:58.742093+00 https://www.pharmasalmanac.com/articles/upcoming-hiv-study-to-focus-on-chronic-conditions-affecting-people-with-aids 2025-03-24 16:46:38.593455+00 https://www.pharmasalmanac.com/articles/from-niche-to-necessity-how-single-use-transformed-biomanufacturing 2025-03-24 14:57:38.953786+00 https://www.pharmasalmanac.com/articles/the-white-houses-war-on-the-nih-and-the-disasters-ahead 2025-03-24 14:34:51.807543+00 https://www.pharmasalmanac.com/articles/driving-therapeutic-innovation-with-omvs-and-evs 2025-03-21 16:39:12.176506+00 https://www.pharmasalmanac.com/articles/beyond-mrna-vaccines-the-expanding-world-of-rna-based-therapeutics 2025-03-21 16:39:02.090951+00 https://www.pharmasalmanac.com/articles/genomics-and-the-next-era-of-precision-medicine 2025-03-20 18:03:06.236723+00 https://www.pharmasalmanac.com/articles/resetting-the-biological-clock-oksm-and-the-reversal-of-aging 2025-03-20 17:52:57.274207+00 https://www.pharmasalmanac.com/articles/magnetogenetics-and-the-future-of-remote-biological-control 2025-03-17 15:15:48.457471+00 https://www.pharmasalmanac.com/articles/boolean-biology-the-future-of-logic-gated-cell-and-gene-therapies 2025-03-15 20:57:59.223725+00 https://www.pharmasalmanac.com/articles/conversations-with-carleone-leadership-wisdom-worth-sharing 2025-03-15 20:57:44.305497+00 https://www.pharmasalmanac.com/articles/employees-who-think-like-stakeholders-the-power-of-transparency-and-empowerment 2025-03-15 20:57:16.014531+00 https://www.pharmasalmanac.com/articles/five-small-biotechs-to-watch-march-2025 2025-03-15 20:57:01.762345+00 https://www.pharmasalmanac.com/articles/rising-interest-in-radioconjugate-therapies 2025-03-15 20:56:24.157543+00 https://www.pharmasalmanac.com/articles/science-under-siege-the-devastating-consequences-of-public-health-and-research-cuts 2025-03-15 20:55:41.795352+00 https://www.pharmasalmanac.com/articles/nih-funding-cuts-put-innovation-health-equity-and-lives-at-risk 2025-03-15 20:55:22.342743+00 https://www.pharmasalmanac.com/articles/the-collapse-of-usaid-funded-clinical-trials-a-blow-to-global-health-and-biopharma-innovation 2025-03-15 20:54:49.658996+00 https://www.pharmasalmanac.com/articles/five-small-biotechs-to-watch-february-2025 2025-03-15 20:53:49.780793+00 https://www.pharmasalmanac.com/articles/tackling-plastic-waste-the-elephant-in-the-room-of-pharmas-sustainability-drive 2025-03-15 20:53:33.213861+00 https://www.pharmasalmanac.com/articles/clinical-trials-without-borders-the-evolution-of-global-drug-development 2025-03-14 21:20:36.877736+00 https://www.pharmasalmanac.com/articles/achieving-scalable-and-sustainable-precision-fermentation-using-process-analytical-technology 2025-03-14 14:40:40.109673+00 https://www.pharmasalmanac.com/articles/leveraging-biopharma-sensor-technologies-for-cultivated-meat-processes 2025-03-14 14:27:48.144506+00 https://www.pharmasalmanac.com/articles/the-final-frontier-biomanufacturing-in-space 2025-03-14 12:38:21.974779+00 https://www.pharmasalmanac.com/articles/from-patients-to-partners-the-rising-power-of-advocacy-in-drug-development 2025-03-13 17:06:28.578579+00 https://www.pharmasalmanac.com/articles/accelerating-patient-access-through-decentralized-clinical-trials 2025-03-12 15:30:49.646032+00 https://www.pharmasalmanac.com/articles/global-health-at-a-crossroads-and-the-future-of-pandemic-preparedness 2025-03-12 15:18:12.910736+00 https://www.pharmasalmanac.com/articles/gannet-biochem-names-nicholas-shackley-as-chief-executive-officer-announces-leadership-team-expansion 2025-03-11 19:25:33.3747+00 https://www.pharmasalmanac.com/articles/from-coleys-toxins-to-mrna-reflecting-on-the-history-of-cancer-vaccines 2025-03-11 19:13:59.984789+00 https://www.pharmasalmanac.com/articles/harnessing-the-human-microbiome-30-years-of-discovery-and-innovation-in-biopharma 2025-03-11 19:13:47.22307+00 https://www.pharmasalmanac.com/articles/biosimilars-through-the-years-transforming-access-and-cost-in-biologics 2025-03-11 19:13:31.451845+00 https://www.pharmasalmanac.com/articles/unlocking-new-frontiers-with-cannabinoid-and-psychedelic-therapies 2025-03-11 19:13:16.514862+00 https://www.pharmasalmanac.com/articles/from-market-failures-to-lifesaving-innovations-the-evolution-of-orphan-drugs 2025-03-11 19:13:00.299374+00 https://www.pharmasalmanac.com/articles/overcoming-challenges-and-unlocking-the-potential-of-real-world-evidence 2025-03-11 19:12:48.196191+00 https://www.pharmasalmanac.com/articles/immuno-oncology-at-the-forefront-of-cancer-medicine 2025-03-11 19:12:36.474657+00 https://www.pharmasalmanac.com/articles/the-disruptive-impact-of-structural-biology-on-biopharmaceutical-innovation 2025-03-11 19:12:22.309575+00 https://www.pharmasalmanac.com/articles/breaking-the-cycle-of-chronic-disease-with-new-therapeutic-strategies 2025-03-11 19:12:01.540307+00 https://www.pharmasalmanac.com/articles/the-future-is-continuous-accelerating-the-shift-in-biomanufacturing 2025-03-11 19:11:44.284856+00 https://www.pharmasalmanac.com/articles/30-years-of-accelerated-approvals-fast-tracking-innovation-in-drug-development 2025-03-11 19:11:03.82101+00 https://www.pharmasalmanac.com/articles/the-high-throughput-screening-transformation-in-modern-drug-development 2025-03-11 19:10:20.334297+00 https://www.pharmasalmanac.com/articles/three-decades-of-collaboration-evolution-from-basic-partnerships-to-complex-open-innovation-models 2025-03-11 19:09:44.757306+00 https://www.pharmasalmanac.com/articles/the-biomarker-revolution-in-medicine-and-drug-development 2025-03-11 19:08:34.32914+00 https://www.pharmasalmanac.com/articles/vetter-boosts-pharmaceutical-storage-capacity-with-major-warehouse-expansion 2025-03-11 13:55:59.735532+00 https://www.pharmasalmanac.com/articles/advancing-subvisible-particle-characterization-with-artificial-intelligence 2025-03-11 13:12:28.2001+00 https://www.pharmasalmanac.com/articles/amgen-and-kyowa-kirin-provide-top-line-results-from-rocatinlimab-phase-3-ignite-study-in-atopic-dermatitits 2025-03-10 14:56:12.074767+00 https://www.pharmasalmanac.com/articles/moleculin-to-present-at-the-37th-annual-roth-conference 2025-03-10 14:49:25.285588+00 https://www.pharmasalmanac.com/articles/bio-techne-begins-shipping-leo-a-next-generation-high-throughput-simple-western-system 2025-03-10 14:43:45.535918+00 https://www.pharmasalmanac.com/articles/vanda-pharmaceuticals-announces-the-publication-of-an-article-personalized-treatment-for-charcot-marie-tooth-disease-type-2s 2025-03-06 22:23:50.069347+00 https://www.pharmasalmanac.com/articles/frontier-scientific-solutions-appoints-kevin-nash-as-president-of-european-operations 2025-03-06 22:22:51.384066+00 https://www.pharmasalmanac.com/articles/integrated-multi-omic-data-powering-precision-medicine 2025-03-06 20:09:00.704583+00 https://www.pharmasalmanac.com/articles/ultima-genomics-increases-output-by-over-50-and-lowers-sequencing-costs-by-a-further-20-with-the-introduction-of-ug-100-solaris 2025-03-04 15:58:21.170897+00 https://www.pharmasalmanac.com/articles/patients-switched-to-alkermes-aristada-showed-significant-improvement-in-schizophrenia-symptoms-after-inadequate-response-or-intolerance-to-invega-sustenna 2025-03-03 05:48:41.462144+00 https://www.pharmasalmanac.com/articles/overcoming-challenges-to-high-concentration-formulation-development 2025-03-02 22:00:39.375481+00 https://www.pharmasalmanac.com/articles/is-ai-truly-transforming-drug-development-or-are-we-still-navigating-through-the-hype 2025-02-26 13:59:18.714313+00 https://www.pharmasalmanac.com/articles/what-strategies-are-ensuring-supply-chain-resilience-in-a-post-covid-world 2025-02-26 13:59:02.979488+00 https://www.pharmasalmanac.com/articles/meeting-the-complex-challenges-of-micronization-with-experience-and-technology 2025-02-25 19:45:10.60749+00 https://www.pharmasalmanac.com/articles/labcorp-announces-clinical-availability-of-liquid-biopsy-test-to-guide-personalized-treatment-plans 2025-02-25 01:00:34.243589+00 https://www.pharmasalmanac.com/articles/kineticos-launches-kinvard-bio-to-advance-next-generation-antibiotics-in-the-fight-against-antimicrobial-resistance 2025-02-24 23:07:07.69501+00 https://www.pharmasalmanac.com/articles/swarm-oncology-and-cellex-cell-professionals-announce-partnership-to-advance-swarms-t-cell-therapies-for-solid-cancers 2025-02-24 22:20:38.907611+00 https://www.pharmasalmanac.com/articles/personalized-medicine-and-the-cdmo-adapting-to-a-new-era-of-healthcare 2025-02-21 20:58:47.012525+00 https://www.pharmasalmanac.com/articles/ge-healthcare-to-become-standalone-company 2025-02-21 01:34:09.318076+00 https://www.pharmasalmanac.com/articles/ford-works-with-3m-ge-uaw-to-speed-production-of-respirators-for-healthcare-workers-ventilators-for-coronavirus-patients 2025-02-21 01:34:09.318076+00 https://www.pharmasalmanac.com/articles/boehringers-zongertinib-receivesfda-priority-review-for-the-treatment-of-her2-erbb2-nsclc 2025-02-20 18:17:21.639357+00 https://www.pharmasalmanac.com/articles/accessdx-laboratory-announces-integration-with-pointclickcare 2025-02-19 23:35:23.93041+00 https://www.pharmasalmanac.com/articles/clarity-receives-us-fda-fast-track-designation-for-treating-metastatic-castration-resistant-prostate-cancer-with-cu-67-sar-bispsma 2025-02-19 23:21:18.116274+00 https://www.pharmasalmanac.com/articles/yourbio-health-strengthens-leadership-team-to-propel-next-phase-of-growth 2025-02-19 21:24:11.787103+00 https://www.pharmasalmanac.com/articles/bio-techne-announces-release-of-gmp-tcbuster-non-viral-genome-engineering-system 2025-02-19 21:09:08.707688+00 https://www.pharmasalmanac.com/articles/anixa-biosciences-announces-approval-of-protocol-amendment-for-ovarian-cancer-car-t-clinical-trial 2025-02-19 20:29:02.806873+00 https://www.pharmasalmanac.com/articles/genprex-provides-update-on-diabetes-gene-therapy-program 2025-02-19 20:17:21.348914+00 https://www.pharmasalmanac.com/articles/frontier-scientific-solutions-free-trade-zone-advantage-matters-amid-tariff-changes-strengthening-life-sciences-supply-chain 2025-02-19 15:27:06.902806+00 https://www.pharmasalmanac.com/articles/ensuring-biologic-stability-with-tailored-and-cutting-edge-lyophilization-solutions 2025-02-18 19:28:54.176878+00 https://www.pharmasalmanac.com/articles/cryoport-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-2025 2025-02-18 18:31:34.170757+00 https://www.pharmasalmanac.com/articles/shift-bioscience-establishes-north-american-facilities-to-expand-capabilities-of-ai-powered-virtual-cell-technology 2025-02-18 18:00:38.870278+00 https://www.pharmasalmanac.com/articles/chris-rombach-appointed-president-of-asahi-kasei-bioprocess-america 2025-02-18 18:00:08.291249+00 https://www.pharmasalmanac.com/articles/the-valuation-equation-speculating-on-why-marketing-and-communication-might-matter-more-than-you-think 2025-02-13 22:42:26.454748+00 https://www.pharmasalmanac.com/articles/fda-approves-gsks-blenrep-for-the-treatment-of-patients-with-relapsed-or-refractory-multiple-myeloma 2025-02-13 19:51:23.81015+00 https://www.pharmasalmanac.com/articles/revolutionizing-xrna-production-the-economic-case-for-continuous-manufacturing 2025-02-13 18:34:03.196293+00 https://www.pharmasalmanac.com/articles/roche-receives-fda-510k-clearance-for-the-first-blood-test-in-the-us-measuring-lpa-in-nolar-units 2025-02-11 20:14:19.096981+00 https://www.pharmasalmanac.com/articles/exuma-biotech-announces-phase-1-results-for-its-autologous-her2-directed-car-t-product-at-asco-gi-2025 2025-02-11 16:10:37.766297+00 https://www.pharmasalmanac.com/articles/statement-from-aaron-j-kowalski-the-type-1-diabetes-research-and-advocacy-organization-on-nih-indirect-costs-cuts 2025-02-11 00:28:58.055903+00 https://www.pharmasalmanac.com/articles/carsgens-first-enrolled-subject-in-the-thank-u-plus-platform-based-allogeneic-car-t-trial-achieves-scr-at-week-4 2025-02-11 00:03:16.270845+00 https://www.pharmasalmanac.com/articles/caliway-announces-cbl-514-second-phase-2b-study-results-cbl-0205-met-endpoints 2025-02-10 23:33:33.680634+00 https://www.pharmasalmanac.com/articles/nektar-therapeutics-receives-fast-track-designation-for-the-treatment-of-moderate-to-severe-atopic-dermatitis 2025-02-10 22:32:39.937242+00 https://www.pharmasalmanac.com/articles/advanced-pharmaceutical-manufacturing-concepts-are-quickly-becoming-realities 2025-02-10 20:38:52.761097+00 https://www.pharmasalmanac.com/articles/frontier-scientific-builds-north-americas-largest-gmp-temperature-controlled-life-sciences-facility-at-wilmington-intl-airport 2025-02-10 20:35:41.494+00 https://www.pharmasalmanac.com/articles/bio-x-cell-expands-global-reach-with-new-distribution-center-in-beijing-china 2025-02-10 17:19:54.449001+00 https://www.pharmasalmanac.com/articles/enabling-cost-effective-rapid-access-to-rna-vaccines-and-therapeutics-with-enzymatically-generated-z-dbdna 2025-02-10 16:57:22.367191+00 https://www.pharmasalmanac.com/articles/fda-accepts-integral-moleculars-membrane-proteome-array-qualification-plan-advancing-approval-platform-of-drug-development-tool 2025-02-08 02:27:10.040716+00 https://www.pharmasalmanac.com/articles/transcode-therapeutics-announces-completion-of-cohort-3-initial-dosing-with-lead-candidate-in-phase-1-clinical-trial 2025-02-07 21:02:57.085181+00 https://www.pharmasalmanac.com/articles/citius-pharma-and-oncology-announce-a-unique-permanent-j-code-for-lymphir-from-centers-for-medicare-and-medicaid-services 2025-02-07 20:43:06.218058+00 https://www.pharmasalmanac.com/articles/mozart-therapeutics-presents-compelling-new-preclinical-data-on-mtx-201-at-the-2025-crohns-and-colitis-congress 2025-02-07 19:22:28.642293+00 https://www.pharmasalmanac.com/articles/hemab-shares-phase-2-hmb-001-data-for-glanzmann-thrombasthenia-and-hmb-002-preclinical-data-for-von-willebrand-at-eahad-2025 2025-02-07 18:39:34.380086+00 https://www.pharmasalmanac.com/articles/five-small-biotechs-to-watch-october-2024 2025-02-06 21:39:48.020678+00 https://www.pharmasalmanac.com/articles/how-todays-pharmaceutical-industry-is-transforming-to-support-the-medicines-of-the-future 2025-02-06 21:24:46.996605+00 https://www.pharmasalmanac.com/articles/how-do-you-see-advances-in-personalized-medicine-reshaping-patient-care-and-what-are-the-key-challenges-and-opportunities-ahead 2025-02-06 16:30:11.852088+00 https://www.pharmasalmanac.com/articles/reducing-tarmac-exposure-to-enhance-biopharma-product-stability-and-reduce-losses 2025-02-05 23:30:01.121822+00 https://www.pharmasalmanac.com/articles/managing-temperature-controlled-logistics-for-glp-1-drugs 2025-02-05 20:38:17.198584+00 https://www.pharmasalmanac.com/articles/bio-techne-appoints-dr-amy-e-herr-to-board-of-directors 2025-02-04 21:42:36.473122+00 https://www.pharmasalmanac.com/articles/durect-corporation-to-present-at-oppenheimer-35th-annual-healthcare-life-sciences-conference 2025-02-04 21:13:49.082483+00 https://www.pharmasalmanac.com/articles/cyrano-therapeutics-launches-clinical-study-of-cyr-064-for-smell-loss-hyposmia-in-parkinsons-disease-patients 2025-02-04 17:22:57.998169+00 https://www.pharmasalmanac.com/articles/sano-chemicals-inc-announces-approval-to-start-phase-1-mad-study 2025-02-04 17:02:08.837709+00 https://www.pharmasalmanac.com/articles/avirmax-biopharma-completes-first-cohort-enrollment-in-abi-110-gene-therapy-trial-for-wet-amd-including-pcv 2025-02-04 16:13:51.602996+00 https://www.pharmasalmanac.com/articles/synthetic-dna-delivers-a-sustainable-future-for-genetic-medicines 2025-02-04 16:04:13.896696+00 https://www.pharmasalmanac.com/articles/vetigenics-secures-6-million-seed-financing-sees-meaningful-clinical-progress 2025-02-03 22:43:49.364704+00 https://www.pharmasalmanac.com/articles/helix-launches-worlds-largest-clinico-genomic-cohort-of-glp-1-agonist-treated-patients 2025-02-03 22:22:36.240102+00 https://www.pharmasalmanac.com/articles/how-can-pharma-manufacturing-align-with-green-initiatives-while-maintaining-efficiency-and-compliance 2025-01-31 14:08:17.49022+00 https://www.pharmasalmanac.com/articles/supporting-global-direct-to-patient-clinical-trials-during-challenging-times 2025-01-31 13:35:43.654241+00 https://www.pharmasalmanac.com/articles/cell-and-gene-therapies-evolving-temperature-controlled-requirements-call-for-specialized-logistics-solutions 2025-01-31 13:35:22.399917+00 https://www.pharmasalmanac.com/articles/clarity-receives-us-fda-fast-track-designation-for-cu-64-sar-bispsma-in-biochemical-recurrence-of-prostate-cancer 2025-01-29 15:50:46.492822+00 https://www.pharmasalmanac.com/articles/from-research-to-clinical-trials-to-commercialization-advancing-cgt-with-frozen-cellular-starting-materials 2025-01-28 19:21:38.118424+00 https://www.pharmasalmanac.com/articles/streamlining-drug-development-with-integrated-in-silico-and-laboratory-developability-assessments 2025-01-27 18:03:27.213039+00 https://www.pharmasalmanac.com/articles/ensuring-nuclease-free-process-consumables-for-biopharma-applications 2025-01-22 20:20:27.676986+00 https://www.pharmasalmanac.com/articles/protein-science-and-the-future-of-biotherapeutics 2025-01-22 18:30:05.550521+00 https://www.pharmasalmanac.com/articles/sapient-teams-with-alamar-biosciences-to-advance-proteomics-using-nulisa-assays-for-cytokines-chemokines-and-inflammation 2025-01-21 22:34:17.925908+00 https://www.pharmasalmanac.com/articles/chromatin-biosciences-synthetic-promoter-supports-esobiotecs-eso-t01-car-t-therapy-as-it-enters-the-clinic 2025-01-20 18:03:45.113333+00 https://www.pharmasalmanac.com/articles/biovaxys-developing-dpx-to-be-the-carrier-of-choice-for-mrna-vaccines-a-market-projected-to-grow-to-usd48000000000-by-2030 2025-01-20 16:26:01.848637+00 https://www.pharmasalmanac.com/articles/northx-biologics-appoints-patrick-depalma-senior-vice-president-of-north-american-business-development 2025-01-20 16:24:55.647543+00 https://www.pharmasalmanac.com/articles/caris-life-sciences-strategically-collaborates-with-ontada-to-advance-oncology-research-and-the-adoption-of-precision-medicine 2025-01-20 15:50:22.708666+00 https://www.pharmasalmanac.com/articles/axcynsis-therapeutics-receives-fda-clearance-for-ind-application-of-at03-65-powered-by-axcyndot-technology 2025-01-16 22:12:30.667787+00 https://www.pharmasalmanac.com/articles/regulatory-approval-clears-path-for-oncolytics-biotech-to-pancreatic-cancer-treatment 2025-01-16 21:46:03.466397+00 https://www.pharmasalmanac.com/articles/samsung-biologics-presents-business-updates-at-2025-jp-morgan-healthcare-conference 2025-01-16 20:47:04.982809+00 https://www.pharmasalmanac.com/articles/gene-therapeutics-nggt-announces-publication-of-early-clinical-trial-results-for-the-treatment-of-biettis-crystalline-dystrophy 2025-01-16 20:32:22.446445+00 https://www.pharmasalmanac.com/articles/moffitt-cancer-center-and-cryoport-announce-strategic-collaboration 2025-01-16 17:11:20.57893+00 https://www.pharmasalmanac.com/articles/enabling-digital-twins-with-computational-fluid-dynamics-modeling 2025-01-15 16:26:38.799283+00 https://www.pharmasalmanac.com/articles/johnson-and-johnson-submits-applications-seeking-approval-as-subcutaneous-monotherapy-for-high-risk-moldering-multiple-myeloma 2025-01-14 20:42:42.378309+00 https://www.pharmasalmanac.com/articles/samsung-invests-in-generate-biomedicines-to-advance-ai-driven-protein-therapeutics-discovery 2025-01-14 20:40:01.210402+00 https://www.pharmasalmanac.com/articles/servier-expands-tibsovo-ivosidenib-program-to-study-safety-and-efficacy-in-idh1-mutated-hematologic-and-solid-tumor-cancers 2025-01-14 20:38:37.436884+00 https://www.pharmasalmanac.com/articles/vetter-introduces-the-next-evolution-of-the-v-ovs-syringe-closure-system 2025-01-14 17:19:18.998963+00 https://www.pharmasalmanac.com/articles/lilly-to-acquire-scorpion-therapeutics-mutant-selective-pi3k-inhibitor-program 2025-01-14 17:18:49.582179+00 https://www.pharmasalmanac.com/articles/bioduro-opens-new-solid-phase-peptide-synthesis-scale-up-facility 2025-01-14 16:18:28.89304+00 https://www.pharmasalmanac.com/articles/regenxbio-and-nippon-shinyaku-announce-exclusive-partnership-to-develop-and-commercialize-rgx-121-and-rgx-111-for-mps-diseases 2025-01-14 16:11:37.208157+00 https://www.pharmasalmanac.com/articles/hybryte-expanded-treatment-continues-to-demonstrate-positive-outcomes-in-early-stage-cutaneous-t-cell-lymphoma 2025-01-14 15:54:23.064825+00 https://www.pharmasalmanac.com/articles/ultima-genomics-announces-ug-100-sequencing-platform-selected-for-uk-biobanks-groundbreaking-human-proteome-study 2025-01-10 22:29:01.498013+00 https://www.pharmasalmanac.com/articles/timberlyne-therapeutics-secures-180m-series-a-to-advance-cm313-a-promising-anti-cd38-antibody-for-high-need-diseases 2025-01-10 20:36:23.120748+00 https://www.pharmasalmanac.com/articles/mediar-therapeutics-and-lilly-sign-global-licensing-agreement-to-advance-wisp1-antibody-to-treat-idiopathic-pulmonary-fibrosis 2025-01-10 16:59:17.242749+00 https://www.pharmasalmanac.com/articles/bio-techne-expands-randd-systems-ai-engineered-designer-protein-portfolio-to-advance-cell-therapy-and-regenerative-medicine 2025-01-10 16:28:55.66826+00 https://www.pharmasalmanac.com/articles/navigating-the-complexities-of-microbial-and-mammalian-manufacturing 2025-01-09 14:17:43.323972+00 https://www.pharmasalmanac.com/articles/samsung-biologics-listed-among-top-most-sustainable-companies-in-dow-jones-sustainability-world-index 2025-01-08 22:39:37.64283+00 https://www.pharmasalmanac.com/articles/1cbio-and-alesta-therapeutics-sign-global-deal-to-develop-a-first-in-class-small-molecule-treatment-for-hypophosphatasia 2025-01-08 22:33:29.855566+00 https://www.pharmasalmanac.com/articles/impact-of-strategic-location-on-supply-chain-efficiency 2025-01-08 22:25:14.806029+00 https://www.pharmasalmanac.com/articles/superior-performance-of-sanisure-pharm-a-clear-lh-tubing-in-extended-fillfinish-applications 2025-01-07 20:49:35.476068+00 https://www.pharmasalmanac.com/articles/screening-t7-polymerases-to-optimize-xrna-yield-and-quality 2025-01-07 16:11:02.524484+00 https://www.pharmasalmanac.com/articles/veeda-group-rebrands-as-veeda-lifesciences 2025-01-03 18:31:20.282718+00 https://www.pharmasalmanac.com/articles/opportunities-abound-in-chinas-pharmaceutical-market 2025-01-03 17:42:38.919726+00 https://www.pharmasalmanac.com/articles/chime-biologics-and-mabgeek-achieve-mg-k10-ppq-milestone-advancing-therapies-clinical-trials-and-commercialization 2025-01-03 16:19:18.990501+00 https://www.pharmasalmanac.com/articles/nona-biosciences-announces-update-on-its-collaborator-dualitybios-antibody-drug-conjugate-adc-collaboration-with-beigene 2025-01-03 16:18:36.172916+00 https://www.pharmasalmanac.com/articles/economic-and-environmental-benefits-of-utilizing-a-foreign-trade-zone 2025-01-02 18:19:45.645576+00 https://www.pharmasalmanac.com/articles/managing-pharmacovigilance-challenges-for-biosimilars 2025-01-02 18:15:50.626318+00 https://www.pharmasalmanac.com/articles/revolutionizing-autoimmune-disease-management-with-soluble-bispecific-receptors 2024-12-20 16:53:17.254581+00 https://www.pharmasalmanac.com/articles/enhancing-biopharmaceutical-stability-through-lyophilization 2024-12-20 16:52:37.342064+00 https://www.pharmasalmanac.com/articles/improving-aav-vector-quality-with-in-process-monitoring-of-capsid-formation 2024-12-20 16:52:13.357976+00 https://www.pharmasalmanac.com/articles/why-autoimmune-diseases-are-taking-center-stage-rising-prevalence-breakthroughs-and-market-opportunities 2024-12-20 16:50:59.18852+00 https://www.pharmasalmanac.com/articles/the-improvements-of-the-production-and-stability-of-a-mab-chelator-conjugate-by-modified-transchelation-conditions 2024-12-20 15:26:16.987158+00 https://www.pharmasalmanac.com/articles/genbio-ai-releases-phase-1-of-worlds-first-digital-organism-to-transform-medical-research 2024-12-19 21:49:50.403001+00 https://www.pharmasalmanac.com/articles/cellfe-announces-strategic-placements-with-leading-pharma-and-biotech-companies 2024-12-19 20:58:29.156861+00 https://www.pharmasalmanac.com/articles/inceptor-bio-and-grit-bio-cooperate-to-advance-ib-t101-a-next-generation-solid-tumor-car-t-utilizing-the-outlast-platform 2024-12-18 20:53:20.867532+00 https://www.pharmasalmanac.com/articles/labcorp-launches-h5-bird-flu-test-in-the-us-now-available-for-order-through-physicians 2024-12-17 23:58:18.087995+00 https://www.pharmasalmanac.com/articles/ginkgo-carnegie-mellon-get-94m-from-arpa-h-to-develop-implantable-bioelectronic-devices-for-disease-treatment 2024-12-17 23:19:24.288013+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-to-conduct-investor-meetings-during-the-jp-morgan-43rd-annual-healthcare-conference 2024-12-17 16:56:38.874931+00 https://www.pharmasalmanac.com/articles/rewriting-the-rules-of-gene-therapy-with-nonviral-dna-delivery-using-dbdna 2024-12-16 11:37:42.946984+00 https://www.pharmasalmanac.com/articles/ai-implementation-to-enhance-quality 2024-12-13 14:00:33.10193+00 https://www.pharmasalmanac.com/articles/karyopharm-announces-the-appointment-of-brendan-strong-as-senior-vice-president-of-investor-relations-and-corporate-communications 2024-12-12 22:05:09.247508+00 https://www.pharmasalmanac.com/articles/porton-pharma-solutions-and-aojin-life-sciences-strategically-collaborate-to-advance-xdc-conjugate-drugs-for-dual-ind-filings 2024-12-12 18:39:24.133547+00 https://www.pharmasalmanac.com/articles/olon-releases-its-annual-esg-report 2024-12-12 18:30:43.408356+00 https://www.pharmasalmanac.com/articles/how-can-biopharmaceutical-companies-contribute-to-improving-global-access-to-essential-medications 2024-12-12 18:12:01.347948+00 https://www.pharmasalmanac.com/articles/abbvie-announces-topline-results-for-the-phase-3-tempo-2-trial-evaluating-tavapadon-as-a-monotherapy-for-parkinsons-disease 2024-12-11 20:35:04.89057+00 https://www.pharmasalmanac.com/articles/biolexis-therapeutics-announces-positive-results-from-expanded-diet-induced-obesity-dio-model-study-for-blx-7006 2024-12-10 22:47:55.499635+00 https://www.pharmasalmanac.com/articles/carisma-therapeutics-announces-strategic-restructuring-to-re-prioritize-pipeline 2024-12-10 16:17:10.755408+00 https://www.pharmasalmanac.com/articles/amgen-announces-1-billion-manufacturing-expansion-in-north-carolina 2024-12-09 16:44:28.584014+00 https://www.pharmasalmanac.com/articles/beacon-therapeutics-announces-positive-3-month-data-from-phase-2-dawn-trial-in-patients 2024-12-06 22:00:32.855901+00 https://www.pharmasalmanac.com/articles/probio-announces-new-executive-appointments 2024-12-05 21:27:51.717068+00 https://www.pharmasalmanac.com/articles/advancing-the-science-of-technical-and-therapeutic-proteins 2024-12-04 13:50:10.480679+00 https://www.pharmasalmanac.com/articles/johnson-and-johnson-seeks-us-fda-approval-for-first-pediatric-indications-for-tremfya 2024-12-03 21:09:00.260826+00 https://www.pharmasalmanac.com/articles/samsung-biologics-hosts-esg-event-with-suppliers-to-strengthen-decarbonization-efforts 2024-12-03 21:08:35.335611+00 https://www.pharmasalmanac.com/articles/spyre-therapeutics-announces-first-participants-dosed-in-phase-1-trials-of-novel-half-life-extended-anti-tl1a-antibodies 2024-12-03 15:52:58.276906+00 https://www.pharmasalmanac.com/articles/agile-cell-supply-and-processing-to-accelerate-development-of-the-medicines-of-the-future 2024-12-03 15:27:05.599297+00 https://www.pharmasalmanac.com/articles/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule 2024-12-03 15:13:50.659558+00 https://www.pharmasalmanac.com/articles/oncolytic-virotherapy-real-potential-and-difficult-challenges 2024-12-02 21:36:22.047259+00 https://www.pharmasalmanac.com/articles/newfound-mechanism-may-explain-why-some-cancer-treatments-boost-risk-of-heart-disease 2024-12-02 17:03:12.583638+00 https://www.pharmasalmanac.com/articles/fast-path-to-market-going-from-gmp1-to-ppq-in-just-12-months 2024-12-02 16:48:55.877348+00 https://www.pharmasalmanac.com/articles/ampersand-capital-partners-aquired-nektar-therapeutics-peg-reagent-manufacturing-business-launching-newly-branded-gannet-biochem 2024-12-02 16:32:35.742792+00 https://www.pharmasalmanac.com/articles/vetter-strengthens-senior-management-team-for-further-sustainable-growth 2024-12-02 15:54:04.457019+00 https://www.pharmasalmanac.com/articles/transforming-xrna-manufacturing-with-digital-technologies-and-continuous-processing 2024-11-28 05:31:58.102178+00 https://www.pharmasalmanac.com/articles/adapting-medical-information-services-to-japans-distinct-needs 2024-11-22 21:20:12.770791+00 https://www.pharmasalmanac.com/articles/sophia-genetics-launches-msk-impact-powered-with-sophia-ddm-at-amp-2024 2024-11-21 20:23:47.734973+00 https://www.pharmasalmanac.com/articles/transposon-therapeutics-acquired-a-portfolio-of-novel-nucleoside-analogs-for-oncology-to-enhance-development-pipeline 2024-11-21 19:27:51.932019+00 https://www.pharmasalmanac.com/articles/skyhawk-therapeutics-to-present-preclinical-data-of-sky-1214-combination-treatment-in-hematologic-cancers 2024-11-21 19:01:53.463771+00 https://www.pharmasalmanac.com/articles/eqt-life-sciences-leads-54-million-series-a-financing-of-atb-therapeutics 2024-11-20 23:08:36.44362+00 https://www.pharmasalmanac.com/articles/bio-techne-and-alzpath-announce-strategic-partnership-to-advance-neurdegenerative-disease-research 2024-11-20 15:04:02.984981+00 https://www.pharmasalmanac.com/articles/gene-silencing-therapies-market-set-to-boom-says-leading-biotech 2024-11-20 14:47:19.004585+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-and-chirhoclin-partner-to-prevent-shortage-of-critical-orphan-pancreatic-drug 2024-11-19 23:22:48.675586+00 https://www.pharmasalmanac.com/articles/abbott-opens-state-of-the-art-global-manufacturing-facility-in-kilkenny-ireland 2024-11-19 22:57:29.784288+00 https://www.pharmasalmanac.com/articles/lindus-health-rolls-out-all-in-one-infectious-disease-cro-bespoke-to-clinical-trials-for-infectious-disease-interventions 2024-11-19 15:50:45.883749+00 https://www.pharmasalmanac.com/articles/concerto-biosciences-announces-first-participant-dosed-with-live-biotherapeutic-ens-002-in-phase-1-trial-for-atopic-dermatitis 2024-11-19 15:07:12.127317+00 https://www.pharmasalmanac.com/articles/atlas-venture-targets-450m-for-14th-biotech-fund-the-same-size-as-its-2022-raise 2024-11-18 21:45:39.172239+00 https://www.pharmasalmanac.com/articles/building-the-future-of-e-coli-biomanufacturing-with-protein-secretion 2024-11-18 18:54:32.629187+00 https://www.pharmasalmanac.com/articles/exploring-the-microbiome-with-servatus 2024-11-18 18:45:20.30394+00 https://www.pharmasalmanac.com/articles/leveraging-formulation-development-experience-for-effective-particle-identification 2024-11-18 18:40:43.341156+00 https://www.pharmasalmanac.com/articles/qbi-is-helping-translate-brain-research-into-treatments 2024-11-18 16:21:45.395871+00 https://www.pharmasalmanac.com/articles/karyopharm-to-present-selinexor-data-at-the-66th-american-society-of-hematology-annual-meeting-and-exposition 2024-11-18 14:45:16.609039+00 https://www.pharmasalmanac.com/articles/celltrion-receives-eu-approval-for-trastuzumab-biosimilar 2024-11-15 21:26:24.019122+00 https://www.pharmasalmanac.com/articles/celltrion-to-launch-both-antigen-and-antibody-testing-kits-in-the-u.s 2024-11-15 21:26:24.019122+00 https://www.pharmasalmanac.com/articles/combination-of-encorafenib-binimetinib-and-cetuximab-demonstrated-an-8-month-median-progression-free-survival 2024-11-15 21:16:15.356698+00 https://www.pharmasalmanac.com/articles/leaps-and-bounds-for-synthetic-biology-startups 2024-11-15 20:58:58.338177+00 https://www.pharmasalmanac.com/articles/translating-academic-pursuits-into-real-world-applications 2024-11-15 20:56:13.150239+00 https://www.pharmasalmanac.com/articles/genomadix-inc-enters-into-collaboration-with-mayo-clinic-on-precision-medicine-for-telestroke 2024-11-15 20:46:48.731453+00 https://www.pharmasalmanac.com/articles/advancing-personalized-medicines-and-precision-therapeutics 2024-11-15 20:44:51.004738+00 https://www.pharmasalmanac.com/articles/shining-light-on-the-communicable-disease-plight-in-australias-koalas 2024-11-15 20:44:35.022999+00 https://www.pharmasalmanac.com/articles/boston-scientific-closes-acquisition-of-axonics-inc 2024-11-15 17:31:02.342456+00 https://www.pharmasalmanac.com/articles/better-outcomes-for-cancer-patients-begin-with-screening 2024-11-15 15:24:21.808129+00 https://www.pharmasalmanac.com/articles/frontier-scientific-solutions-unveils-plans-for-a-trade-zone-gateway-dedicated-for-life-sciences-supply-chain 2024-11-15 15:22:28.136085+00 https://www.pharmasalmanac.com/articles/orsini-now-distributing-casgevy-exagamglogene-autotemcel-a-gene-editing-therapy 2024-11-15 15:11:02.493036+00 https://www.pharmasalmanac.com/articles/moleculin-accelerates-planned-unblinded-data-readout-for-miracle-phase-3-rr-acute-myeloid-leukemia-aml-pivotal-trial-to-h2-2025 2024-11-15 15:04:47.278798+00 https://www.pharmasalmanac.com/articles/fda-approves-first-gene-therapy-for-treatment-of-aromatic-l-amino-acid-decarboxylase-deficiency 2024-11-15 15:03:22.77189+00 https://www.pharmasalmanac.com/articles/building-on-australias-existing-biopharma-infrastructure 2024-11-15 15:01:45.012957+00 https://www.pharmasalmanac.com/articles/queensland-university-of-technologys-cutting-edge-synthetic-biology-lab 2024-11-15 14:55:02.038297+00 https://www.pharmasalmanac.com/articles/navigating-the-australian-clinical-trials-landscape 2024-11-15 14:50:23.014854+00 https://www.pharmasalmanac.com/articles/lexogen-launches-streamlined-large-scale-rna-seq-service-for-blood-samples 2024-11-15 14:43:28.582828+00 https://www.pharmasalmanac.com/articles/spirovant-sciences-doses-first-patient-in-phase-12-trial-of-its-aerosol-delivered-genetic-medicine-for-treating-cystic-fibrosis 2024-11-15 14:41:50.14031+00 https://www.pharmasalmanac.com/articles/tcbp-awarded-non-dilutive-funding-scalereadys-g-rex-grant 2024-11-14 19:06:17.32607+00 https://www.pharmasalmanac.com/articles/broad-clinical-labs-and-genomes2veterans-partner-on-veterans-affairs-prostate-cancer-genetic-risk-and-equitable-screening-study 2024-11-14 19:05:10.880494+00 https://www.pharmasalmanac.com/articles/flagship-pioneering-appoints-craig-williams-as-ceo-partner-and-chief-executive-officer-of-apriori-bio 2024-11-13 15:28:52.662265+00 https://www.pharmasalmanac.com/articles/state-of-the-art-multi-modality-bioanalysis-in-brisbane 2024-11-12 17:57:18.259051+00 https://www.pharmasalmanac.com/articles/primal-organixs-nutraceutical-approach-to-better-mental-health 2024-11-12 17:01:48.011986+00 https://www.pharmasalmanac.com/articles/supporting-oral-solid-development-in-australia-and-beyond 2024-11-12 16:56:19.529868+00 https://www.pharmasalmanac.com/articles/metabolon-services-used-in-pioneering-multiomic-research-on-brain-metabolism-and-neurodegenerative-disorders 2024-11-12 15:23:47.911748+00 https://www.pharmasalmanac.com/articles/cryoport-expands-integricell-cryopreservation-services-solution-with-opening-of-new-center-of-excellence-in-europe 2024-11-12 15:20:37.657426+00 https://www.pharmasalmanac.com/articles/moleculin-receives-institutional-review-approval-for-miracle-phase-3-pivotal-trial-of-annamycin-for-the-treatment 2024-11-12 15:00:42.788572+00 https://www.pharmasalmanac.com/articles/chime-biologics-and-waterstone-jointly-develop-and-manufacture-antibody-drug-conjugate-adc 2024-11-12 14:57:13.937627+00 https://www.pharmasalmanac.com/articles/ginkgo-bioworks-advances-collaboration-with-merck-to-improve-biologics-manufacturing 2024-11-12 14:48:10.904154+00 https://www.pharmasalmanac.com/articles/genezen-welcomes-industry-experts-dr-pam-stetkiewicz-and-stuart-auerbach-to-board-of-directors 2024-11-11 22:47:05.176164+00 https://www.pharmasalmanac.com/articles/nektar-presents-late-breaking-results-from-phase-2-study-of-nktr-255-for-the-treatment-of-radiation-induced-lymphopenia 2024-11-08 17:20:54.033838+00 https://www.pharmasalmanac.com/articles/carisma-unveils-promising-pre-clinical-data-on-anti-gpc3-in-vivo-car-m-therapy-for-hepatocellular-carcinoma 2024-11-08 17:17:30.904635+00 https://www.pharmasalmanac.com/articles/how-is-the-pharmaceutical-industry-integrating-innovations-from-adjacent-industries-to-enhance-drug-development-and-production 2024-11-08 17:10:55.176324+00 https://www.pharmasalmanac.com/articles/can-you-discuss-the-anticipated-impacts-of-the-biosecure-act-on-the-biopharmaceutical-landscape 2024-11-08 17:09:28.046077+00 https://www.pharmasalmanac.com/articles/bio-techne-to-present-at-investor-conferences 2024-11-08 16:02:35.225155+00 https://www.pharmasalmanac.com/articles/samsung-biologics-earns-iso-certifications-in-recognition-of-business-excellence 2024-11-08 15:51:23.092878+00 https://www.pharmasalmanac.com/articles/celebrating-more-than-a-decade-of-excellence-at-the-world-adc-awards-winners-announcement 2024-11-08 15:38:47.062849+00 https://www.pharmasalmanac.com/articles/periodontal-disease-treatment-market-to-hit-usd-363-billion-by-2030-with-59-cagr-marketsandmarkets 2024-11-07 22:19:13.057486+00 https://www.pharmasalmanac.com/articles/global-hla-typing-for-transplant-market-to-reach-usd-21-billion-by-2031-driven-by-advancements-in-diagnostic-technologies 2024-11-07 20:47:55.227926+00 https://www.pharmasalmanac.com/articles/genomoncology-and-genomenon-partner-to-enhance-germline-variant-classification-and-genomic-reporting 2024-11-07 17:55:17.389284+00 https://www.pharmasalmanac.com/articles/huidagene-therapeutics-receives-the-first-ever-fda-clearance-of-crisprcas13-rna-editing-hg202-for-macular-degeneration 2024-11-07 17:40:10.757819+00 https://www.pharmasalmanac.com/articles/i-mab-appoints-sean-fu-phd-mba-as-chief-executive-officer 2024-11-07 17:17:06.514754+00 https://www.pharmasalmanac.com/articles/transposon-to-present-results-from-phase-2-study-for-the-treatment-of-alsftd-at-the-7th-annual-als-one-research-symposium 2024-11-07 16:20:59.888665+00 https://www.pharmasalmanac.com/articles/precision-biologics-to-announce-development-of-new-monoclonal-antibody-mab-pb-223-at-sitc-houston-tx-november-7-8-2024 2024-11-07 16:03:54.486412+00 https://www.pharmasalmanac.com/articles/microbiologics-acquires-sensid-expanding-expertise-in-diagnostic-quality-controls 2024-11-06 22:56:27.375128+00 https://www.pharmasalmanac.com/articles/modernizing-dated-approaches-to-oncology-care 2024-11-06 12:48:56.781146+00 https://www.pharmasalmanac.com/articles/university-industry-partnerships-tackling-genetic-disease-therapies-and-diagnostic-innovation 2024-11-06 12:48:48.548983+00 https://www.pharmasalmanac.com/articles/avicena-systems-cutting-edge-biopreparedness-and-testing-platform 2024-11-06 12:48:39.665256+00 https://www.pharmasalmanac.com/articles/reshaping-the-approach-to-therapeutic-development-with-i-bodies 2024-11-06 12:48:30.522405+00 https://www.pharmasalmanac.com/articles/more-efficient-and-cost-effective-clinical-trials-down-under 2024-11-06 12:48:20.09831+00 https://www.pharmasalmanac.com/articles/the-partnerships-powering-next-gen-oncology-care 2024-11-06 12:47:58.401236+00 https://www.pharmasalmanac.com/articles/the-groundbreaking-potential-of-crispr-gene-editing 2024-11-05 21:02:52.883455+00 https://www.pharmasalmanac.com/articles/celebrating-a-decade-of-oncology-innovation-at-onj 2024-11-05 21:02:43.399205+00 https://www.pharmasalmanac.com/articles/new-select-trial-analysis-with-semaglutide-24-mg-showed-a-reduction-in-hospital-admissions-with-heart-disease-and-overweight 2024-11-05 19:42:52.953103+00 https://www.pharmasalmanac.com/articles/oncoresponse-to-present-phase-1-results-of-clinical-study-of-or502-anti-lilrb2-antibody-as-a-late-breaker-poster 2024-11-05 19:07:31.638269+00 https://www.pharmasalmanac.com/articles/understanding-the-challenges-in-tackling-melanoma-and-other-forms-of-cancer 2024-11-05 17:18:20.126014+00 https://www.pharmasalmanac.com/articles/up-close-and-personal-with-scientists-on-the-cutting-edge-of-melanoma-research 2024-11-05 17:18:02.556932+00 https://www.pharmasalmanac.com/articles/olon-is-ready-to-host-productions-in-the-new-facility-dedicated-to-ultra-potent-compounds 2024-11-04 20:26:41.575993+00 https://www.pharmasalmanac.com/articles/neurocrine-biosciences-presents-breadth-of-data-over-time-following-treatment-with-ingrezza-capsules 2024-11-04 20:05:14.205407+00 https://www.pharmasalmanac.com/articles/propharma-group-is-supporting-better-clinical-outcomes-down-under 2024-11-04 19:43:00.316536+00 https://www.pharmasalmanac.com/articles/one-of-our-first-looks-at-the-burgeoning-australia-biotech-ecosystem 2024-11-04 19:42:47.269127+00 https://www.pharmasalmanac.com/articles/road-tripping-is-much-easier-with-your-own-mechanic-on-hand 2024-11-04 16:36:55.159136+00 https://www.pharmasalmanac.com/articles/why-storage-and-quality-go-hand-in-hand-in-advancing-therapies 2024-11-04 16:36:41.694734+00 https://www.pharmasalmanac.com/articles/eisai-completes-submission-to-us-fda-for-leqembi-application-for-maintenance-dosing-for-the-treatment-of-early-alzheimers-disease 2024-11-04 03:02:55.526624+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-wins-supply-chain-excellence-award-for-digital-platform-to-manage-clinical-trials-and-commercial-lifespans 2024-10-30 16:13:00.995172+00 https://www.pharmasalmanac.com/articles/pharma-tech-industries-names-darrin-t-schellin-new-ceo 2024-10-30 16:11:41.486792+00 https://www.pharmasalmanac.com/articles/designing-quality-into-biomanufacturing 2024-10-29 19:44:23.763733+00 https://www.pharmasalmanac.com/articles/passion-and-understanding-essential-for-rare-disease-clinical-trials 2024-10-29 19:44:06.420406+00 https://www.pharmasalmanac.com/articles/kicking-off-road-to-the-max 2024-10-29 19:23:01.156511+00 https://www.pharmasalmanac.com/articles/artificial-intelligence-in-biotechnology-market-to-hit-usd-775-billion-by-2029-with-191-cagr-marketsandmarkets 2024-10-29 19:17:34.196547+00 https://www.pharmasalmanac.com/articles/chime-biologics-and-medpacto-form-strategic-partnership-to-accelerate-global-biologics-development-and-manufacturing 2024-10-29 19:04:45.489236+00 https://www.pharmasalmanac.com/articles/abbvie-to-acquire-aliada-therapeutics-strengthening-focus-in-alzheimers-disease-and-neuroscience-pipeline 2024-10-29 18:47:36.16848+00 https://www.pharmasalmanac.com/articles/tremfya-is-the-first-and-only-il-23-inhibitor-to-demonstrate-robust-results-with-regimen-in-both-induction-and-maintenance 2024-10-28 21:56:47.073657+00 https://www.pharmasalmanac.com/articles/poseida-therapeutics-to-present-new-preclinical-data-supporting-non-viral-gene-for-the-treatment-of-hereditary-angioedema 2024-10-25 16:14:39.068556+00 https://www.pharmasalmanac.com/articles/skyhawk-therapeutics-presents-compelling-preclinical-data-at-the-molecular-targets-and-cancer-therapeutics-symposium 2024-10-25 15:57:33.770206+00 https://www.pharmasalmanac.com/articles/abbott-initiates-new-clinical-trial-to-improve-outcomes-in-patients-with-advanced-heart-failure 2024-10-25 15:36:24.109262+00 https://www.pharmasalmanac.com/articles/childrens-hospital-of-philadelphia-researchers-find-promising-new-immunotherapy-target-in-neuroblastoma-and-other-cancers 2024-10-25 15:20:59.342646+00 https://www.pharmasalmanac.com/articles/a-new-vision-for-progressing-advanced-therapies 2024-10-25 11:41:51.359667+00 https://www.pharmasalmanac.com/articles/sk-bioscience-announces-approval-of-its-quadrivalent-influenza-vaccine-in-indonesia 2024-10-23 21:16:25.456872+00 https://www.pharmasalmanac.com/articles/samsung-biologics-reports-third-quarter-2024-financial-results 2024-10-23 20:53:59.331613+00 https://www.pharmasalmanac.com/articles/dotmatics-introduces-luma-antibody-and-protein-engineering-solution-for-end-to-end-antibody-discovery 2024-10-22 21:24:39.731329+00 https://www.pharmasalmanac.com/articles/cryoport-and-gulf-coast-regional-blood-center-launch-strategic-alliance-to-enhance-cellular-therapy-services 2024-10-22 21:06:19.998201+00 https://www.pharmasalmanac.com/articles/mikart-adds-nitrogen-purged-capability-to-liquid-and-suspension-suites 2024-10-22 20:17:28.726013+00 https://www.pharmasalmanac.com/articles/navigating-the-complex-landscape-of-oncology-trials 2024-10-22 18:33:25.534243+00 https://www.pharmasalmanac.com/articles/pioneering-innovation-in-pharmaceutical-lyophilization 2024-10-22 14:07:50.924779+00 https://www.pharmasalmanac.com/articles/inovio-announces-new-data-at-scientific-conferences-for-lead-candidate-ino-3107-as-a-potential-treatment-for-rrp 2024-10-21 20:49:28.58131+00 https://www.pharmasalmanac.com/articles/life-sciences-and-cryoport-form-partnership-to-elevate-standards-for-frozen-egg-embryo-etc-offsite-storage-and-biologistics 2024-10-21 20:26:25.772597+00 https://www.pharmasalmanac.com/articles/mobilion-systems-unveils-novel-high-resolution-mass-spectrometry-functionality-for-proteomics-workflows 2024-10-21 20:00:32.027707+00 https://www.pharmasalmanac.com/articles/why-life-science-companies-surged-amid-a-global-manda-downturn 2024-10-18 19:18:44.826031+00 https://www.pharmasalmanac.com/articles/enabling-stable-high-viscosity-injectable-drug-products-with-new-excipient-combinations 2024-10-18 18:00:30.046574+00 https://www.pharmasalmanac.com/articles/abbvie-receives-a-positive-recommendation-from-the-cadth-canadian-drug-expert-committee-for-maviret 2024-10-18 18:00:14.901529+00 https://www.pharmasalmanac.com/articles/how-is-pii-preparing-to-face-the-future-of-healthcare 2024-10-18 17:57:46.34291+00 https://www.pharmasalmanac.com/articles/how-is-spi-pharma-preparing-to-face-the-future-of-healthcare 2024-10-18 17:56:29.048537+00 https://www.pharmasalmanac.com/articles/how-is-federal-equipment-company-preparing-to-face-the-future-of-healthcare 2024-10-18 17:55:51.518502+00 https://www.pharmasalmanac.com/articles/how-is-sanaclis-preparing-to-face-the-future-of-healthcare 2024-10-18 17:53:41.750244+00 https://www.pharmasalmanac.com/articles/how-is-olon-preparing-to-face-the-future-of-healthcare 2024-10-18 17:52:18.84759+00 https://www.pharmasalmanac.com/articles/overcoming-challenges-in-the-complex-market-for-clinical-trials-and-clinical-logistics 2024-10-18 17:51:44.609763+00 https://www.pharmasalmanac.com/articles/ensuring-confidence-in-viral-vector-manufacturing 2024-10-18 17:51:07.074074+00 https://www.pharmasalmanac.com/articles/quality-and-experience-crucial-for-sterility-assurance 2024-10-18 17:50:37.401034+00 https://www.pharmasalmanac.com/articles/investing-in-new-technologies-for-innovative-functional-solutions 2024-10-18 17:50:05.193394+00 https://www.pharmasalmanac.com/articles/manda-activity-in-a-fragmented-cdmo-market 2024-10-18 17:49:12.883313+00 https://www.pharmasalmanac.com/articles/hard-shell-capsule-solutions-for-sensitive-compounds-a-focus-on-probiotics 2024-10-18 17:48:38.07938+00 https://www.pharmasalmanac.com/articles/evolution-is-essential-in-the-dynamic-pharmaceutical-industry 2024-10-18 17:46:47.13654+00 https://www.pharmasalmanac.com/articles/an-randd-engine-for-novel-immune-therapies 2024-10-18 17:45:12.53716+00 https://www.pharmasalmanac.com/articles/rna-biomarkers-for-early-lung-cancer-diagnosis 2024-10-18 17:43:42.793568+00 https://www.pharmasalmanac.com/articles/leveraging-bioinformatics-for-nontraditional-drug-discovery 2024-10-18 17:42:33.907169+00 https://www.pharmasalmanac.com/articles/a-new-approach-for-diseases-associated-with-bh4-dependent-enzymatic-pathways 2024-10-18 17:41:07.267893+00 https://www.pharmasalmanac.com/articles/function-and-form-advanced-pharma-packaging-design-and-processing 2024-10-18 17:40:00.274702+00 https://www.pharmasalmanac.com/articles/quality-and-reliability-will-continue-to-drive-outsourcing-relationships-in-2013 2024-10-18 17:38:46.170495+00 https://www.pharmasalmanac.com/articles/evolving-strategic-partnership-models 2024-10-18 17:38:05.57532+00 https://www.pharmasalmanac.com/articles/nice-insight-overview-the-key-to-pharmas-next-generation-success 2024-10-18 17:37:29.566999+00 https://www.pharmasalmanac.com/articles/specialized-know-how-and-capacity-to-support-demand-for-oncolytic-viruses 2024-10-18 17:36:38.845367+00 https://www.pharmasalmanac.com/articles/nantkwest-harnessing-natural-killer-cells-to-treat-cancer 2024-10-18 17:35:59.062825+00 https://www.pharmasalmanac.com/articles/a-maturing-gene-and-cell-therapy-market-drives-interest-in-acquisitions 2024-10-18 17:35:10.178955+00 https://www.pharmasalmanac.com/articles/how-to-tell-if-youre-using-a-quality-hard-capsule 2024-10-18 17:33:54.545269+00 https://www.pharmasalmanac.com/articles/something-special-reporting-from-cphi 2024-10-18 17:33:12.5187+00 https://www.pharmasalmanac.com/articles/cancers-new-foesnovel-oncology-approaches-in-the-battle-against-cancer 2024-10-18 17:32:32.666104+00 https://www.pharmasalmanac.com/articles/implementing-ready-to-use-glass-vials-for-flexible-aseptic-filling 2024-10-18 17:32:01.229085+00 https://www.pharmasalmanac.com/articles/how-is-sgd-pharma-preparing-to-face-the-future-of-healthcare 2024-10-18 17:31:28.248121+00 https://www.pharmasalmanac.com/articles/expanding-sterile-crystallization-capabilities-to-meet-rising-customer-demand 2024-10-18 17:30:42.490147+00 https://www.pharmasalmanac.com/articles/accelerated-innovation-is-the-key-to-the-uks-post-brexit-life-sciences-leadership 2024-10-18 17:29:32.950117+00 https://www.pharmasalmanac.com/articles/pharmaceutics-know-how-and-service-excellence-to-re-energize-a-cdmo 2024-10-18 17:19:14.832024+00 https://www.pharmasalmanac.com/articles/analytical-method-development-key-to-process-development 2024-10-18 17:18:33.891821+00 https://www.pharmasalmanac.com/articles/how-is-trirx-preparing-to-face-the-future-of-healthcare 2024-10-18 17:17:25.679053+00 https://www.pharmasalmanac.com/articles/process-performance-qualification-prep-a-strategic-approach-leads-to-success 2024-10-18 17:15:52.064558+00 https://www.pharmasalmanac.com/articles/a-vision-for-achieving-worldwide-biopharmaceutical-cdmo-leadership 2024-10-18 17:14:56.42243+00 https://www.pharmasalmanac.com/articles/strategic-facility-planning-for-cell-and-gene-therapy-facilities 2024-10-18 17:12:48.150959+00 https://www.pharmasalmanac.com/articles/cenexi-a-brand-evolution 2024-10-18 17:11:30.13439+00 https://www.pharmasalmanac.com/articles/the-value-of-experience-and-strategic-thinking 2024-10-18 17:10:45.911231+00 https://www.pharmasalmanac.com/articles/applying-advanced-protein-engineering-technologies-to-biotherapeutic-development 2024-10-18 17:10:02.34377+00 https://www.pharmasalmanac.com/articles/quality-by-design-transforming-21st-century-pharmaceutical-manufacturing 2024-10-18 17:09:16.804632+00 https://www.pharmasalmanac.com/articles/track-and-trace-systems-for-serialization-and-aggregation 2024-10-18 17:08:35.493419+00 https://www.pharmasalmanac.com/articles/facilitating-pharma-licensing-and-partnering 2024-10-18 17:07:41.571734+00 https://www.pharmasalmanac.com/articles/reaping-the-benefits-of-economies-of-scale 2024-10-18 17:04:00.814213+00 https://www.pharmasalmanac.com/articles/environmental-monitoring-benefits-from-technological-innovation 2024-10-18 17:02:25.111679+00 https://www.pharmasalmanac.com/articles/sustainable-strategies-for-contract-development-and-manufacturing-service-growth 2024-10-18 17:00:58.796786+00 https://www.pharmasalmanac.com/articles/the-future-of-the-cdmo-market-the-art-of-the-possible 2024-10-18 16:59:34.758489+00 https://www.pharmasalmanac.com/articles/understanding-a-dynamic-industry-through-mergers-and-acquisitions 2024-10-18 16:58:34.923036+00 https://www.pharmasalmanac.com/articles/remembering-the-details-partnering-with-an-equipment-supplier-during-a-merger-or-acquisition 2024-10-18 16:57:39.21569+00 https://www.pharmasalmanac.com/articles/benefits-of-integrated-small-volume-manufacturing-capabilities 2024-10-18 16:56:32.476279+00 https://www.pharmasalmanac.com/articles/how-close-is-crispr-to-eradicating-disease-and-correcting-genetic-defects 2024-10-18 16:55:44.661228+00 https://www.pharmasalmanac.com/articles/current-trends-and-future-prospects-in-outsourced-pharmaceutical-manufacturing 2024-10-18 16:55:10.571184+00 https://www.pharmasalmanac.com/articles/visualizing-the-future-of-contract-development-and-manufacturing-for-cell-and-gene-therapies 2024-10-18 16:54:12.328959+00 https://www.pharmasalmanac.com/articles/a-look-back-at-the-road-to-bio 2024-10-18 16:53:12.514939+00 https://www.pharmasalmanac.com/articles/exploring-europe-on-the-road-to-cphi-milano 2024-10-18 16:45:27.668743+00 https://www.pharmasalmanac.com/articles/impurity-identification-in-small-molecule-apis 2024-10-18 16:44:32.320717+00 https://www.pharmasalmanac.com/articles/running-a-cdmo-business-is-hard-so-now-lets-talk-about-value-creation 2024-10-18 16:42:53.794704+00 https://www.pharmasalmanac.com/articles/the-bruker-maldi-biotyper-solution-receives-aoac-international-approvals-for-two-omas-in-food-microbiology 2024-10-18 16:42:20.567677+00 https://www.pharmasalmanac.com/articles/is-the-us-biosimilars-market-poised-for-takeoff 2024-10-18 16:41:34.450249+00 https://www.pharmasalmanac.com/articles/realizing-technology-transfer-in-a-successful-and-sustainable-manner 2024-10-18 16:23:53.034811+00 https://www.pharmasalmanac.com/articles/customer-engagement-and-information-sharing-are-essential-for-success-in-orphan-drug-outsourcing 2024-10-18 16:23:15.552257+00 https://www.pharmasalmanac.com/articles/should-you-choose-a-commercial-hpapi-manufacturer-for-your-clinical-program 2024-10-18 16:22:43.051651+00 https://www.pharmasalmanac.com/articles/joint-venture-contract-services-a-cdmos-approach-to-being-a-true-partner 2024-10-18 16:22:10.646922+00 https://www.pharmasalmanac.com/articles/providing-self-care-experiences-with-functional-cannabis 2024-10-18 16:21:34.231022+00 https://www.pharmasalmanac.com/articles/facilitating-the-commercialization-of-disruptive-industrial-life-science-technologies 2024-10-18 16:21:00.736204+00 https://www.pharmasalmanac.com/articles/business-leadership-a-requirement-for-successful-manda-outcomes 2024-10-18 16:20:13.049648+00 https://www.pharmasalmanac.com/articles/legal-issues-in-licensing-and-manda 2024-10-18 16:19:31.745582+00 https://www.pharmasalmanac.com/articles/putting-pressure-on-quality-research-drug-development-and-cannabis-cbd-products 2024-10-18 16:18:44.909615+00 https://www.pharmasalmanac.com/articles/translating-epigenetic-research-into-promising-cancer-therapies 2024-10-18 16:18:06.771833+00 https://www.pharmasalmanac.com/articles/proving-the-link-between-the-microbiota-and-the-human-immune-system-in-non-human-primates 2024-10-18 16:03:09.717185+00 https://www.pharmasalmanac.com/articles/innovating-to-increase-adherence-for-colon-cancer-screening 2024-10-18 16:02:02.4981+00 https://www.pharmasalmanac.com/articles/cdmo-services-designed-to-support-evolving-pharma-business-models 2024-10-18 16:01:30.414962+00 https://www.pharmasalmanac.com/articles/new-mannitol-formulations-are-a-gem-of-a-collection 2024-10-18 16:01:03.493379+00 https://www.pharmasalmanac.com/articles/manda-fundamental-to-pharma-industry-growth 2024-10-18 16:00:25.413454+00 https://www.pharmasalmanac.com/articles/proprietary-tracking-and-visibility-tools-ensure-secure-transportation 2024-10-18 15:59:54.319451+00 https://www.pharmasalmanac.com/articles/in-their-25th-year-thats-nice-looks-forward-to-the-future-of-healthcare 2024-10-18 15:59:13.471412+00 https://www.pharmasalmanac.com/articles/first-vaccine-carrier-approved-by-world-health-organization-to-prevent-vaccine-freezing-during-transport-commercially-available 2024-10-18 15:58:39.515776+00 https://www.pharmasalmanac.com/articles/revolutionizing-silica-nanoparticle-drug-delivery 2024-10-18 15:57:48.978013+00 https://www.pharmasalmanac.com/articles/artificial-intelligence-in-biopharmaceutical-manufacturing 2024-10-18 15:57:16.494136+00 https://www.pharmasalmanac.com/articles/british-lung-cancer-patients-will-get-access-to-pfizers-vizimpro 2024-10-18 15:56:12.575791+00 https://www.pharmasalmanac.com/articles/hansa-biopharma-announces-exclusive-agreement-with-sarepta-therapeutics-to-develop-imlifidase 2024-10-18 14:28:58.041773+00 https://www.pharmasalmanac.com/articles/takeda-and-enzyre-to-develop-diagnostic-device-allowing-hemophilia-patients-to-determine-their-coagulation-status-at-home2 2024-10-18 14:28:13.134323+00 https://www.pharmasalmanac.com/articles/being-at-the-right-place-at-the-right-time 2024-10-18 14:27:15.848033+00 https://www.pharmasalmanac.com/articles/small-scale-screening-technology-for-amorphous-solid-dispersion-development 2024-10-18 14:26:36.663401+00 https://www.pharmasalmanac.com/articles/is-the-pharma-industry-developing-cultural-intelligence 2024-10-18 14:25:53.589982+00 https://www.pharmasalmanac.com/articles/facilitating-drug-re-innovation-with-artificial-intelligence 2024-10-18 14:25:06.374682+00 https://www.pharmasalmanac.com/articles/amri-solidifying-and-modernizing-brand-identity 2024-10-18 14:24:26.798614+00 https://www.pharmasalmanac.com/articles/healthcare-in-the-european-union 2024-10-18 14:23:27.658026+00 https://www.pharmasalmanac.com/articles/patient-centric-drug-development-designing-medicines-to-succeed 2024-10-18 14:22:01.86228+00 https://www.pharmasalmanac.com/articles/creating-a-global-crdmo-for-the-future-of-biopharma-effective-strategies-and-tactics 2024-10-18 14:21:14.929281+00 https://www.pharmasalmanac.com/articles/nice-insight-annual-pharmaceutical-equipment-report 2024-10-18 14:20:32.637333+00 https://www.pharmasalmanac.com/articles/roche-launches-ce-marked-ventana-mmr-ihc-panel-for-patients-diagnosed-with-colorectal-cancer 2024-10-18 14:19:37.092971+00 https://www.pharmasalmanac.com/articles/novel-equipment-solutions-leading-to-manufacturing-efficiency-and-productivity 2024-10-18 14:18:59.195154+00 https://www.pharmasalmanac.com/articles/innovating-equipment-inline-buffer-dilution-technology 2024-10-18 14:18:11.661921+00 https://www.pharmasalmanac.com/articles/pennsylvanias-doylestown-hospital-selects-eclinicalworks-cloud-based-electronic-health-record-system-for-its-169-providers 2024-10-18 14:14:18.368094+00 https://www.pharmasalmanac.com/articles/future-pharma-partner-models-pharma-30 2024-10-18 14:13:37.776898+00 https://www.pharmasalmanac.com/articles/immune-regulation-announces-rebranding-to-revolo-biotherapeutics-reflecting-a-revolutionary-approach-to-resetting-the-immune-system-to-treat-autoimmune-1614958030347 2024-10-18 11:36:11.142094+00 https://www.pharmasalmanac.com/articles/brukers-molecular-phenomics-research-tools-enable-new-insights-into-long-covid-and-post-acute-metabolic-abnormalities 2024-10-18 11:34:23.769964+00 https://www.pharmasalmanac.com/articles/vaxxas-announces-22-million-award-from-u.s.-government-to-advance-vaxxas-needle-free-hd-map-vaccine-patch-technology-for-pandemic-response 2024-10-18 11:33:04.667098+00 https://www.pharmasalmanac.com/articles/vetter-and-microdermics-will-develop-microneedle-delivery-systems 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-approves-celltrion/teva-bla-for-rituximab-biosimilar 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/nih-awards-318-million-contract-to-develop-hiv-vaccine 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/merck-and-astrazeneca-team-up-to-fight-cancer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/brains-on-line-acquired-by-charles-river-laboratories-for-21-million 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/mallinckrodt-acquires-infacare-pharmaceutical-corporation-for-425-million 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/greenovation-biotech-gmbh-announces-completion-of-its-phase-1-safety-study-for-moss-agal-targeting-fabry-disease 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/road-to-bio-coming-soon-to-your-screen 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-lifts-clinical-hold-on-cellectis-phase-1-clinical-trials-with-ucart123-in-aml-and-bpdcn 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/university-of-michigan-innovates-with-kevlar-cartilage 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/cancer-research-as-art 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/hovione-announces-enrollment-of-first-patient-in-mars-a-phase-2-clinical-trial 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-demonstrates-continuous-commitment-to-its-venture-fund-and-fostering-innovation-by-more-than-doubling-funding-to-250-m 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/promacta-gets-breakthrough-therapy-designation 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/recipharm-expands-stake-in-india 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/evonik-fufeng-partner-to-produce-threonine 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/hovione-strengthens-inhalation-services-portfolio 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/novacap-tmt-enters-into-definitive-agreement-to-acquire-horizon-telcom 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/ppd-names-maria-teresa-hilado-cfo-of-allergan-to-its-board-of-directors 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/dsm-and-evonik-establish-joint-venture-for-omega-3-fatty-acids-from-natural-marine-algae-for-animal-nutrition 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/lonza-to-present-latest-research-into-more-physiologically-relevant-adme-tox-models-at-the-society-of-toxicology-meeting 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-launches-advanced-library-compound-initiative-on-labnetwork.com 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/novartis-receives-fda-approval-for-cosentyx-label-update-to-include-moderate-to-severe-scalp-psoriasis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-demonstrates-their-commitment-to-site-relationships-by-joining-scrs-global-impact-partner-program 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-sta-and-regulus-announce-microrna-development-and-manufacturing-collaboration 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-congratulates-mabspace-on-fda-clearance-of-ind-for-msb2311 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-innovations-offer-greater-connectivity-and-ease-of-use 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/beacon-discovery-announces-multi-year-gpcr-drug-discovery-collaboration-with-takeda-focused-on-gastrointestinal-disorders 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/amgen-receives-positive-chmp-opinion-for-delivery-system-of-neulasta-pegfilgrastim 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/the-ups-store-marken-team-up-for-drop-off-service-for-clinical-trial-samples-in-u.s 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/bmg-pharma-s.r.l-announces-the-launch-of-its-aftacure-gel-and-aftacure-spray- 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/neofluidics-announces-collaboration-with-pfizer-inc 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-named-company-of-the-year-by-selectscience 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/perrigo-announces-final-fda-approval-and-planned-launch-for-the-store-brand-otc-equivalent-of-mucinex-dm-maximum-strength-extended-release-tablets 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/celgene-completes-acquisition-of-juno-therapeutics-inc.-advancing-global-leadership-in-cellular-immunotherapy 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/ge-healthcare-saves-providers-time-and-money-with-more-workflows-and-new-analytics-solutions-powered-by-the-cloud 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/dsm-sinochem-pharmaceuticals-hosts-second-public-private-dialogue-on-combating-antimicrobial-resistance-during-dcat-week 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-grants-fast-track-designation-to-nintedanib-for-the-treatment-of-systemic-sclerosis-with-associated-interstitial-lung-disease 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/ampac-fine-chemicals-announces-new-addition-to-their-executive-team 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/sartorius-stedim-biotech-supports-abl-europe-in-successful-completion-of-viral-vector-gmp-capacity-expansion 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/hovione-reports-on-recent-capacity-expansion-and-future-plans-to-support-growth 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/late-breaking-clinical-trial-data-further-demonstrate-safety-and-effectiveness-of-the-rhythmia-mapping-system 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/favorable-safety-profile-of-pradaxa-dabigatran-etexilate-confirmed-in-large-prospective-real-world-analysis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/abbvie-announces-results-from-phase-2-study-evaluating-rovalpituzumab-tesirine-rova-t- 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/new-als-gene-discovered-kif5a 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/bluebird-bio-and-celgene-corporation-enter-into-agreement-to-co-develop-and-co-promote-anti-bcma-car-t-cell-therapy-bb2121-in-the-united-states 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/outcome-health-and-the-colorectal-cancer-alliance-announce-campaign-to-support-patient-education 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-approves-blincyto-blinatumomab-to-treat-minimal-residual-disease-positive-b-cell-precursor-acute-lymphoblastic-leukemia-in-adults-and-children 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/medicrea-partners-with-key-distributor-to-form-joint-venture-in-belgium 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/sientra-reports-the-long-term-safety-and-effectiveness-of-silicone-gel-breast-implants-with-results-from-the-largest-core-breast-implant-trial-to-date 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/merck-projected-to-spend-the-most-on-licensing-deals-in-2018 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/u.s.-fda-grants-fast-track-designation-to-taris-for-tar-200-gemris-in-muscle-invasive-bladder-cancer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/science-exchange-and-ranomics-collaborate-to-offer-online-access-to-their-variantfindtm-mutagenesis-platform 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/leukocare-and-boehringer-ingelheim-enter-into-a-long-term-agreement-in-the-field-of-animal-health 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/tolero-pharmaceuticals-to-present-preclinical-data-supporting-apoptosis-inducing-activity-of-alvocidib-in-acute-myeloid-leukemia 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/seracare-announces-expansion-of-industrys-most-complete-and-patient-like-ctdna-reference-materials 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/evotec-and-bayer-advance-third-endometriosis-programme-into-phase-i-clinical-development 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/roche-expands-indication-for-cobas-egfr-mutation-test-v2-as-a-companion-diagnostic-with-tagrisso 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/pfizer-granted-fda-breakthrough-therapy-designation-for-trumenbameningococcal-group-b-vaccine 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/samsung-announces-commitment-to-lower-dose-exposure-within-its-digital-radiography-suite 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/abbvie-submits-biologics-license-application-to-u.s.-fda-for-investigational-treatment-risankizumab-for-moderate-to-severe-plaque-psoriasis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/parexel-announces-appointment-of-peyton-howell-as-chief-commercial-and-strategy-officer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-sta-to-build-a-new-rd-center-in-shanghai 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-to-invest-325-million-to-build-largest-biomanufacturing-facility-using-single-use-bioreactors-in-ireland 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/praxbind-specific-reversal-agent-for-pradaxa-now-available-in-3200-hospitals-nationwide 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/evotec-and-celgene-enter-into-strategic-oncology-partnership 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/pfizer-begins-a-phase-1/2-study-to-evaluate-respiratory-syncytial-virus-rsv-vaccine 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-approves-new-drug-for-patients-with-chronic-liver-disease-who-have-low-blood-platelets-and-are-undergoing-a-medical-procedure 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-laboratory-testing-division-propelling-innovation-and-better-treatments-for-patients 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/tackling-powder-flow-problems-by-choosing-the-right-equipment 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/recent-developments-in-the-medical-and-legal-cannabis-industry 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/optimapharm-europes-fast-growing-cro-expands-office-network-to-us-and-hungary 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/insomnia-treatment-market-to-gain-valuation-worth-us-7.5-bn-by-2026-persistence-market-research 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/global-gene-therapy-market-opportunity-analysis-and-industry-forecast-2023 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/samus-therapeutics-announces-pu-h71-granted-orphan-drug-designation-and-first-patient-dosed-in-phase-1b-study-in-myelofibrosis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/biomarin-doses-first-participant-in-phase-2-study-of-vosoritide-for-treatment-of-infants-and-young-children-with-achondroplasia 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/array-biopharma-to-present-overall-survival-results-from-the-phase-3-lungevity-takes-step-forward-in-clinical-trial-eligibility-reform-for-lung-cancer-patients 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/grifols-expands-its-nat-solutions-portfolio-with-new-fda-approvals-for-two-assays 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/artemis-therapeutics-announces-two-recent-publications-highlighting-artemisones-activity-against-human-cytomegalovirus-and-malaria 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/numedii-expands-board-of-directors-and-scientific-advisory-board-with-the-addition-of-two-oncology-experts 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/aminex-therapeutics-initiates-first-clinical-trial-of-novel-immunotherapy-amxt-1501-dfmo-in-cancer-patients 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/sanofi-completes-its-acquisition-of-ablynx-following-the-expiration-of-the-squeeze-out-procedure 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/west-appoints-bernard-birkett-to-chief-financial-officer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/roche-and-foundation-medicine-reach-definitive-merger-agreement-to-accelerate-broad-availability-of-comprehensive-genomic-profiling-in-oncology 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/oramed-initiates-food-effect-study-for-its-oral-insulin-capsule-ormd-0801 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/bnbuilders-completes-construction-on-vertex-pharmaceuticals-research-center-in-san-diego 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/kaleido-raises-more-money-for-development-of-microbiome-based-therapeutics 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/india-gets-first-immunotherapy-for-lung-cancer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/automated-insulin-delivery-system-approved-for-use-by-more-pediatric-patients 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/javara-launches-next-generation-integrated-clinical-trials-platform 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/abbvie-and-calico-announce-extension-of-groundbreaking-collaboration 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/distek-inc.-releases-the-prepengine-mini-sample-prep-station 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/microbiology-testing-market-to-grow-at-6.4-cagr-to-2023 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/cannabics-pharmaceuticals-enters-a-memorandum-of-understanding-with-clinical-stage-biopharmaceutical-company-focused-on-the-treatment-of-ophthalmic-disorders 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/broad-and-bayer-expand-partnership-launching-new-research-effort-to-develop-therapies-for-heart-failure 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/bc-platforms-and-tieto-partner-to-integrate-genomic-and-clinical-data-to-advance-precision-medicine 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/biogen-exercises-option-to-increase-ownership-in-samsung-bioepis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/governor-murphy-announces-teva-pharmaceuticals-to-locate-us-headquarters-in-new-jersey 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/bausch-lomb-announces-u.s.-fda-filing-acceptance-for-loteprednol-etabonate-ophthalmic-gel-0.38 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/medline-announces-acquisition-of-neurogym-technologies 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/otsuka-pharmaceutical-to-acquire-visterra 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/cstones-pd-1-inhibitor-cs1003-receives-clinical-trial-approval-in-china 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/natera-announces-pricing-of-follow-on-offering 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-approves-the-first-drug-with-an-indication-for-treatment-of-smallpox 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/braeburn-announces-pdufa-date-for-cam2038-for-the-treatment-of-opioid-use-disorder 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/novartis-kisqali-now-first-and-only-cdk4/6-inhibitor-indicated-in-us 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/new-nature-medicine-study-demonstrates-ability-of-the-guardant360-assay-to-predict-patient-response-to-immunotherapy-in-advanced-gastric-cancer-patients 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/allergan-receives-fda-fast-track-designation-for-agn-241751-for-the-treatment-of-major-depressive-disorder-mdd 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/amneal-announces-fda-approval-and-launch-of-generic-potassium-chloride-oral-solution 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/braftovi-encorafenib-mektovi-binimetinib-receives-positive-chmp-opinion-for-advanced-braf-mutant-melanoma 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/glenmark-pharmaceuticals-and-harbour-biomed-sign-agreement-for-greater-china-to-develop-gbr-1302 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/trovagene-announces-completion-of-second-dosing-cohort-of-patients-treated-with-onvansertib-pcm-075-in-ongoing-phase-1b/2-aml-trial 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/eisai-and-merck-announce-fda-approval-of-lenvima-lenvatinib-capsules-for-first-line-treatment-of-unresectable-hepatocellular-carcinoma-hcc 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/researchers-make-major-breakthrough-in-controlling-the-3d-structure-of-molecules 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-takes-important-steps-to-encourage-appropriate-and-rational-prescribing-of-opioids 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/medtronic-to-acquire-mazor-robotics 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/one-year-results-from-real-world-study-showed-abbotts-portico-transcatheter-aortic-valve-safely-and-successfully-reduced-severe-aortic-stenosis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/neovasc-announces-collaboration-and-licensing-agreement-with-penn-medicine-and-the-gorman-cardiovascular-research-group 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/first-light-biosciences-develops-a-novel-method-for-rapidly-determining-effective-antibiotics-for-treating-infections 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/international-center-for-materials-nanoarchitectonics-ebulletin-next-generation-innovative-organic-electronics 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/the-va-recognizes-ketamine-as-an-emergency-treatment-for-ptsd-and-depression-patients-at-high-suicide-risk 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/increasing-number-of-cancer-cases-to-fuel-the-global-cancer-immunotherapy-market-growth 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/shining-a-light-on-depression-how-infrared-light-can-treat-depression 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/zynex-obtains-u.s.-patent-for-blood-volume-monitor 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/global-proton-therapy-market-forecast-2018-2024-europe-will-significantly-drive-the-global-proton-therapy-market-due-to-the-rising-number-of-proton-therapy-centers 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-approves-grifols-id-core-xt-test-for-molecular-red-blood-cell-typing 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/clarivate-analytics-launches-cortellis-cmc-intelligence-to-expand-drug-availability-in-low-and-middle-income-countries 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/targovax-reports-encouraging-disease-free-survival-dfs-data-from-tg01-trial-in-resected-pancreatic-cancer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/microsoft-genomics-ventures-into-the-microbiome-with-eagle-genomics 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/innovent-receives-ind-approval-to-initiate-clinical-trials-in-china-with-sintilimab-in-combination-with-its-biosimilar-to-bevacizumab 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/ghit-fund-welcomes-ono-pharmaceutical-co.-ltd.-as-new-funding-partner 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/cellect-announces-positive-clinical-results 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-fdas-comprehensive-framework-to-reduce-tobacco-related-disease-and-death 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/liquid-biopsy-market-to-reach-3805-mn-globally-by-2023-at-28.9-cagr-says-allied-market-research 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-grants-breakthrough-device-status-for-medibeacons-transdermal-gfr-measurement-system 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/abbott-introduces-the-next-generation-of-influenza-a-b-and-strep-a-assays-with-fastest-ever-time-to-molecular-results 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-elects-new-director-to-board 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/sosei-enters-collaboration-to-combine-pioneering-dna-technologies-with-star-technology-to-accelerate-new-drug-discovery 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-to-present-at-the-credit-suisse-27th-annual-healthcare-conference 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/nextcure-bags-40-million-from-eli-lilly 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/global-crohns-disease-therapeutics-market-to-2025-with-johnson-johnson-services-inc.-pfizer-inc.-allergan-and-abbvie-dominating 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/regen-biopharma-inc.-reports-additional-new-nr2f6-small-molecule-inhibitors 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/infectious-diseases-experts-convene-to-explore-lifesaving-antibiotic-research-methods 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/patients-launch-new-study-to-shed-light-on-egfr-positive-lung-cancers 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/american-diabetes-association-issues-position-statement-on-comprehensive-care-of-pediatric-patients-with-type-2-diabetes 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/kodiak-sciences-announces-third-quarter-2018-financial-results-and-recent-business-highlights 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-specifically-for-patients-with-rare-and-life-threatening-type-of-immune-disease 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/target-pharmasolutions-to-advance-research-in-nash-and-hepatitis-b-through-new-collaboration-with-gilead-sciences 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/3d-systems-medical-workflow-enables-ophearts-mission-with-3d-printed-anatomical-models-for-pediatric-heart-surgeries 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-announces-first-patient-dosed-in-phase-2-study-of-td-1473-in-patients-with-crohns-disease 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/milliporesigma-wins-two-rd-100-awards-for-innovation-in-2018 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/regenxbio-and-rocket-pharmaceuticals-announce-new-license-agreement-for-the-treatment-of-danon-disease-using-nav-aav9-vector 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/first-trial-launches-to-test-effectiveness-of-male-contraceptive-gel 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-abl-bio-enter-an-exclusive-development-and-clinical-manufacturing-partnership-for-multiple-bispecific-antibodies 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/aquestive-therapeutics-announces-late-breaking-findings-of-its-investigational-diazepam-buccal-film-dbf-formulation-in-adults-with-epilepsy 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/late-breaking-clinical-trials-advance-targeted-therapies-for-patients-with-cll-and-multiple-myeloma 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-accepts-filing-of-new-estrogen-free-oral-contraceptive-developed-by-exeltis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/investor-group-purchases-110-acre-pharmaceutical-campus-in-huntsville-alabama 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/histo-scientific-research-laboratories-and-vet-path-services-merge 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/brii-biosciences-builds-innovative-pipeline-forges-public-private-partnerships-to-bring-novel-medicines-to-chinese-patients 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/astellas-launches-xospata-gilteritinib-in-the-u.s.-for-the-treatment-of-adult-patients-with-relapsed/refractory-acute-myeloid-leukemia-aml-with-a-flt3-mutation 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/eiger-announces-prime-designation-granted-by-european-medicines-agency-for-lonafarnib-for-treatment-of-hepatitis-delta-virus-infection 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/rakuten-aspyrian-enrolling-phase-3-trial-of-asp-1929-for-head-and-neck-cancer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/aobiome-therapeutics-expands-intellectual-property-estate-with-issuance-of-u.s.-patent-for-use-of-ammonia-oxidizing-bacteria-aob-for-the-treatment-of-eczema 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/the-global-single-use-bioprocessing-market-is-anticipated-to-reach-revenues-of-approximately-7-billion-by-2024 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/collaborative-medicinal-development-llc-reports-that-lead-drug-modifies-als-progression 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/amgen-makes-all-repatha-evolocumab-device-options-available-in-the-us-at-a-60-percent-reduced-list-price 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/john-theurer-cancer-center-leading-enrollment-for-global-phase-2-wizard-study-evaluating-dsp-7888-in-patients-with-recurrent-glioblastoma 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/analysis-of-medicare-claims-show-benefits-of-hyperbaric-oxygen-therapy-for-diabetic-foot-ulcer-treatment 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/kaneka-invests-in-a-us-based-medical-device-company 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/compliance-at-hovione-annual-inspection-review 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/fda-advances-new-proposed-regulation-to-make-sure-that-sunscreens-are-safe-and-effective 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/u.s.-medical-device-market-reaches-156-billion-mark 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-continues-to-deliver-record-results 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/portage-makes-additional-investment-in-stimunity-s.a-a-paris-based-cancer-immunotherapy-company 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/janssen-submits-supplemental-new-drug-application-to-u.s.-fda-for-invokana-canagliflozin-for-the-treatment-of-chronic-kidney-disease-in-patients-with-type-2-diabetes 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/novo-nordisk-turns-the-switch-on-renewable-energy 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/flatiron-health-appoints-cancer-researcher-and-pharmaceutical-executive-dr.-michael-vasconcelles-as-chief-medical-officer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/roche-receives-chmp-positive-opinion-for-new-tecentriq-based-combination-therapy-as-an-initial-treatment-for-most-common-form-of-advanced-lung-cancer 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/pricing-concerns-already-raised-about-development-treatments-for-peanut-allergies 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/uk-hopes-subscription-payment-model-will-drive-innovation-in-antibiotics 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/juvenescence-completes-100-million-series-b-financing-round 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/genewiz-celebrates-opening-of-european-headquarters-in-germany 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/gho-capital-raises-975m-in-largest-ever-european-healthcare-fund 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/zebra-medical-vision-joins-forces-with-nuance-to-bring-more-ai-to-diagnostic-imaging 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/halix-celebrates-grand-opening-of-its-state-of-the-art-cgmp-facility 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/visual-marketing-strategy-for-libtayo 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/peregrine-pharmaceuticals-announces-name-change-to-avid-bioservices-as-part-of-transition-to-dedicated-contract-development-and-manufacturing-organization-cdmo 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/harvard-bioengineers-biomaterial-based-cancer-immunotherapies-to-be-developed-by-novartis 2024-10-18 06:47:18.063813+00 https://www.pharmasalmanac.com/articles/bioinformatics-solutions-inc.-chooses-science-exchange-as-the-primary-online-channel-to-offer-protein-de-novo-sequencing-services-to-scientists 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/fda-removes-expired-drug-establishment-registrations-and-uncertified-listings-from-its-database 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-receives-manufacturing-leaders-innovation-award 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/dell-boomi-nalta.com-and-digitalangel-partner-to-revolutionise-the-future-of-healthcare 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/biostage-awarded-sbir-fast-track-grant-to-develop-cellspan-esophageal-implant-cei-as-a-novel-treatment-for-esophageal-atresia-in-pediatric-patients 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/vicam-introduces-a-new-method-for-bpa-detection 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/sellas-life-sciences-announces-positive-interim-data-from-phase-2b-neuvax-nelipepimut-s-clinical-trial- 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-lilly-announce-an-academic-collaboration-with-university-of-oxford 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/biogen-and-ionis-expand-strategic-collaboration-to-develop-drug-candidates-for-a-broad-range-of-neurological-diseases 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/novartis-juliet-trial-of-kymriah-demonstrates-more-than-one-year-durability-of-responses-in-adults-with-relapsed-or-refractory-dlbcl 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/dr.-reddys-laboratories-announces-usfda-final-approval-and-launch-of-buprenorphine-and-naloxone-sublingual-film-in-the-u.s.-market 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/the-us-fda-approves-first-supplemental-abbreviated-new-drug-application-sanda-for-glenmark-pharmaceuticals-manufacturing-facility-in-monroe-north-carolina 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/global-transfer-membrane-market-2018-2023-increasing-rd-spending-by-pharmaceutical-and-biotechnology-companies 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/fda-approves-first-drug-comprised-of-an-active-ingredient-derived-from-marijuana-to-treat-rare-severe-forms-of-epilepsy 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/aseptic-sampling-market-worth-1247.0-million-usd-by-2023 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/eisai-announces-fda-approval-of-fycompa-in-pediatric-patients-as-young-as-4-years-old-for-the-treatment-of-partial-onset-seizures 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/global-consumer-spending-on-cannabis-to-rise-as-equity-financing-of-startups-grows 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/fda-authorizes-first-next-generation-sequencing-based-test 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/aivita-biomedical-announces-treatment-of-first-two-patients-in-phase-2-glioblastoma-trial 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/ptc-therapeutics-launches-new-program-to-support-research-projects-in-rare-genetic-disorders 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/startup-gets-significant-funding-to-support-novel-biosensing-technology 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/trump-nominates-fda-commissioner-and-it-isnt-sharpless 2024-10-18 06:45:26.714165+00 https://www.pharmasalmanac.com/articles/how-is-arranta-bio-preparing-to-face-the-future-of-healthcare 2024-10-17 19:08:02.910459+00 https://www.pharmasalmanac.com/articles/embracing-formulation-expertise-to-extend-exclusivity-and-improve-the-patient-experience 2024-10-17 19:07:24.68429+00 https://www.pharmasalmanac.com/articles/integrating-adc-manufacturing-for-the-future 2024-10-17 19:05:38.507666+00 https://www.pharmasalmanac.com/articles/cdmos-crucial-for-bringing-promising-next-generation-therapies-to-market 2024-10-17 19:04:33.623804+00 https://www.pharmasalmanac.com/articles/investment-recovery-for-pharma-equipment-part-2 2024-10-17 19:02:55.274401+00 https://www.pharmasalmanac.com/articles/buying-used-equipment-can-save-time-and-money 2024-10-17 19:01:55.393281+00 https://www.pharmasalmanac.com/articles/microbial-and-biological-decontamination-of-equipment-brings-peace-of-mind 2024-10-17 18:58:41.909744+00 https://www.pharmasalmanac.com/articles/avoiding-the-headaches-of-asset-management-in-pharma 2024-10-17 18:51:34.168515+00 https://www.pharmasalmanac.com/articles/procuring-equipment-at-the-speed-of-business 2024-10-17 18:50:52.234105+00 https://www.pharmasalmanac.com/articles/steps-ahead-planning-for-future-equipment-surpluses-from-the-point-of-procurement 2024-10-17 18:49:59.641653+00 https://www.pharmasalmanac.com/articles/integrated-ancillary-sourcing-services-for-clinical-trials 2024-10-17 18:49:21.675297+00 https://www.pharmasalmanac.com/articles/how-is-avara-preparing-to-face-the-future-of-healthcare 2024-10-17 18:48:42.937317+00 https://www.pharmasalmanac.com/articles/your-project-is-cancelled-what-do-you-do-with-all-that-equipment-you-just-ordered 2024-10-17 18:47:13.836593+00 https://www.pharmasalmanac.com/articles/mrna-synthesis-and-manufacturing-market-to-hit-usd-7383-million-by-2029-with-34-cagr-marketsandmarkets 2024-10-17 16:27:18.587464+00 https://www.pharmasalmanac.com/articles/orasis-pharmaceuticals-announces-licensing-agreement-with-optus-pharmaceuticals-for-commercialization-of-qlosi-04-in-korea 2024-10-17 16:11:33.054879+00 https://www.pharmasalmanac.com/articles/update-on-novavaxs-covid-19-influenza-combination-and-stand-alone-influenza-phase-3-trial 2024-10-17 15:32:55.088134+00 https://www.pharmasalmanac.com/articles/bio-x-cell-announces-board-of-director-appointments 2024-10-17 10:54:46.378436+00 https://www.pharmasalmanac.com/articles/triumvira-immunologics-announces-publication-demonstrating-the-safety-and-efficacy-of-tac-t-cells-targeting-claudin-182 2024-10-16 22:01:01.125998+00 https://www.pharmasalmanac.com/articles/firefly-neuroscience-announces-use-of-its-brain-network-analytics-platform-in-phase-1-study-for-major-depressive-disorder 2024-10-16 12:52:53.010446+00 https://www.pharmasalmanac.com/articles/us-food-and-drug-administration 2024-10-14 18:31:20.300595+00 https://www.pharmasalmanac.com/articles/fda-approves-imuldosa-accord-biopharmas-biosimilar-to-stelara-for-the-treatment-of-chronic-inflammatory-conditions 2024-10-14 17:56:35.906012+00 https://www.pharmasalmanac.com/articles/megabulb-dna-a-non-viral-ssdna-breakthrough-revolutionizing-gene-editing 2024-10-14 16:31:12.83045+00 https://www.pharmasalmanac.com/articles/systimmune-inc-announces-fda-clearance-of-ind-application-for-bl-m11d1-in-relapsedrefractory-acute-myeloid-leukemia 2024-10-14 16:12:11.909834+00 https://www.pharmasalmanac.com/articles/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development 2024-10-14 15:19:25.574972+00 https://www.pharmasalmanac.com/articles/prime-therapeutics-bolsters-its-position-as-industry-leader-with-10-research-studies-at-amcp-nexus-2024 2024-10-11 21:47:34.34338+00 https://www.pharmasalmanac.com/articles/harbour-biomed-announces-the-phase-i-study-results-in-combination-with-toripalimab-in-advanced-melanoma-and-other-solid-tumors 2024-10-11 21:26:05.396631+00 https://www.pharmasalmanac.com/articles/waters-new-bioseparations-tools-accelerate-and-improve-development-of-rna-based-vaccines-and-therapies-using-lc-ms-analysis 2024-10-11 21:16:05.120013+00 https://www.pharmasalmanac.com/articles/revolutionary-cdmo-wheeler-bio-appoints-patrick-lucy-as-ceo 2024-10-11 20:21:45.93456+00 https://www.pharmasalmanac.com/articles/world-adc-san-diego-celebrates-15th-anniversary-with-industry-leading-agenda 2024-10-10 16:15:14.701889+00 https://www.pharmasalmanac.com/articles/genezen-appoints-mike-wourms-as-chief-operations-officer 2024-10-08 15:05:23.416364+00 https://www.pharmasalmanac.com/articles/stemcytes-hpc-cord-blood-receives-rmat-designation-for-long-covid-19-treatment 2024-10-08 02:33:32.985144+00 https://www.pharmasalmanac.com/articles/soligenix-announces-partnership-with-sterling-pharma-solutions 2024-10-07 20:51:50.705806+00 https://www.pharmasalmanac.com/articles/hybryte-expanded-treatment-results-to-be-presented-at-the-european-organisation-for-research-and-treatment-of-cancer-conference 2024-10-07 20:50:42.345247+00 https://www.pharmasalmanac.com/articles/anixa-biosciences-appoints-suyasha-gupta-as-senior-director-of-clinical-development 2024-10-07 20:49:12.832808+00 https://www.pharmasalmanac.com/articles/cryoport-launches-its-integricell-cryopreservation-solution-with-opening-of-new-facility-at-its-houston-campus 2024-10-07 20:48:12.735102+00 https://www.pharmasalmanac.com/articles/innovating-and-collaborating-to-support-biopharma-beyond-the-typical-cdmo 2024-10-07 19:44:02.064388+00 https://www.pharmasalmanac.com/articles/plan-ahead-mastering-your-ai-budget-for-2025-success 2024-10-07 14:41:23.846739+00 https://www.pharmasalmanac.com/articles/leveraging-a-biomanufacturing-legacy-to-support-new-business 2024-10-04 20:30:57.566064+00 https://www.pharmasalmanac.com/articles/halozyme-announces-expansion-of-global-collaboration-and-license-agreement-with-argenx-for-enhanze 2024-10-04 17:53:44.401267+00 https://www.pharmasalmanac.com/articles/harnessing-cdmo-expertise-for-fill-finish-and-inspection-of-sterile-pharmaceuticals 2024-10-04 03:08:31.954926+00 https://www.pharmasalmanac.com/articles/expanding-u.s.-supply-options-for-large-volume-parenterals 2024-10-04 03:04:27.963876+00 https://www.pharmasalmanac.com/articles/continuous-quality-is-essential-in-parenteral-manufacturing 2024-10-04 03:02:00.288247+00 https://www.pharmasalmanac.com/articles/thryv-therapeutics-granted-fda-orphan-drug-designation-for-lqt-1213-in-long-qt-syndrome-treatment 2024-10-03 21:47:17.36083+00 https://www.pharmasalmanac.com/articles/ptc-therapeutics-announces-fda-acceptance-for-filing-of-nda-for-the-treatment-of-pediatric-and-adult-phenylketonuria-patients 2024-10-03 21:18:41.064145+00 https://www.pharmasalmanac.com/articles/sgd-pharma-presents-new-optimized-solutions-at-cphi-worldwide-2024-continuing-its-leadership-in-sustainability-and-innovation 2024-10-01 20:30:44.156651+00 https://www.pharmasalmanac.com/articles/optimized-residual-dsrna-detection-for-mrna-therapeutics 2024-09-30 21:48:54.739712+00 https://www.pharmasalmanac.com/articles/developing-a-toolbox-of-functional-bioassays-for-optimizing-adcc 2024-09-30 21:37:43.117735+00 https://www.pharmasalmanac.com/articles/cphi-ww-olon-will-attend-with-a-stronger-market-position-after-the-two-international-acquisitions 2024-09-30 21:37:22.450255+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-announces-80m-expansion-plan-for-sterile-injectables-facility-in-lexington-kentucky 2024-09-30 18:03:26.734863+00 https://www.pharmasalmanac.com/articles/amd-drugs-market-to-hit-usd-1737-billion-by-2029-with-107-cagr-marketsandmarkets 2024-09-27 21:15:23.8012+00 https://www.pharmasalmanac.com/articles/talvey-and-darzalex-faspro-shows-deep-and-durable-responses-in-patients-with-relapsed-or-refractory-multiple-myeloma 2024-09-27 20:28:16.055706+00 https://www.pharmasalmanac.com/articles/talvey-and-tecvayli-suggests-high-response-rates-in-triple-class-refractory-patients-with-relapsed-or-refractory-multiple-myeloma 2024-09-27 20:03:57.772493+00 https://www.pharmasalmanac.com/articles/qa-building-a-successful-cdmo-brand 2024-09-26 18:54:58.114926+00 https://www.pharmasalmanac.com/articles/from-proof-of-concept-to-commercialization 2024-09-26 18:52:58.114883+00 https://www.pharmasalmanac.com/articles/investing-for-successful-advancement-of-viral-vector-manufacturing 2024-09-26 18:52:23.091743+00 https://www.pharmasalmanac.com/articles/abzelectpro-enables-biopharma-customers-to-reach-their-research-cell-bank-in-10-weeks-with-8gl 2024-09-26 18:16:38.904086+00 https://www.pharmasalmanac.com/articles/abbvie-announces-positive-topline-results-from-phase-3-tempo-1-trial-evaluating-tavapadon-as-a-monotherapy-for-parkinsons-disease 2024-09-26 16:28:20.654485+00 https://www.pharmasalmanac.com/articles/sk-pharmteco-and-cryoport-partner-for-cell-and-gene-therapy-logistics-and-bioservices 2024-09-26 15:49:36.760048+00 https://www.pharmasalmanac.com/articles/reflections-on-a-10-year-journey-in-the-microbiome 2024-09-25 19:53:27.425943+00 https://www.pharmasalmanac.com/articles/building-an-entrepreneurial-society-in-scotland 2024-09-25 19:45:17.944229+00 https://www.pharmasalmanac.com/articles/isolator-design-for-cell-therapy-facilities 2024-09-25 19:44:07.621315+00 https://www.pharmasalmanac.com/articles/integrated-design-and-engineering-focused-on-the-end-goal 2024-09-25 19:42:52.090402+00 https://www.pharmasalmanac.com/articles/true-integration-is-integral-to-providing-one-stop-shop-cdmo-services 2024-09-25 19:41:34.124991+00 https://www.pharmasalmanac.com/articles/meeting-the-growing-need-for-complex-injectable-product-development-and-manufacturing 2024-09-25 19:40:32.970055+00 https://www.pharmasalmanac.com/articles/providing-solutions-at-fair-value-a-spray-drying-case-study 2024-09-25 19:39:06.907684+00 https://www.pharmasalmanac.com/articles/accelerating-approval-and-reducing-costs-of-spray-dried-drugs-through-development-by-design-dbd 2024-09-25 19:37:31.996569+00 https://www.pharmasalmanac.com/articles/enabling-commercial-manufacturing-for-highly-complex-small-molecule-drugs-through-process-engineering-and-technological-innovation 2024-09-25 19:35:06.524529+00 https://www.pharmasalmanac.com/articles/biotech-funding-ups-and-downs 2024-09-25 19:23:34.092386+00 https://www.pharmasalmanac.com/articles/pci-invests-over-365-million-in-facilities-for-supply-of-advanced-drug-delivery-and-drug-device-combination-products 2024-09-24 21:46:17.088776+00 https://www.pharmasalmanac.com/articles/economic-benefits-of-digital-process-development 2024-09-24 15:36:16.086928+00 https://www.pharmasalmanac.com/articles/wheeler-bio-licenses-atums-mifuc-technology-to-expand-their-portable-cmc-platform-capabilities 2024-09-24 14:57:54.179328+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-niemann-pick-disease-type-c 2024-09-23 20:51:38.20496+00 https://www.pharmasalmanac.com/articles/immusoft-to-announce-positive-phase-1-data-for-first-engineered-b-cell-therapy-in-a-clinical-trial 2024-09-23 20:51:20.211738+00 https://www.pharmasalmanac.com/articles/ucb-announces-fda-approvals-for-bimzelx-for-psoriatic-arthritis-axial-spondyloarthritis-and-ankylosing-spondylitis 2024-09-23 20:51:05.952046+00 https://www.pharmasalmanac.com/articles/actinium-pharmaceuticals-announces-publication-of-results-from-the-phase-3-sierra-trial-of-iomab-b-in-clinical-oncology 2024-09-20 19:22:00.257374+00 https://www.pharmasalmanac.com/articles/transforming-drug-development-through-a-female-perspective 2024-09-18 16:05:43.462873+00 https://www.pharmasalmanac.com/articles/development-strategies-for-overcoming-commercialization-challenges 2024-09-17 20:19:17.14664+00 https://www.pharmasalmanac.com/articles/seran-bioscience-announces-200-million-strategic-growth-transaction-and-plans-for-new-commercial-facility 2024-09-17 20:14:19.288575+00 https://www.pharmasalmanac.com/articles/minervax-and-wacker-biotech-announce-manufacturing-collaboration-for-prophylactic-vaccine-targeting-group-b-streptococcus 2024-09-17 20:13:59.22533+00 https://www.pharmasalmanac.com/articles/kyverna-therapeutics-announces-leadership-update 2024-09-16 20:59:14.907446+00 https://www.pharmasalmanac.com/articles/kairos-pharma-prices-62-million-initial-public-offering 2024-09-16 20:59:01.771708+00 https://www.pharmasalmanac.com/articles/piramal-pharmas-ghg-commitment-validated-and-approved-by-sbti 2024-09-16 19:12:01.143155+00 https://www.pharmasalmanac.com/articles/the-shift-from-early-to-late-phase-ophthalmology-retina-market-in-2024-proactive-planning-for-late-stage-clinical-success 2024-09-16 18:45:07.142997+00 https://www.pharmasalmanac.com/articles/doe-for-clone-selection-and-process-development-to-meet-biosimilar-critical-qualities-attributes-and-high-productivity 2024-09-12 18:52:24.193676+00 https://www.pharmasalmanac.com/articles/harnessing-longitudinal-data-for-better-healthcare-outcomes-in-long-term-care 2024-09-11 14:40:20.559911+00 https://www.pharmasalmanac.com/articles/leveraging-risk-assessment-for-demonstrating-product-comparability-after-manufacturing-process-changes 2024-09-11 14:39:25.91876+00 https://www.pharmasalmanac.com/articles/firefly-neuroscience-announces-partnership-to-integrate-and-distribute-its-bna-technology-with-zetos-eeg-device-platform 2024-09-10 20:28:20.817603+00 https://www.pharmasalmanac.com/articles/building-on-a-pioneering-biomanufacturing-legacy-with-client-centricity 2024-09-09 11:43:53.213191+00 https://www.pharmasalmanac.com/articles/statement-on-fdas-request-for-information-on-requiring-fixed-quantity-blister-packaging-for-certain-opioid-pain-medicines 2024-09-05 19:58:18.489217+00 https://www.pharmasalmanac.com/articles/soligenix-announces-phase-3-flash-study-continues-to-demonstrate-positive-benefits-in-patients-with-cutaneous-t-cell-lymphoma 2024-09-05 19:52:35.443636+00 https://www.pharmasalmanac.com/articles/ocugen-secures-manufacturing-partnership-for-us-production-of-covid-19-vaccine-candidate-covaxin 2024-09-05 19:32:02.328758+00 https://www.pharmasalmanac.com/articles/nuvo-pharmaceuticals-ireland-limited-acquires-u.s.-product-rights-to-resultz-from-piedmont-pharmaceuticals-llc 2024-09-05 19:31:32.714947+00 https://www.pharmasalmanac.com/articles/probiotic-ingredients-market-worth-over-3-billion-by-2024-global-market-insights-inc 2024-09-05 19:01:06.060989+00 https://www.pharmasalmanac.com/articles/gilead-and-novo-nordisk-present-new-data-from-proof-of-concept-trial-in-nash 2024-09-05 19:00:35.266672+00 https://www.pharmasalmanac.com/articles/fda-approves-trodelvy-the-first-treatment-for-metastatic-triple-negative-breast-cancer-shown-to-improve-progression-free-survival-and-overall-survival 2024-09-05 19:00:35.266672+00 https://www.pharmasalmanac.com/articles/emerging-medical-device-market-expected-to-exceed-400-billion-by-2023 2024-09-05 18:58:40.752094+00 https://www.pharmasalmanac.com/articles/overlooked-molecular-machine-in-cell-nucleus-may-hold-key-to-treating-aggressive-leukemia 2024-09-05 18:49:50.838889+00 https://www.pharmasalmanac.com/articles/tanvex-appoints-biopharma-industry-veteran-stephen-lam-as-ceo 2024-09-05 18:04:50.940996+00 https://www.pharmasalmanac.com/articles/lilly-and-incytes-baricitinib-improved-hair-regrowth-for-alopecia-areata-patients-in-second-phase-3-study 2024-09-05 11:53:22.954414+00 https://www.pharmasalmanac.com/articles/transforming-precision-medicine-through-a-high-resolution-temporal-exposome-platform 2024-09-05 10:49:15.562871+00 https://www.pharmasalmanac.com/articles/breakthrough-results-for-jardiance-empagliflozin-confirm-emperor-preserved-as-first-and-only-successful-trial-for-heart-failure-with-preserved-ejection-fraction 2024-09-05 10:13:27.408214+00 https://www.pharmasalmanac.com/articles/lilly-to-present-phase-3-data-at-ahs-2018-highlighting-innovative-potential-treatments-for-migraine-and-cluster-headache 2024-09-05 09:55:05.113856+00 https://www.pharmasalmanac.com/articles/dermira-receives-fda-approval-for-qbrexza-glycopyrronium-cloth-to-treat-primary-axillary-hyperhidrosis 2024-09-05 09:55:05.113856+00 https://www.pharmasalmanac.com/articles/lilly-announces-extension-of-cancer-research-collaboration-with-dana-farber-cancer-institute 2024-09-05 09:55:05.113856+00 https://www.pharmasalmanac.com/articles/stratford-pharmaceuticals-llc-acquired-by-eli-global 2024-09-05 09:55:05.113856+00 https://www.pharmasalmanac.com/articles/new-data-showcasing-lillys-growing-commitment-in-rheumatology-to-be-featured-at-the-acr/arhp-annual-meeting 2024-09-05 09:55:05.113856+00 https://www.pharmasalmanac.com/articles/baricitinib-receives-emergency-use-authorization-from-the-fda-for-the-treatment-of-hospitalized-patients-with-covid-19 2024-09-05 09:55:05.113856+00 https://www.pharmasalmanac.com/articles/mitigating-early-development-risks-with-samsung-biologics-developick-platform 2024-09-04 12:43:19.934614+00 https://www.pharmasalmanac.com/articles/olon-continues-its-growth-path-and-announces-a-new-acquistion 2024-09-04 10:12:42.49456+00 https://www.pharmasalmanac.com/articles/german-cdmo-richter-helm-expands-plant-to-serve-demand-for-biologics-manufacturing 2024-09-04 08:51:48.696186+00 https://www.pharmasalmanac.com/articles/ppd-names-colin-hill-ceo-of-gns-healthcare-to-its-board-of-directors 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/ppd-laboratories-named-a-top-innovator-in-drug-development 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/ppd-and-neogenomics-forming-global-strategic-alliance-for-pathology-and-molecular-testing-solutions 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/ppd-expands-gmp-lab-testing-capabilities-for-biologics 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/ppd-signs-new-service-agreement-with-pfizer 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/how-can-oncology-trials-be-decentralized 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/estimands-in-oncology-trials 2024-09-04 08:51:08.669425+00 https://www.pharmasalmanac.com/articles/actobio-therapeutics-receives-ind-green-light-for-new-antigen-specific-immunotherapy-study-aimed-at-improving-celiac-patients-tolerance-of-gluten 2024-09-01 02:35:50.299697+00 https://www.pharmasalmanac.com/articles/minitablets-enhancing-safety-and-palatability-for-pediatric-medicines 2024-08-30 21:50:09.245976+00 https://www.pharmasalmanac.com/articles/nanocarriers-to-overcome-the-bloodbrain-barrier-bbb 2024-08-30 21:49:02.015142+00 https://www.pharmasalmanac.com/articles/list-biotherapeutics-and-sacco-system-announce-lead-share-agreement 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-sale-of-paragard-intrauterine-copper-contraceptive-to-coopersurgical 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-receives-corporate-health-awards-recognition-of-excellence 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/talazoparib-significantly-extends-progression-free-survival-in-phase-3-embraca-trial-of-patients-with-metastatic-breast-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-admelog-the-first-short-acting-follow-on-insulin-product-to-treat-diabetes 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/distributed-bio-announces-superhuman-platform-license-agreement-with-pfizer-inc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-establishes-new-partnering-model-for-early-stage-academic-research 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/regeneron-forms-consortium-of-leading-life-sciences-companies-to-accelerate-largest-widely-available-big-data-human-sequencing-resource-with-uk-biobank 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-and-merck-receive-breakthrough-therapy-designation-from-fda-for-lenvima-lenvatinib-mesylate-and-keytruda-pembrolizumab-as-combination-therapy- 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cimzia-certolizumab-pegol-label-change-marks-important-advance-for-european-women-of-childbearing-age-with-chronic-rheumatic-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-breast-cancer-with-a-certain-inherited-genetic-mutation 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/croda-buys-tech-companies-in-canada-finland 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/secant-group-develops-the-first-synthetic-regenerative-cardiovascular-graft 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-u.s.-fda-approval-of-trisenox-arsenic-trioxide-injection-for-first-line-treatment-of-acute-promyelocytic-leukemia 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/servier-canada-and-the-new-brunswick-health-research-foundation-announce-the-creation-of-the-servier-new-brunswick-cardiac-health-improvement-fund-chif 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mercks-keytrudar-pembrolizumab-significantly-improved-overall-survival 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dsm-sinochem-pharmaceuticals-successfully-launches-rosuvastatin-finished-dosage-formulation-in-western-europe 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cambrex-astrazeneca-hold-ceremony-to-mark-long-term-supply-agreement-at-karlskoga-sweden-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bio-rad-gains-additional-u.s.-fda-clearances-for-blood-typing-products-expanding-its-offering-for-the-blood-testing-market 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-announces-positive-top-line-results-for-potential-biosimilar-to-rituxan/mabthera 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-automated-uv-visible-spectrophotometers-are-designed-for-todays-modern-lab 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/rentschler-biopharma-se-appoints-international-biopharma-expert-dr.-ralf-otto-as-chief-operating-officer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/celgene-corporation-commences-tender-offer-for-juno-therapeutics-inc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-kgaa-darmstadt-germany-certified-as-one-of-the-top-employers-north-america-2018 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/evonik-launches-a-new-metamino-marketing-campaign-to-the-middle-east-and-african-markets-at-viv-mea-in-abu-dhabi 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-launch-of-a-generic-version-of-syprine-in-the-united-states 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/u.s.-eu-and-japan-health-authorities-accept-regulatory-submissions-for-review-of-pfizers-third-generation-alk-inhibitor-lorlatinib 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-u.s.-launch-of-qvar-redihaler-beclomethasone-dipropionate-hfa-inhalation-aerosol 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-completes-acquisition-of-sucampo-pharmaceuticals-inc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cytovance-biologics-inc.-announces-completion-of-first-batch-in-new-state-of-the-art-1000l-microbial-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-announces-discontinuation-of-apecs-study-evaluating-verubecestat-mk-8931-for-the-treatment-of-people-with-prodromal-alzheimers-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-enrolls-first-patient-in-phase-1-study-of-expressgraftc9t1-skin-tissue 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/selumetinib-granted-orphan-drug-designation-by-the-u.s.-fda-for-neurofibromatosis-type-1 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-treatment-for-a-certain-type-of-prostate-cancer-using-novel-clinical-trial-endpoint 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/milliporesigma-receives-two-more-patents-for-crispr-technology 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-receives-fda-acceptance-of-stannsoporfin-new-drug-application-filing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-receives-positive-chmp-opinion-for-two-hematology-medicines-mylotargand-bosulif 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-announces-update-on-european-marketing-authorization-application-for-sutent-sunitinib-in-adult-patients-at-high-risk-of-recurrent-renal-cell-carcinoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/lynparza-olaparib-receives-positive-eu-chmp-opinion-in-platinum-sensitive-relapsed-ovarian-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/covance-enters-into-strategic-technology-agreement-with-gsk 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-to-present-new-data-from-studies-of-investigational-hiv-therapies-doravirine-and-mk-8591-at-croi-2018 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mylan-to-bring-a-biosimilar-of-botox-to-the-market-through-a-collaboration-and-license-agreement-with-revance-therapeutics 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-kgaa-darmstadt-germany-announces-positive-phase-iib-results-for-evobrutinib-in-relapsing-multiple-sclerosis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bruker-and-evosep-announce-new-integrated-clinical-research-proteomics-solution-to-quantify-over-a-thousand-proteins-in-five-minutes 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-accepts-for-filing-supplemental-biologics-license-application-sbla-for-xeomin-incobotulinumtoxina-in-adult-patients-with-sialorrhea 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-grants-priority-review-to-mercks-supplemental-biologics-license-application-sbla-for-keytruda-pembrolizumab-for-treatment-of-advanced-cervical-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/revolutionary-dowdupont-technology-available-for-the-first-time-worldwide-to-accelerate-discovery-of-novel-protein-drugs 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-the-launch-of-a-generic-version-of-lialda-in-the-united-states 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-and-allogene-therapeutics-enter-into-asset-contribution-agreement-for-pfizers-allogeneic-car-t-immuno-oncology-portfolio 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/inception-neuroscience-program-acquired-by-roche 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-provides-update-on-phase-3-trial-of-axitinib-as-adjuvant-treatment-for-patients-at-high-risk-of-renal-cell-carcinoma-recurrence-after-surgery 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-finalizes-guidances-to-accelerate-the-development-of-reliable-beneficial-next-generation-sequencing-based-tests 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mercks-keytruda-pembrolizumab-reduced-the-risk-of-disease-recurrence-or-death-by-more-than-40-percent- 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-announces-worldwide-development-and-commercialization-collaboration-with-bristol-myers-squibb-to-advance-a-next-generation-therapy-for-cardiovascular-diseases 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bruker-acquires-nanoir-company-anasys-instruments 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-therapy-for-rare-inherited-form-of-rickets-x-linked-hypophosphatemia 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/nelson-labs-significantly-expands-lab-operations-and-testing-capabilities-in-itasca-illinois-to-better-serve-customer-needs 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-authorizes-new-use-of-test-first-to-identify-the-emerging-pathogen-candida-auris 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-presents-new-long-term-data-demonstrating-efficacy-and-safety-of-copaxone-glatiramer-acetate-injection-40-mg/ml 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/renalsense-announces-distribution-agreement-with-fresenius-medical-care 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-to-acquire-benevir-biopharm-to-advance-immunotherapy-regimens 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-provides-update-on-keynote-407-trial 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-to-present-data-in-treatment-resistant-mental-ilnesses 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/durect-announces-amendment-to-licensing-agreement-with-sandoz-related-to-posimir-saber-bupivacaine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cytovance-biologics-successfully-completes-fda-inspection 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/positive-phase-3-trial-of-dupixent-dupilumab-in-adolescents-with-inadequately-controlled-moderate-to-severe-atopic-dermatitis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/regeneron-and-sanofi-share-first-positive-clinical-data-for-cemiplimab-in-advanced-non-small-cell-lung-cancer-at-asco 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-the-first-non-opioid-treatment-for-management-of-opioid-withdrawal-symptoms-in-adults 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/erleada-significantly-reduced-risk-of-prostate-specific-antigen-psa-progression-in-patients-with-non-metastatic-castration-resistant-prostate-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-announces-european-commission-approval-of-juluca-dolutegravir/rilpivirine-the-first-two-drug-regimen-once-daily-single-pill-for-the-treatment-of-hiv-1 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/sun-pharma-announces-usfda-approval-of-yonsa-abiraterone-acetate-to-treat-metastatic-castration-resistant-prostate-cancer-in-combination-with-methylprednisolone 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mercks-keytruda-pembrolizumab-significantly-improved-overall-survival-and-progression-free-survival-for-squamous-non-small-cell-lung-cancer-nsclc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-real-world-study-finds-long-term-xarelto-rivaroxaban-use-resulted-in-fewer-strokes-and-systemic-emboli- 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/etherna-completes-enrolment-of-low-dose-cohort-for-phase-1b-study-of-trimix-mrna-based-cancer-specific-immunotherapy-eci-006-in-melanoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ipsen-and-md-anderson-announce-bench-to-bedside-cancer-drug-development-partnership 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-announces-initiation-of-phase-1b/2-clinical-development-program-evaluating-jnj-68284528-car-t-cells-for-the-treatment-of-multiple-myeloma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/genecentric-therapeutics-to-present-first-data-on-cancer-subtyping-platform-for-bladder-cancer-potential-for-use-as-drug-response-biomarker 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-and-premier-inc.-collaborating-to-help-reduce-clostridium-difficile-c.-diff-infection 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/u.s.-fda-and-european-medicines-agency-accept-regulatory-submissions-for-review-of-talazoparib-for-metastatic-breast-cancer-patients-with-an-inherited-brca-mutation 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-kgaa-darmstadt-germany-provides-update-on-tepotinib-phase-ii-results-in-advanced-hepatocellular-carcinoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-inc.-to-launch-center-for-genetics-guided-dementia-discovery-in-cambridge-massachusetts 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-new-efforts-to-advance-medical-product-communications-to-support-drug-competition-and-value-based-health-care 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/organ-on-chip-market-2026 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/prometic-presents-new-data-on-nash-drug-candidate-pbi-4547 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-launches-scientific-advisory-council 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-novel-device-for-treating-breathing-difficulty-from-severe-emphysema 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-rheumatoid-arthritis-phase-4-clinical-study-for-h.p.-acthar-gel-repository-corticotropin-injection-achieves-its-enrollment-target 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-announces-it-will-defer-companys-price-increases 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/scynexis-reports-positive-results-from-phase-2b-dose-finding-study-of-oral-scy-078-in-vulvovaginal-candidiasis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-inc.-announces-positive-topline-results-from-camellia-timi-61-a-large-scale-cardiovascular-outcome-trial-for-the-anti-obesity-agent-belviq 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-announces-u.s.-fda-approval-of-symtuza-d/c/f/taf-the-first-and-only-complete-darunavir-based-single-tablet-regimen-for-the-treatment-of-hiv-1-infection 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-cancer-drug-through-new-oncology-review-pilot-that-enables-greater-development-efficiency 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cambrex-to-acquire-halo-pharma-adding-drug-development-and-finished-dosage-capabilities-to-global-api-manufacturing-network 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-announces-week-96-data-from-pivotal-phase-3-drive-forward-study-of-its-investigational-hiv-therapy-doravirine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-continues-taking-key-actions-on-bulk-drug-substances-used-for-compounding-to-advance-the-regulatory-framework-governing-compounded-drugs-and-to-protect-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ptc-therapeutics-announces-publication-of-data-demonstrating-the-clinical-differentiated-benefit-of-deflazacort 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/glenmark-pharmaceuticals-announces-encouraging-phase-1-results-supporting-biosimilarity-criteria-for-gbr-310 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/keytruda-pembrolizumab-monotherapy-met-a-primary-endpoint-in-the-phase-3-keynote-048-trial 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-magnetic-device-system-for-guiding-sentinel-lymph-node-biopsies-in-certain-patients-with-breast-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/keytruda-pembrolizumab-is-the-first-anti-pd-1-therapy-approved-in-china-for-advanced-melanoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-receives-recommendation-for-approval-in-21-eu-countries-for-the-new-formulation-of-euthyrox 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-and-biogen-present-detailed-results-from-phase-ii-clinical-study-of-elenbecestat-in-mci-and-mild-to-moderate-alzheimers-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/i-mab-biopharma-and-abl-bio-announce-global-collaboration-on-innovative-bispecific-antibodies 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/european-medicines-agency-adopts-positive-opinion-for-keytrudapembrolizumab-combination-with-pemetrexed-and-platinum-chemotherapy 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/united-therapeutics-announces-fda-approval-of-the-implantable-system-for-remodulin 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/selumetinib-granted-orphan-designation-in-europe-for-neurofibromatosis-type-1 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-forms-collaborative-research-partnership-with-washington-university-in-st.-louis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/durects-licensee-pain-therapeutics-receives-complete-response-letter-from-fda-for-remoxy-er-oxycodone-extended-release-capsules-cii 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/glenmark-pharmaceuticals-announces-fda-acceptance-of-the-companys-first-new-drug-application-for-ryaltris-for-patients-with-seasonal-allergic-rhinitis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-orkambi-for-children 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/novadoz-receives-marketing-approval-for-generic-versions-of-rosuvastatin-capecitabine-moxifloxacin 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-submits-u.s.-eu-regulatory-applications-seeking-approval-of-darzalex-daratumumab-split-dosing-regimen 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/i-mabs-announces-china-clinical-trial-approval-of-long-acting-hglp-1-to-treat-type-2-diabetes 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-treatment-for-two-rare-types-of-non-hodgkin-lymphoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-generic-drug-under-new-pathway-aimed-at-enhancing-market-competition-for-sole-source-drugs 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-treatment-for-a-rare-genetic-disorder-fabry-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-allows-marketing-of-first-direct-to-consumer-app-for-contraceptive-use-to-prevent-pregnancy 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/regeneron-provides-regulatory-update-on-eylea-aflibercept-injection-sbla-in-wet-age-related-macular-degeneration 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cellect-and-cell2in-launch-collaboration-to-significantly-improve-stem-cell-selection-and-expansion 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-reports-positive-topline-results-for-atlas-phase-iii-study-of-a-novel-long-acting-injectable-two-drug-regimen-for-the-treatment-of-hiv-1 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/sun-pharma-announces-u.s.-fda-approval-of-cequa-to-treat-dry-eye-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-and-regeneron-announce-positive-topline-phase-3-fasinumab-results-in-patients-with-chronic-pain-from-osteoarthritis-of-the-knee-or-hip 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-kalydeco-ivacaftor 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/sirnaomics-oncology-ind-receives-green-light-from-us-fda-to-initiate-study-for-treatment-of-cholangiocarcinoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/biohaven-reports-positive-results-from-double-blind-placebo-controlled-investigator-initiated-proof-of-concept-trial-of-bhv-0223-for-anxiety 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-generic-version-of-epipen 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-permits-marketing-of-transcranial-magnetic-stimulation-for-treatment-of-obsessive-compulsive-disorder 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-submits-new-drug-application-to-u.s.-fda-seeking-approval-of-erdafitinib-for-the-treatment-of-metastatic-urothelial-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/28.77-billion-medical-robots-market-to-2025-evolution-of-nanorobots-in-cancer-treatment-increased-preferences-of-patient-for-robotic-surgeries 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-endometrial-cancer-therapeutics-markets-2018-2022-increase-in-small-molecules-in-drug-development-pipeline 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-granted-fda-breakthrough-therapy-designation-for-20-valent-pneumococcal-conjugate-vaccine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-by-fda-commissioner-scott-gottlieb-m.d.-on-preparations-for-the-upcoming-flu-season-and-vaccinations 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/portage-to-acquire-salvarx-limited 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-advanced-form-of-the-second-most-common-skin-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-a-new-antibacterial-drug-to-treat-a-serious-lung-disease-using-a-novel-pathway-to-spur-innovation 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/the-u.s.-skin-grafts-market-to-2025-a-522.5-million-opportunity 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-allows-marketing-of-first-self-fitting-hearing-aid-controlled-by-the-user 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/regeneron-to-report-third-quarter-2018-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-6-2018 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-pediatric-vaccine-market-2015-2024-technologic-advancements-and-increase-in-government-and-non-government-funding 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-real-world-data-analyses-support-the-long-term-use-of-entyvio 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bausch-healths-bryhalhalobetasol-propionate-lotion-0.01-receives-tentative-fda-approval-for-plaque-psoriasis-in-adults 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/etherna-opens-state-of-the-art-manufacturing-facility-in-belgium-to-support-the-development-of-its-trimix-based-mrna-cancer-immunotherapies 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-expanded-use-of-gardasil-9-to-include-individuals-27-through-45-years-old 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/wearable-injectors-on-body-and-off-body-injectors-infusion-pump-devices-market-global-forecast-to-2023 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dmd-drugs-market-size-worth-4.11-billion-by-2023-cagr-41.3-grand-view-research-inc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodts-stratatech-company-awarded-26-million-in-additional-barda-funding-for-pediatric-studies-of-stratagraft-skin-tissue-in-thermal-burns 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/guardant-health-presents-data-on-immunotherapy-related-biomarkers-msi-and-tmb-in-blood-of-advanced-cancer-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-wound-care-market-report-2018-2024 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/jazz-pharmaceuticals-announces-fda-approval-of-xyrem-for-the-treatment-of-cataplexy-or-excessive-daytime-sleepiness-in-pediatric-narcolepsy-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-data-presented-at-psych-congress-2018-sheds-light-on-the-significant-economic-burden-of-treatment-resistant-depression-amongst-u.s.-veterans 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/regenerx-partner-updates-on-clinical-trials 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-the-fdas-new-consideration-of-labeling-for-sesame-allergies 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/salix-and-alfasigma-will-initiate-late-stage-program-to-study-rifaximin-in-patients-with-postoperative-crohns-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-specialty-pharmaceutical-partnering-terms-and-agreements-report-2012-2018-analysis-by-headline-value-upfront-payments-milestone-payments-and-royalties 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/perrigo-confirms-patent-challenge-for-generic-version-of-kerydin 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/i-mab-and-genexine-announce-china-ind-approval-for-innovative-immunotherapy 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-agencys-approval-of-dsuvia-and-the-fdas-future-consideration-of-new-opioids 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-and-infinity-pharmaceuticals-announce-a-new-clinical-collaboration-to-evaluate-opdivo-nivolumab-in-combination-with-ipi-549-in-urothelial-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-autoinjectors-market-to-2023-high-value-biologics-boosting-market-growth 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/trovagene-announces-third-quarter-2018-highlights-and-financial-results 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/oncosec-doses-first-patient-in-keynote-890-phase-2-clinical-trial 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-proposed-new-steps-to-protect-youth-by-preventing-access-to-flavored-tobacco-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-60-billion-blockbuster-oncology-brands-market-to-2027-featuring-bristol-myers-squibb-merck-co-roche-pfizer-astrazeneca-tesaro 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-by-fda-commissioner-scott-gottlieb-m.d.-on-efforts-to-reduce-animal-testing-through-a-study-aimed-at-eliminating-the-use-of-dogs-in-certain-trials 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-by-fda-commissioner-scott-gottlieb-m.d.-on-the-fdas-efforts-to-hold-industry-accountable-for-fulfilling-critical-post-marketing-studies 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-line-treatment-for-peripheral-t-cell-lymphoma-under-new-review-pilot 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/crispr-technology-market-worth-1715-million-by-2023-exclusive-report-by-marketsandmarkets 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-warns-marketers-of-products-labeled-as-dietary-supplements-that-contain-tianeptine-for-making-unproven-claims-to-treat-serious-conditions 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-and-jeff-shuren-m.d.-director-of-the-cdrh-on-fda 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/perrigo-launches-its-ab-rated-generic-version-of-solaraze-gel-3 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-an-oncology-drug-that-targets-a-key-genetic-driver-of-cancer-rather-than-a-specific-type-of-tumor 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-biosimilar-for-treatment-of-adult-patients-with-non-hodgkins-lymphoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-cancer-immunotherapy-market-2017-2027-featuring-leading-players-pfizer-merck-amgen-and-roche 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-analyses-evaluate-long-term-convulsive-seizure-freedom-rates-with-use-of-adjunctive-fycompa-perampanel-ciii-in-adult-patients-presented- 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-darzalex-daratumumab-phase-3-study-shows-efficacy-and-safety-data-of-anti-cd38-monoclonal-antibody-in-patients-with-newly-diagnosed-multiple-myeloma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/migraine-drugs-market-size-worth-7.8-billion-by-2025-cagr-18.0-grand-view-research-inc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/worldwide-opportunity-outlook-on-the-anti-obesity-drugs-market-to-2022-key-players-are-eisai-novo-nordisk-and-vivus-researchandmarkets.com 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/first-drug-candidate-from-eisai-ucl-research-collaboration-to-enter-alzheimers-disease-clinical-trials 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-new-actions-advancing-the-agencys-biosimilars-policy-framework 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-on-fdas-new-strategic-framework-to-advance-use-of-real-world-evidence 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/biohaven-announces-proposed-public-offering-of-common-shares 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-jeff-shuren-director-of-the-cdrh-on-updated-safety-communication-about-rates-of-duodenoscope 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-report-on-declining-sales/distribution-of-antimicrobial-drugs-for-food-animals-a-reflection-of-improved-antimicrobial-stewardship 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-on-new-steps-to-promote-innovations-in-medical-devices-that-help-advance-patient-safety 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/rentschler-biopharma-completes-acquisition-of-u.s.-manufacturing-site 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-acquires-manufacturing-facility-in-india 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-on-the-agencys-new-actions-under-the-pre-cert-pilot-program 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-on-the-fdas-new-effort-for-developing-and-class-labeling-of-in-vitro-companion-diagnostics 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-how-modern-predicates-can-promote-innovation-and-advance-safety-and-effectiveness- 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-generic-version-of-sabril-to-help-treat-seizures-in-adults-and-pediatric-patients-with-epilepsy 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/trovagene-announces-new-patent-issued-for-combination-of-onvansertib-with-anti-androgen-drugs-to-treat-non-metastatic-and-metastatic-prostate-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-statement-announcing-efforts-to-improve-the-quality-of-the-information-used-to-assess-the-effectiveness-of-rems-programs 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/upmc-health-plan-announces-innovative-value-based-agreement-with-astrazeneca 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/trovagene-and-poc-capital-enter-agreement-to-fund-clinical-development-of-onvansertib-in-metastatic-colorectal-cancer-mcrc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-and-purdue-pharma-present-efficacy-and-safety-data-from-second-pivotal-phase-3-study-advances-in-sleep-and-circadian-science 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-launch-of-alyq-tadalafil-tablets-usp-a-generic-version-of-adcirca-in-the-united-states 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-on-the-agencys-efforts-to-strengthen-regulation-of-dietary-supplements 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/u.s.-fda-approves-darzalex-daratumumab-split-dosing-regimen 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/invitae-launches-non-invasive-prenatal-screening-nips-offering-in-depth-genetic-information-in-early-pregnancy 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-advisory-committee-recommends-approval-of-spravato-esketamine-nasal-spray-ciii-for-adults-with-treatment-resistant-depression 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-new-programs-to-promote-the-adoption-of-innovations-in-drug-manufacturing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-ongoing-efforts-to-secure-the-u.s.-supply-chain-and-confront-the-opioid-epidemic 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-advances-new-efforts-to-promote-development-of-safe-and-effective-regenerative-medicine-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-new-policy-to-improve-access-for-drugs-that-face-inadequate-generic-competition 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-authorizes-first-interoperable-insulin-pump-intended-to-allow-patients-to-customize-treatment-through-their-individual-diabetes-management-devices 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-and-empatica-enter-an-agreement-to-co-promote-the-embrace2-device-for-people-living-with-epilepsy-in-the-u.s 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-scott-gottlieb-m.d.-on-the-agencys-2019-policy-and-regulatory-agenda-for-continued-action-to-forcefully-address-opioid-abuse 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-cdc-and-cms-launch-task-force-to-help-facilitate-rapid-availability-of-diagnostic-tests-during-public-health-emergencies 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/regenerative-medicine-market-2023-high-investment-from-pharma-giants-such-as-eli-lilly-bms-astra-zeneca-and-sanofi 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-on-the-fdas-modern-approach-to-advanced-pharmaceutical-manufacturing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-responds-to-safety-signal-reported-in-required-postmarketing-trial-for-xeljanz 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-provides-update-on-its-ongoing-investigation-into-arb-drug-products-and-losartan-product-recall 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-receives-positive-chmp-opinion-for-lorviqua-lorlatinib-for-certain-adult-patients-with-previously-treated-alk-positive-advanced-non-small-cell-lung-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/milliporesigma-awarded-canadian-crispr-nickase-patent-for-foundational-genome-editing-technology 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-presents-data-on-cutaneous-t-cell-lymphoma-at-2019-american-academy-of-dermatology-annual-meeting 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/the-first-wuxi-healthcare-forum-opens-in-shanghai 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-nasal-spray-medication-for-treatment-resistant-depression-available-only-at-a-certified-doctors-office-or-clinic 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-on-naming-of-biological-medicines-to-balance-competition-and-safety-for-patients-receiving-these-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/piramal-announces-the-launch-of-cinacalcet-by-its-partner-slate-run-pharmaceuticals-in-the-u.s 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/xarelto-significantly-reduced-ischemic-stroke-in-real-world-meta-analysis-of-non-vitamin-k-antagonist-oral-anticoagulants 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-kgaa-darmstadt-germany-and-pfizer-announce-discontinuation-of-phase-iii-javelin-ovarian-parp-100-trial-in-previously-untreated-advanced-ovarian-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-postpartum-depression 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-device-for-treating-moderate-to-severe-chronic-heart-failure-in-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-commissioner-on-preventing-medical-device-shortages-and-effective-sterilization-amid-contract-sterilization-facility-shutdown 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-treatment-for-patients-with-a-type-of-inflammatory-arthritis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bio-techne-and-nanostring-partner-to-co-develop-integrated-workflow-for-rna-spatial-profiling 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-by-fda-on-expanded-patient-access-looking-forward 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-warns-homeopathic-firms-for-putting-patients-at-risk-with-significant-violations-of-manufacturing-quality-standards 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-on-new-2019-efforts-to-improve-the-quality-of-compounded-drugs 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-by-fda-on-efforts-to-stop-stem-cell-clinics-and-manufacturers-from-marketing-unapproved-products-and-advance-legitimate-development 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-and-cbp-bolster-collaboration-to-protect-public-health-and-safety 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-on-the-agencys-list-of-known-nitrosamine-free-valsartan-and-arb-class-medicines 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-warns-about-risks-of-using-home-use-test-strips-that-are-pre-owned-or-not-authorized-for-sale-in-u.s.-including-those-for-glucose-warfarin 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-treatment-for-osteoporosis-in-postmenopausal-women-at-high-risk-of-fracture 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-statement-on-new-opioid-analgesic-labeling-changes 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-orders-important-safety-labeling-changes-for-addyi 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-efforts-to-mitigate-temporary-shortage-of-pediatric-breathing-tubes-due-to-recent-closure-of-illinois-sterilization-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-targeted-therapy-for-metastatic-bladder-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-statement-from-deputy-commissioner-on-new-steps-to-protect-consumers-from-unlawful-ingredients-in-dietary-supplements 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-orders-manufacturers-of-surgical-mesh-intended-for-transvaginal-repair-of-pelvic-organ-prolapse-to-stop-selling-all-devices 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bio-rad-appoints-andrew-last-as-executive-vice-president-and-chief-operating-officer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-launch-of-a-generic-version-of-vesicare-solifenacin-succinate-tablets-in-the-united-states 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-the-fdas-center-for-devices-and-radiological-health-on-reducing-risks-associated-with-surgical-staplers 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-update-on-fremanezumab-clinical-development-for-use-in-episodic-cluster-headache 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/the-generic-pharmaceutical-market-in-kenya-nigeria-forecast-to-2022 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/artificial-intelligence-in-diabetes-management-market-global-industry-analysis-trends-market-size-and-forecasts-up-to-2024 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/1.01-billion-viral-vector-manufacturing-global-market-outlook-2017-2026 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-1.82-billion-asthma-spacers-market-outlook-2026 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-bausch-healths-duobrii-halobetasol-propionate-and-tazarotene-lotion-0.01/0.045-for-plaque-psoriasis-in-adults 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-provides-update-on-phase-3-keynote-062-trial 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-receives-positive-chmp-opinion-for-talzennatalazoparib-for-patients-with-inherited-germline-brca-mutated-locally-advanced-or-metastatic-breast-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/the-next-generation-sequencing-ngs-market-is-expected-to-surpass-us-30-billion-by-the-end-of-year-2025-with-double-digit-cagr-during-2019-2025 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-submits-application-to-u.s.-fda-seeking-approval-of-erleada-apalutamide-for-patients-with-metastatic-castration-sensitive-prostate-cance 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-trade-name-lexette-tm-halobetasol-propionate-foam-0.05 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/takeda-opens-new-global-research-center-in-san-diego 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/grand-river-aseptic-manufacturing-inc.-implements-fully-automated-serialization-and-aggregation-solutions-ahead-of-2023-dscsa-deadline 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/eisai-inc.-deepens-its-commitment-to-alzheimers-disease-with-key-executive-appointments 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-from-fda-on-new-efforts-to-protect-womens-health-and-help-to-ensure-the-safety-of-breast-implants 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/gluten-free-food-labeling-important-information-for-those-with-celiac-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/u.s.-fda-approves-vyndaqel-and-vyndamax-for-use-in-patients-with-transthyretin-amyloid-cardiomyopathy-a-rare-and-fatal-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/servier-cuts-ribbon-on-new-boston-headquarters 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dissection-of-the-global-73-billion-probiotics-market-by-2024 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-launch-of-a-generic-version-of-tarceva-erlotinib-tablets-in-the-united-states 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-venetoclax-for-cll-and-sll 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/syncona-founds-quell-therapeutics-with-35-million-series-a-financing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-to-acquire-peloton-therapeutics-bolstering-oncology-pipeline 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-permits-marketing-of-first-diagnostic-test-to-aid-in-detecting-prosthetic-joint-infections 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-pi3k-inhibitor-for-breast-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-revlimid-lenalidomide-in-combination-with-rituximab-for-the-treatment-of-follicular-lymphoma-or-marginal-zone-lymphoma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-updates-plans-for-company-separation-and-spin-off-of-specialty-generics-business-to-shareholders 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/neurorx-reports-phase-2-efficacy-for-nrx-101-a-breakthrough-therapy-targeting-suicidal-bipolar-depression 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/medtronic-announces-its-forthcoming-robotic-assisted-surgical-platform-to-feature-three-dimensional-vision-system-from-karl-storz 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-permits-marketing-of-first-medical-device-for-ibs-pain-relief-in-adolescent-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ibm-kpmg-merck-and-walmart-to-collaborate-as-part-of-fdas-program-to-evaluate-the-use-of-blockchain-to-protect-pharmaceutical-product-integrity 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ibio-announces-first-agreement-for-fill-finish-services 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-pembrolizumab-for-metastatic-small-cell-lung-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-treatment-for-hypoactive-sexual-desire-disorder-in-premenopausal-women 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-expands-approval-of-treatment-for-cystic-fibrosis-to-include-patients-ages-6-and-older 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-chronic-rhinosinusitis-with-nasal-polyps 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cdc-advisory-recommends-vaccination-of-adults-ages-27-45-with-gardasil9-harmonization-of-catch-up-vaccination-for-males-and-females-through-age-26 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dova-pharmaceuticals-announces-fda-approval-of-supplemental-new-drug-application-for-doptelet-avatrombopag-for-treatment-of-chronic-immune-thrombocytopenia-itp 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/takeda-selects-five-new-partnerships-for-annual-global-corporate-social-responsibility-csr-program 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-warns-patients-and-healthcare-providers-about-potential-cybersecurity-concerns-with-certain-medtronic-insulin-pumps 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-receives-u.s.-fda-approval-for-its-oncology-biosimilar-zirabev-bevacizumab-bvzr 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-presents-initial-clinical-data-on-phase-1b-gene-therapy-study-for-duchenne-muscular-dystrophy-dmd 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/evotec-and-venture-capital-consortium-form-breakpoint-therapeutics-gmbh 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/idex-health-science-llc-launches-dedicated-protein-analyzer-for-bioprocessing-tridex 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mallinckrodt-and-silence-therapeutics-announce-collaboration-to-develop-and-commercialize-rnai-therapeutics-for-complement-mediated-diseases 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-generics-of-lyrica 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-severe-hypoglycemia-that-can-be-administered-without-an-injection 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-requests-allergan-voluntarily-recall-certain-breast-implants-and-tissue-expanders-from-market 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-boxed-warning-about-increased-risk-of-blood-clots-and-death-with-higher-dose-of-xeljanz 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-phosphoinositide-3-kinase-pi3k-inhibitors-market-outlook-2019-2023-with-bayer-gilead-sciences-novartis-tg-therapeutics-and-verastem-leading-the-competition 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-completes-acquisition-of-array-biopharma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-clears-new-indications-for-existing-lyme-disease-tests-that-may-help-streamline-diagnoses 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/mylan-and-upjohn-a-division-of-pfizer-to-combine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/celgene-reports-second-quarter-2019-operating-and-financial-result 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-inc.-issues-a-voluntary-nationwide-recall-for-2-lots-of-relpax-due-to-potential-microbiological-contamination-of-non-sterile-product 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-drug-for-treatment-resistant-forms-of-tuberculosis-that-affects-the-lungs 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-device-to-improve-symptoms-in-patients-with-advanced-heart-failure 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-of-its-kind-device-to-treat-pediatric-patients-with-progressive-idiopathic-scoliosis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-antibiotic-to-treat-community-acquired-bacterial-pneumonia 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dr.-reddys-laboratories-announces-the-launch-of-versavo-bevacizumab-biosimilar-in-india 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-announces-availability-of-a-generic-equivalent-of-epipen-jr-in-the-united-states 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dr.-reddys-laboratories-announces-the-launch-of-vigabatrin-powder-for-oral-solution-usp-in-the-u.s.-market 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-add-on-drug-to-treat-off-episodes-in-adults-with-parkinsons-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pacifico-national-inc.-dba-amex-pharmacy-issues-voluntary-nationwide-recall-for-all-lots-of-bevacizumab 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-sends-warning-to-company-for-selling-unapproved-umbilical-cord-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-announces-positive-preliminary-results-from-a-2-study-of-its-20-valent-pneumococcal-conjugate-vaccine-candidate-for-disease-prevention-in-infants 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/statement-alerting-patients-and-health-care-professionals-of-ndma-found-in-samples-of-ranitidine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetters-chicago-site-wins-award-one-of-best-and-brightest-companies-to-work-for 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ibios-collaboration-with-south-africas-azargen-biotechnologies-advances-to-next-stage 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ian-read-to-retire-as-executive-chairman-of-pfizers-board-of-directors-chief-executive-officer-dr.-albert-bourla-named-chairman 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-of-losartan-potassium-tablets 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/global-170-billion-air-freight-domestic-international-market-forecast-2019-2023 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-allows-marketing-of-first-rapid-diagnostic-test-for-detecting-ebola-virus-antigens 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/takeda-agrees-to-divest-select-otc-and-non-core-assets-to-acino-for-over-200-million-usd 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-new-treatment-for-patients-with-migraine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/janssen-announces-u.s.-fda-approval-of-stelara-ustekinumab-for-the-treatment-of-adults-with-moderately-to-severely-active-ulcerative-colitis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-updates-and-press-announcements-on-ndma-in-zantac-ranitidine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-provides-greater-flexibility-in-secondary-packaging-through-collaborative-work 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/dicerna-enters-agreement-with-roche-to-develop-and-commercialize-dcr-hbvs-for-the-treatment-of-chronic-hepatitis-b-virus-hbv-infection 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/the-fda-warns-that-biotin-may-interfere-with-lab-tests 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-authorizes-marketing-of-first-next-generation-sequencing-test-for-detecting-hiv-1-drug-resistance-mutations 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/edinburgh-instruments-ltd-joins-bio-rads-knowitall-raman-spectral-identification-partner-program 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vistagen-reports-topline-phase-2-results-for-av-101-as-an-adjunctive-treatment-of-major-depressive-disorder 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fetroja-approved-for-complicated-urinary-tract-infections 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vectura-group-appoints-new-chief-executive-officer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-inherited-rare-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-sends-warning-to-companies-for-offering-unapproved-umbilical-cord-blood-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-to-acquire-arqule-advancing-leadership-in-oncology 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/sartorius-and-the-german-research-center-for-artificial-intelligence-launch-joint-research-laboratory 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-vaccine-for-the-prevention-of-ebola-virus-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-statement-on-low-cost-biosimilar-and-interchangeable-protein-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/lynparza-olaparib-approved-by-fda-as-first-line-maintenance-treatment-of-germline-brca-mutated-metastatic-pancreatic-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/new-insomnia-treatment-approved-by-the-fda-for-adults 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/idex-health-science-launches-film-degasser-for-enhanced-hplc-performance 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/wuxi-advanced-therapies-launches-new-world-class-aav-vector-suspension-platform 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/evotec-and-bristol-myers-squibb-expand-ipsc-collaboration 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/seqens-north-america-identifies-trends-affecting-the-generic-drugs-sector-in-2020 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-invests-25-million-cad-to-expand-its-aurora-canada-facility-with-a-state-of-the-art-api-manufacturing-wing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-aligns-its-development-service-laboratory-portfolio-under-one-roof 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/proqr-receives-rare-pediatric-disease-designation-from-fda-for-qr-421a 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pressure-biosciences-accelerating-rollout-of-proprietary-ust-platform-for-water-soluble-cbd-with-planned-release-of-additional-baroshear-instrument 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/novo-nordisk-invests-in-upgrading-and-expanding-production-facilities-in-kalundborg 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-and-ftc-announce-new-efforts-to-further-deter-anti-competitive-business-practices-support-competitive-market-for-biological-products 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/sun-pharma-launches-new-ad-campaign-to-raise-awareness-of-acne-and-its-impact-on-everyday-life 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/takeda-issues-us-recall-of-two-lots-of-vonvendi 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/twist-bioscience-and-sophia-genetics-collaborate-to-offer-optimized-genomic-solutions 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-kgaa-darmstadt-germany-and-amcm-/-eos-cooperate-in-3d-printing-of-tablets 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/coronavirus-covid-19-update-fda-issues-new-policy-to-help-expedite-availability-of-diagnostics 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-postpones-foreign-inspections-due-to-coronavirus-outbreak 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-postpones-domestic-inspections-due-to-covid-19-outbreak 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ibio-announces-development-of-proprietary-covid-19-vaccine-candidates 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ibio-joins-the-alliance-for-biosecurity 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-takes-action-to-increase-u.s.-supplies-through-instructions-for-ppe-and-device-manufacturers 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-expedites-review-of-diagnostic-tests-to-combat-covid-19 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-to-donate-300000-masks-to-new-jersey-for-covid-19-emergency-response 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/ibio-announces-advancement-of-covid-19-vaccine-program 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-statement-on-oral-fluid-test-for-covid-19 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/milliporesigma-boosts-commercial-viral-vector-and-gene-therapy-manufacturing-capacity-with-110-million-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/prothera-biologics-and-takeda-develop-novel-plasma-derived-therapy-based-on-inter-alpha-inhibitor-proteins 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-authorizes-first-test-for-patient-at-home-sample-collection 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/glenmark-receives-approval-to-conduct-clinical-trials-in-india-on-favipiravir-antiviral-tablets-for-covid-19-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pharmaceutics-international-selected-as-a-winner-of-two-ghp-awards 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-authorizes-first-antigen-test-to-help-in-the-rapid-detection-of-the-virus-that-causes-covid-19-in-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-authorizes-first-standalone-at-home-sample-collection-kit-that-can-be-used-with-certain-authorized-tests 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/hkbu-scientists-eliminate-drug-side-effects-by-manipulating-molecular-chirality 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-to-acquire-themis 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/iavi-and-merck-collaborate-to-develop-vaccine-against-sars-cov-2 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-provides-promised-transparency-for-antibody-tests 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-wins-axia-best-managed-companies-award 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-establishes-new-program-to-support-continued-biotechnology-innovation 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-reissues-emergency-use-authorizations-revising-which-types-of-respirators-can-be-decontaminated-for-reuse 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pii-announces-positive-inspection-news-from-fda-and-mhra 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pharmaceutics-international-inc.-pii-expands-aseptic-filling-capabilities-with-fully-robotic-filling-line 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-accepts-shionogis-supplemental-new-drug-application-for-the-treatment-of-ventilator-associated-bacterial-pneumonia 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-alerts-patients-of-amneal-and-impax-laboratories-epinephrine-auto-injector-device-malfunctions 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/neurocrine-biosciences-and-takeda-announce-collaboration-to-develop-and-commercialize-potential-therapies-for-psychiatric-disorders 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-permits-marketing-of-first-game-based-digital-therapeutic-to-improve-attention-function-in-children-with-adhd 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/teva-pharmaceuticals-usa-inc.-initiates-voluntary-nationwide-recall-of-metformin-hydrochloride 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/inovio-receives-71-million-contract-from-u.s.-department-of-defense-to-scale-up-manufacture-of-covid-19-dna-vaccine-delivery-device 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-announces-first-of-its-kind-pilot-program-to-communicate-patient-reported-outcomes-from-cancer-clinical-trials 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/the-fda-confirms-certain-covid-19-serology-and-antibody-tests-should-not-be-used 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/how-is-federal-equipment-company-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-announce-early-positive-data-from-an-ongoing-phase-1/2-study-of-mrna-based-vaccine-candidate-against-sars-cov-2 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-takes-action-to-help-facilitate-timely-development-of-safe-effective-covid-19-vaccines 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/tesla-to-make-molecule-printers-for-german-covid-19-vaccine-developer-curevac 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-further-expands-its-development-service-with-new-site-in-austria 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-prepares-for-resumption-of-domestic-inspections-with-new-risk-assessment-system 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/milliporesigma-invests-20-million-in-new-switzerland-laboratory 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/biohaven-recruits-khloe-kardashian-for-migraine-campaign 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-issues-first-emergency-authorization-for-sample-pooling-in-diagnostic-testing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-report-t-cell-response-in-covid-19-vaccine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-to-receive-2-billion-from-u.s.-government 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-achieves-carbon-dioxide-neutral-levels 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/how-is-sgd-pharma-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/rlf-100-clinical-trial-shows-rapid-recovery-from-respiratory-failure-due-to-coronavirus 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-issues-emergency-use-authorization-to-yale-school-of-public-health-for-salivadirect-covid-19-test 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-of-its-kind-automated-insulin-delivery-and-monitoring-system-for-use-in-young-pediatric-patients 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/curevac-expected-to-receive-up-to-252-million-euros-from-the-german-federal-ministry-of-research-for-further-covid-19-vaccine-development 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/milliporesigma-announces-65-million-antibody-drug-conjugate-manufacturing-expansion 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-announce-data-from-preclinical-studies-of-covid-19-vaccine-candidate 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-announces-positive-topline-results-from-two-phase-3-adult-studies-evaluating-pneumococcal-conjugate-vaccine 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/seqens-cdmo-north-america-appoints-jean-noel-david-as-managing-director 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/how-is-fec-evolving-its-business-model-to-meet-the-future-of-healthcare 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/how-is-sgd-pharma-evolving-its-business-model-to-meet-the-future-of-healthcare 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-treatment-for-ebola-virus 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-continues-its-long-term-investment-strategy-to-sustain-future-growth 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/curevac-reports-positive-interim-phase-1-data-for-its-covid-19-vaccine-candidate-cvncov 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/neurorx-and-relief-therapeutics-announce-continuation-of-rlf-100-trial-for-the-treatment-of-covid-19-respiratory-failure 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/merck-to-acquire-velosbio 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-continues-to-implement-its-long-term-sustainability-strategy 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-approves-first-psma-targeted-pet-imaging-drug-for-men-with-prostate-cancer 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/how-does-sgd-pharma-envision-the-future-of-the-pharma/biopharma-industry 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/how-does-federal-equipment-company-envision-the-future-of-the-pharma/biopharma-industry 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/facing-the-challenges-of-the-covid-19-pandemic-rentschler-biopharma 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/neurorx-announces-zyesami-met-the-primary-endpoint-of-its-phase-2b/3-clinical-trial-and-also-demonstrated-a-meaningful-benefit-in-survival-from-critical-covid-19 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/versant-ventures-raises-950-million-across-three-vehicles 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vertex-and-obsidian-therapeutics-establish-collaboration-to-discover-novel-therapies-that-regulate-gene-editing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bluebird-bio-provides-update-on-severe-genetic-disease-programs-and-business-operations 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-receive-first-u.s.-authorization-for-emergency-use-of-covid-19-vaccine-in-adolescents 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/caris-life-sciences-raises-830-million-in-growth-equity-capital-to-continue-to-expand-its-precision-medicine-platform 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-once-again-wins-axia-best-managed-companies-award 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-and-ucsf-to-open-cell-therapy-cgmp-manufacturing-and-collaboration-center 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bruker-launches-timstof-truescp-for-unbiased-single-cell-4d-proteomics-and-next-gen-timstof-pro-2 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/novavax-covid-19-vaccine-demonstrates-90-overall-efficacy-and-100-protection-against-moderate-and-severe-disease-in-prevent-19-phase-3-trial 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-announces-a-new-highly-potent-api-expansion-in-its-rodano-site 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetters-new-clinical-manufacturing-site-now-fully-integrated 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/trirx-completes-acquisition-of-elanco-animal-health-facility-in-shawnee-kansas 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pii-to-use-west-pharmaceuticals-daikyo-crystal-zenith-container-closure-components-for-aseptic-fill-finish 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/trirx-hosted-state-and-community-leaders-to-celebrate-acquisition-of-shawnee-kansas-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-presents-its-new-sustainability-manifesto 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-announces-a-strategic-expansion-to-produce-proteins-with-an-advanced-and-sustainable-approach 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetters-contribution-to-climate-protection-corporate-sites-around-the-world-are-co2-neutral 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-group-in-partnership-with-aguettant-pharmaceutical-announces-a-remarkable-expansion-and-renovation-of-the-plant-located-in-mulazzano-dedicated-to-e-1635456334785 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cphi-worldwide-a-significant-expansion-of-apis-pipeline-for-olon-group 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bighat-biosciences-completes-first-stage-of-research-collaboration-with-amgen 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetters-new-clinical-manufacturing-site-now-officially-authorized 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/genscript-sets-up-state-of-art-manufacturing-facility-in-singapore-to-strengthen-manufacturing-capability 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/innovating-at-the-forefront-of-mrna-lnp-therapies 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/recipharm-acquires-arranta-bio-a-cdmo-leader-in-advanced-therapy-medicinal-products-atmps-to-expand-its-biologics-offering-in-the-u.s 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bosch-packaging-technology-is-now-syntegon 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/integrating-development-and-manufacturing-experience-with-inhalation-solutions 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-makes-low-risk-determination-for-marketing-of-products-from-genome-edited-beef-cattle-after-safety-review 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/top-results-for-vetter-in-university-of-st.-gallen-benchmarking 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/coronavirus-covid-19-update-fda-authorizes-first-covid-19-diagnostic-test-using-breath-samples 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/heat-biologics-scorpion-subsidiary-announces-planned-development-of-new-kansas-commercial/biodefense-biomanufacturing-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/scorpion-biological-services-announces-new-kansas-commercial-biomanufacturing-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/fda-permits-marketing-for-new-test-to-improve-diagnosis-of-alzheimers-disease 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-achieves-a-three-peat-in-winning-the-best-managed-companies-award 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/scorpion-biological-services-appoints-stephan-kutzer-ph.d.-as-interim-chief-executive-officer-ceo 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/scorpion-biological-services-celebrates-grand-opening-of-its-san-antonio-facility 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/piramal-critical-care-pcc-commits-to-reduce-its-environmental-footprint-and-growing-responsibly-through-sustainable-operations 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/integrating-and-automating-biomanufacturing-and-bioanalytics 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetters-clinical-facility-demonstrates-success-with-five-client-products-now-on-the-market 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-and-the-chemistry-department-of-politecnico-university-launch-a-research-project-on-polymorphism-and-characterization-of-api-solid-state 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/cdmo-joins-united-nations-global-compact 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/olon-has-been-selected-as-champion-in-five-categories-of-2023-cdmo-leadership-awards 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vantage-nutrition-llc-acquires-combocap-inc 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/pharma-service-provider-further-expands-offerings-for-clinical-development-and-manufacturing 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-joins-science-based-targets-initiative 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/vetter-becomes-a-member-of-the-german-association-of-research-based-pharmaceutical-companies-vfa 2024-08-30 12:37:12.333056+00 https://www.pharmasalmanac.com/articles/bellwyck-and-faller-establish-joint-venture-in-germany 2024-08-30 07:30:00.134903+00 https://www.pharmasalmanac.com/articles/avid-bioservices-enters-into-contract-manufacturing-agreements-with-new-and-existing-customers 2024-08-30 07:30:00.134903+00 https://www.pharmasalmanac.com/articles/avid-bioservices-announces-further-expansion-of-process-development-capacity-for-mammalian-cell-business 2024-08-30 07:30:00.134903+00 https://www.pharmasalmanac.com/articles/avid-bioservices-inc.-and-crb-highlight-efforts-that-enabled-opening-of-first-phase-of-new-viral-vector-facility-in-california-in-only-eight-months 2024-08-30 07:30:00.134903+00 https://www.pharmasalmanac.com/articles/astellas-presents-updated-results-from-phase-1-study-of-gilteritinib-plus-chemotherapy-in-patients-with-newly-diagnosed-acute-myeloid-leukemia-aml 2024-08-30 07:17:16.026032+00 https://www.pharmasalmanac.com/articles/astellas-and-frequency-therapeutics-enter-into-license-agreement-for-fx-322-a-regenerative-treatment-candidate-for-hearing-loss 2024-08-30 07:17:16.026032+00 https://www.pharmasalmanac.com/articles/arranta-bio-announces-addition-of-130000-sq.-ft.-boxborough-mass.-manufacturing-facility-to-supply-clinical-and-commercial-microbiome-products-for-clien-1615563763910 2024-08-30 07:16:44.859147+00 https://www.pharmasalmanac.com/articles/aridis-expands-research-agreement-with-the-cystic-fibrosis-foundation-and-is-awarded-fda-expedited-program-designations 2024-08-30 07:15:24.145859+00 https://www.pharmasalmanac.com/articles/aobiome-therapeutics-announces-appointment-of-dr.-judith-ng-cashin-as-chief-medical-officer 2024-08-30 06:08:52.90193+00 https://www.pharmasalmanac.com/articles/abbvie-and-anima-biotech-announce-collaboration-for-the-discovery-and-development-of-mrna-biology-modulators-against-oncology-and-immunology-targets 2024-08-30 06:08:20.876058+00 https://www.pharmasalmanac.com/articles/ani-pharmaceuticals-announces-the-launch-of-ani-global-source-its-contract-development-and-manufacturing-business 2024-08-30 06:06:09.666657+00 https://www.pharmasalmanac.com/articles/ani-pharmaceuticals-announces-acquisition-of-commercial-and-pipeline-generic-products-from-amerigen-pharmaceuticals-ltd 2024-08-30 06:06:09.666657+00 https://www.pharmasalmanac.com/articles/amneal-announces-approval-of-generic-version-of-amicar 2024-08-30 06:02:01.000006+00 https://www.pharmasalmanac.com/articles/allergan-and-editas-medicine-announce-exercise-of-options-to-jointly-develop-crispr-genome-editing-experimental-medicine-edit-101 2024-08-30 06:01:21.830378+00 https://www.pharmasalmanac.com/articles/allergan-appoints-neurobiology-expert-michael-e.-greenberg-phd-to-its-board-of-directors-as-part-of-active-board-refreshment-process 2024-08-30 06:01:21.830378+00 https://www.pharmasalmanac.com/articles/allergan-receives-fda-approval-for-ubrelvy-for-migraines 2024-08-30 06:01:21.830378+00 https://www.pharmasalmanac.com/articles/alconox-inc.-announced-its-75th-anniversary-as-an-internationally-distributed-manufacturer-of-critical-cleaning-detergents 2024-08-30 06:00:52.106761+00 https://www.pharmasalmanac.com/articles/albemarle-fine-chemistry-services-expands-rsm-capabilities-in-tyrone-pennsylvania 2024-08-30 06:00:00.160788+00 https://www.pharmasalmanac.com/articles/ajinomoto-and-xl-protein-forge-strategic-alliance-to-develop-pasylated-therapeutics-applying-the-corynex-platform 2024-08-30 04:35:03.730559+00 https://www.pharmasalmanac.com/articles/agilent-technologies-completes-acquisition-of-advanced-analytical-technologies-inc 2024-08-30 04:34:01.57382+00 https://www.pharmasalmanac.com/articles/agilent-announces-update-on-pd-l1-ce-ivd-in-urothelial-carcinoma 2024-08-30 04:34:01.57382+00 https://www.pharmasalmanac.com/articles/aes-releases-3-new-standard-cleanroom-models 2024-08-30 04:10:00.338952+00 https://www.pharmasalmanac.com/articles/how-does-aes-clean-technologies-envision-the-future-of-the-pharma/biopharma-industry 2024-08-30 04:10:00.338952+00 https://www.pharmasalmanac.com/articles/sarepta-therapeutics-appoints-renowned-biotech-executive-john-c.-martin-to-its-board-of-directors 2024-08-30 04:05:59.835523+00 https://www.pharmasalmanac.com/articles/radical-bioprocessing-efficiencies-and-cost-reductions-the-next-wave-of-biopharmaceutical-innovation 2024-08-26 17:16:54.86658+00 https://www.pharmasalmanac.com/articles/assessing-developability-and-designing-advanceable-formulations-from-the-start 2024-08-26 17:16:39.532107+00 https://www.pharmasalmanac.com/articles/taiho-oncology-announces-positive-topline-results-from-pivotal-phase-3-trial-of-lonsurf-trifluridine-tipiracil-in-metastatic-gastric-cancer 2024-08-24 17:57:31.977486+00 https://www.pharmasalmanac.com/articles/samsung-biologics-and-stcube-enter-into-development-and-manufacturing-agreement-for-novel-target-anticancer-drug 2024-08-24 17:29:45.82227+00 https://www.pharmasalmanac.com/articles/samsung-biologics-reports-fourth-quarter-fiscal-year-2021-financial-results 2024-08-24 17:29:39.02392+00 https://www.pharmasalmanac.com/articles/samsung-biologics-reaches-agreement-with-biogen-to-acquire-full-ownership-of-samsung-bioepis 2024-08-24 17:29:29.840236+00 https://www.pharmasalmanac.com/articles/samsung-biologics-reports-first-quarter-2022-financial-results 2024-08-24 17:29:23.797015+00 https://www.pharmasalmanac.com/articles/fda-approves-samsung-bioepis-hadlima-adalimumab-bwwd 2024-08-24 17:26:33.821626+00 https://www.pharmasalmanac.com/articles/advancing-a-new-class-of-immunotherapies 2024-08-24 03:24:55.048803+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-12-poland-czechia 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-50-new-jersey-and-new-york 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-49-pennsylvania-and-new-jersey 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-48-pennsylvania 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-47-delaware-and-pennsylvania 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-46-maryland-and-delaware 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-45-west-virginia-and-maryland 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-44-north-carolina-and-west-virginia 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-43-north-carolina 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-42-south-carolina-and-north-carolina 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-41-georgia-and-south-carolina 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-40-florida-and-georgia 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-39-florida 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-38-alabama-and-florida 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-37-tennessee-and-alabama 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-36-missouri-and-tennessee 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-35-arkansas-and-missouri 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-34-mississippi-and-arkansas 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-33-louisiana-and-mississippi 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-32-texas-and-louisiana 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-31-texas 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-30-oklahoma-and-texas 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-29-kansas-and-oklahoma 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-28-nebraska-and-kansas 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-27-new-mexico-and-colorado 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-26-new-mexico-and-colorado 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-25-arizona-and-new-mexico 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-42-nevada-and-arizona 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-22-california-1 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-22-california 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-21-oregon-and-california 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-20-hawaii-and-oregon 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-19-alaska-and-hawaii 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-17-washington-1 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-17-washington 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-16-utah-and-washington 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-15-utah 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-14-wyoming-and-utah 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-12-south-dakota-and-montana-1 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-12-south-dakota-and-montana 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-11-wisconsin-and-south-dakota 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-10-illinois-and-wisconsin 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-09-kentucky-and-illinois 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-08-michigan-and-kentucky 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-06-ohio-and-michigan 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-06-vermont 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-05-maine-and-vermont 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-04-massachusetts-and-maine 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-01-massachusetts 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-02-connecticut-and-massachusetts 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-road-to-50-states-day-01-connecticut 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/covid-19-in-hungary 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/understanding-healthcare-and-pharma-in-slovenia 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-future-of-bioprocessing-and-fermentation 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-future-of-healthcare-today-in-luxembourg 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/wrapping-up-our-exploration-of-the-future-of-healthcare 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/the-evolving-technology-supporting-api-manufacturing 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/artificial-intelligence-in-pharma-as-told-by-artificial-intelligence 2024-08-24 03:09:25.525644+00 https://www.pharmasalmanac.com/articles/how-are-advancements-in-technology-reshaping-the-roles-and-capabilities-of-cdmos-and-cros-in-the-drug-development-life-cycle 2024-08-21 16:53:35.075947+00 https://www.pharmasalmanac.com/articles/accelerating-protein-sequence-variant-analysis 2024-08-21 12:55:12.160691+00 https://www.pharmasalmanac.com/articles/managing-complex-sample-and-ip-logistics-in-support-of-cell-and-gene-therapies 2024-08-20 20:42:19.73764+00 https://www.pharmasalmanac.com/articles/ind-enablement-and-drug-product-development-mitigating-risk-and-accelerating-through-the-valley-of-death 2024-08-19 19:18:42.073089+00 https://www.pharmasalmanac.com/articles/revolutionizing-the-genetic-medicine-landscape-with-enzymatic-dna 2024-08-19 11:33:48.841345+00 https://www.pharmasalmanac.com/articles/civentichem-increases-capacity-by-300-with-new-facility-celebrates-30th-anniversary 2024-08-13 13:47:25.691972+00 https://www.pharmasalmanac.com/articles/bio-x-cell-announces-ceo-appointment 2024-08-12 10:23:03.654307+00 https://www.pharmasalmanac.com/articles/overcoming-variability-and-scaling-challenges-in-aav-manufacturing 2024-08-08 21:10:32.405403+00 https://www.pharmasalmanac.com/articles/the-biopharma-industry-is-well-prepared-for-an-overhaul-of-the-dna-to-ind-cmc-process-for-antibodies 2024-08-08 13:50:34.501134+00 https://www.pharmasalmanac.com/articles/facing-the-dual-scientific-and-financial-challenges-to-advance-cell-and-gene-therapies 2024-08-08 13:48:14.754084+00 https://www.pharmasalmanac.com/articles/biosimilars-manufacturing-and-supply-chain-for-worldwide-patients 2024-08-07 14:30:23.042832+00 https://www.pharmasalmanac.com/articles/disaster-strikes 2024-08-07 11:00:56.83485+00 https://www.pharmasalmanac.com/articles/sailing-into-the-trade-winds 2024-08-07 11:00:42.781453+00 https://www.pharmasalmanac.com/articles/assembling-the-crew 2024-08-07 11:00:24.750159+00 https://www.pharmasalmanac.com/articles/preparing-the-yacht-for-the-race 2024-08-07 11:00:08.469581+00 https://www.pharmasalmanac.com/articles/streamlining-the-path-to-approval-with-developability-and-preformulation-platforms 2024-08-01 10:40:38.547685+00 https://www.pharmasalmanac.com/articles/transforming-the-economics-of-aav-manufacture-while-optimizing-quality-with-dbdna 2024-07-31 10:16:29.454187+00 https://www.pharmasalmanac.com/articles/building-a-path-to-approval-with-effective-regulatory-support 2024-07-31 03:17:04.038301+00 https://www.pharmasalmanac.com/articles/rethinking-the-conventional-cdmo-model 2024-07-29 18:30:15.005306+00 https://www.pharmasalmanac.com/articles/transforming-the-management-of-chronic-diseases-with-biosimilars 2024-07-29 18:22:21.397248+00 https://www.pharmasalmanac.com/articles/why-multimodal-data-is-growing-in-pharma 2024-07-28 11:07:52.103742+00 https://www.pharmasalmanac.com/articles/partnering-with-scientific-excellence-to-derisk-and-accelerate-drug-development 2024-07-16 13:55:14.726913+00 https://www.pharmasalmanac.com/articles/pioneering-affordable-healthcare-biosidus-journey-in-biosimilars 2024-07-16 13:54:55.295388+00 https://www.pharmasalmanac.com/articles/enhancing-global-access-to-biotherapeutics-the-role-of-biosimilars-in-underserved-markets 2024-07-16 13:54:34.60088+00 https://www.pharmasalmanac.com/articles/navigating-the-global-regulatory-landscape-for-biosimilars 2024-07-16 13:53:52.823442+00 https://www.pharmasalmanac.com/articles/beyond-pills-the-rise-of-liquid-auspensions-for-complex-formulations 2024-07-16 02:11:08.474944+00 https://www.pharmasalmanac.com/articles/facilitating-organoid-production-for-biopharmaceutical-applications 2024-07-16 02:09:40.863253+00 https://www.pharmasalmanac.com/articles/overcoming-development-challenges-with-digital-solutions 2024-07-16 02:07:19.585649+00 https://www.pharmasalmanac.com/articles/transforming-pharmaceutical-packaging-with-sustainable-cutting-edge-solutions 2024-07-16 02:06:19.411246+00 https://www.pharmasalmanac.com/articles/revolutionizing-biologics-and-biology-through-a-focus-on-women 2024-07-16 02:02:02.001998+00 https://www.pharmasalmanac.com/articles/challenges-to-process-validation-for-viral-vectors 2024-07-04 08:19:39.322418+00 https://www.pharmasalmanac.com/articles/genezen-to-acquire-uniqures-commercial-gene-therapy-manufacturing-operations-in-lexington-ma 2024-07-02 12:48:20.99979+00 https://www.pharmasalmanac.com/articles/cros-cmos-focusing-on-innovation 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/oral-solid-dose-and-the-psychology-of-appearance 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/advancing-solid-dose-processing-efficiency-and-effectiveness 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/disease-in-a-dish-leveraging-human-models-to-advance-drug-discovery 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/mayo-clinic-and-baxter-launch-patient-centric-kidney-disease-initiative 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/amri-signs-acquisition-agreement 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/takeda-begins-expansion-of-its-manufacturing-footprint-in-ireland-0 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/us-diabetes-patients-now-have-access-to-an-artificial-pancreas-for-automatic-insulin-delivery 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/eli-lily-keybioscience-agree-to-work-on-the-development-of-new-diabetes-drugs 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/cmc-and-trellis-agree-to-develop-mab-therapies-to-treat-viral-bacterial-infections 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/us-spending-on-medicines-slows-by-half-says-study 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/orphan-xermelo-begins-commercial-manufacture 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/harmonized-protocol-templates-available-for-clinical-trial-sponsors 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/inovio-ebola-dna-vaccine-demonstrates-robust-immune-response 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/first-in-class-cancer-treatment-enters-new-era 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-announces-expansion-of-cold-chain-capacity-at-philadelphia-site 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/alcami-establishes-new-center-of-excellence 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/alcami-announces-grand-opening-of-st.-louis-missouri-facility-in-cortex-innovation-community 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/looking-forward-what-technologies-do-you-anticipate-having-the-greatest-impact-in-2018 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/achieving-efficient-pharmaceutical-synthesis-with-process-intensification 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/factory-cro-acquires-milestone-research-organization-builds-north-american-presence 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/ab-biotechnologies-inc.-names-bryan-hudson-as-director-of-quality-validation-and-it-and-ben-lisby-as-director-of-operations-and-facilities 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/cdmo-pfizer-centreone-expands-contract-manufacturing-to-nagoya-japan 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/brammer-bio-completes-renovations-at-manufacturing-site-in-massachusetts 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/russias-biocad-to-manufacture-biosimilars-in-north-africa 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/zika-vaccine-candidate-enters-phase-i-trial 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/bio-world-congress-on-industrial-biotechnology-announces-call-for-presentations 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/st.-jude-gene-therapy-improves-immunity-in-babies-with-bubble-boy-disease 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/kite-announces-long-term-data-from-pivotal-zuma-1-study-of-yescarta-axicabtagene-ciloleucel-in-patients-with-refractory-large-b-cell-lymphoma 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-marks-great-progress-in-immuno-oncology-research-partnerships-in-2017 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/nda-submitted-for-antimalarial-drug-1 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/hot-electrons-might-enable-new-synthetic-methods 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/abzena-selects-sartorius-stedim-biotech-to-equip-its-us-based-development-and-manufacturing-sites-in-san-diego-and-bristol 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/federal-equipment-company-adds-new-equipment-expands-classroom-capacity-and-welcomes-a-new-class-for-the-manufacturing-process-by-techceuticals-llc 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-designs-flexible-manufacturing-site-for-flexion-therapeutics-inc 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fda-approves-new-indication-for-gilotrif-in-egfr-mutation-positive-nsclc 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/point-of-care-diagnostics-market-is-estimated-to-register-a-cagr-of-6.9-by-2024-globally-transparency-market-research 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/focal-segmental-glomerulosclerosis-market-to-reach-us15.83-billion-by-2025-globally-transparency-market-research 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/biocartis-immunexpress-sign-partnership-for-a-sepsis-host-immune-response-test-on-the-idylla-platform 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/wuxi-partners-with-swedish-firm-to-establish-new-contract-manufacturer 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/immunoqure-ag-and-servier-enter-into-strategic-partnership-for-the-development-of-an-interferon-alpha-human-autoantibody 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/roche-achieves-two-major-milestones-in-the-evolution-of-decision-support-platform 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/driving-change-in-the-pharma-industry-and-biotech-one-relationship-at-a-time 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-long-term-data-show-improved-survival-and-lower-rates-of-stroke-and-pump-thrombosis-for-abbotts-heartmate-3-heart-pump 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/worldwide-clinical-trials-acquires-continuum-clinicals-late-stage-research-practice 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fda-approves-toujeo-max-solostar 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-study-finds-younger-aged-children-with-symptoms-of-adhd-have-reduced-brain-size 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/bioivt-acquires-ascendance-biotechnology-expanding-its-drug-safety-testing-and-toxicology-portfolios- 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/evotec-ag-plans-conversion-into-european-company-se 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/ipsen-announces-ema-validation-of-filing-of-a-new-application-for-additional-indication-for-cabometyx 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/biovica-international-ab-new-positive-results-support-early-treatment-evaluation-of-breast-cancer-using-divitum 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-minor-league-baseball-team-up-to-raise-awareness-of-rare-lung-disease-ipf 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/scholar-rock-granted-orphan-drug-designation-by-the-fda-for-srk-015-for-the-treatment-of-patients-with-spinal-muscular-atrophy 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/sancilio-pharmaceuticals-company-to-present-new-research-on-altemia-to-treat-sickle-cell-disease-at-the-aspho-conference 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/evotec-expands-crispr-based-technology-offering-with-licence-from-ers-genomics 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/innovative-drugs-and-anti-cancer-compounds-are-most-welcome-in-the-chinese-market-says-asia-pacific-cro-george-clinical 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/lilly-to-acquire-aurka-pharma 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-treatment-for-excessive-sweating-gets-fda-approval 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/bryan-zerhusen-ph.d.-joins-cantor-colburn-to-chair-its-life-sciences-practice-group 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/optimapharm-europes-fast-growing-cro-expands-office-network-to-the-united-kingdom 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/60-day-window-for-clinical-trial-approval-official-says-george-clinical-a-leading-asia-pacific-cro 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/sotera-healths-nordion-completes-the-sale-of-its-medical-isotopes-business-to-bwxt 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/flumist-shipped-by-astrazeneca 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/product-and-service-concepts-driving-speed-to-market 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/collplant-and-united-therapeutics-announce-global-licensing-and-commercialization-agreement-for-3d-bioprinting-of-solid-organ-scaffolds-for-human-transplants 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/bd-announces-clinical-trial-data-for-the-lutonix-014-drug-coated-balloon-below-the-knee-ide-trial 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-chief-executive-officer-dr.-chris-chen-to-serve-on-board-of-directors-at-ispe-and-delivered-keynote-speech-at-2018-annual-meeting 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/astellas-global-health-foundation-launches 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/kaleido-biosciences-announces-appointment-of-katharine-knobil-m.d.-as-chief-medical-officer-and-head-of-research-development 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/dps-group-selected-to-design-two-cgmp-commercial-manufacturing-facilities-for-brammer-bio 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/china-cancer-drugs-market-2018-2024-rising-demand-of-targeted-drug-therapy-and-the-patent-expiration-of-key-cancer-drugs 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/perrigo-appoints-james-dillard-to-role-of-chief-scientific-officer 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/newly-discovered-phagocyte-plays-role-in-autoimmune-disease 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/phillips-medisize-named-winner-of-2019-pharmapack-innovation-award-best-innovation-in-drug-delivery 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/culture-biosciences-secures-5.5m-to-pioneer-biomanufacturing-as-a-service 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/applied-biology-to-enter-into-a-license-agreement-with-hairmore-for-its-novel-treatment-for-traction-alopecia 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/study-of-singing-mice-suggests-how-mammalian-brain-achieves-conversation 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-form-of-herceptin-approved-by-u.s.-fda-for-breast-cancer 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/generics-manufacturing-and-changing-equipment-needs 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/genomics-market-size-worth-usd-27.6-billion-by-2025-cagr-9.1-grand-view-research-inc 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fda-gets-new-acting-head 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-acquire-brammer-bio-a-leader-in-viral-vector-manufacturing 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/billiontoone-announces-15-million-series-a-co-led-by-hummingbird-and-neotribe 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/luye-pharmas-rykindo-expected-to-be-the-first-chinese-innovative-drug-to-receive-u.s.-fda-approval 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/genetic-biochemical-changes-to-astronaut-in-space-disappeared-upon-return-to-earth 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/n8-medical-announces-first-in-human-use-of-its-cerashield-endotracheal-tube 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fbi-investigating-pharma-companies-for-corruption-in-brazil 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/gt-biopharma-gtb-1550-clinical-development-update 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/immunogen-announces-completion-of-operational-review 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/sartorius-starts-up-operations-at-expanded-site-in-puerto-rico 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/imfinzi-improves-survival-in-the-phase-iii-caspian-trial-in-1st-line-extensive-stage-small-cell-lung-cancer 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/xencor-announces-the-planned-retirement-of-chief-medical-officer-paul-foster-m.d 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/targeting-new-treatments-for-concussions-by-transforming-brain-pathology 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/msn-labs/novadoz-pharmaceuticals-early-success-continues-with-fda-approval-of-generic-abiraterone 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/gsk-ships-2019-20-seasonal-influenza-vaccines-for-us-market 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/northway-biotechpharma-has-successfully-implemented-eu-funded-rd-project 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/northway-biotechpharma-celebrates-15-years-of-growth-and-success 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-treatment-approach-for-pancreatic-cancer 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/sanofi-delivered-solid-growth-in-q2-2019 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/cambrex-to-be-acquired-by-the-permira-funds-for-60.00-per-share-in-cash 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-and-md-anderson-form-unique-virtual-research-and-development-center-to-rapidly-advance-new-cancer-therapies 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/astrazeneca-agrees-to-buy-us-fda-priority-review-voucher-from-sobi 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/trakcel-announces-strategic-partnership-with-wuxi-apptec-advanced-therapies-for-optimization-of-supply-chain-for-cell-and-gene-therapy-treatments 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-trends-in-tech-impacting-pharma-facility-design-and-construction 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/applying-an-established-and-continuously-upgraded-global-network-for-cdmo-services 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/glocalization-of-drug-manufacturing 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/halozyme-announces-actions-to-focus-strategy-on-enhanze-drug-delivery-technology 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/exicure-and-allergan-enter-into-collaboration-option-and-license-agreement-to-discover-and-develop-sna-based-treatments-for-hair-loss-disorders 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/measuring-the-time-and-cost-benefits-of-integrated-product-development 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/winning-the-war-on-talent-with-behavioral-interviewing 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/yposkesi-selected-to-produce-clinical-and-large-scale-commercial-material-of-micro-dystrophin-for-genethon-and-sarepta-therapeutics-program 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/parenteral-drugs-market-to-exhibit-6-cagr-on-back-of-surging-demand-for-self-administered-drugs 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/astrazenecas-ambition-zero-carbon-strategy-to-eliminate-emissions-by-2025-and-be-carbon-negative-across-the-entire-value-chain-by-2030 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/surgical-robots-begin-first-nhs-procedures 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/cphi-japan-to-be-postponed-on-request-of-event-attendees 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/roche-initiates-phase-iii-clinical-trial-of-actemra/roactemra-in-patients-with-severe-covid-19-pneumonia 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/new-35-co-pay-now-available-through-lilly-insulin-value-program-in-response-to-covid-19-crisis-in-u.s 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/dr.-gustavo-mahler-now-a-general-partner-at-dynamk-capital 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/catalent-signs-agreement-with-johnson-johnson-to-be-u.s.-manufacturing-partner-for-lead-covid-19-vaccine-candidate 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/novartis-announces-fda-approval-of-met-inhibitor-tabrecta-for-metastatic-non-small-cell-lung-cancer-with-metex14 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/abbvie-and-allergan-receive-clearance-from-u.s.-federal-trade-commission-for-abbvies-acquisition-of-allergan 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/enlivex-announces-initiation-of-multi-center-phase-ii-investigator-initiated-clinical-trial-of-allocetra-in-covid-19-patients 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/seaweed-extract-reduces-flu-severity 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/trxade-group-inc.-withdraws-its-previously-filed-fda-emergency-use-authorization-for-rapid-covid-19-testing-kit 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/viiv-healthcares-injectable-formulation-dosed-every-two-months-shows-higher-efficacy-than-daily-oral-prep 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/roches-highly-accurate-antibody-test-for-covid-19-goes-live-at-more-than-20-initial-lab-sites-in-the-u.s 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/vaxcyte-announces-pricing-of-upsized-initial-public-offering 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/calquence-showed-long-term-efficacy-and-tolerability-for-patients-with-chronic-lymphocytic-leukemia-in-two-trials 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fulcrum-therapeutics-to-evaluate-losmapimod-as-potential-treatment-for-covid-19 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/melinta-therapeutics-enters-into-agreement-to-acquire-tetraphase-pharmaceuticals 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/daiichi-sankyo-announces-start-of-discussions-with-astrazeneca-regarding-supply-in-japan-of-novel-coronavirus-vaccine 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/clew-receives-fda-emergency-use-authorization-for-its-predictive-analytics-platform-in-support-of-covid-19-patients 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fda-approves-first-of-its-kind-percep-pc-neurostimulator-with-brainsense-technology 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/johnson-johnson-announces-agreement-with-u.s.-government-for-100-million-doses-of-investigational-covid-19-vaccine 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/premier-research-adds-to-diverse-team-of-oncology-experts 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/frontida-biopharm-inc.-announces-highly-potent-compound-contract-manufacturing-suite 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/biopharma-leaders-unite-to-stand-with-science 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/grail-announces-filing-of-registration-statement-for-proposed-initial-public-offering 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/takeda-opens-new-rd-cell-therapy-manufacturing-facility-to-support-expansion-of-next-generation-clinical-programs 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/the-scripps-research-institute-to-pay-10-million-to-settle-false-claims-act-allegations-related-to-mischarging-nih-sponsored-research-grants 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/kymanox-adds-top-experts-in-human-factors-to-enhance-combination-product-capabilities 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/intuitive-launches-100-million-venture-capital-fund 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/lilly-announces-agreement-with-u.s.-government-to-supply-300000-vials-of-investigational-neutralizing-antibody-to-fight-covid-19 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/nereid-therapeutics-raises-50m-in-series-a-funding 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/the-bristol-myers-squibb-foundation-and-national-medical-fellowships-launch-100-million-program-to-help-increase-diversity-and-inclusion-in-clinical-trials 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/twist-bioscience-announces-positive-preclinical-data-for-sars-cov-2-antibodies 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/russias-sputnik-v-covid-19-vaccine-is-91-effective 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/enhancing-interferometry-with-dolomites-mitos-dropix 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/q1-amri-good-laboratory-practices-lead-to-good-manufacturing-in-cdmos 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/curi-bio-raises-6m-series-a-financing-round-for-ipsc-derived-predictive-platforms 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/lilly-vir-biotechnology-and-gsk-announce-positive-topline-data-from-the-phase-2-blaze-4-trial-evaluating-bamlanivimab-with-vir-7831-in-low-risk-adults-with-covid-19 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/fda-authorizes-first-single-use-pcr-quality-over-the-counter-otc-lucira-check-it-covid-19-at-home-test.-available-now 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/sanofi-to-help-manufacture-modernas-covid-19-vaccine 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/irsf-recognizes-15-clinics-with-new-center-of-excellence-awards 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/ema-starts-evaluating-use-of-covid-19-vaccine-comirnaty-in-young-people-aged-12-to-15 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/farxiga-approved-in-the-us-for-the-treatment-of-chronic-kidney-disease-in-patients-at-risk-of-progression-with-and-without-type-2-diabetes 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/jazz-pharmaceuticals-completes-acquisition-of-gw-pharmaceuticals-plc 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/allergan-aesthetics-to-acquire-soliton-expanding-body-contouring-portfolio 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/milliporesigma-announces-vectory-as-winner-of-its-advance-biotech-grant 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/cvs-health-introduces-clinical-trial-services 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/biogen-and-ginkgo-bioworks-announce-collaboration-and-license-agreement-to-develop-novel-gene-therapy-manufacturing-platform 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/collaboration-in-action-new-milestones-efficiency-and-simplifying-the-complexities-of-drug-development 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/gea-opens-a-new-chapter-for-biopharmaceutical-separation-processes-with-pharma-separator-lines-aseptic-and-pure 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/crb-expands-board-level-leadership-team 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/governor-cuomo-announces-regenerons-1.8-billion-expansion-in-westchester-county 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/training-the-immune-system-to-recognize-cancer-cells 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/focusing-on-the-patient-experience-in-clinical-trials-with-ancillary-kitting-supplies 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/helping-companies-with-big-data-challenges 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/idt-biologika-celebrates-100-years-of-successful-vaccine-development-and-u.s.-expansion 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/facilitating-clinical-manufacturing-of-recombinant-proteins-with-large-scale-single-use-fermentation-technology 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/closing-the-gender-gap-in-clinical-research 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/advancing-diagnostics-to-address-brain-tumors 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/driving-the-future-of-investment-in-the-life-sciences 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/integrating-omics-approaches 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/leveraging-organoids-to-address-neurodegenerative-diseases 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/bruker-launches-novel-7-tesla-and-9.4-tesla-preclinical-mri-magnets 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/agc-biologics-invests-in-viral-vector-suspension-at-new-u.s.-campus 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/vernal-biosciences-raises-21-million-to-accelerate-mrna-manufacturing-growth 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/multiple-crb-projects-selected-for-2022-facility-of-the-year-awards-by-ispe 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/niimbl-announces-15.8m-to-fund-14-new-biopharmaceutical-manufacturing-projects 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/actylis-debuts-signaling-the-creation-of-an-integrated-global-specialty-ingredients-manufacturing-and-sourcing-powerhouse 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/a-guide-on-comprehensive-decontamination-solutions-for-the-pharmaceutical-industry 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/integrating-experimental-data-and-artificial-intelligence-to-accelerate-drug-discovery 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/goodwin-biotechnology-inc.-is-now-gbi-as-part-of-their-rebranding-initiative-on-their-30-year-anniversary 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/hovione-and-gea-announce-a-strategic-collaboration-to-advance-continuous-tableting 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/expanding-patient-access-to-gene-therapies-through-aav-capsid-engineering 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/be-the-match-biotherapies-and-cryoport-partner-to-accelerate-the-development-of-cell-and-gene-therapies 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/modifying-the-gut-microbiome-to-improve-car-t-hsct-and-other-therapeutic-responses 2024-06-29 08:53:54.571143+00 https://www.pharmasalmanac.com/articles/q-what-do-you-think-most-differentiates-the-u.s.-pharma-biopharma-industry-or-the-market 2024-06-29 08:52:25.628925+00 https://www.pharmasalmanac.com/articles/q-whats-the-next-big-thing-on-the-horizon-that-will-significantly-alter-the-pharma-biopharma-market-your-operations-or-the-way-you-do-business 2024-06-29 08:52:25.628925+00 https://www.pharmasalmanac.com/articles/the-conversation-that-got-me-thinking-of-a-new-business-concept-2 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/from-cell-culture-to-cell-therapy-drug-applications-continue-to-surge-as-science-grows 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/what-role-has-ma-played-in-your-companys-growth 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/rightbio-metrics-receives-innovative-technology-contract-from-vizient-inc.-for-rightspotph-indicators 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-rd-pushes-to-transcend-disease-boundaries 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/arcus-biosciences-and-infinity-pharmaceuticals-announce-clinical-collaboration-to-evaluate-lead-programs-in-triple-combination-studies 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/skyhawk-therapeutics-announces-strategic-collaboration-with-celgene-to-discover-and-develop-novel-mrna-splicing-modifiers-using-skyhawks-star-technology-platform 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/neuroaid-combined-with-rehabilitation-has-shown-additive-and-sustained-benefits-on-post-stroke-recovery 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/new-approvals-allow-chronic-pain-sufferers-to-try-abbotts-non-opioid-pain-therapy-before-getting-device-implant 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/tenax-therapeutics-announces-pricing-of-10-million-underwritten-offering 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/erasca-launches-with-42-million-series-a-financing-to-support-bold-mission-of-erasing-cancer 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/life-biosciences-llc-leads-strategic-investment-of-up-to-a44.5-million-us31.4-million-in-prana 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/innovent-announces-first-patient-dosed-in-a-phase-iii-clinical-trial-of-anti-pd-1-antibody-tyvyt 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/prokidney-announces-62-million-acquisition-of-inregen 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-support-mrna-based-vaccine-candidate-production-for-biontech 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/the-ideal-capsule-supplier-using-a-holistic-approach-to-facilitate-customer-success 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/formulated-solutions-redefining-the-consumer-healthcare-experience 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/cell-based-assays-market-is-projected-to-collect-revenue-of-us19710.7-million-by-2022-says-tmr 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/apollo-proton-cancer-centre-chennai-performs-indias-first-total-marrow-irradiation-procedure 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/ag-mednet-and-median-technologies-partnership-supports-global-clinical-trials-portfolio-including-extensive-programs-in-china 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-acquires-amal-therapeutics-significantly-enriching-its-cancer-immunology-portfolio-with-novel-cancer-vaccines-platform 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/identifying-new-targets-for-weight-loss-drugs 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/luca-biologics-launches-to-develop-live-biotherapeutics-for-womens-health-starting-with-urinary-tract-infection-uti 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/brain-computer-interface-tech-advances 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/novo-nordisk-launching-additional-us-insulin-affordability-offerings-in-january-2020 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/healthcare-ads-are-going-digital 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/movement-in-cases-against-pharma-regarding-the-opioid-crisis 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/alkermes-announces-the-appointment-of-board-of-directors 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-announces-update-for-patients-with-resected-high-risk-melanoma-and-pd-l1-1 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/fda-grants-orphan-drug-designation-to-epidermolysis-bullosa-treatment 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-almirall-sign-strategic-collaboration-agreement-for-multiple-bispecific-antibodies-targeting-dermatology-diseases 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/biohaven-to-advance-vazegepant-into-phase-3-for-acute-migraine-treatment 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/genentechs-phase-iii-empacta-study-showed-actemra-reduced-the-likelihood-of-needing-mechanical-ventilation-in-hospitalized-patients-with-covid-19-associ-1600446288810 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/abbott-receives-fda-emergency-use-authorization-for-its-covid-19-blood-test 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/leveraging-biosynthesis-to-create-pure-cannabinoids-for-less 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/paris-sites-and-digital-solutions-0 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/paris-sites-and-digital-solutions 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/the-future-of-personalized-medicine-in-luxembourg 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/hitting-our-27th-country-in-22-days 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/the-pedestrian-road-through-milano 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/understanding-the-swiss-way 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/recharging-at-the-alpine-pass 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/public-healthcare-trumps-private-in-eastern-europe 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/preclinical-trials-and-personalized-dosing 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/meeting-two-trip-sponsors-in-bratislava 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/learning-about-pharmacovigilance-in-bratislava 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/a-change-of-plans-leads-us-to-prague 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/police-encounter-and-soviet-aircraft-0 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/police-encounter-and-soviet-aircraft 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/onward-into-the-baltics 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/a-relaxing-voyage-past-the-fjords 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/heavy-rain-and-nobel-prizes 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/a-day-of-serious-driving-across-germany-and-into-denmark 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/a-gorgeous-and-relaxing-day-in-the-bene-region 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/scotland-our-collective-favorite-stop-of-the-trip 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/exploring-the-emerald-isle-without-pubs 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/trip-kickoff-at-home-house-in-kensington-london 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/monte-carlo-and-along-the-french-riviera 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/four-countries-in-a-day-but-few-masks 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/on-the-road-to-2021-there-were-no-passengers-on-this-journey 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/southward-through-the-uk-and-across-the-channel-to-europe 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/the-power-of-repligut-in-vitro-intestinal-stem-cell-models 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/amneal-completes-acquisition-of-kashiv-specialty-pharmaceuticals 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/car-t-cell-and-gene-therapy-market-challenges-and-opportunities 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/catalent-to-acquire-rheincell-therapeutics-strengthening-a-path-towards-industrialization-of-induced-pluripotent-stem-cell-based-therapies 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-acquire-ppd-inc.-a-leading-clinical-research-organization-1 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/trip-kickoff-at-home-house-in-kensington-london-0 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/prime-medicine-launches-with-315-million-financing-to-deliver-on-the-promise-of-prime-editing 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/andelyn-biosciences-a-new-cdmo-with-roots-in-gene-therapy-research-set-to-drive-key-manufacturing-advances 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/accelerated-drug-development-for-acute-cardiovascular-and-pulmonary-care 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/integrating-heterogeneous-data-to-enable-precision-medicine 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/enabling-4d-proteomics-and-epiproteomics 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/solving-the-patient-centric-formulation-riddle 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/streamlining-osd-operations-from-tableting-through-serialization 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/arranta-bio-announces-completion-of-sale-of-florida-site-and-progress-on-150m-investment-plan-to-expand-development-and-commercial-manufacturing-services 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/embracing-the-idea-of-change-in-facility-design-and-engineering 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/investing-in-mrna-production 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/2021-roundup-the-year-of-cell-and-gene-therapy 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/leveraging-true-expertise-and-flexibility-for-lipid-nanoparticle-clinical-manufacturing 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/quality-plant-made-mabs-with-fastpharming 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/10-promising-biotechs-aiming-to-transform-medicine 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/accelerating-inclusive-growth-in-st.-louis 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/assuring-excipient-quality-for-parenteral-products 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/deepmind-ai-learns-simple-physics-like-an-infant 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/three-benefits-of-using-in-silico-technologies-for-drug-discovery 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/improving-the-handling-and-safety-of-pharmaceutical-raw-materials-through-dry-granulation 2024-06-29 08:38:47.303687+00 https://www.pharmasalmanac.com/articles/partnerships-for-success 2024-06-25 14:32:26.669408+00 https://www.pharmasalmanac.com/articles/how-can-life-science-technology-providers-support-the-pharmaceutical-industry 2024-06-18 04:04:32.362574+00 https://www.pharmasalmanac.com/articles/what-are-the-current-investment-trends-in-the-pharmaceutical-industry 2024-06-18 02:45:39.646454+00 https://www.pharmasalmanac.com/articles/coriolis-pharma-launches-us-entity-alongside-innovative-drug-product-platform-service-offerings-for-monoclonal-antibodies 2024-06-13 15:35:36.820212+00 https://www.pharmasalmanac.com/articles/accelerating-and-improving-bioprocess-development-with-machine-learning-solutions 2024-06-06 13:47:46.185353+00 https://www.pharmasalmanac.com/articles/implementation-challenges-for-hybrid-and-decentralized-clinical-trials 2024-06-06 13:30:16.671238+00 https://www.pharmasalmanac.com/articles/biotech-training-is-a-challenge 2024-06-06 13:12:18.431993+00 https://www.pharmasalmanac.com/articles/protacs-upgrading-small-molecule-inhibitors 2024-06-06 12:50:25.576914+00 https://www.pharmasalmanac.com/articles/navigating-shifting-requirements-and-an-explosion-of-data-in-pharmacovigilance 2024-06-05 08:33:06.821069+00 https://www.pharmasalmanac.com/articles/feasibility-studies-and-cgmp-design-supporting-continuous-lipid-nanoparticle-manufacturing 2024-05-30 16:00:00+00 https://www.pharmasalmanac.com/articles/optimizing-oncology-and-rare-disease-clinical-trials-by-focusing-on-patients-investigators-and-sites 2024-05-26 15:54:42.846594+00 https://www.pharmasalmanac.com/articles/intelligent-cell-processing-enables-consistent-reproducible-and-scalable-gmp-compliant-processes 2024-05-26 14:47:17.171754+00 https://www.pharmasalmanac.com/articles/leveraging-innovative-transposase-technology-for-a-highly-reliable-and-productive-cmc-platform 2024-05-26 14:25:58.336588+00 https://www.pharmasalmanac.com/articles/the-next-frontier-in-neurological-diagnostics-and-therapeutics 2024-05-25 05:12:50.871619+00 https://www.pharmasalmanac.com/articles/bright-outlook-for-exosome-based-therapeutics-and-diagnostics-despite-numerous-hurdles 2024-05-09 16:33:26.221+00 https://www.pharmasalmanac.com/articles/how-synergistic-collaborations-between-outsourcing-partners-can-accelerate-clinical-success 2024-05-08 09:00:00.579+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-begins-installation-of-sterile-fill-finish-and-lyophilization-line-as-part-of-100-million-new-facility-expansion 2024-05-02 15:57:19.54+00 https://www.pharmasalmanac.com/articles/building-a-regulatory-roadmap-for-ind-nda-and-bla 2024-04-30 17:09:18.686+00 https://www.pharmasalmanac.com/articles/possible-new-hope-for-metastatic-cancer-patients-food-and-drug-administration-grants-approval-for-clinical-trials-for-lamassus-groundbreaking-cancer-tre-1713550958910 2024-04-19 18:27:44.541+00 https://www.pharmasalmanac.com/articles/exploring-new-possibilities-with-3d-printing-of-pharmaceuticals 2024-04-19 15:49:50.08+00 https://www.pharmasalmanac.com/articles/expediting-biologics-drug-development-downstream-strategies-to-accelerate-preclinical-development-timelines 2024-04-17 15:10:05.015+00 https://www.pharmasalmanac.com/articles/how-microfluidic-devices-are-benefitting-biopharmaceutical-development-and-manufacturing 2024-04-17 13:28:07.01+00 https://www.pharmasalmanac.com/articles/technology-advances-needed-to-drive-future-mrna-growth 2024-04-15 09:00:00.722+00 https://www.pharmasalmanac.com/articles/navigating-regulatory-complexity-for-cell-and-gene-therapies 2024-04-12 09:00:00.516+00 https://www.pharmasalmanac.com/articles/navigating-mrna-manufacturing-with-flexibility-and-innovation 2024-04-08 18:25:18.028+00 https://www.pharmasalmanac.com/articles/leveraging-biologic-development-experience-in-support-of-cdmo-clients-rapid-effective-and-tailored-analytical-method-development 2024-04-05 20:05:17.125+00 https://www.pharmasalmanac.com/articles/how-can-pharmaceutical-and-biopharmaceutical-companies-demonstrate-their-commitment-to-esg-principles-in-manufacturing 2024-04-04 15:26:35.629+00 https://www.pharmasalmanac.com/articles/what-strategies-are-being-employed-to-accelerate-product-development-and-commercialization-without-compromising-quality 2024-04-03 14:55:36.245+00 https://www.pharmasalmanac.com/articles/overcoming-pdna-supply-challenges-for-mrna-manufacturing 2024-04-01 09:00:00.512+00 https://www.pharmasalmanac.com/articles/small-molecule-api-discovery-and-development-trends 2024-03-28 19:30:13.359+00 https://www.pharmasalmanac.com/articles/a-closer-look-at-small-molecule-drug-substance-and-drug-product-manufacturing 2024-03-28 19:28:52.593+00 https://www.pharmasalmanac.com/articles/leading-cdmo-pci-pharma-services-releases-inaugural-comprehensive-esg-report 2024-03-27 15:15:38.638+00 https://www.pharmasalmanac.com/articles/is-synthetic-plasmid-dna-one-of-the-solutions-for-meeting-growing-demand-for-next-gen-therapies 2024-03-26 19:21:56.979+00 https://www.pharmasalmanac.com/articles/consistent-formulation-continuous-improvement-introducing-robust-easier-to-use-detergent-packaging 2024-03-22 16:24:05.816+00 https://www.pharmasalmanac.com/articles/integrated-spatial-genomics-real-potential-to-provide-truly-novel-biological-insights 2024-03-22 16:20:52.159+00 https://www.pharmasalmanac.com/articles/reducing-time-to-first-in-human-trials-with-robotic-sterile-fill/finish-manufacturing-services 2024-03-22 16:18:04.312+00 https://www.pharmasalmanac.com/articles/the-translational-index-score-improving-the-entire-drug-development-cycle 2024-03-22 16:17:08.222+00 https://www.pharmasalmanac.com/articles/transparent-communication-supports-tech-transfers-of-cis-targeted-immunotherapies 2024-03-22 16:15:28.862+00 https://www.pharmasalmanac.com/articles/cis-targeted-immunotherapies-need-large-cdmo-expertise-but-also-flexibility 2024-03-22 16:14:46.76+00 https://www.pharmasalmanac.com/articles/genezen-enters-licensing-agreement-with-csl-for-the-cytegrity-stable-lentivirus-production-system 2024-03-22 16:14:14.327+00 https://www.pharmasalmanac.com/articles/advancing-disease-research-and-drug-development-on-an-enterprise-pathology-platform 2024-03-22 16:12:00.76+00 https://www.pharmasalmanac.com/articles/a-viral-vector-cdmo-vision-that-resonates 2024-03-22 15:14:46.573+00 https://www.pharmasalmanac.com/articles/the-innovators-bringing-continuous-manufacturing-to-lipid-nanoparticles 2024-03-22 15:05:02.857+00 https://www.pharmasalmanac.com/articles/expediting-radioimmune-conjugate-pharmaceuticals-for-first-in-human-phase-0-proof-of-concept-human-studies-from-stable-pool 2024-03-15 15:22:21.929+00 https://www.pharmasalmanac.com/articles/leveraging-decentralized-clinical-trial-strategies-to-reduce-health-care-disparities 2024-03-15 14:46:04.142+00 https://www.pharmasalmanac.com/articles/antheia-and-olon-continue-partnership-for-biomanufacturing-antheias-pipeline-of-ksms-and-apis-for-essential-medicines 2024-03-13 18:47:58.452+00 https://www.pharmasalmanac.com/articles/advanced-technologies-unlocking-the-future-of-drug-manufacturing 2024-03-11 18:27:53.425+00 https://www.pharmasalmanac.com/articles/genezen-announces-strategic-process-development-and-manufacturing-partnership-agreement-with-seattle-childrens-research-institute-for-x-linked-agammaglo-1709680248075 2024-03-06 14:00:03.596+00 https://www.pharmasalmanac.com/articles/accelerating-the-development-and-production-of-high-quality-bispecific-antibodies 2024-03-06 00:26:25.947+00 https://www.pharmasalmanac.com/articles/nmdp-announces-enrollment-of-first-patient-in-optimize-clinical-trial 2024-03-05 18:45:03.709+00 https://www.pharmasalmanac.com/articles/pediatric-clinical-trials-considerations-for-enrollment-and-retention 2024-03-01 09:30:00.529+00 https://www.pharmasalmanac.com/articles/wheeler-bio-seals-agreement-with-charles-river-to-offer-portable-cmc-to-discovery-clients-to-accelerate-their-journey-to-first-in-human-use 2024-02-29 14:00:00.468+00 https://www.pharmasalmanac.com/articles/expanding-capabilities-for-clientsolon-to-open-new-high-potency-api-suite-in-us 2024-02-28 16:48:33.63+00 https://www.pharmasalmanac.com/articles/suanfarma-unifies-its-industrial-brands-in-a-rebranding-initiative-under-suanfarma-cdmo 2024-02-28 16:46:01.087+00 https://www.pharmasalmanac.com/articles/right-from-the-start-identifying-clinically-and-commercially-advanceable-formulations-and-processes-at-phase-i 2024-02-26 19:09:54.182+00 https://www.pharmasalmanac.com/articles/successful-formulation-development-for-biologics-using-a-unique-biophysical-prediction-and-screening-platform 2024-02-15 17:37:38.97+00 https://www.pharmasalmanac.com/articles/cell-free-protein-synthesis-holds-real-potential-to-transform-drug-development-and-manufacturing 2024-02-14 17:32:05.686+00 https://www.pharmasalmanac.com/articles/revolutionizing-early-stage-biopharma-development-introducing-wheeler-bios-portable-cmc-platform 2024-02-09 02:18:21.306+00 https://www.pharmasalmanac.com/articles/recombinant-antibody-technology-is-crucial-to-past-and-future-success-in-biopharma 2024-01-24 14:43:03.688+00 https://www.pharmasalmanac.com/articles/the-potential-of-molecular-machines-enhanced-drug-delivery-and-beyond 2024-01-22 20:10:22.649+00 https://www.pharmasalmanac.com/articles/leveraging-the-tenacity-of-biotherapeutics-development-experience-to-build-a-dynamic-cdmo 2024-01-17 15:07:10.614+00 https://www.pharmasalmanac.com/articles/market-trends-driving-the-embrace-of-plant-based-cell-culture-media-ingredients 2024-01-17 15:05:25.825+00 https://www.pharmasalmanac.com/articles/enabling-controlled-end-to-end-biomanufacturing-with-animal-free-culture-media-products 2024-01-17 15:04:30.736+00 https://www.pharmasalmanac.com/articles/sgd-pharma-announces-the-appointment-of-fabio-invernizzi-general-manager-west-business-unit 2024-01-17 14:17:02.411+00 https://www.pharmasalmanac.com/articles/an-adaptive-ecosystem-of-solutions-evolving-clinical-trials-in-a-decentralized-world 2024-01-17 10:30:00.482+00 https://www.pharmasalmanac.com/articles/navigating-hplc-method-development-tips-for-success 2024-01-17 09:00:00.624+00 https://www.pharmasalmanac.com/articles/podcast-insights-from-cdo-experts-from-samsung-biologics 2024-01-16 09:00:01.251+00 https://www.pharmasalmanac.com/articles/maximizing-outsourcing-benefits-for-virtual-pharma-companies 2024-01-11 20:35:56.513+00 https://www.pharmasalmanac.com/articles/pioneering-breakthroughs-in-retinal-disease-treatment 2024-01-08 11:29:49.857+00 https://www.pharmasalmanac.com/articles/technological-innovations-enhancing-downstream-productivity-and-their-critical-process-parameters-for-real-time-control 2024-01-04 21:04:59.942+00 https://www.pharmasalmanac.com/articles/what-do-you-see-as-the-most-significant-regulatory-decision-or-guidance-on-the-horizon-for-2024-or-beyond 2024-01-02 20:45:01.7+00 https://www.pharmasalmanac.com/articles/what-do-you-think-was-the-single-most-consequential-event-or-result-in-pharma/biopharma-in-2023 2023-12-27 20:06:57.061+00 https://www.pharmasalmanac.com/articles/rethinking-the-pharma/biopharma-supply-chain-to-maximize-resilience 2023-12-19 16:40:07.173+00 https://www.pharmasalmanac.com/articles/abc-analytics-for-biomanufacturing-and-clinical-trials-of-biomanufactured-products 2023-12-15 20:51:49.728+00 https://www.pharmasalmanac.com/articles/what-is-your-plan-to-build-a-more-sustainable-business-practice-in-the-coming-years 2023-12-15 15:24:35.269+00 https://www.pharmasalmanac.com/articles/designing-a-recipe-for-stem-cell-therapy-success 2023-12-14 22:15:15.636+00 https://www.pharmasalmanac.com/articles/s-glyntm-optimizing-n-glycan-profiles-and-their-effector-functions-using-a-design-of-experiments-approach 2023-12-14 18:41:15.792+00 https://www.pharmasalmanac.com/articles/rethinking-cell-engineering-for-cell-therapy-manufacturing 2023-12-13 20:59:07.596+00 https://www.pharmasalmanac.com/articles/fostering-a-sustainable-future-in-clinical-trials-through-decentralized-trial-models 2023-12-13 17:11:12.661+00 https://www.pharmasalmanac.com/articles/enabling-client-success-with-complementary-services-built-upon-a-strong-chemistry-foundation 2023-12-13 10:00:00.577+00 https://www.pharmasalmanac.com/articles/creating-efficiencies-in-engineered-cell-therapy-development-with-comprehensive-electroporation-support 2023-12-12 22:31:36.007+00 https://www.pharmasalmanac.com/articles/scaling-cell-and-gene-therapy-processes-from-rd-to-production 2023-12-12 15:31:21.222+00 https://www.pharmasalmanac.com/articles/why-fina-biosolutions-partnered-with-scorpius-biomanufacturing-for-cgmp-production-of-ecocrm-crm197 2023-12-11 15:07:12.661+00 https://www.pharmasalmanac.com/articles/the-power-of-aqueous-detergents-in-critical-cleaning 2023-12-05 20:07:09.873+00 https://www.pharmasalmanac.com/articles/fully-supporting-customer-needs-for-biologics-development-and-manufacturing 2023-11-15 18:36:48.751+00 https://www.pharmasalmanac.com/articles/reducing-adc-development-timelines-with-integrated-development-and-manufacturing-services 2023-11-13 13:59:04.348+00 https://www.pharmasalmanac.com/articles/delivering-a-next-generation-covid-19-vaccine-for-immunocompromised-patients-and-novel-cancer-vaccines 2023-11-09 12:11:08.364+00 https://www.pharmasalmanac.com/articles/alloy-therapeutics-and-wheeler-bio-announce-preferred-service-offering-for-alloy-partners-to-accelerate-the-translation-from-discovery-to-cmc 2023-11-08 15:17:38.318+00 https://www.pharmasalmanac.com/articles/design-build-cleanroom-projects-a-proven-risk-mitigating-methodology 2023-11-06 14:19:06.847+00 https://www.pharmasalmanac.com/articles/facilitating-development-and-scale-up-of-nanoparticle-drug-products-with-an-end-to-end-adaptable-manufacturing-platform 2023-11-01 12:53:34.267+00 https://www.pharmasalmanac.com/articles/modifying-rna-splicing-with-morpholinos 2023-10-27 17:45:55.893+00 https://www.pharmasalmanac.com/articles/green-energy-is-almost-here-a-cdmos-approach-to-sustainability 2023-10-26 13:57:08.395+00 https://www.pharmasalmanac.com/articles/samsung-biologics-and-kurma-partners-announce-strategic-partnership-for-development-and-manufacturing-of-biologics-for-kurmas-portfolio-companies 2023-10-24 13:36:04.648+00 https://www.pharmasalmanac.com/articles/maximizing-resources-and-potential-for-success-by-failing-fast 2023-10-23 07:00:00.801+00 https://www.pharmasalmanac.com/articles/digitalization-ai-and-automation-lead-pack-of-advances-fueling-life-sciences-industry-growth-new-crb-report-finds 2023-10-19 19:54:26.53+00 https://www.pharmasalmanac.com/articles/is-this-pharmas-best-kept-secret-partnering-with-australian-companies-for-pharmaceutical-development-and-manufacturing 2023-10-19 13:40:51.779+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-launches-in-vitro-biology-capabilities-at-ahmedabad-discovery-services-site 2023-10-17 21:09:45.296+00 https://www.pharmasalmanac.com/articles/vetter-looks-ahead-to-further-expansions-to-meet-supply-chain-demand 2023-10-17 15:21:54.262+00 https://www.pharmasalmanac.com/articles/redesigning-anda-or-novel-drug-products-at-all-stages-for-the-u.s.-market 2023-10-16 13:32:15.094+00 https://www.pharmasalmanac.com/articles/agc-biologics-completes-pdna-and-mrna-expansion-at-heidelberg-location 2023-10-12 19:44:22.2+00 https://www.pharmasalmanac.com/articles/wheeler-bio-announces-grand-opening-of-biomanufacturing-facility 2023-10-05 13:41:05.116+00 https://www.pharmasalmanac.com/articles/view-from-the-top-cell-and-gene-therapy-successes-and-promise 2023-10-03 18:36:23.067+00 https://www.pharmasalmanac.com/articles/addressing-swallowing-and-palatability-issues-with-patient-friendly-dosage-forms 2023-10-03 09:45:00.97+00 https://www.pharmasalmanac.com/articles/unleashing-the-power-of-3d-cell-culture-revolutionizing-research-drug-discovery-and-biomedicine 2023-10-02 14:51:04.474+00 https://www.pharmasalmanac.com/articles/what-piece-of-conventional-industry-wisdom-do-you-think-is-misguided-outdated-or-just-plain-wrong 2023-09-21 20:39:48.418+00 https://www.pharmasalmanac.com/articles/how-is-your-organization-currently-leveraging-real-world-data/evidence-and-what-uses-do-you-anticipate-in-the-future 2023-09-21 15:17:33.301+00 https://www.pharmasalmanac.com/articles/experience-meets-flexibility 2023-09-18 15:03:02.01+00 https://www.pharmasalmanac.com/articles/addressing-the-evolving-nitrosamine-contamination-issue 2023-09-15 11:31:42.293+00 https://www.pharmasalmanac.com/articles/who-is-using-fair-data-in-life-sciences-rd-today 2023-09-11 15:38:27.646+00 https://www.pharmasalmanac.com/articles/taking-a-page-from-the-hsct-playbook-for-allogeneic-cell-therapy-advancement 2023-09-06 15:51:58.967+00 https://www.pharmasalmanac.com/articles/engineering-immune-cells-to-realize-the-promise-of-cancer-cell-therapies 2023-09-05 11:51:10.543+00 https://www.pharmasalmanac.com/articles/embracing-fair-data-on-the-path-to-ai-readiness 2023-09-01 15:39:25.537+00 https://www.pharmasalmanac.com/articles/innovating-dcts-through-application-and-cross-functional-delivery 2023-08-29 17:36:29.161+00 https://www.pharmasalmanac.com/articles/webinar-a-developers-guide-to-partnering-with-the-right-cdmo-presented-by-samsung-biologics 2023-08-24 16:25:45.252+00 https://www.pharmasalmanac.com/articles/deltatraks-flashtrak-global-supply-chain-management-system-ready-for-swedens-export-oriented-economy 2023-08-21 19:46:37.451+00 https://www.pharmasalmanac.com/articles/wheeler-bio-appoints-dr.-stewart-mcnaull-as-chief-business-officer 2023-08-18 13:51:53.095+00 https://www.pharmasalmanac.com/articles/scale-up-expertise-to-support-your-biologics-life-cycle 2023-08-18 13:47:18.009+00 https://www.pharmasalmanac.com/articles/considerations-in-viral-vector-analytical-development-to-enable-smooth-transfer-to-quality-control 2023-08-18 13:46:44.143+00 https://www.pharmasalmanac.com/articles/biologics-outsourcing-decision-drivers-and-key-considerations 2023-08-18 11:30:28.274+00 https://www.pharmasalmanac.com/articles/an-experienced-cdmo-can-be-a-differentiator-in-the-rapidly-growing-biologics-market-1 2023-08-17 22:42:23.519+00 https://www.pharmasalmanac.com/articles/webinar-capitalizing-on-cdmo-expertise-in-aseptic-fill/finish-presented-by-samsung-biologics 2023-08-16 19:05:32.094+00 https://www.pharmasalmanac.com/articles/taking-a-customer-focused-approach-to-custom-antibody-development-and-manufacturing 2023-08-15 22:26:25.358+00 https://www.pharmasalmanac.com/articles/wheeler-bio-appoints-marc-helouin-as-chief-quality-and-regulatory-officer 2023-08-15 09:00:00.731+00 https://www.pharmasalmanac.com/articles/viscosity-reduction-with-an-excipient-platform-and-feasibility-testing-service 2023-08-10 18:56:28.26+00 https://www.pharmasalmanac.com/articles/preparing-today-for-a-potential-ban-on-titanium-dioxide-in-pharmaceutical-drug-products 2023-08-10 15:55:50.857+00 https://www.pharmasalmanac.com/articles/how-is-an-increased-focus-on-patient-centric-concerns-influencing-the-way-that-you-work 2023-08-09 21:48:07.538+00 https://www.pharmasalmanac.com/articles/in-what-areas-of-pharma-or-biopharma-are-you-most-excited-to-see-increased-adoption-of-artificial-intelligence-and-machine-learning 2023-08-09 21:47:33.923+00 https://www.pharmasalmanac.com/articles/reach-the-patient-quicker-with-gbis-manufacturing-solutions 2023-08-08 09:00:00.696+00 https://www.pharmasalmanac.com/articles/building-on-experience-and-investing-in-an-integrated-mrna-offering 2023-07-31 15:21:04.32+00 https://www.pharmasalmanac.com/articles/managing-risk-in-cutting-edge-mrna-therapeutics 2023-07-31 15:20:56.094+00 https://www.pharmasalmanac.com/articles/us-food-and-drug-administration-fda-purchase-the-lift-system-from-diant-pharma-inc 2023-07-31 14:20:27.91+00 https://www.pharmasalmanac.com/articles/fina-biosolutions-selects-scorpius-biomanufacturing-for-production-of-cgmp-crm197 2023-07-27 15:55:37.995+00 https://www.pharmasalmanac.com/articles/be-the-match-biotherapies-marks-cord-blood-awareness-month-with-the-announcement-of-the-cord-blood-bank-alliance 2023-07-27 15:14:31.741+00 https://www.pharmasalmanac.com/articles/does-your-biologics-cdmo-truly-have-a-culture-of-quality-0 2023-07-27 13:25:16.583+00 https://www.pharmasalmanac.com/articles/integrating-digital-solutions-to-streamline-biopharma-operations 2023-07-17 16:20:43.372+00 https://www.pharmasalmanac.com/articles/on-the-journey-to-support-drug-developers-with-end-to-end-outsourcing 2023-07-17 08:00:00.74+00 https://www.pharmasalmanac.com/articles/enhance-patient-engagement-in-decentralized-trials-with-home-healthcare-solutions 2023-07-11 13:31:00.331+00 https://www.pharmasalmanac.com/articles/accelerating-drug-development-with-ai-enabled-3d-spatial-biology 2023-07-11 09:00:00.62+00 https://www.pharmasalmanac.com/articles/investing-in-innovation-with-global-solution-centers 2023-07-10 16:20:58.396+00 https://www.pharmasalmanac.com/articles/collaboration-is-key-to-the-development-of-effective-bioprocess-analysis-solutions-to-address-complex-data-needs 2023-07-10 14:45:28.228+00 https://www.pharmasalmanac.com/articles/why-choosing-the-right-cdmo-partner-is-essential-in-todays-pharmaceutical-market 2023-06-19 18:44:31.284+00 https://www.pharmasalmanac.com/articles/100-years-young-how-science-collaboration-and-innovation-are-driving-cornings-future 2023-06-13 15:05:51.712+00 https://www.pharmasalmanac.com/articles/richter-helms-biomanufacturing-facility-expansion-progress-inauguration-of-new-office-building 2023-06-12 20:45:26.623+00 https://www.pharmasalmanac.com/articles/simplifying-modified-release-drug-formulations-with-high-quality-multiparticulate-cores 2023-06-06 20:44:30.224+00 https://www.pharmasalmanac.com/articles/redefining-innovation-and-growth-in-pharmaceutical-distribution 2023-06-06 15:30:30.535+00 https://www.pharmasalmanac.com/articles/wheeler-bio-and-charles-river-laboratories-announce-agreement-to-build-and-operate-rightsource-laboratory 2023-06-05 18:57:17.847+00 https://www.pharmasalmanac.com/articles/addressing-cancer-therapy-resistance-by-targeting-translational-regulation 2023-06-01 16:06:29.676+00 https://www.pharmasalmanac.com/articles/q1-what-do-you-view-as-the-most-disruptive-or-transformational-technology-or-development-on-the-horizon 2023-05-23 16:50:43.049+00 https://www.pharmasalmanac.com/articles/q2-in-what-international-markets-do-you-anticipate-significant-developments-in-the-near-future 2023-05-22 14:43:43.949+00 https://www.pharmasalmanac.com/articles/new-name-same-expertise-goodwin-biotechnology-is-becoming-gbi 2023-05-18 15:17:05.065+00 https://www.pharmasalmanac.com/articles/olon-presents-the-first-results-announcing-to-have-achieved-developing-a-new-production-process-through-engineering-target-enzyme 2023-05-10 14:54:35.942+00 https://www.pharmasalmanac.com/articles/enhanced-solubility-through-api-processing-salt-and-cocrystal-formation 2023-05-09 20:44:59.002+00 https://www.pharmasalmanac.com/articles/facilitating-lipid-nanoparticle-production-with-a-unique-continuous-manufacturing-solution 2023-05-06 02:15:05.87+00 https://www.pharmasalmanac.com/articles/transforming-drug-development-with-frictionless-access-to-real-time-preclinical-data 2023-05-05 11:00:01.045+00 https://www.pharmasalmanac.com/articles/expanding-point-of-care-and-cme-support-for-clinicians 2023-05-03 13:28:01.493+00 https://www.pharmasalmanac.com/articles/using-artificial-intelligence-to-get-the-right-drug-to-the-right-patient-at-the-right-time 2023-05-02 13:37:23.982+00 https://www.pharmasalmanac.com/articles/an-introduction-to-hpapis-and-cytotoxic-drugs 2023-04-25 20:07:48.68+00 https://www.pharmasalmanac.com/articles/techceuticals-announces-relaunch-with-an-expanded-focus-on-the-pharmaceutical-industry 2023-04-25 15:05:35.407+00 https://www.pharmasalmanac.com/articles/exothera-nucleic-acids-will-be-the-worlds-first-cdmo-with-access-to-quantooms-revolutionary-nfinity-platform-for-the-continuous-production-of-rna-which-1681833953070 2023-04-25 15:00:30.281+00 https://www.pharmasalmanac.com/articles/lipid-technology-for-delivery-of-gene-editing-therapies 2023-04-24 16:15:43.754+00 https://www.pharmasalmanac.com/articles/aqueous-critical-cleaning-for-pharma-and-biopharma-applications-companion-to-aqueous-cleaning-handbook 2023-04-20 18:44:16.903+00 https://www.pharmasalmanac.com/articles/planning-for-success-addressing-quality-early-for-gene-therapies 2023-04-17 18:19:37.6+00 https://www.pharmasalmanac.com/articles/simplifying-target-discovery-with-an-artificial-intelligence-engine-and-natural-language-chat 2023-04-13 20:32:12.624+00 https://www.pharmasalmanac.com/articles/combining-rna-splicing-and-ai-technologies-to-accelerate-drug-discovery-and-development 2023-04-12 09:00:00.737+00 https://www.pharmasalmanac.com/articles/unleashing-the-power-of-the-microbiome-advancements-challenges-and-the-therapeutic-future 2023-04-04 21:22:13.587+00 https://www.pharmasalmanac.com/articles/optimizing-plasmid-production-to-meet-growing-demand 2023-04-03 20:45:14.857+00 https://www.pharmasalmanac.com/articles/targeted-protein-degradation-provides-promising-alternative-to-address-unmet-medical-needs 2023-03-30 16:41:50.792+00 https://www.pharmasalmanac.com/articles/supporting-the-drug-development-paradigm-with-broad-service-support 2023-03-24 14:26:09.792+00 https://www.pharmasalmanac.com/articles/hovione-and-laxxon-medical-establish-an-agreement-for-the-cgmp-production-of-3d-screen-printed-pharmaceutical-applications 2023-03-22 17:31:34.953+00 https://www.pharmasalmanac.com/articles/helping-clinicians-make-better-decisions-more-easily 2023-03-22 17:26:28.246+00 https://www.pharmasalmanac.com/articles/harnessing-the-power-of-the-tumor-microenvironment-with-first-in-class-therapies 2023-03-21 16:00:42.139+00 https://www.pharmasalmanac.com/articles/a-novel-technology-platform-for-bone-regeneration-and-cancer-treatment 2023-03-20 18:06:56.253+00 https://www.pharmasalmanac.com/articles/samsung-biologics-announces-construction-of-plant-5-to-commence-bio-campus-ii-capacity-expansion 2023-03-17 13:54:40.008+00 https://www.pharmasalmanac.com/articles/on-the-journey-to-a-new-industry-standard-for-e.-coli-based-protein-production 2023-03-15 14:46:18.803+00 https://www.pharmasalmanac.com/articles/charles-river-launches-apollo-an-industry-leading-secure-cloud-based-platform-for-real-time-toxicology-study-data 2023-03-14 16:29:39.839+00 https://www.pharmasalmanac.com/articles/many-first-in-class-drugs-approved-by-fda-in-2022-but-overall-approval-numbers-down 2023-03-13 17:23:53.45+00 https://www.pharmasalmanac.com/articles/addition-of-new-u.s.-rd-center-is-the-next-step-in-asymchems-globalization-strategy 2023-03-09 21:42:29.955+00 https://www.pharmasalmanac.com/articles/overcoming-bottlenecks-in-mrna-manufacturing 2023-03-09 21:29:18.89+00 https://www.pharmasalmanac.com/articles/ultra-cold-chain-and-supply-chain-management-strategies-for-mrna 2023-03-09 17:52:07.415+00 https://www.pharmasalmanac.com/articles/a-media-platform-for-cost-effective-and-scalable-2d-and-3d-bioreactor-msc-expansion 2023-03-09 16:59:51.832+00 https://www.pharmasalmanac.com/articles/a-cdmo-dedicated-to-supporting-small-volume-small-molecule-parenteral-projects 2023-03-09 16:36:03.686+00 https://www.pharmasalmanac.com/articles/hovione-receives-the-2023-cdmo-leadership-award-in-all-six-categories-and-is-champion-in-compatibility-and-expertise 2023-03-08 17:50:35.613+00 https://www.pharmasalmanac.com/articles/accelerating-oncology-clinical-trials-with-deep-digitalization-of-patient-data 2023-03-08 15:21:59.55+00 https://www.pharmasalmanac.com/articles/the-powerful-potential-of-digital-twin-technology-to-improve-drug-discovery-development-manufacturing-and-more 2023-03-07 17:41:39.267+00 https://www.pharmasalmanac.com/articles/the-opportunities-and-challenges-posed-by-biosimilar-interchangeability 2023-03-07 16:55:22.361+00 https://www.pharmasalmanac.com/articles/ascelia-pharma-meets-major-milestone-with-patient-enrollment-completion-of-phase-3-study-for-orviglance-novel-mri-contrast-agent-for-patients-with-kidney-impairment 2023-02-27 15:41:52.236+00 https://www.pharmasalmanac.com/articles/terumo-blood-and-cell-technologies-presents-first-quantum-flex-data-for-multiple-size-bioreactors-showing-rapid-t-cell-expansion-to-numbers-equivalent-o-1677187817433 2023-02-23 22:07:40.002+00 https://www.pharmasalmanac.com/articles/leveraging-a-state-of-the-art-cdmo-facility-to-advance-healthcare 2023-02-23 21:22:53.825+00 https://www.pharmasalmanac.com/articles/early-reports-of-positive-experiences-with-emas-new-clinical-trials-information-system 2023-02-23 18:04:18.642+00 https://www.pharmasalmanac.com/articles/the-right-materials-for-success-in-bioprinting 2023-02-15 16:46:56.853+00 https://www.pharmasalmanac.com/articles/expanding-research-and-development-to-meet-challenges-in-biopharmaceutical-processes 2023-02-14 20:38:44.18+00 https://www.pharmasalmanac.com/articles/unlocking-new-possibilities-in-research-therapeutics-and-beyond-with-morpholino-antisense-oligos 2023-02-09 22:49:37.488+00 https://www.pharmasalmanac.com/articles/dotmatics-scientific-rd-platform-introduces-built-in-graphpad-prism-integrations 2023-02-09 19:10:23.231+00 https://www.pharmasalmanac.com/articles/lipid-nanoparticles-transforming-the-nanomedicines-market 2023-02-07 18:12:43.514+00 https://www.pharmasalmanac.com/articles/staying-ahead-of-the-curve-with-outsourced-program-management 2023-02-07 17:11:25.66+00 https://www.pharmasalmanac.com/articles/from-llamas-to-yeast-producing-functional-therapeutic-antibody-fragments-in-saccharomyces-cerevisiae 2023-02-07 16:54:52.793+00 https://www.pharmasalmanac.com/articles/cytodyn-takes-steps-towards-a-brighter-future 2023-02-06 17:46:42.923+00 https://www.pharmasalmanac.com/articles/controlled-substances-in-clinical-trials-considerations-challenges-and-growing-demand 2023-01-31 19:44:03.407+00 https://www.pharmasalmanac.com/articles/moving-from-autologous-to-allogeneic-cell-therapies-drivers-and-hurdles 2023-01-31 19:39:45.953+00 https://www.pharmasalmanac.com/articles/what-key-indicators-do-you-look-at-to-predict-the-future-of-this-industry 2023-01-26 19:36:38.809+00 https://www.pharmasalmanac.com/articles/overcoming-the-challenges-of-an-ever-changing-biopharma-landscape 2023-01-24 19:48:21.846+00 https://www.pharmasalmanac.com/articles/rapid-supply-of-anti-idiotype-antibodies-facilitates-preclinical-and-clinical-antibody-based-drug-development 2023-01-17 21:00:45.487+00 https://www.pharmasalmanac.com/articles/q-what-important-company-milestone-do-you-anticipate-reaching-in-2022 2023-01-17 12:13:17.03+00 https://www.pharmasalmanac.com/articles/accelerated-and-cost-effective-antibody-design-using-artificial-intelligence 2023-01-13 15:34:23.786+00 https://www.pharmasalmanac.com/articles/innovating-to-optimize-quality-in-injectable-drugs 2023-01-12 15:50:00.587+00 https://www.pharmasalmanac.com/articles/a-concerted-qbd-approach-to-development-and-manufacturing-of-nucleic-acid-therapies 2023-01-10 18:53:48.597+00 https://www.pharmasalmanac.com/articles/the-expanding-role-for-recombinant-proteins-in-research 2023-01-06 19:34:11.159+00 https://www.pharmasalmanac.com/articles/the-value-of-a-custom-lipid-solutions-provider-for-mrna-delivery 2023-01-05 14:39:06.644+00 https://www.pharmasalmanac.com/articles/targeted-immune-system-activation-a-paradigm-shift-in-immuno-oncology 2023-01-04 15:55:43.289+00 https://www.pharmasalmanac.com/articles/enabling-greater-patient-access-to-car-t-cell-therapies-with-off-the-shelf-delivery-solutions 2023-01-04 14:22:19.021+00 https://www.pharmasalmanac.com/articles/synthetic-biology-a-potential-game-changer-for-the-biopharma-industry 2022-12-23 17:23:40.825+00 https://www.pharmasalmanac.com/articles/scorpion-biological-services-becomes-scorpius-biomanufacturing-to-reflect-expansion 2022-12-21 16:07:55.756+00 https://www.pharmasalmanac.com/articles/digital-therapeutics-and-the-song-of-the-future-of-healthcare 2022-12-20 17:26:02.742+00 https://www.pharmasalmanac.com/articles/a-strategic-approach-to-pre-licensing-inspections-a-strategic-approach-to-pre-licensing-inspections 2022-12-16 15:21:05.856+00 https://www.pharmasalmanac.com/articles/expanding-a-leadership-position-in-microbiome-based-contract-development-and-manufacturing 2022-12-13 18:27:37.539+00 https://www.pharmasalmanac.com/articles/leveraging-experience-to-reduce-timelines-for-ind-enabling-activitiesleveraging-experience-to-reduce-timelines-for-ind-enabling-activities 2022-12-05 21:38:53.323+00 https://www.pharmasalmanac.com/articles/theranostic-manufacturing-solutions 2022-12-05 19:05:59.15+00 https://www.pharmasalmanac.com/articles/vaccines-present-a-novel-strategy-for-opioid-overdose-prevention 2022-12-05 18:51:05.749+00 https://www.pharmasalmanac.com/articles/interest-in-decentralized-trials-rising-in-asia-pacific 2022-12-02 18:21:21.252+00 https://www.pharmasalmanac.com/articles/alcami-builds-cgmp-biostorage-facility-in-north-carolina 2022-12-01 16:09:01.303+00 https://www.pharmasalmanac.com/articles/wheeler-bio-licenses-atums-proprietary-leap-in-transposase-technology-in-support-of-its-disruptive-cdmo-service-offering 2022-11-30 21:15:57.961+00 https://www.pharmasalmanac.com/articles/advancing-extrusion-based-3d-printing-for-drug-production 2022-11-29 21:15:01.27+00 https://www.pharmasalmanac.com/articles/high-intensity-sweeteners-for-taste-optimization 2022-11-29 14:05:39.099+00 https://www.pharmasalmanac.com/articles/olon-international-api-supplier-releases-new-2022-sustainability-report 2022-11-28 23:53:41.278+00 https://www.pharmasalmanac.com/articles/sustainability-in-pharmaceutical-manufacturing-a-cdmos-contribution 2022-11-22 19:47:17.733+00 https://www.pharmasalmanac.com/articles/addressing-poor-api-solubility-with-comprehensive-particle-engineering-technology 2022-11-18 18:09:45.138+00 https://www.pharmasalmanac.com/articles/revisiting-comparative-drug-development 2022-11-18 13:44:35.406+00 https://www.pharmasalmanac.com/articles/reducing-the-challenges-sites-face-when-implementing-decentralized-trials 2022-11-17 23:05:47.062+00 https://www.pharmasalmanac.com/articles/the-evolving-role-of-remote-monitoring 2022-11-17 22:54:34.311+00 https://www.pharmasalmanac.com/articles/the-critical-role-of-continuous-improvement-in-parenteral-drug-manufacturing 2022-11-17 21:01:45.659+00 https://www.pharmasalmanac.com/articles/bedside-cell-therapies-point-of-care 2022-11-17 14:38:47.392+00 https://www.pharmasalmanac.com/articles/optimizing-transient-transfection-for-viral-vector-production 2022-11-17 14:38:25.66+00 https://www.pharmasalmanac.com/articles/stopping-bleeds-and-saving-lives 2022-11-17 14:36:57.953+00 https://www.pharmasalmanac.com/articles/investing-in-the-future-of-mrna-manufacturing 2022-11-16 10:00:00.5+00 https://www.pharmasalmanac.com/articles/the-exciting-potential-of-inhalation-vaccines 2022-11-15 20:57:53.507+00 https://www.pharmasalmanac.com/articles/overcoming-limitations-with-transient-protein-expression-to-accelerate-development 2022-11-15 20:22:34.683+00 https://www.pharmasalmanac.com/articles/ecolab-and-pharmas-almanac-present-contamination-control-event 2022-11-15 10:00:00.824+00 https://www.pharmasalmanac.com/articles/umoja-biopharma-presents-new-preclinical-data-on-its-integrated-in-vivo-car-t-and-engineered-ipsc-platform-technologies-at-the-sitc-37th-annual-meeting 2022-11-11 20:11:34.291+00 https://www.pharmasalmanac.com/articles/orgenesis-secures-up-to-usd-50-million-subsidiary-level-investment-from-metalmark-capital-to-accelerate-growth-of-point-of-care-services 2022-11-11 19:47:46.46+00 https://www.pharmasalmanac.com/articles/resolution-therapeutics-and-ccrm-sign-collaboration-agreement-to-develop-and-scale-up-manufacturing-for-induced-pluripotent-stem-cell-ipsc-derived-macro-1667844215402 2022-11-11 19:47:24.209+00 https://www.pharmasalmanac.com/articles/accelerating-drug-development-using-robotic-sterile-fill-finish-platforms 2022-11-11 16:05:22.071+00 https://www.pharmasalmanac.com/articles/applying-an-advanced-pharma-4.0-perspective-to-design-the-facility-of-the-future 2022-11-08 14:55:35.543+00 https://www.pharmasalmanac.com/articles/quality-in-equals-quality-out-in-mrna-manufacturing 2022-11-08 10:00:01.079+00 https://www.pharmasalmanac.com/articles/synbiotic-health-announces-the-expansion-of-their-rd-and-commercial-capabilities-with-the-acquisition-of-a-new-facility-in-madison-wisconsin 2022-11-02 15:17:50.507+00 https://www.pharmasalmanac.com/articles/epic-rx-announces-ceo-appointment 2022-11-02 15:06:23.978+00 https://www.pharmasalmanac.com/articles/achieving-better-cell-therapy-outcomes-with-data-driven-decision-making 2022-11-01 15:43:22.054+00 https://www.pharmasalmanac.com/articles/risk-based-optimization-of-viral-vector-processes-adds-real-value 2022-10-31 13:37:49.625+00 https://www.pharmasalmanac.com/articles/formulating-flexibility-with-actimask-taste-masking 2022-10-31 13:37:16.788+00 https://www.pharmasalmanac.com/articles/platform-processes-and-end-to-end-capabilities-position-vernal-biosciences-as-a-critical-cdmo-resource-for-mrna-developers 2022-10-31 13:36:48.665+00 https://www.pharmasalmanac.com/articles/new-fully-automated-vetter-warehouse-expands-storage-and-boosts-logistical-infrastructure 2022-10-27 13:44:04.168+00 https://www.pharmasalmanac.com/articles/leveraging-big-data-artificial-intelligence-and-machine-learning-for-drug-discovery-development-manufacturing-and-more 2022-10-21 13:36:00.765+00 https://www.pharmasalmanac.com/articles/asymchem-leading-with-technology 2022-10-20 22:24:51.659+00 https://www.pharmasalmanac.com/articles/enabling-seamless-workflows-for-small-molecule-drug-discovery 2022-10-20 22:23:05.424+00 https://www.pharmasalmanac.com/articles/cloud-control-maintaining-compliance-as-regulated-apps-move-off-premise 2022-10-20 22:22:21.282+00 https://www.pharmasalmanac.com/articles/duplicated-document-and-data-creation-must-stop 2022-10-20 22:20:50.859+00 https://www.pharmasalmanac.com/articles/beyond-drug-sales-adding-value-with-digital-health 2022-10-20 22:20:03.973+00 https://www.pharmasalmanac.com/articles/unlocking-the-therapeutic-potential-of-plant-inspired-minimum-essential-mixtures 2022-10-20 22:19:09.872+00 https://www.pharmasalmanac.com/articles/closing-the-developability-gap-for-rna-therapeutics-and-vaccines-with-a-fit-for-purpose-analysis-kit 2022-10-20 22:17:44.125+00 https://www.pharmasalmanac.com/articles/targeting-cancers-by-leveraging-the-biology-of-gamma-delta-t-cells 2022-10-20 22:16:48.719+00 https://www.pharmasalmanac.com/articles/improving-the-therapeutic-index-of-adcs-with-a-peptide-linker-technology 2022-10-20 22:15:52.379+00 https://www.pharmasalmanac.com/articles/adding-value-with-patent-protection-for-novel-tailor-made-bacterial-production-strains 2022-10-20 22:12:41.262+00 https://www.pharmasalmanac.com/articles/supporting-biodefense-countermeasures-with-strong-capabilities-and-expertise 2022-10-20 22:09:20.965+00 https://www.pharmasalmanac.com/articles/evolving-solutions-to-optimize-clinical-trial-decentralization 2022-10-20 22:05:08.88+00 https://www.pharmasalmanac.com/articles/bringing-mass-spectrometry-out-of-the-lab-and-to-the-point-of-need 2022-10-20 21:53:49.546+00 https://www.pharmasalmanac.com/articles/univar-solutions-accelerates-innovation-in-the-life-science-markets-with-new-pharmaceutical-ingredients-laboratories 2022-10-20 20:12:58.007+00 https://www.pharmasalmanac.com/articles/reimaging-the-pharmaceutical-supply-chain 2022-10-17 14:43:48.042+00 https://www.pharmasalmanac.com/articles/how-all-clinical-trial-stakeholders-can-collaborate-as-one-study-team 2022-10-13 20:53:51.27+00 https://www.pharmasalmanac.com/articles/potential-applications-for-antisense-oligonucleotide-therapies-continue-to-expand 2022-10-12 20:09:36.078+00 https://www.pharmasalmanac.com/articles/limitless-potential-of-mrna-creates-tremendous-excitement-despite-uncertainties 2022-10-12 20:08:07.523+00 https://www.pharmasalmanac.com/articles/antibiotic-resistance-advances-in-understanding-and-drug-development 2022-10-11 18:33:43.608+00 https://www.pharmasalmanac.com/articles/state-of-the-cell-and-gene-therapy-market 2022-10-11 18:21:00.328+00 https://www.pharmasalmanac.com/articles/examining-the-potential-of-precision/personalized-medicine 2022-10-11 18:20:48.757+00 https://www.pharmasalmanac.com/articles/raman-spectroscopy-as-a-pat-tool-advancing-biopharma-manufacturing 2022-10-11 13:32:57.404+00 https://www.pharmasalmanac.com/articles/five-ways-to-embed-truly-diverse-and-inclusive-patient-engagement-into-pharmas-dna 2022-10-11 13:31:32.709+00 https://www.pharmasalmanac.com/articles/cosmeceuticals-are-here.-when-will-regulations-catch-up 2022-10-11 13:30:47.193+00 https://www.pharmasalmanac.com/articles/decentralized-clinical-trials-the-future-is-now 2022-10-11 13:29:42.835+00 https://www.pharmasalmanac.com/articles/optimized-multispecific-antibody-design-development-and-manufacturing 2022-10-11 13:28:28.578+00 https://www.pharmasalmanac.com/articles/contamination-control-strategies-for-the-manufacture-of-conventional-and-next-generation-biologics 2022-10-11 13:25:15.27+00 https://www.pharmasalmanac.com/articles/life-science-industrials-are-key-to-the-growth-of-the-biopharma-industry 2022-10-11 13:24:06.183+00 https://www.pharmasalmanac.com/articles/omniabio-ccrm-and-stakeholders-celebrate-commencement-of-construction-of-hamilton-biomanufacturing-facility 2022-10-06 20:55:12.391+00 https://www.pharmasalmanac.com/articles/pluristyx-pancella-and-implant-therapeutics-announce-definitive-merger-agreement 2022-10-06 15:08:27.229+00 https://www.pharmasalmanac.com/articles/exploring-challenges-and-considerations-for-operationalizing-dcts-in-the-european-union 2022-10-06 15:00:17.714+00 https://www.pharmasalmanac.com/articles/wheeler-bio-announces-initial-closing-of-series-a-round-supporting-new-biologics-drug-substance-gmp-expansion-in-oklahoma 2022-10-05 14:53:08.221+00 https://www.pharmasalmanac.com/articles/searching-for-more-the-hunt-for-diversification-multimodal-approaches-and-top-talent-are-rapidly-reshaping-life-sciences-new-horizons-report-finds 2022-10-04 21:20:17.608+00 https://www.pharmasalmanac.com/articles/reducing-time-to-ind-increasing-quality-and-building-trust-through-shared-data 2022-09-30 21:47:39.043+00 https://www.pharmasalmanac.com/articles/scbio-debuts-refreshed-branding-for-life-sciences-organization-launches-new-website 2022-09-29 19:53:29.881+00 https://www.pharmasalmanac.com/articles/comparative-study-ranks-philadelphia-region-2-among-14-cell-and-gene-therapy-hubs 2022-09-27 20:41:43.861+00 https://www.pharmasalmanac.com/articles/preparing-for-growth-in-neurodegenerative-treatment-opportunities-how-clinical-teams-can-best-position-study-design-and-strategy-to-reach-study-participants 2022-09-27 18:22:03.018+00 https://www.pharmasalmanac.com/articles/what-do-you-consider-the-biggest-challenge-that-the-pharma/biopharma-industry-currently-faces 2022-09-27 01:54:45.771+00 https://www.pharmasalmanac.com/articles/olon-leading-international-api-supplier-announces-a-new-investment-that-will-further-expand-its-global-high-containment-platform-a-new-high-containment-1664236762146 2022-09-27 00:06:35.501+00 https://www.pharmasalmanac.com/articles/wheeler-bio-announces-roger-lias-ph.d.-as-president-and-chief-operating-officer 2022-09-22 19:54:02.608+00 https://www.pharmasalmanac.com/articles/olon-announces-the-appointment-of-roberta-pachera-as-vice-president-of-cdmo-small-molecules-and-global-key-account-division 2022-09-19 21:40:28.198+00 https://www.pharmasalmanac.com/articles/nu-tek-biosciences-cuts-ribbon-on-state-of-the-art-manufacturing-facility 2022-09-15 06:00:00.569+00 https://www.pharmasalmanac.com/articles/milliporesigma-announces-investment-of-more-than-130-million-to-strengthen-manufacturing-capabilities-in-molsheim-france 2022-09-08 14:50:17.349+00 https://www.pharmasalmanac.com/articles/dr.-glenn-haifer-and-ampersand-capital-partners-acquire-australian-biologics-cdmo-luina-bio-rebranding-as-acurabio 2022-09-07 19:53:47.413+00 https://www.pharmasalmanac.com/articles/integrating-cell-line-and-cmc-development 2022-09-02 14:56:44.309+00 https://www.pharmasalmanac.com/articles/a-cellular-engineering-breakthrough-high-yield-crispr-without-viral-vectors 2022-08-25 17:13:59.188+00 https://www.pharmasalmanac.com/articles/listening-to-clients-and-expanding-across-the-clinical-supply-chain 2022-08-17 20:05:04.781+00 https://www.pharmasalmanac.com/articles/staying-agile-to-bring-therapies-to-patients-with-rare-diseases 2022-08-16 22:31:41.881+00 https://www.pharmasalmanac.com/articles/ipscs-moving-from-drug-testing-to-novel-cell-therapies 2022-08-16 22:24:54.89+00 https://www.pharmasalmanac.com/articles/regulatory-considerations-for-lipid-excipients 2022-08-16 21:29:46.72+00 https://www.pharmasalmanac.com/articles/trakcel-celebrates-10-years-of-market-leading-cell-orchestration-solutions-by-setting-out-future-plans 2022-08-16 18:32:42.943+00 https://www.pharmasalmanac.com/articles/roosterbio-and-agc-biologics-announce-collaboration-to-accelerate-manufacturing-of-cell-and-exosome-therapies 2022-08-16 17:40:40.762+00 https://www.pharmasalmanac.com/articles/be-the-match-biotherapies-now-offers-a-central-point-of-access-to-fully-characterized-cord-blood-units-for-commercial-and-clinical-use 2022-08-13 22:25:25.544+00 https://www.pharmasalmanac.com/articles/is-it-possible-that-machine-learning-could-cause-a-reproducibility-crisis-in-the-science-industry 2022-08-09 17:38:58.199+00 https://www.pharmasalmanac.com/articles/ai-predicts-the-shape-of-almost-every-protein-in-the-realm-of-science 2022-08-09 17:37:20.898+00 https://www.pharmasalmanac.com/articles/the-smart-approach-to-preclinical-development-for-bacterially-expressed-biologics 2022-08-08 15:01:52.136+00 https://www.pharmasalmanac.com/articles/unique-vector-expression-technologies-for-boosting-protein-production-in-e.-coli 2022-08-08 14:31:38.352+00 https://www.pharmasalmanac.com/articles/process-of-carbon-dating-hindered-as-a-result-of-the-rising-fossil-fuel-emissions 2022-08-05 19:23:37.867+00 https://www.pharmasalmanac.com/articles/mrna-technology-is-the-long-path-behind-leading-to-endless-successes-ahead 2022-07-29 15:07:19.566+00 https://www.pharmasalmanac.com/articles/procurement-leader-valerie-silva-joins-crb-as-company-addresses-supply-chain-risk-challenges 2022-07-27 21:17:36.824+00 https://www.pharmasalmanac.com/articles/enr-ranks-crb-among-top-design-and-construction-firms-for-life-sciences-food-and-beverage-facilities 2022-07-27 21:13:29.296+00 https://www.pharmasalmanac.com/articles/ginkgo-bioworks-signs-definitive-agreement-to-acquire-fgen-ag-a-leading-bioengineering-company-and-its-proprietary-ultra-high-throughput-screening-platform 2022-07-25 13:24:51.156+00 https://www.pharmasalmanac.com/articles/used-hemp-processing-equipment-the-5-trends-increasing-demand 2022-07-21 22:11:21.886+00 https://www.pharmasalmanac.com/articles/10-more-biotechs-making-moves-in-2022 2022-07-21 13:09:32.478+00 https://www.pharmasalmanac.com/articles/dotmatics-launches-small-molecule-drug-discovery-solution-helping-researchers-accelerate-life-improving-therapies-1 2022-07-19 14:33:52.707+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-holds-grand-opening-ceremony-for-new-api-plant-at-aurora-canada-manufacturing-site 2022-07-13 14:11:23.95+00 https://www.pharmasalmanac.com/articles/driving-further-innovation-by-integrating-a-decentralized-rd-network 2022-07-12 21:22:55.816+00 https://www.pharmasalmanac.com/articles/expanding-manufacturing-capacity-to-meet-market-demand-for-vaccines-and-cell-and-gene-therapeutics 2022-07-12 21:22:51.906+00 https://www.pharmasalmanac.com/articles/adding-dimensionality-to-data-mapping-for-higher-level-analysis 2022-07-12 21:20:41.203+00 https://www.pharmasalmanac.com/articles/olon-presents-olon-biotech-a-new-division-operating-by-biotechnological-processes 2022-07-12 14:46:07.754+00 https://www.pharmasalmanac.com/articles/optimizing-fed-batch-processes-with-chemically-defined-media-and-feeds 2022-07-11 20:27:35.749+00 https://www.pharmasalmanac.com/articles/inspection-of-bfs-containers-reaching-new-heights-of-performance-with-13-cameras 2022-07-07 21:16:20.849+00 https://www.pharmasalmanac.com/articles/inline-solutions-to-overcome-inspection-challenges-for-parenteral-products 2022-07-07 21:15:08.324+00 https://www.pharmasalmanac.com/articles/advancing-visual-inspection-of-printed-pharmaceutical-materials 2022-07-07 21:12:55.298+00 https://www.pharmasalmanac.com/articles/piramal-pharma-ltd-strengthens-board-by-inducting-three-new-board-members 2022-07-07 14:49:23.744+00 https://www.pharmasalmanac.com/articles/merger-of-rephine-with-forum-auditorias-tdv-creates-clear-market-leader-in-global-gmp-audit-services 2022-07-07 14:03:41.119+00 https://www.pharmasalmanac.com/articles/ipos-have-not-recovered-in-2022.-when-will-biotech-bounce-back-1 2022-07-06 19:48:39.02+00 https://www.pharmasalmanac.com/articles/in-which-orphan-spaces-or-unmet-medical-needs-do-you-think-we-will-see-the-next-treatment-innovations 2022-07-06 17:51:32.487+00 https://www.pharmasalmanac.com/articles/taking-adoptive-cell-therapies-to-the-next-level 2022-07-05 16:18:53.576+00 https://www.pharmasalmanac.com/articles/quantum-computing-will-transform-drug-discovery-development-manufacturing-and-supply-chain-management 2022-07-05 16:08:08.61+00 https://www.pharmasalmanac.com/articles/car-t-study-shines-new-spotlight-on-clinical-trials-representation 2022-07-05 16:07:34.836+00 https://www.pharmasalmanac.com/articles/productlife-group-strengthens-foothold-in-northern-europe-with-pharma-it-acquisition 2022-06-30 15:27:09.584+00 https://www.pharmasalmanac.com/articles/vetters-newest-clinical-manufacturing-site-successfully-completed-its-first-customer-fills 2022-06-28 18:47:30.809+00 https://www.pharmasalmanac.com/articles/whos-left-to-acquire-in-cdmo-biomanufacturing-a-select-few 2022-06-24 20:13:39.629+00 https://www.pharmasalmanac.com/articles/new-drug-watch-a-validation-of-the-twincretin-approach-to-type-2-diabetes 2022-06-24 20:13:17.852+00 https://www.pharmasalmanac.com/articles/the-price-of-pain-acknowledging-a-crisis-and-encouraging-an-alternative 2022-06-24 20:10:22.811+00 https://www.pharmasalmanac.com/articles/digital-frontiers-what-nfts-can-do-for-pharma 2022-06-24 20:10:13.25+00 https://www.pharmasalmanac.com/articles/creating-a-more-resilient-pharmaceutical-supply-chain-one-segment-at-a-time 2022-06-24 20:09:55.285+00 https://www.pharmasalmanac.com/articles/mental-health-during-a-global-pandemic 2022-06-24 20:09:33.435+00 https://www.pharmasalmanac.com/articles/small-molecule-api-market-trends 2022-06-24 20:06:44.977+00 https://www.pharmasalmanac.com/articles/a-next-generation-bakers-yeast-biofoundry-presents-transformative-potential-for-biomanufacturing 2022-06-24 17:56:41.368+00 https://www.pharmasalmanac.com/articles/guide-to-resource-recovery-for-fortune-500-companies 2022-06-24 16:46:54.034+00 https://www.pharmasalmanac.com/articles/better-bioprocessing-efficiency-through-centralized-orchestration 2022-06-23 19:04:32.07+00 https://www.pharmasalmanac.com/articles/unique-manufacturing-challenges-associated-with-sterile-eye-ointments 2022-06-23 19:03:19.758+00 https://www.pharmasalmanac.com/articles/bringing-novel-solutions-to-market-for-unmet-needsbringing-novel-solutions-to-market-for-unmet-needs 2022-06-23 19:02:44.561+00 https://www.pharmasalmanac.com/articles/how-the-developability-classification-system-and-advanced-excipients-enable-the-formulation-of-poorly-soluble-apis 2022-06-23 19:02:28.86+00 https://www.pharmasalmanac.com/articles/increasing-safety-efficacy-and-global-equity-with-intranasal-vaccines 2022-06-23 19:02:12.217+00 https://www.pharmasalmanac.com/articles/addressing-regulatory-challenges-for-ophthalmic-combination-products 2022-06-23 19:01:34.139+00 https://www.pharmasalmanac.com/articles/the-intersection-of-mrna-biology-and-artificial-intelligence-is-yielding-unique-mrna-drug-candidates 2022-06-23 19:00:59.964+00 https://www.pharmasalmanac.com/articles/the-bioanalytical-development-journey 2022-06-23 19:00:41.897+00 https://www.pharmasalmanac.com/articles/approaching-viral-vector-manufacturing-with-an-emphasis-on-quality-and-design 2022-06-23 19:00:25.003+00 https://www.pharmasalmanac.com/articles/transformative-early-and-patient-centric-treatments-for-retinal-diseases 2022-06-23 19:00:12.051+00 https://www.pharmasalmanac.com/articles/translating-three-decades-of-experience-in-plasmid-dna-into-customer-success 2022-06-23 18:59:40.451+00 https://www.pharmasalmanac.com/articles/nfts-are-bringing-the-regenerative-medicine-community-together 2022-06-23 18:59:02.884+00 https://www.pharmasalmanac.com/articles/a-podular-approach-could-fundamentally-change-the-car-t-cell-therapy-landscape 2022-06-23 18:58:43.628+00 https://www.pharmasalmanac.com/articles/new-polymer-lipid-delivery-system-for-mrna 2022-06-23 18:58:26.623+00 https://www.pharmasalmanac.com/articles/tackling-liver-disease-with-a-multimodal-cyclophilin-inhibitor 2022-06-23 18:57:55.004+00 https://www.pharmasalmanac.com/articles/tuning-the-myeloid-compartment-with-a-best-in-class-cdmo 2022-06-23 18:57:27.834+00 https://www.pharmasalmanac.com/articles/accelerating-the-development-of-high-quality-cell-and-gene-therapies-with-comprehensive-in-house-analytical-support 2022-06-23 18:56:41.881+00 https://www.pharmasalmanac.com/articles/real-world-data-and-artificial-intelligence-are-transforming-clinical-development 2022-06-23 18:56:10.858+00 https://www.pharmasalmanac.com/articles/gaining-insights-into-the-challenges-trends-and-needs-of-animal-health-organizations 2022-06-23 15:50:04.771+00 https://www.pharmasalmanac.com/articles/generis-celebrates-new-milestones-as-swathes-of-the-global-pharma-industry-default-to-cara-life-sciences-to-manage-critical-data-and-content 2022-06-21 22:12:21.919+00 https://www.pharmasalmanac.com/articles/meeting-the-needs-of-the-evolving-sterile-injectables-marketmeeting-the-needs-of-the-evolving-sterile-injectables-market 2022-06-17 16:13:49.192+00 https://www.pharmasalmanac.com/articles/wheeler-bio-integrates-the-solentim-ecosystem-by-advanced-instruments-to-deliver-the-highest-level-of-consistency-across-their-cell-line-development-workflow 2022-06-14 16:48:24.651+00 https://www.pharmasalmanac.com/articles/yourway-announces-new-flagship-european-depot-in-dublin-ireland 2022-06-08 18:16:50.006+00 https://www.pharmasalmanac.com/articles/fighting-solid-tumors-by-targeting-neoantigens-in-a-personalized-manner 2022-06-06 11:00:01.578+00 https://www.pharmasalmanac.com/articles/driving-the-industry-forward-on-multiple-boards 2022-06-01 21:25:12.608+00 https://www.pharmasalmanac.com/articles/supporting-advanced-biotherapeutic-development 2022-05-26 17:55:57.101+00 https://www.pharmasalmanac.com/articles/olon-announces-the-creation-of-a-major-center-of-research-and-development-in-italy-that-will-give-rise-to-an-innovative-global-rd-model 2022-05-26 10:00:00.958+00 https://www.pharmasalmanac.com/articles/umotif-the-patient-first-data-capture-and-decentralized-clinical-trials-platform-announces-25.5m-of-new-investment-from-a-fund-managed-by-athyrium-capital-management 2022-05-25 15:39:11.877+00 https://www.pharmasalmanac.com/articles/7-reasons-specialty-chemical-manufacturers-are-embracing-used-chemical-equipment 2022-05-24 17:47:27.39+00 https://www.pharmasalmanac.com/articles/building-multiple-platforms-to-address-difficult-to-treat-cancers 2022-05-24 14:00:50.759+00 https://www.pharmasalmanac.com/articles/enabling-drug-discovery-targeting-ion-channels 2022-05-19 21:36:44.655+00 https://www.pharmasalmanac.com/articles/data-based-regulatory-submissions-what-dadi-means-for-you 2022-05-18 16:47:24.256+00 https://www.pharmasalmanac.com/articles/exploring-the-biohealth-capital-region 2022-05-18 13:40:57.487+00 https://www.pharmasalmanac.com/articles/reshoring-manufacturing-and-targeted-specialty-medicines 2022-05-17 17:57:52.766+00 https://www.pharmasalmanac.com/articles/olon-invests-in-new-spray-dryer-at-rodano-rd-centre 2022-05-17 16:10:37.865+00 https://www.pharmasalmanac.com/articles/for-mabs-a-small-biotech-recognizes-the-value-in-lonzas-expertise-and-track-record 2022-05-17 14:09:15.064+00 https://www.pharmasalmanac.com/articles/a-small-biotech-with-two-complex-bispecific-antibody-candidates-benefits-from-lonzas-blend-of-expertise-and-flexibility 2022-05-17 13:23:46.514+00 https://www.pharmasalmanac.com/articles/illustrating-a-successful-small-biotech-cdmo-relationship 2022-05-17 13:22:57.686+00 https://www.pharmasalmanac.com/articles/rna-9000-purity-and-integrity-kit-allows-for-critical-high-resolution-analysis-for-mrna-therapeutics 2022-05-16 22:02:50.87+00 https://www.pharmasalmanac.com/articles/facilitating-the-full-spectrum-of-decentralized-trials 2022-05-12 19:39:20.144+00 https://www.pharmasalmanac.com/articles/enzymaster-completes-round-c-financing-to-accelerate-innovation-increase-capabilities-and-expand-capacity 2022-05-12 17:11:17.761+00 https://www.pharmasalmanac.com/articles/strategic-partnerships-for-pharmas-chemistry-needs 2022-05-12 15:25:14.326+00 https://www.pharmasalmanac.com/articles/changing-the-paradigm-of-cancer-drug-discovery-and-development-with-plants 2022-05-11 18:26:31.191+00 https://www.pharmasalmanac.com/articles/kindeva-and-bol-pharma-using-low-global-warming-potential-gwp-propellant-in-development-of-inhaled-cannabinoid-products 2022-05-11 16:45:52.74+00 https://www.pharmasalmanac.com/articles/unlocking-new-possibilities-with-fastpharming 2022-05-11 15:11:33.653+00 https://www.pharmasalmanac.com/articles/pci-pharma-services-announces-major-manufacturing-expansion-with-100-million-investment-in-new-england-providing-global-capacity-to-clients 2022-05-11 13:32:55.142+00 https://www.pharmasalmanac.com/articles/manufacturing-opportunities-in-virginia 2022-05-10 19:10:14.988+00 https://www.pharmasalmanac.com/articles/transforming-market-insights-into-growth 2022-05-09 17:20:19.573+00 https://www.pharmasalmanac.com/articles/hovione-and-jixing-announce-an-exclusive-global-license-agreement-for-ophthalmology-program 2022-05-09 14:50:24.006+00 https://www.pharmasalmanac.com/articles/supporting-small-biotechs-in-outsourcing 2022-05-06 21:03:59.612+00 https://www.pharmasalmanac.com/articles/digital-therapeutics-leader-sidekick-raises-55m-series-b-to-drive-further-growth 2022-05-05 15:39:35.084+00 https://www.pharmasalmanac.com/articles/building-a-healthier-future-for-arkansas-communities 2022-05-05 13:16:43.51+00 https://www.pharmasalmanac.com/articles/growing-a-forward-thinking-cdmo 2022-05-04 15:13:25.303+00 https://www.pharmasalmanac.com/articles/capa-management-is-worth-doing-and-worth-doing-well 2022-05-04 14:08:49.206+00 https://www.pharmasalmanac.com/articles/nference-enters-into-an-rd-data-science-strategic-partnership-with-janssen 2022-05-03 17:49:10.717+00 https://www.pharmasalmanac.com/articles/escs-innovations-in-cleanrooms-and-critical-environments-to-be-showcased-at-interphex-2022 2022-05-03 14:55:03.131+00 https://www.pharmasalmanac.com/articles/remembering-the-du-pont-contribution-to-pharma 2022-05-03 13:44:38.049+00 https://www.pharmasalmanac.com/articles/digitalizing-quality-management-what-the-food-industry-can-teach-pharma 2022-04-29 20:40:47.203+00 https://www.pharmasalmanac.com/articles/bringing-value-to-pharma-and-biopharma 2022-04-29 20:39:11.858+00 https://www.pharmasalmanac.com/articles/eliminating-immunosuppression-in-regenerative-medicine 2022-04-29 20:34:37.178+00 https://www.pharmasalmanac.com/articles/pluristyx-and-accelerated-biosciences-announce-availability-of-clinical-grade-immune-privileged-human-trophoblast-stem-cells-htscs 2022-04-28 18:08:12.932+00 https://www.pharmasalmanac.com/articles/the-global-fight-against-covid-19 2022-04-28 17:38:05.774+00 https://www.pharmasalmanac.com/articles/the-future-of-digital-health 2022-04-28 17:33:44.447+00 https://www.pharmasalmanac.com/articles/the-future-of-sterile-fill/finish 2022-04-28 17:29:15.702+00 https://www.pharmasalmanac.com/articles/optimizing-surface-functionalities 2022-04-28 17:24:59.14+00 https://www.pharmasalmanac.com/articles/keeping-pharma-manufacturing-alive-in-italy-during-covid-19 2022-04-28 16:56:27.318+00 https://www.pharmasalmanac.com/articles/on-the-future-of-ocular-therapies 2022-04-28 16:49:10.12+00 https://www.pharmasalmanac.com/articles/the-italian-pharma-landscape 2022-04-28 16:43:41.385+00 https://www.pharmasalmanac.com/articles/the-future-of-pharma-facilities 2022-04-28 16:33:50.534+00 https://www.pharmasalmanac.com/articles/healthcare-in-croatia 2022-04-28 16:29:24.534+00 https://www.pharmasalmanac.com/articles/assessing-the-hungarian-healthcare-system 2022-04-28 15:58:23.538+00 https://www.pharmasalmanac.com/articles/keeping-clinical-trials-running-during-a-pandemic 2022-04-28 15:52:33.298+00 https://www.pharmasalmanac.com/articles/planning-for-growth-as-blockbusters-give-way-to-personalized-medicine 2022-04-28 15:31:50.534+00 https://www.pharmasalmanac.com/articles/expert-support-for-histology-pathology-and-archiving 2022-04-27 21:45:48.4+00 https://www.pharmasalmanac.com/articles/optimizing-intranasal-drug-delivery 2022-04-26 13:34:54.134+00 https://www.pharmasalmanac.com/articles/delivering-pluripotent-stems-cells-primed-to-differentiate 2022-04-26 13:29:00.821+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-14-slovakia-hungary 2022-04-21 20:24:11.422+00 https://www.pharmasalmanac.com/articles/the-value-of-data-based-decision-making 2022-04-21 13:49:43.612+00 https://www.pharmasalmanac.com/articles/the-evolution-of-drug-safety 2022-04-20 19:41:32.225+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-11-lithuania-poland 2022-04-20 18:55:25.167+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-24-france-england 2022-04-20 18:54:05.104+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-24-france 2022-04-20 18:53:35.67+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-23-france-luxembourg 2022-04-20 18:52:52.732+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-21-italy-monaco-france 2022-04-20 18:51:51.226+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-20-italy 2022-04-20 18:51:22.723+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-19-switzerland-italy 2022-04-20 18:50:52.665+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-16-croatia-slovenia-austria 2022-04-20 18:48:55.191+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-15-hungary-croatia 2022-04-20 18:48:21.897+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-13-czechia-slovakia 2022-04-20 18:46:50.945+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-10-latvia-lithuania 2022-04-20 18:46:23.364+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-9-finland-estonia-latvia 2022-04-20 18:45:55.022+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-7-denmark-sweden 2022-04-20 18:45:17.135+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-6-netherlands-germany 2022-04-20 18:44:49.912+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-5-belgium-the-netherlands 2022-04-20 18:44:20.128+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-4-england-france-belgium 2022-04-20 18:43:40.514+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-3-scotland-england 2022-04-20 18:43:01.452+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-2-wales-ireland-and-northern-ireland 2022-04-20 18:42:06.087+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-22-france-luxembourg 2022-04-20 18:18:14.273+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-18-austria-germany-liechtenstein-switzerland 2022-04-20 18:08:35.985+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-17-austria 2022-04-20 18:01:31.333+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-8-sweden-finland 2022-04-20 17:39:28.029+00 https://www.pharmasalmanac.com/articles/road-to-2021-day-1-england-wales 2022-04-20 17:19:29.498+00 https://www.pharmasalmanac.com/articles/the-end-of-the-road...-but-not-for-long 2022-04-20 15:17:45.807+00 https://www.pharmasalmanac.com/articles/all-roads-lead-to-2021 2022-04-20 15:16:03.31+00 https://www.pharmasalmanac.com/articles/farewell-to-our-beloved-albear 2022-04-20 15:14:36.63+00 https://www.pharmasalmanac.com/articles/southern-hospitality-on-the-road-to-bio 2022-04-20 15:13:08.417+00 https://www.pharmasalmanac.com/articles/putting-the-bayou-in-road-to-bio 2022-04-20 15:11:29.278+00 https://www.pharmasalmanac.com/articles/hit-the-road-jackson 2022-04-20 15:09:19.593+00 https://www.pharmasalmanac.com/articles/discovering-the-empire-state-of-the-south 2022-04-20 15:07:31.055+00 https://www.pharmasalmanac.com/articles/welcome-to-charleston-south-carolina 2022-04-20 15:05:53.459+00 https://www.pharmasalmanac.com/articles/over-the-blue-ridge-mountains 2022-04-20 15:04:15.233+00 https://www.pharmasalmanac.com/articles/bristol-is-a-good-place-to-live 2022-04-20 14:28:49.962+00 https://www.pharmasalmanac.com/articles/day-of-reckoning-on-the-road-to-bio 2022-04-20 14:26:38.293+00 https://www.pharmasalmanac.com/articles/snipr-biome-initiates-first-in-human-clinical-trial-with-snipr001 2022-04-20 14:23:29.851+00 https://www.pharmasalmanac.com/articles/biotech-hub-to-nyc-the-epic-journey-begins 2022-04-20 14:21:42.81+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-an-epic-journey 2022-04-20 14:17:27.317+00 https://www.pharmasalmanac.com/articles/the-exciting-research-potential-of-new-mexico 2022-04-19 21:00:53.099+00 https://www.pharmasalmanac.com/articles/tackling-inflammation-with-novel-peptide-drugs 2022-04-19 20:57:21.869+00 https://www.pharmasalmanac.com/articles/applying-revolutionary-thinking-to-autoimmune-and-allergic-diseases 2022-04-19 20:51:52.501+00 https://www.pharmasalmanac.com/articles/driving-transformational-change-in-the-middle-market 2022-04-14 19:52:21.545+00 https://www.pharmasalmanac.com/articles/life-in-poland 2022-04-14 15:25:36.039+00 https://www.pharmasalmanac.com/articles/the-enduring-usefulness-of-microbial-fermentation 2022-04-14 14:56:51.117+00 https://www.pharmasalmanac.com/articles/maintaining-api-supply-during-a-pandemic 2022-04-14 14:40:25.933+00 https://www.pharmasalmanac.com/articles/checking-in-with-the-road-to-2021-team 2022-04-14 14:36:12.505+00 https://www.pharmasalmanac.com/articles/assessing-the-dynamic-market-for-biologics 2022-04-14 14:31:23.517+00 https://www.pharmasalmanac.com/articles/reflecting-on-covid-19-in-germany 2022-04-14 14:07:43.069+00 https://www.pharmasalmanac.com/articles/the-future-of-intensified-processing 2022-04-13 21:43:19.528+00 https://www.pharmasalmanac.com/articles/preserving-the-value-of-critical-anti-infectives 2022-04-13 21:34:40.733+00 https://www.pharmasalmanac.com/articles/supporting-inhalation-development-for-both-drugs-and-devices 2022-04-13 21:29:27.998+00 https://www.pharmasalmanac.com/articles/the-future-of-decentralized-trials 2022-04-13 21:07:33.083+00 https://www.pharmasalmanac.com/articles/coverting-viruses-into-therapeutic-tools 2022-04-12 20:13:01.098+00 https://www.pharmasalmanac.com/articles/fighting-cancer-and-supporting-patients 2022-04-12 20:09:31.502+00 https://www.pharmasalmanac.com/articles/growing-science-businesses-in-idaho 2022-04-12 20:05:05.376+00 https://www.pharmasalmanac.com/articles/gb-sciences-to-begin-dosage-study-for-its-novel-parkinsons-disease-formulations-at-the-university-of-lethbridge 2022-04-12 19:59:40.87+00 https://www.pharmasalmanac.com/articles/yourway-adds-additional-capacity-for-controlled-ambient-storage-in-allentown-pa 2022-04-12 14:43:53.987+00 https://www.pharmasalmanac.com/articles/the-future-of-inhalation 2022-04-08 20:45:31.88+00 https://www.pharmasalmanac.com/articles/incorporating-the-patient-voice-into-pharma-development 2022-04-08 20:31:05.489+00 https://www.pharmasalmanac.com/articles/innovating-in-the-fight-against-brain-tumors 2022-04-08 15:14:02.49+00 https://www.pharmasalmanac.com/articles/building-a-future-of-leadership-in-scotland 2022-04-08 15:08:10.66+00 https://www.pharmasalmanac.com/articles/training-the-next-generation-of-scottish-entrepreneurs 2022-04-08 14:41:19.946+00 https://www.pharmasalmanac.com/articles/promoting-science-education-in-glasgow 2022-04-08 14:37:13.936+00 https://www.pharmasalmanac.com/articles/patient-centric-innovations-in-osd 2022-04-08 14:30:54.837+00 https://www.pharmasalmanac.com/articles/exploring-the-limb-implant-market 2022-04-08 14:25:06.493+00 https://www.pharmasalmanac.com/articles/innovating-cell-therapy-manufacturing 2022-04-08 14:19:20.582+00 https://www.pharmasalmanac.com/articles/the-future-of-pharma-in-space 2022-04-07 21:55:31.713+00 https://www.pharmasalmanac.com/articles/novo-holdings-portfolio-company-reviral-to-be-acquired-by-pfizer 2022-04-07 15:33:30.454+00 https://www.pharmasalmanac.com/articles/tegmine-therapeutics-announces-collaboration-with-alloy-therapeutics-to-advance-solid-tumor-treatment 2022-04-07 15:19:41.004+00 https://www.pharmasalmanac.com/articles/crb-welcomes-veteran-engineering-leader-as-new-senior-director-of-client-services-for-slatexpace 2022-04-07 15:19:05.125+00 https://www.pharmasalmanac.com/articles/applying-synthetic-biology-to-elevate-probiotics 2022-04-07 14:42:57.006+00 https://www.pharmasalmanac.com/articles/covid-19s-impact-on-sustainability 2022-04-06 20:38:43.276+00 https://www.pharmasalmanac.com/articles/building-supply-chain-infrastructure-for-cell-and-gene-therapies 2022-04-06 19:29:33.862+00 https://www.pharmasalmanac.com/articles/covid-19s-impact-on-specialty-supply-chain-logistics 2022-04-06 19:10:50.877+00 https://www.pharmasalmanac.com/articles/personalizing-cancer-treatment-recommendations 2022-04-06 16:27:38.053+00 https://www.pharmasalmanac.com/articles/the-future-of-healthcare-in-the-u.s.-and-the-u.k 2022-04-06 16:26:54.678+00 https://www.pharmasalmanac.com/articles/covid-19-in-scotland-and-in-publishing 2022-04-06 16:20:16.577+00 https://www.pharmasalmanac.com/articles/discussing-healthcare-across-europe 2022-04-06 16:15:18.529+00 https://www.pharmasalmanac.com/articles/advancing-technologies-in-cell-and-gene-therapy 2022-04-05 17:38:30.69+00 https://www.pharmasalmanac.com/articles/developing-rna-screening-for-cancer-diagnosis 2022-04-05 17:35:29.183+00 https://www.pharmasalmanac.com/articles/fujifilm-completes-acquisition-of-a-dedicated-cell-therapy-manufacturing-facility-from-atara-biotherapeutics-inc 2022-04-04 22:28:28.15+00 https://www.pharmasalmanac.com/articles/growing-as-a-trusted-dedicated-commercial-biologics-cdmo 2022-04-04 17:33:42.117+00 https://www.pharmasalmanac.com/articles/bringing-artificial-intelligence-to-biopharma 2022-04-01 17:05:20.108+00 https://www.pharmasalmanac.com/articles/the-need-for-onshoring-and-domestic-production 2022-04-01 17:01:14.916+00 https://www.pharmasalmanac.com/articles/high-resolution-next-generation-dna-sequencing 2022-04-01 16:58:10.9+00 https://www.pharmasalmanac.com/articles/biotechnology-growth-in-arizona 2022-04-01 16:53:36.306+00 https://www.pharmasalmanac.com/articles/exploring-pharmacokinetics-and-safety-for-drugs-targeting-the-gut 2022-04-01 16:49:18.062+00 https://www.pharmasalmanac.com/articles/looking-at-the-future-of-u.s.-api-manufacturing 2022-04-01 16:44:28.378+00 https://www.pharmasalmanac.com/articles/realizing-the-promise-of-molecular-electronics 2022-04-01 16:41:15.528+00 https://www.pharmasalmanac.com/articles/anixa-biosciences-announces-the-initiation-of-its-ovarian-cancer-car-t-phase-i-trial-at-moffitt-cancer-center 2022-03-30 18:57:16.788+00 https://www.pharmasalmanac.com/articles/leveraging-existing-technologies-with-new-dedicated-facilities-for-mrna-projects 2022-03-29 21:46:05.201+00 https://www.pharmasalmanac.com/articles/q-whats-the-key-to-being-a-leader-in-the-industry 2022-03-29 21:29:17.557+00 https://www.pharmasalmanac.com/articles/moving-beyond-the-industrialization-of-mscs 2022-03-29 21:28:57.178+00 https://www.pharmasalmanac.com/articles/the-exciting-growth-curve-for-hmscs-must-be-facilitated-by-manufacturing-advances 2022-03-29 21:28:41.555+00 https://www.pharmasalmanac.com/articles/the-limitless-potential-of-thin-film-freezing 2022-03-29 21:28:23.876+00 https://www.pharmasalmanac.com/articles/pioneering-nanocatalysis-to-revolutionize-treatments-for-neurodegenerative-diseases 2022-03-29 21:28:06.665+00 https://www.pharmasalmanac.com/articles/developing-new-antibody-therapeutics-for-covid-19-and-beyond 2022-03-29 21:27:34.123+00 https://www.pharmasalmanac.com/articles/rare-disease-patients-benefit-from-clinical-trial-flexibility 2022-03-29 21:27:16.818+00 https://www.pharmasalmanac.com/articles/the-global-immunization-disparity 2022-03-29 21:26:42.993+00 https://www.pharmasalmanac.com/articles/optimizing-yields-tech-transfer-and-the-supply-chain-for-viral-vector-manufacturing 2022-03-29 21:26:26.878+00 https://www.pharmasalmanac.com/articles/smart-scale-up-expanding-viral-vectors-with-microcarrier-bead-technology 2022-03-29 21:25:42.21+00 https://www.pharmasalmanac.com/articles/uncovering-new-drug-targets-for-neurological-diseases 2022-03-29 21:25:23.998+00 https://www.pharmasalmanac.com/articles/expanding-access-to-cell-therapies-with-a-patient-centric-focus 2022-03-29 21:25:06.926+00 https://www.pharmasalmanac.com/articles/developing-a-novel-anti-inflammatory-for-patients-with-severe-asthma 2022-03-29 21:24:48.122+00 https://www.pharmasalmanac.com/articles/fighting-cancer-by-focusing-on-nuclear-export 2022-03-29 21:24:27.044+00 https://www.pharmasalmanac.com/articles/designing-more-effective-therapeutic-proteins-using-an-integrated-laboratory-and-computational-platform 2022-03-29 21:24:06.218+00 https://www.pharmasalmanac.com/articles/rentschler-biopharma-and-vetter-unveil-xpert-alliance 2022-03-29 14:29:49.829+00 https://www.pharmasalmanac.com/articles/alcami-expands-biopharma-storage-at-masy-bioservices 2022-03-29 14:28:47.354+00 https://www.pharmasalmanac.com/articles/hek-cells-vs.-cho-cells-in-recombinant-antibody-production-whats-the-better-choice 2022-03-28 20:50:00.031+00 https://www.pharmasalmanac.com/articles/expanding-the-cell-and-gene-therapy-ecosystem-in-philadelphia 2022-03-28 20:49:45.716+00 https://www.pharmasalmanac.com/articles/how-artificial-intelligence-may-drive-the-future-of-clinical-trials 2022-03-28 20:48:52.755+00 https://www.pharmasalmanac.com/articles/will-the-second-wave-of-covid-19-vaccines-have-the-improved-properties-needed-to-end-the-pandemic 2022-03-28 20:47:36.313+00 https://www.pharmasalmanac.com/articles/why-the-big-shifts-in-gene-therapy-investments-its-late-in-the-game 2022-03-28 20:46:51.237+00 https://www.pharmasalmanac.com/articles/2021-was-a-great-year-for-biotech-ipos-depending-on-when-you-got-out 2022-03-28 20:46:17.266+00 https://www.pharmasalmanac.com/articles/new-drug-watch-alzheimer-drug-still-controversial 2022-03-28 20:45:22.793+00 https://www.pharmasalmanac.com/articles/regulatory-spotlight-new-fda-guidance-on-real-world-evidence/real-world-data 2022-03-28 20:44:55.769+00 https://www.pharmasalmanac.com/articles/global-investment-trends-and-getting-noticed-by-pe/vc-firms 2022-03-28 19:10:57.193+00 https://www.pharmasalmanac.com/articles/sterile-injectables-device-and-packaging-trends 2022-03-28 19:07:16.177+00 https://www.pharmasalmanac.com/articles/streamlining-process-validation-for-drug-substance-manufacturing 2022-03-28 16:48:26.266+00 https://www.pharmasalmanac.com/articles/biocytogen-expands-global-footprint-with-the-opening-of-biocytogen-europe-innovation-center-in-germany 2022-03-28 13:53:58.704+00 https://www.pharmasalmanac.com/articles/incannex-to-acquire-apirx-pharmaceuticals-usa-llc 2022-03-24 15:33:10.85+00 https://www.pharmasalmanac.com/articles/biondvax-signs-definitive-collaboration-agreement-for-the-development-of-a-pipeline-of-innovative-nanosized-antibody-nanoab-therapies 2022-03-24 15:13:56.344+00 https://www.pharmasalmanac.com/articles/gmp-certification-for-exothera-further-extends-its-viral-vector-manufacturing-capacity 2022-03-23 13:39:31.956+00 https://www.pharmasalmanac.com/articles/exploring-living-cells-with-fluorescent-biosensors 2022-03-22 15:41:26.074+00 https://www.pharmasalmanac.com/articles/intravacc-announces-the-publication-of-a-gmp-process-for-a-semi-synthetic-shigella-glycoconjugate-vaccine-candidate-from-institut-pasteur 2022-03-22 14:42:14.123+00 https://www.pharmasalmanac.com/articles/overcoming-analytical-challenges-for-gene-therapies 2022-03-21 17:57:01.812+00 https://www.pharmasalmanac.com/articles/enabling-precision-medicine-via-precision-diagnostics 2022-03-21 17:55:48.117+00 https://www.pharmasalmanac.com/articles/applying-nanocatalysis-to-the-fight-against-als 2022-03-21 17:55:33.047+00 https://www.pharmasalmanac.com/articles/new-facilities-help-agc-biologics-discover-whats-possible 2022-03-21 17:54:57.084+00 https://www.pharmasalmanac.com/articles/changing-the-future-of-cell-culture-and-accelerating-next-generation-therapies 2022-03-21 17:54:25.302+00 https://www.pharmasalmanac.com/articles/nuance-pharma-announces-license-and-supply-agreement-with-bavarian-nordic-on-the-development-and-commercialization-of-respiratory-syncytial-virus-rsv-vaccine 2022-03-21 17:13:18.586+00 https://www.pharmasalmanac.com/articles/connecting-genetic-mutations-to-health 2022-03-21 16:43:17.253+00 https://www.pharmasalmanac.com/articles/best-practices-for-oncolytic-virus-design-development-and-manufacturingbest-practices-for-oncolytic-virus-design-development-and-manufacturing 2022-03-18 14:11:42.651+00 https://www.pharmasalmanac.com/articles/chimeric-partners-with-be-the-match-biotherapies-to-advance-chm-1101-cltx-car-t 2022-03-17 15:54:23.791+00 https://www.pharmasalmanac.com/articles/will-remote-pharma-gmp-auditing-continue-post-covid 2022-03-16 19:36:38.141+00 https://www.pharmasalmanac.com/articles/araclon-biotech-advances-in-its-innovative-vaccine-and-diagnostic-test-for-alzheimers 2022-03-15 16:13:55.214+00 https://www.pharmasalmanac.com/articles/battling-ischemia-with-therapeutic-angiogenesis 2022-03-15 15:47:23.279+00 https://www.pharmasalmanac.com/articles/contract-manufacturing-at-the-leading-edge-of-process-innovation 2022-03-15 15:39:33.434+00 https://www.pharmasalmanac.com/articles/world-class-solutions-for-livestock-vaccines 2022-03-14 20:22:40.826+00 https://www.pharmasalmanac.com/articles/accelerating-operations-by-aligning-training-with-it 2022-03-14 19:47:31.385+00 https://www.pharmasalmanac.com/articles/former-surgeon-general-jerome-adams-announced-as-chairman-of-the-board-of-total-diversity-clinical-trial-management 2022-03-08 18:56:12.458+00 https://www.pharmasalmanac.com/articles/the-evolution-and-the-future-of-pharma 2022-03-08 17:39:55.998+00 https://www.pharmasalmanac.com/articles/modernizing-respiratory-care-with-a-focus-on-long-covid 2022-03-07 19:45:10.226+00 https://www.pharmasalmanac.com/articles/investment-opportunities-in-the-medical-device-sector 2022-03-07 19:17:01.086+00 https://www.pharmasalmanac.com/articles/innovating-in-automation-and-data-management-to-advance-microbiology 2022-03-07 18:16:05.038+00 https://www.pharmasalmanac.com/articles/expecting-more-for-drug-discovery-and-development 2022-03-07 18:07:12.968+00 https://www.pharmasalmanac.com/articles/achieving-long-term-implantable-drug-delivery 2022-03-07 18:00:07.83+00 https://www.pharmasalmanac.com/articles/more-accurate-results-with-better-skin-models 2022-03-07 17:54:27.72+00 https://www.pharmasalmanac.com/articles/advancing-the-science-of-whats-possible 2022-03-07 17:48:35.612+00 https://www.pharmasalmanac.com/articles/leveraging-ai-and-rna-to-fight-rare-diseases 2022-03-07 17:40:49.775+00 https://www.pharmasalmanac.com/articles/accelerating-large-molecule-drug-development 2022-03-07 17:25:18.64+00 https://www.pharmasalmanac.com/articles/fluence-analytics-announces-new-biopharma-analysis-product 2022-03-03 21:58:16.894+00 https://www.pharmasalmanac.com/articles/samsung-biologics-becomes-the-first-in-the-south-korean-pharma-industry-to-achieve-iso-22301-certificate 2022-03-03 20:02:55.349+00 https://www.pharmasalmanac.com/articles/focusing-on-the-potential-of-midsized-pharma-service-organizations 2022-03-02 15:04:18.33+00 https://www.pharmasalmanac.com/articles/investing-and-expanding-for-high-quality-biopharmaceuticals 2022-03-01 16:46:32.83+00 https://www.pharmasalmanac.com/articles/idt-biologika-collaborates-with-exothera-to-push-forward-the-scale-up-of-viral-vaccines 2022-03-01 16:38:12.932+00 https://www.pharmasalmanac.com/articles/personalized-physiology-analytics-for-real-time-insights 2022-02-28 17:48:00.777+00 https://www.pharmasalmanac.com/articles/supporting-growth-for-middle-market-companies 2022-02-28 17:47:40.113+00 https://www.pharmasalmanac.com/articles/jean-luc-herbeaux-to-become-hovione-ceo 2022-02-25 15:55:47.862+00 https://www.pharmasalmanac.com/articles/hovione-and-zerion-pharma-announce-a-strategic-partnership-to-market-the-dispersome-technology-platform 2022-02-25 15:43:08.162+00 https://www.pharmasalmanac.com/articles/innovating-nanoparticles-for-pharmaceutical-applications 2022-02-24 19:30:16.276+00 https://www.pharmasalmanac.com/articles/abzena-alira-health-and-oncodesign-launch-drive-biologics-to-support-access-to-specialist-services-from-discovery-to-clinical-development 2022-02-24 17:45:29.785+00 https://www.pharmasalmanac.com/articles/solving-problems-through-creative-applications-of-science 2022-02-24 16:28:19.67+00 https://www.pharmasalmanac.com/articles/astrazeneca-to-supply-canada-with-100000-doses-of-evusheld-a-long-acting-antibody-combination-for-the-prevention-of-covid-19 2022-02-23 21:01:09.311+00 https://www.pharmasalmanac.com/articles/milliporesigma-announces-closing-of-exelead-acquisition-and-plans-to-invest-more-than-500-million-in-technology-scale-up 2022-02-23 14:40:19.905+00 https://www.pharmasalmanac.com/articles/vibalogics-acquired-by-top-global-cdmo-recipharm-ab 2022-02-18 15:09:57.622+00 https://www.pharmasalmanac.com/articles/crb-announces-courtney-holt-as-new-general-counsel 2022-02-17 18:59:37.722+00 https://www.pharmasalmanac.com/articles/discovery-life-sciences-streamlines-cell-and-gene-therapy-manufacturing-with-expanded-human-cellular-starting-materials 2022-02-17 17:03:42.825+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-expands-millersburg-pa.-bioprocessing-manufacturing-site 2022-02-17 16:20:36.941+00 https://www.pharmasalmanac.com/articles/composition-of-gut-microbiome-predicts-the-onset-of-type-2-diabetes 2022-02-16 15:00:05.749+00 https://www.pharmasalmanac.com/articles/helping-sponsors-navigate-complex-ancillary-supply-sourcing-challenges-with-integrated-services 2022-02-15 17:26:23.495+00 https://www.pharmasalmanac.com/articles/myelin-repair-discovery-step-forward-in-search-to-stop-ms 2022-02-14 22:00:23.21+00 https://www.pharmasalmanac.com/articles/amazing-nanoparticles-from-maize-a-potent-and-economical-anti-cancer-therapeutic 2022-02-14 17:48:46.08+00 https://www.pharmasalmanac.com/articles/looking-to-another-50-years-of-growth 2022-02-14 16:51:17.688+00 https://www.pharmasalmanac.com/articles/considering-talent-acquisition-in-the-wake-of-covid-19 2022-02-11 18:33:08.468+00 https://www.pharmasalmanac.com/articles/integrating-services-across-the-full-spectrum-of-cell-and-gene-therapy 2022-02-11 18:07:44.353+00 https://www.pharmasalmanac.com/articles/leveraging-broad-capabilities-in-the-growing-animal-health-market 2022-02-11 18:06:36.86+00 https://www.pharmasalmanac.com/articles/altis-biosystems-awards-new-research-funding-to-armed-forces-radiobiology-research-institute 2022-02-09 19:02:05.63+00 https://www.pharmasalmanac.com/articles/merck-kgaa-darmstadt-germany-enters-into-option-agreement-with-quris-on-its-bioai-platform-for-clinical-safety-prediction 2022-02-09 17:49:56.116+00 https://www.pharmasalmanac.com/articles/agc-biologics-supports-omicron-based-vaccine-candidate-manufacturing-with-starting-material 2022-02-09 17:32:21.787+00 https://www.pharmasalmanac.com/articles/trirx-completes-acquisition-of-elanco-manufacturing-facility-in-speke-united-kingdom 2022-02-08 22:25:18.955+00 https://www.pharmasalmanac.com/articles/model-medicines-oral-anti-covid-19-drug-candidate-mdl-001-found-to-significantly-reduce-viral-load-in-lungs-accepted-into-nihs-antiviral-program-for-pandemics-app 2022-02-08 16:33:57.324+00 https://www.pharmasalmanac.com/articles/strengthening-onshore-manufacturing-capabilities-over-the-pandemic 2022-02-07 22:52:16.207+00 https://www.pharmasalmanac.com/articles/biofidelity-raises-23m-in-series-a-financing-led-by-octopus-ventures-to-launch-aspyre-technology 2022-02-07 15:10:30.191+00 https://www.pharmasalmanac.com/articles/milliporesigma-announces-organizational-transformation-to-strengthen-cdmo-offering-and-accelerate-future-growth 2022-02-07 14:41:17.795+00 https://www.pharmasalmanac.com/articles/advancing-drug-development-with-emerging-technologies 2022-02-04 15:28:12.894+00 https://www.pharmasalmanac.com/articles/accelerating-innovation-in-regenerative-medicine 2022-02-04 15:26:02.385+00 https://www.pharmasalmanac.com/articles/adapting-critical-cleaning-to-address-new-industry-demands 2022-02-03 19:29:43.627+00 https://www.pharmasalmanac.com/articles/etherna-announces-research-agreement-with-merck-kgaa-darmstadt-germany-to-access-mrna-technologies 2022-02-03 17:17:53.488+00 https://www.pharmasalmanac.com/articles/expanding-the-bioscience-industry-in-montana 2022-02-03 15:32:53.435+00 https://www.pharmasalmanac.com/articles/expanding-the-philadelphia-cell-and-gene-therapy-hub 2022-02-02 17:53:21.669+00 https://www.pharmasalmanac.com/articles/fda-approves-spikevax-modernas-mrna-covid-19-vaccine 2022-02-01 16:39:43.769+00 https://www.pharmasalmanac.com/articles/transforming-drug-delivery-with-innovative-biomaterials 2022-01-31 21:46:49.001+00 https://www.pharmasalmanac.com/articles/helping-biopharma-companies-grow-with-insight 2022-01-31 21:13:20.465+00 https://www.pharmasalmanac.com/articles/changing-lives-one-patient-at-a-time 2022-01-31 20:39:56.033+00 https://www.pharmasalmanac.com/articles/genetically-engineered-dual-receptor-t-cells-double-trouble-for-cancer-cells 2022-01-31 19:47:45.255+00 https://www.pharmasalmanac.com/articles/realizing-the-promise-of-cell-and-gene-therapy-with-an-advanced-manufacturing-platform 2022-01-31 19:33:14.08+00 https://www.pharmasalmanac.com/articles/the-global-potential-of-transdermals 2022-01-31 17:50:18.575+00 https://www.pharmasalmanac.com/articles/confirmation-that-the-license-to-develop-oral-vaccine-delivery-platform-has-been-executed 2022-01-31 17:23:59.1+00 https://www.pharmasalmanac.com/articles/100-years-in-vaccines-and-looking-toward-the-future 2022-01-28 21:57:42.329+00 https://www.pharmasalmanac.com/articles/providing-equipment-and-training-for-growth-in-pharma-manufacturing 2022-01-28 19:35:09.831+00 https://www.pharmasalmanac.com/articles/assessing-modular-vs.-stick-built-facility-construction 2022-01-28 19:04:00.86+00 https://www.pharmasalmanac.com/articles/incorporating-patient-voices-from-the-start-of-drug-development 2022-01-28 18:56:33.518+00 https://www.pharmasalmanac.com/articles/staying-ahead-of-trends-in-small-volume-parenteral-manufacturing 2022-01-28 18:32:54.973+00 https://www.pharmasalmanac.com/articles/meeting-the-renewed-demand-for-microbial-protein-production 2022-01-28 18:25:10.833+00 https://www.pharmasalmanac.com/articles/advancing-research-on-heat-shock-proteins-to-treat-disease 2022-01-27 19:46:28.519+00 https://www.pharmasalmanac.com/articles/generis-appoints-head-of-life-sciences-as-cara-growth-soars 2022-01-27 19:21:58.271+00 https://www.pharmasalmanac.com/articles/mitosense-and-the-u.s.-department-of-veterans-affairs-enter-into-cooperative-research-and-development-agreement 2022-01-27 16:48:01.682+00 https://www.pharmasalmanac.com/articles/presenting-an-integrated-solution-for-mrna-vaccine-manufacturing 2022-01-27 15:12:36.262+00 https://www.pharmasalmanac.com/articles/focusing-on-flexibility-in-facility-design 2022-01-27 15:01:50.184+00 https://www.pharmasalmanac.com/articles/fujifilm-expands-its-advanced-therapies-cdmo-business-with-the-acquisition-of-a-dedicated-cell-therapy-manufacturing-facility-from-atara-biotherapeutics-inc 2022-01-26 22:35:53.876+00 https://www.pharmasalmanac.com/articles/the-potential-of-life-science-industrials 2022-01-26 22:09:17.416+00 https://www.pharmasalmanac.com/articles/expanding-a-full-service-cro-offering-into-the-united-states 2022-01-26 17:31:32.901+00 https://www.pharmasalmanac.com/articles/mu-study-identifies-mutations-specific-to-omicron-variant 2022-01-25 21:53:51.383+00 https://www.pharmasalmanac.com/articles/benchsci-raises-63-million-series-c-to-solve-pharmas-biggest-rd-challenges-with-ai-powered-software-platform 2022-01-24 11:00:00.973+00 https://www.pharmasalmanac.com/articles/discussing-the-advancements-in-oncology 2022-01-22 15:16:04.852+00 https://www.pharmasalmanac.com/articles/enzymasters-sanming-minhe-acquisition-increases-production-capacity-by-50-to-keep-pace-with-rapidly-growing-demand 2022-01-20 20:28:04.149+00 https://www.pharmasalmanac.com/articles/idt-biologika-is-increasing-its-production-capacity-of-vaccines-saxony-anhalts-prime-minister-reiner-haseloff-visited-the-new-facilities 2022-01-20 17:01:15.884+00 https://www.pharmasalmanac.com/articles/paradigm4-joins-the-tetra-partner-network-to-leverage-tetra-data-into-high-performing-analytical-computing-applications-for-pharmaceutical-customers 2022-01-18 21:17:55.821+00 https://www.pharmasalmanac.com/articles/q-what-do-you-see-as-the-key-innovations-or-technologies-that-will-make-personalized/precision-medicine-a-reality 2022-01-14 17:08:55.89+00 https://www.pharmasalmanac.com/articles/q-for-what-therapeutic-area-do-you-think-we-will-see-the-greatest-progress-in-the-coming-years 2022-01-13 21:54:27.258+00 https://www.pharmasalmanac.com/articles/fda-accepts-gmp-plasmid-dmf-and-capacity-expansion-enabling-andelyn-biosciences-to-offer-faster-gene-therapy-development 2022-01-13 11:00:00.63+00 https://www.pharmasalmanac.com/articles/analytical-service-leaders-in-biopharmaceutical-and-gene-therapy-development-unify-operations-and-re-brand-as-protagene 2022-01-12 17:23:41.093+00 https://www.pharmasalmanac.com/articles/accp-policy-statements-off-label-use-of-ketamine-a-challenging-drug-treatment-delivery-model-with-an-inherently-unfavorable-risk-benefit-profile-pharmac-1641910711526 2022-01-11 15:23:02.163+00 https://www.pharmasalmanac.com/articles/immune-biosolutions-reports-that-its-lead-immunotherapy-product-ibio123-neutralizes-100-of-the-sars-cov-2-variants-of-concern-vocs-including-omicron 2022-01-10 16:04:39.542+00 https://www.pharmasalmanac.com/articles/fujifilm-cellular-dynamics-and-phenovista-biosciences-announce-strategic-alliance-to-improve-the-drug-discovery-process 2022-01-06 16:19:47.113+00 https://www.pharmasalmanac.com/articles/crb-names-experienced-business-leader-as-cfo 2022-01-06 15:30:49.854+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-expands-in-vitro-biology-capabilities-at-ahmedabad-discovery-services-site 2022-01-04 14:59:22.111+00 https://www.pharmasalmanac.com/articles/with-omicron-variant-on-the-rise-thermal-custom-packaging-tcp-is-providing-secure-transportation-of-covid-vaccine 2022-01-04 14:27:24.023+00 https://www.pharmasalmanac.com/articles/wheeler-bio-announces-14m-seed-round-to-expand-access-to-portable-cmc 2022-01-04 07:00:00.573+00 https://www.pharmasalmanac.com/articles/evaluating-single-use-technologies-for-biomanufacturing 2021-12-29 18:18:28.689+00 https://www.pharmasalmanac.com/articles/redefining-the-lab-of-the-future 2021-12-20 14:08:46.107+00 https://www.pharmasalmanac.com/articles/valneva-and-idt-biologika-announce-collaboration-for-production-of-inactivated-covid-19-vaccine-vla2001 2021-12-15 17:18:21.146+00 https://www.pharmasalmanac.com/articles/biohaven-announces-nurtec-odt-receives-first-global-approval-outside-the-u.s.-for-prevention-of-migraine 2021-12-13 19:57:13.163+00 https://www.pharmasalmanac.com/articles/growing-life-science-and-biotech-in-montana 2021-12-08 22:24:19.48+00 https://www.pharmasalmanac.com/articles/serving-an-accelerated-market-with-mrna-production 2021-12-08 13:15:10.751+00 https://www.pharmasalmanac.com/articles/boosting-cell-densities-and-productivity-with-tailored-media-in-seed-train 2021-12-03 20:05:56.869+00 https://www.pharmasalmanac.com/articles/how-are-you-growing-your-business-development-activities-in-the-absence-of-conventional-trade-shows-and-other-traditional-business-development-marketing-activities 2021-12-02 23:46:09.097+00 https://www.pharmasalmanac.com/articles/q-putting-aside-covid-19-vaccines-and-therapeutics-what-do-you-think-will-be-the-most-significant-development-in-the-industry-in-2021 2021-12-02 23:45:25.899+00 https://www.pharmasalmanac.com/articles/seamlessly-sharing-supply-chain-information-to-deliver-measurable-efficiencies-for-clients 2021-12-02 23:44:44.202+00 https://www.pharmasalmanac.com/articles/how-are-you-rethinking-your-supply-chain-and-operational-fitness-in-light-of-the-covid-19-pandemic 2021-12-02 23:43:58.162+00 https://www.pharmasalmanac.com/articles/what-steps-is-your-company-taking-to-address-drug-pricing-issues 2021-12-02 23:43:16.631+00 https://www.pharmasalmanac.com/articles/kohlberg-and-mubadala-sign-a-definitive-agreement-to-acquire-majority-stake-in-pci-pharma-services 2021-12-02 23:42:35.92+00 https://www.pharmasalmanac.com/articles/the-power-of-digital-transformation 2021-12-02 23:41:52.346+00 https://www.pharmasalmanac.com/articles/advanced-flexible-packaging-solutions-to-meet-parenteral-product-demand 2021-12-02 23:41:10.999+00 https://www.pharmasalmanac.com/articles/pci-unveils-expanded-clinical-center-in-midwest 2021-12-02 23:40:15.631+00 https://www.pharmasalmanac.com/articles/how-important-are-international-partnerships-to-your-success 2021-12-02 23:38:35.676+00 https://www.pharmasalmanac.com/articles/what-is-the-most-significant-recent-advancement-in-downstream-bioprocessing-technology-why-is-it-so-important 2021-12-02 23:37:42.28+00 https://www.pharmasalmanac.com/articles/q-how-is-the-need-to-provide-local-drug-product-supply-in-multiple-regions-around-the-world-impacting-pharmaceutical-manufacturing-facility-and-equipment-design 2021-12-02 23:36:50.19+00 https://www.pharmasalmanac.com/articles/local-vs.-global-manufacturing 2021-12-02 23:36:03.206+00 https://www.pharmasalmanac.com/articles/q-what-challenges-are-associated-with-implementing-cloud-computing-within-cros/cdmos 2021-12-02 23:34:25.829+00 https://www.pharmasalmanac.com/articles/what-impact-do-you-think-the-move-to-cloud-computing 2021-12-02 23:33:21.909+00 https://www.pharmasalmanac.com/articles/an-evolving-biologics-landscape-and-driving-innovation-and-opportunity 2021-12-02 20:07:21.548+00 https://www.pharmasalmanac.com/articles/delivering-the-full-value-chain-for-oncology-clinical-trials 2021-12-02 20:05:38.643+00 https://www.pharmasalmanac.com/articles/supporting-innovative-biotechs-to-bring-cell-and-gene-therapies-to-market 2021-12-01 21:54:16.211+00 https://www.pharmasalmanac.com/articles/a-breath-of-fresh-air-how-decentralized-trial-options-are-changing-respiratory-research 2021-11-30 19:32:15.421+00 https://www.pharmasalmanac.com/articles/expanding-and-serving-the-market-with-flexible-single-use-capacity 2021-11-30 19:28:38.794+00 https://www.pharmasalmanac.com/articles/a-customer-centric-approach-to-cell-and-gene-therapy-manufacturing 2021-11-30 19:02:19.326+00 https://www.pharmasalmanac.com/articles/shortening-biopharmaceutical-process-development-timelines-with-high-throughput-approaches 2021-11-30 18:57:58.605+00 https://www.pharmasalmanac.com/articles/accelerating-biologics-development-with-high-quality-protein-stabilization-excipients 2021-11-29 21:27:04.994+00 https://www.pharmasalmanac.com/articles/limiting-risk-in-mrna-development-and-production 2021-11-22 17:53:22.475+00 https://www.pharmasalmanac.com/articles/integrating-a-fragmented-mrna-supply-chain 2021-11-22 17:53:04.047+00 https://www.pharmasalmanac.com/articles/leveraging-partnerships-and-a-unique-history-to-address-supply-chain-and-capacity-challenges-in-gene-therapy-manufacturing 2021-11-22 16:22:48.04+00 https://www.pharmasalmanac.com/articles/exploring-innovation-and-the-vast-potential-of-transdermal-patch-drug-delivery 2021-11-22 14:23:24.809+00 https://www.pharmasalmanac.com/articles/collaborating-strategically-and-leveraging-innovation-to-drive-success 2021-11-22 11:00:00.493+00 https://www.pharmasalmanac.com/articles/biovectra-mrna-vaccine-and-biomanufacturing-facility-announced 2021-11-18 21:26:11.815+00 https://www.pharmasalmanac.com/articles/bringing-3d-organoid-models-into-a-high-throughput-environment 2021-11-17 17:20:17.754+00 https://www.pharmasalmanac.com/articles/its-all-here-talent.-research.-results 2021-11-10 20:08:52.203+00 https://www.pharmasalmanac.com/articles/ppds-approach-to-practical-translational-medicine 2021-11-10 17:28:10.562+00 https://www.pharmasalmanac.com/articles/viral-vectors-vaccines-a-new-era-of-collaborative-design 2021-11-08 15:35:00.51+00 https://www.pharmasalmanac.com/articles/integrated-mrna-support-facilitates-mrna-product-development-and-commercialization 2021-11-04 20:00:39.246+00 https://www.pharmasalmanac.com/articles/filling-industry-gaps-and-driving-innovation-with-life-science-industrials 2021-11-03 16:34:08.392+00 https://www.pharmasalmanac.com/articles/solving-complex-chemical-problems-across-all-phases-of-nce-programs 2021-10-28 17:27:45.869+00 https://www.pharmasalmanac.com/articles/coping-with-a-talent-shortage-and-talent-war-in-cell-and-gene-therapy 2021-10-26 15:07:23.809+00 https://www.pharmasalmanac.com/articles/a-novel-approach-to-drive-disruptive-innovation-in-cell-and-gene-therapy 2021-10-22 21:24:28.978+00 https://www.pharmasalmanac.com/articles/advancing-pharma-and-medical-device-development-with-novel-biomaterials 2021-10-21 15:26:11.342+00 https://www.pharmasalmanac.com/articles/using-a-natural-molecular-warning-system-to-fight-cancer-and-infectious-diseases 2021-10-19 14:13:38.194+00 https://www.pharmasalmanac.com/articles/evolution-from-basic-distribution-to-a-comprehensive-biopharma-services-company 2021-10-18 13:48:09.455+00 https://www.pharmasalmanac.com/articles/innovating-cleanroom-systems-through-integrated-technology 2021-10-11 19:48:42.157+00 https://www.pharmasalmanac.com/articles/focus-on-commercial-parenteral-manufacturing-at-evonik 2021-10-11 13:18:53.477+00 https://www.pharmasalmanac.com/articles/navigating-analytical-requirements-for-gmp-viral-vectors 2021-10-08 10:00:02.146+00 https://www.pharmasalmanac.com/articles/building-a-bridge-of-equivalence-to-facilitate-and-implement-rapid-process-changes-in-gene-therapy-manufacturing 2021-10-07 19:50:26.993+00 https://www.pharmasalmanac.com/articles/pandemic-playbook-for-gene-therapy-manufacturing 2021-10-05 15:02:50.271+00 https://www.pharmasalmanac.com/articles/lean-and-client-focused-the-future-of-life-sciences-engineering-and-architecture 2021-10-04 18:53:14.9+00 https://www.pharmasalmanac.com/articles/enabling-the-commercialization-of-microbiome-live-biotherapeutic-products-with-fit-for-purpose-cryopreservatives 2021-10-01 19:18:56.162+00 https://www.pharmasalmanac.com/articles/accelerating-the-development-of-a-novel-cell-therapy-for-covid-19-associated-lung-fibrosis 2021-09-29 22:59:36.228+00 https://www.pharmasalmanac.com/articles/phoxbio-announces-breakthrough-clinical-trial-results-concluding-prophylactic-nasal-spray-prevents-infection-from-sars-cov-2 2021-09-24 17:05:06.055+00 https://www.pharmasalmanac.com/articles/arranta-bio-announces-first-end-to-end-manufacturing-for-mrna-vaccines-in-its-commercial-ready-gmp-facility 2021-09-24 16:35:40.806+00 https://www.pharmasalmanac.com/articles/remaining-nimble-in-biopharma-construction-and-engineering 2021-09-22 16:45:54.105+00 https://www.pharmasalmanac.com/articles/designing-more-sustainable-small-molecule-api-manufacturing-processes 2021-09-16 13:30:49.892+00 https://www.pharmasalmanac.com/articles/agc-biologics-expands-pdna-and-mrna-manufacturing-capacity-at-heidelberg-facility 2021-09-15 18:56:10.534+00 https://www.pharmasalmanac.com/articles/integrating-a-personal-approach-to-clinical-supply-services 2021-09-14 20:27:58.553+00 https://www.pharmasalmanac.com/articles/an-easy-to-use-tablet-coating-polymer-to-increase-coating-process-efficiency-and-flexibility 2021-09-14 17:03:34.486+00 https://www.pharmasalmanac.com/articles/quality-and-regulatory-challenges-surrounding-new-cell-and-gene-therapy-products 2021-09-14 17:03:17.348+00 https://www.pharmasalmanac.com/articles/critical-cleaning-and-detergent-synergy 2021-09-09 20:46:43.291+00 https://www.pharmasalmanac.com/articles/enabling-novel-cell-therapies-by-leveraging-established-blood-stem-cell-transplant-infrastructure 2021-09-09 16:56:56.777+00 https://www.pharmasalmanac.com/articles/altis-biosystems-announces-new-research-funding-initiative 2021-09-09 16:09:40.537+00 https://www.pharmasalmanac.com/articles/strong-quality-systems-and-quality-culture-ensure-inspection-ready-status 2021-09-08 14:50:52.251+00 https://www.pharmasalmanac.com/articles/what-to-look-for-when-choosing-the-right-cdmo 2021-09-08 13:50:11.625+00 https://www.pharmasalmanac.com/articles/streamline-hme-projects-with-early-partner-engagement 2021-08-27 22:34:41.196+00 https://www.pharmasalmanac.com/articles/novel-computational-approaches-to-parkinsons-disease-drug-development 2021-08-19 17:17:11.176+00 https://www.pharmasalmanac.com/articles/complex-early-development-studies-managing-fih-to-phase-ib 2021-08-17 10:00:01.265+00 https://www.pharmasalmanac.com/articles/https/vimeo.com/585859020 2021-08-12 13:58:39.01+00 https://www.pharmasalmanac.com/articles/preparing-to-face-the-next-global-challenge-studying-post-acute-covid-19-syndrome 2021-08-10 23:01:56.85+00 https://www.pharmasalmanac.com/articles/the-future-of-the-delivery-of-quality 2021-08-05 16:17:00.77+00 https://www.pharmasalmanac.com/articles/introducing-ultraburst-the-fastest-rapidly-disintegrating-product 2021-08-04 13:00:02.402+00 https://www.pharmasalmanac.com/articles/how-blockchain-will-secure-the-future-of-cannabis-research 2021-08-03 14:37:42.572+00 https://www.pharmasalmanac.com/articles/early-targeting-of-chronic-inflammation-that-precedes-and-causes-synaptic-loss 2021-07-29 19:39:03.366+00 https://www.pharmasalmanac.com/articles/avara-on-client-service-and-innovation-we-make-it.-about-you 2021-07-27 18:41:11.188+00 https://www.pharmasalmanac.com/articles/cleaning-and-validation 2021-07-26 18:27:07.968+00 https://www.pharmasalmanac.com/articles/solving-cleaning-challenges-and-the-question-of-cosmeceuticals 2021-07-26 18:26:41.954+00 https://www.pharmasalmanac.com/articles/resolving-cannabis-cleaning-challenges 2021-07-26 18:26:24.617+00 https://www.pharmasalmanac.com/articles/abbvie-provides-update-regarding-rinvoq-upadacitinib-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-in-the-u.s 2021-07-22 13:00:01.501+00 https://www.pharmasalmanac.com/articles/stemson-therapeutics-secures-15m-series-a-funding-to-cure-hair-loss 2021-07-21 13:00:01.338+00 https://www.pharmasalmanac.com/articles/integrating-sourcing-packaging-labelling-and-distribution-for-efficient-clinical-kitting 2021-07-20 19:52:46.778+00 https://www.pharmasalmanac.com/articles/erasca-announces-pricing-of-upsized-initial-public-offering 2021-07-20 13:00:02.853+00 https://www.pharmasalmanac.com/articles/creating-agility-in-clinical-research-with-remote-monitoring 2021-07-19 22:41:00.871+00 https://www.pharmasalmanac.com/articles/gsk-unveils-plan-for-one-of-europes-largest-life-science-campuses-in-stevenage 2021-07-19 13:00:01.932+00 https://www.pharmasalmanac.com/articles/enabling-gene-edited-hmscs-with-a-fit-for-purpose-transduction-agent 2021-07-15 15:10:57.401+00 https://www.pharmasalmanac.com/articles/lilly-announces-acquisition-of-protomer-technologies 2021-07-15 13:00:04.166+00 https://www.pharmasalmanac.com/articles/ena-respiratory-begins-phase-i-study-of-covid-19-preventative-nasal-spray-designed-to-stimulate-bodys-firstline-immune-defense-in-the-nose 2021-07-14 13:00:04.033+00 https://www.pharmasalmanac.com/articles/disruption-through-innovation-how-additive-manufacturing-may-change-the-healthcare-manufacturing-landscape 2021-07-13 21:45:06.89+00 https://www.pharmasalmanac.com/articles/a-revolutionary-excipient-platform-for-super-fast-disintegrating-odts 2021-07-13 10:00:01.213+00 https://www.pharmasalmanac.com/articles/transferring-3d-printing-into-pharma-the-journey-has-begun 2021-07-12 20:58:04.472+00 https://www.pharmasalmanac.com/articles/spi-pharma-launches-ultraburst-the-first-in-class-preformulated-platform-for-flash-orally-dispersible-tablets 2021-07-12 14:17:08.021+00 https://www.pharmasalmanac.com/articles/advancing-novel-therapeutics-with-end-to-end-lipid-nanoparticle-development-and-manufacturing 2021-07-12 13:51:33.586+00 https://www.pharmasalmanac.com/articles/providing-flexible-capabilities-to-meet-market-demand-for-sterile-fill-finish-services 2021-07-08 16:56:53.422+00 https://www.pharmasalmanac.com/articles/concentrating-on-core-osd-sterile-capabilities-for-assured-client-success 2021-07-08 16:56:22.738+00 https://www.pharmasalmanac.com/articles/how-is-avara-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2021-07-08 16:55:14.458+00 https://www.pharmasalmanac.com/articles/avara-liscate-high-standards-and-expertise-in-sterile-manufacturing 2021-07-08 16:54:51.978+00 https://www.pharmasalmanac.com/articles/avara-pharmaceutical-services-achieving-successful-osd-rx-to-otc-conversions 2021-07-08 16:53:54.444+00 https://www.pharmasalmanac.com/articles/how-is-avara-pharmaceutical-services-evolving-its-business-model-to-meet-the-future-of-healthcare 2021-07-08 16:53:19.449+00 https://www.pharmasalmanac.com/articles/how-does-avara-pharmaceutical-services-envision-the-future-of-the-pharma/biopharma-industry 2021-07-08 16:52:00.674+00 https://www.pharmasalmanac.com/articles/avara-pharmaceutical-services-specialization-with-a-client-centric-approach 2021-07-08 16:51:23.446+00 https://www.pharmasalmanac.com/articles/quality-and-compliance-ensures-business-sustainability-for-avara-arecibo-clients 2021-07-08 16:50:54.323+00 https://www.pharmasalmanac.com/articles/solving-the-industrys-capacity-utilization-problem 2021-07-08 16:49:47.42+00 https://www.pharmasalmanac.com/articles/how-is-trirx-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2021-07-08 16:47:56.918+00 https://www.pharmasalmanac.com/articles/rethinking-pharmas-responsibilities-in-a-time-of-crisis 2021-07-08 16:47:24.282+00 https://www.pharmasalmanac.com/articles/trirx-pharmaceutical-services-acquires-msd-animal-health-manufacturing-site-located-in-segre-en-anjou-bleu-france-including-long-term-supply-agreement 2021-07-08 16:46:50.309+00 https://www.pharmasalmanac.com/articles/how-is-trirx-pharmaceutical-services-evolving-its-business-model-to-meet-the-future-of-healthcare 2021-07-08 16:46:14.068+00 https://www.pharmasalmanac.com/articles/building-an-integrated-and-effective-cdmo-from-the-ground-up 2021-07-08 16:45:43.613+00 https://www.pharmasalmanac.com/articles/restarting-a-manufacturing-campus-and-revitalizing-a-community 2021-07-08 16:45:07.47+00 https://www.pharmasalmanac.com/articles/how-does-trirx-envision-the-future-of-the-pharma/biopharma-industry 2021-07-08 16:43:43.583+00 https://www.pharmasalmanac.com/articles/product-diversification-through-expansion-into-the-animal-health-market 2021-07-08 16:43:14.338+00 https://www.pharmasalmanac.com/articles/the-future-of-innovation-post-pandemic 2021-07-08 16:42:28.312+00 https://www.pharmasalmanac.com/articles/trirx-enters-agreement-for-the-acquisition-of-elanco-animal-health-facilities-in-shawnee-kansas-and-speke-united-kingdom 2021-07-08 16:41:30.913+00 https://www.pharmasalmanac.com/articles/integrated-clinical-packaging-warehousing-and-transport-services-supporting-pharma-and-biopharma 2021-07-08 16:38:31.513+00 https://www.pharmasalmanac.com/articles/the-patient-centric-clinical-supply-chain-for-cell-and-gene-therapies 2021-07-08 16:37:54.461+00 https://www.pharmasalmanac.com/articles/keys-to-successful-storage-management-and-transport-of-biological-materials 2021-07-08 16:36:42.141+00 https://www.pharmasalmanac.com/articles/truly-integrated-premium-courier-and-clinical-packaging-services 2021-07-08 16:35:34.649+00 https://www.pharmasalmanac.com/articles/managing-the-complexities-of-international-clinical-trials 2021-07-08 16:34:52.724+00 https://www.pharmasalmanac.com/articles/expediting-clinical-trials-with-a-global-transportation-footprint-and-clinical-packaging 2021-07-08 16:34:00.978+00 https://www.pharmasalmanac.com/articles/yourway-the-biopharma-services-company-keeps-up-with-covid-19-providing-direct-to-patient-dtp-services-globally 2021-07-08 16:32:25.908+00 https://www.pharmasalmanac.com/articles/yourway-and-firma-clinical-research-collaborate-to-administer-coordinated-supply-delivery-for-home-health-clinical-trial-visits 2021-07-08 16:31:33.46+00 https://www.pharmasalmanac.com/articles/how-is-yourway-evolving-its-business-model-to-meet-the-future-of-healthcare 2021-07-08 16:30:49.965+00 https://www.pharmasalmanac.com/articles/the-integrated-service-offering-driving-yourway 2021-07-08 16:30:00.926+00 https://www.pharmasalmanac.com/articles/how-does-yourway-envision-the-future-of-the-pharma/biopharma-industry 2021-07-08 16:28:50.289+00 https://www.pharmasalmanac.com/articles/yourway-breaks-ground-on-major-expansion-at-allentown-pa-including-phase-i-clinical-trials-unit 2021-07-08 16:19:52.483+00 https://www.pharmasalmanac.com/articles/expanding-to-support-evolving-clinical-trials-needs 2021-07-08 16:19:09.706+00 https://www.pharmasalmanac.com/articles/abbvie-exercises-right-to-acquire-teneoone-and-lead-asset-tnb-383b-for-the-potential-treatment-of-relapsed-or-refractory-multiple-myeloma 2021-07-08 15:00:42.184+00 https://www.pharmasalmanac.com/articles/survey-launched-to-gain-insights-into-the-evolution-of-a-changing-pharmaceutical-market 2021-07-06 18:25:08.993+00 https://www.pharmasalmanac.com/articles/innovating-to-realize-the-benefits-of-data-sharing 2021-07-02 15:48:21.393+00 https://www.pharmasalmanac.com/articles/simplifying-operations-with-ready-to-use-vials 2021-06-30 13:00:01.467+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-acquires-ppd-and-leverages-clinical 2021-06-29 21:22:17.485+00 https://www.pharmasalmanac.com/articles/design-considerations-for-live-biotherapeutic-product-facilities-working-with-spore-forming-bacteria 2021-06-28 21:23:52.23+00 https://www.pharmasalmanac.com/articles/viiv-healthcare-and-halozyme-enter-global-collaboration-for-enhanze-drug-delivery-technology-to-enable-development-of-ultra-long-acting-medicines-for-hiv 2021-06-25 13:00:01.893+00 https://www.pharmasalmanac.com/articles/accelerating-adc-development-with-advanced-payload-intermediates 2021-06-24 15:15:54.816+00 https://www.pharmasalmanac.com/articles/genentech-launches-oncology-clinical-trial-diversity-alliance 2021-06-24 14:39:47.019+00 https://www.pharmasalmanac.com/articles/paramit-corporation-announces-acquisition-by-the-tecan-group 2021-06-24 13:52:41.491+00 https://www.pharmasalmanac.com/articles/utilizing-personalized-analytics-and-biosensors-in-healthcare 2021-06-22 13:00:03.531+00 https://www.pharmasalmanac.com/articles/roche-obtains-ce-mark-for-the-sars-cov-2-antigen-self-test-nasal-allowing-for-rapid-self-testing-of-covid-19-at-home 2021-06-22 13:00:03.085+00 https://www.pharmasalmanac.com/articles/biotage-launches-new-automated-platform-for-plasmid-dna-purification 2021-06-21 21:01:47.328+00 https://www.pharmasalmanac.com/articles/championing-in-vitro-biocompatibility/biological-reactivity-testing-for-plastics-used-in-pharma-manufacturing 2021-06-21 20:32:00.994+00 https://www.pharmasalmanac.com/articles/rapid-cleanroom-builds-for-covid-19-facilities-lessons-learned 2021-06-18 19:22:11.079+00 https://www.pharmasalmanac.com/articles/sage-therapeutics-and-biogen-announce-positive-pivotal-phase-3-results-for-zuranolone-an-investigational-two-week-once-daily-therapeutic-being-evaluated-1623906028105 2021-06-18 13:00:01.205+00 https://www.pharmasalmanac.com/articles/q-how-have-evolving-technologies-like-artificial-intelligence-ai-and-machine-learning-ml-changed-how-you-conduct-research-manufacturing-or-business 2021-06-17 20:40:14.713+00 https://www.pharmasalmanac.com/articles/kahr-announces-46.5-million-financing-to-advance-its-multifunctional-immunotherapeutic-pipeline 2021-06-17 13:00:01.237+00 https://www.pharmasalmanac.com/articles/realizing-the-promise-of-rna-therapies-with-lipid-nanoparticle-delivery 2021-06-16 14:24:12.486+00 https://www.pharmasalmanac.com/articles/exploring-self-care-with-unique-cannabis-experiences 2021-06-16 03:11:20.621+00 https://www.pharmasalmanac.com/articles/q-how-is-your-organization-using-social-media-to-extend-your-marketing-efforts-what-are-your-goals-and-what-has-been-successful 2021-06-15 19:27:14.425+00 https://www.pharmasalmanac.com/articles/inceptor-bio-launches-next-generation-car-t-car-m-and-nk/nkt-platform-focused-on-advancing-cell-and-gene-therapies-to-cure-difficult-to-treat-cancers 2021-06-14 14:24:39.305+00 https://www.pharmasalmanac.com/articles/framing-the-narrative-on-cmc-development-for-microbiome-therapeutics 2021-06-14 14:16:39.117+00 https://www.pharmasalmanac.com/articles/cro-pharmaceutical-product-development-wins-nih-contract-for-hiv-research 2021-06-10 20:15:48+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-acquire-ppd-inc.-a-leading-clinical-research-organization 2021-06-10 20:14:54.101+00 https://www.pharmasalmanac.com/articles/protecting-clinical-research-and-patients-through-decentralized-trial-strategies 2021-06-10 20:12:21.975+00 https://www.pharmasalmanac.com/articles/leveraging-digitally-reported-outcomes-in-clinical-trials 2021-06-10 20:10:36.786+00 https://www.pharmasalmanac.com/articles/modern-strategies-for-dermatology-clinical-trials 2021-06-10 20:09:23.466+00 https://www.pharmasalmanac.com/articles/accelerating-oncology-clinical-research-remotely 2021-06-10 20:08:19.898+00 https://www.pharmasalmanac.com/articles/new-clinical-frontiers-in-neuroscience 2021-06-10 20:06:44.874+00 https://www.pharmasalmanac.com/articles/minimizing-patient-burden-in-cell-and-gene-therapy-trials 2021-06-10 20:05:50.685+00 https://www.pharmasalmanac.com/articles/the-advantage-of-having-a-drug-development-company-behind-manufacturing 2021-06-10 18:34:32.805+00 https://www.pharmasalmanac.com/articles/partnering-for-success-from-concept-to-commercialization 2021-06-10 18:32:53.206+00 https://www.pharmasalmanac.com/articles/accelerating-covid-19-programs-with-comprehensive-support-from-cell-line-to-commercial-production-at-a-single-site 2021-06-10 18:32:05.115+00 https://www.pharmasalmanac.com/articles/a-ceos-perspective-positioning-a-cdmo-for-significant-growth 2021-06-10 18:31:15.167+00 https://www.pharmasalmanac.com/articles/stainless-steel-to-single-use-how-to-adapt-to-the-changing-landscape-in-sut 2021-06-10 18:30:39.482+00 https://www.pharmasalmanac.com/articles/successful-biosimilar-development-requires-an-outsourcing-partner-with-the-right-experience 2021-06-10 18:29:46.35+00 https://www.pharmasalmanac.com/articles/unique-commercial-experience-primes-avid-bioservices-for-growth 2021-06-10 17:55:01.768+00 https://www.pharmasalmanac.com/articles/an-unnatural-phenomenon-how-synthetic-biology-may-disrupt-pharma-and-beyond 2021-06-10 10:00:01.319+00 https://www.pharmasalmanac.com/articles/biogen-and-bio-thera-announce-positive-results-from-phase-3-study-of-bat1806-a-proposed-biosimilar-referencing-actemra 2021-06-10 02:00:54.964+00 https://www.pharmasalmanac.com/articles/grail-introduces-galleri-a-groundbreaking-multi-cancer-early-detection-blood-test 2021-06-09 13:00:00.897+00 https://www.pharmasalmanac.com/articles/rheavita-closes-eur-2.5-million-series-a-financing-co-led-by-novalis-biotech-acceleration-and-pmv 2021-06-08 13:00:03.967+00 https://www.pharmasalmanac.com/articles/fda-grants-accelerated-approval-for-aduhelm-as-the-first-and-only-alzheimers-disease-treatment-to-address-a-defining-pathology-of-the-disease 2021-06-08 13:00:01.091+00 https://www.pharmasalmanac.com/articles/alan-jones-returns-to-crb-as-vice-president-of-business-development 2021-06-08 13:00:01.085+00 https://www.pharmasalmanac.com/articles/preparing-for-the-next-pandemic-the-lessons-learned-from-covid-19-and-preparing-for-the-next-outbreak 2021-06-07 21:36:36.708+00 https://www.pharmasalmanac.com/articles/innovation-vs-monetization-the-curative-therapy-conundrum 2021-06-07 13:17:56.724+00 https://www.pharmasalmanac.com/articles/u.s.-food-and-drug-administration-approves-bristol-myers-squibbs-zeposia-ozanimod-an-oral-treatment-for-adults-with-moderately-to-severely-active-ulcerative-colitis 2021-06-07 13:00:01.767+00 https://www.pharmasalmanac.com/articles/corbus-pharmaceuticals-licenses-two-integrin-targeting-mabs-further-expanding-pipeline-into-cancer-and-fibrotic-diseases 2021-06-07 13:00:01.167+00 https://www.pharmasalmanac.com/articles/biovectra-inc.-looks-inward-for-new-brand-its-all-about-care 2021-06-04 22:38:02.22+00 https://www.pharmasalmanac.com/articles/working-to-overcome-analytical-challenges-posed-by-genetic-vaccines 2021-06-04 16:07:49.407+00 https://www.pharmasalmanac.com/articles/sovereign-backs-the-bioscript-team-to-expand-the-business 2021-06-04 15:46:07.365+00 https://www.pharmasalmanac.com/articles/organon-launches-as-new-global-womens-health-company 2021-06-04 13:00:01.114+00 https://www.pharmasalmanac.com/articles/biovectras-strategic-brand-update 2021-06-02 15:13:13.17+00 https://www.pharmasalmanac.com/articles/novartis-and-molecular-partners-announce-start-of-empathy-clinical-trial-for-ensovibep-for-the-treatment-of-covid-19 2021-06-02 13:00:02.899+00 https://www.pharmasalmanac.com/articles/new-fasenra-data-from-the-meltemi-extension-trial-confirm-long-term-safety-and-efficacy-in-severe-eosinophilic-asthma-for-up-to-five-years 2021-06-02 13:00:01.612+00 https://www.pharmasalmanac.com/articles/novartis-cosentyx-receives-fda-approval-for-treatment-of-children-and-adolescents-with-moderate-to-severe-plaque-psoriasis 2021-06-01 22:16:11.516+00 https://www.pharmasalmanac.com/articles/moderna-and-aldevron-announce-expanded-partnership-for-mrna-vaccine-and-therapeutic-pipeline 2021-06-01 18:22:45.266+00 https://www.pharmasalmanac.com/articles/continuous-inline-viral-inactivation-for-next-generation-bioprocessing 2021-05-28 21:38:38.212+00 https://www.pharmasalmanac.com/articles/expanding-a-comprehensive-platform-to-support-the-future-of-cell-and-gene-therapies 2021-05-27 17:39:10.234+00 https://www.pharmasalmanac.com/articles/hovione-and-ibet-announce-strategic-collaboration 2021-05-27 15:05:47.807+00 https://www.pharmasalmanac.com/articles/understanding-the-link-between-gut-health-and-disease 2021-05-27 13:11:23.425+00 https://www.pharmasalmanac.com/articles/moderna-and-samsung-biologics-announce-agreement-for-fill-finish-manufacturing-of-modernas-covid-19-vaccine 2021-05-26 03:13:14.975+00 https://www.pharmasalmanac.com/articles/docbot-closes-series-a-financing-led-by-khosla-ventures-and-appoints-andrew-j.-ritter-as-ceo 2021-05-25 02:43:02.779+00 https://www.pharmasalmanac.com/articles/a-look-at-genetic-vaccine-development-and-manufacturing 2021-05-20 22:19:29.789+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-to-vaccinate-olympic-athletes-in-tokyo 2021-05-20 13:00:03.35+00 https://www.pharmasalmanac.com/articles/exploring-the-tumor-microenvironment-in-cancer-treatment 2021-05-19 13:20:41.918+00 https://www.pharmasalmanac.com/articles/german-cdmo-richter-helm-triples-cgmp-production-capacity-to-accommodate-global-market-demand 2021-05-18 17:08:21.515+00 https://www.pharmasalmanac.com/articles/recor-medical-announces-results-from-study-showing-clinically-significant-blood-pressure-reduction 2021-05-18 13:00:04.269+00 https://www.pharmasalmanac.com/articles/sanofi-and-gsk-covid-19-vaccine-candidate-demonstrates-strong-immune-responses-across-all-adult-age-groups-in-phase-2-trial 2021-05-18 03:18:47.883+00 https://www.pharmasalmanac.com/articles/aetion-closes-110m-series-c-funding-round-led-by-warburg-pincus 2021-05-14 13:00:01.139+00 https://www.pharmasalmanac.com/articles/the-covid-19-vaccine-journey-continues 2021-05-13 16:43:09.081+00 https://www.pharmasalmanac.com/articles/considering-leadership-in-pharma 2021-05-11 21:09:28.207+00 https://www.pharmasalmanac.com/articles/venair-group-breaks-ground-on-a-new-excellence-center-for-its-bioprocessing-tubing-and-single-use-solutions 2021-05-11 17:17:06.976+00 https://www.pharmasalmanac.com/articles/ibio-reports-successful-covid-19-vaccine-toxicology-study-results-and-announces-next-gen-covid-19-vaccine-program 2021-05-07 18:42:58.463+00 https://www.pharmasalmanac.com/articles/roivant-sciences-and-montes-archimedes-acquisition-corp.-maac-to-combine-and-create-publicly-traded-leader-in-biopharma-and-health-technology 2021-05-07 13:00:01.103+00 https://www.pharmasalmanac.com/articles/digital-therapeutics-redefining-prescription-medication-in-the-information-era 2021-05-06 10:00:00.759+00 https://www.pharmasalmanac.com/articles/vetter-and-rentschler-biopharma-further-strengthen-their-strategic-alliance 2021-05-06 04:09:05.468+00 https://www.pharmasalmanac.com/articles/moderna-announces-supply-agreement-with-gavi-for-up-to-500-million-doses-of-covid-19-vaccine-moderna-for-covax-to-help-end-covid-19-pandemic-in-lowest-i-1620104476373 2021-05-06 03:39:04.506+00 https://www.pharmasalmanac.com/articles/novavax-initiates-pediatric-expansion-for-phase-3-clinical-trial-of-covid-19-vaccine 2021-05-06 03:37:21.732+00 https://www.pharmasalmanac.com/articles/alnylam-announces-positive-early-results-on-clinical-outcome-measures-from-illuminate-a-phase-3-study-of-oxlumo-lumasiran 2021-05-05 13:00:01.358+00 https://www.pharmasalmanac.com/articles/10-ways-to-improve-your-project-execution 2021-05-04 16:19:53.966+00 https://www.pharmasalmanac.com/articles/perception-is-reality-integrating-virtual-and-augmented-reality-across-pharma 2021-05-04 15:38:45.364+00 https://www.pharmasalmanac.com/articles/healed-consortium-successful-in-a-10.5m-dtif-supported-program-to-develop-groundbreaking-new-therapies-for-currently-incurable-cancers 2021-04-30 14:26:06.535+00 https://www.pharmasalmanac.com/articles/dna-script-partners-with-moderna-to-develop-on-demand-vaccines-and-therapeutics-for-darpa 2021-04-29 13:00:01.306+00 https://www.pharmasalmanac.com/articles/the-link-between-covid-19-and-immunity 2021-04-28 19:51:20.079+00 https://www.pharmasalmanac.com/articles/monopteros-therapeutics-initiates-clinical-trial-to-reprogram-regulatory-t-cells-in-solid-tumors 2021-04-28 15:07:50.307+00 https://www.pharmasalmanac.com/articles/evotec-accelerates-access-to-biologic-therapeutics-with-initiation-of-manufacturing-facility-in-toulouse 2021-04-22 18:47:39.059+00 https://www.pharmasalmanac.com/articles/neuropace-inc.-announces-pricing-of-initial-public-offering 2021-04-22 17:32:34.489+00 https://www.pharmasalmanac.com/articles/innovative-approach-to-process-development 2021-04-21 18:30:02.615+00 https://www.pharmasalmanac.com/articles/physiq-announces-strategic-collaboration-to-scale-digital-medicine 2021-04-21 16:49:08.257+00 https://www.pharmasalmanac.com/articles/streamlining-highly-potent-drug-commercialization 2021-04-19 13:46:28.9+00 https://www.pharmasalmanac.com/articles/gigagen-publishes-research-on-companys-recombinant-hyperimmunes-in-nature-biotechnology 2021-04-19 13:00:01.066+00 https://www.pharmasalmanac.com/articles/novartis-to-produce-roches-actemra/roactemra 2021-04-19 13:00:01.063+00 https://www.pharmasalmanac.com/articles/regeneron-phase-iii-trial-shows-81-reduced-risk-of-covid 2021-04-16 12:00:00.926+00 https://www.pharmasalmanac.com/articles/cosmo-announces-fda-approval-of-gi-genius-intelligent-endoscopy-module-its-revolutionary-artificial-intelligence-device-for-lesion-detection-during-colonoscopy 2021-04-16 12:00:00.907+00 https://www.pharmasalmanac.com/articles/biovectra-and-phasebio-discuss-creating-an-optimal-partnership 2021-04-15 13:41:19.369+00 https://www.pharmasalmanac.com/articles/microsoft-accelerates-industry-cloud-strategy-for-healthcare-with-the-acquisition-of-nuance 2021-04-15 12:00:02.644+00 https://www.pharmasalmanac.com/articles/how-agile-construction-practices-can-help-bring-new-drugs-and-vaccines-to-market 2021-04-14 13:03:39.984+00 https://www.pharmasalmanac.com/articles/sanofi-acquires-tidal-therapeutics-and-adds-an-mrna-based-research-platform 2021-04-14 12:00:01.056+00 https://www.pharmasalmanac.com/articles/lilly-modified-covid-19-purchase-agreement-for-bamlanivimab-and-etesevimab-together 2021-04-13 13:00:01.262+00 https://www.pharmasalmanac.com/articles/sanofi-to-invest-in-vaccine-production-site-in-singapore 2021-04-13 12:00:00.715+00 https://www.pharmasalmanac.com/articles/lumiradx-a-next-generation-point-of-care-diagnostics-testing-company-to-list-on-nasdaq-via-merger-with-ca-healthcare-acquisition-corp 2021-04-12 13:00:01.186+00 https://www.pharmasalmanac.com/articles/using-blockchain-to-drive-drug-development-and-healthcare-data-management 2021-04-12 10:00:00.97+00 https://www.pharmasalmanac.com/articles/valneva-reports-positive-phase-1/2-data-for-its-inactivated-adjuvanted-covid-19-vaccine-candidate-vla2001 2021-04-08 16:18:24.565+00 https://www.pharmasalmanac.com/articles/distek-inc.-releases-bione-1250-dual-bioprocess-control-station 2021-04-08 16:02:19.152+00 https://www.pharmasalmanac.com/articles/pharmparts-this-makes-sense-5-reasons-to-consider-purchasing-secondhand-parts 2021-04-06 10:00:00.728+00 https://www.pharmasalmanac.com/articles/united-therapeutics-announces-fda-approval-and-launch-of-tyvaso-for-the-treatment-of-pulmonary-hypertension-associated-with-interstitial-lung-disease 2021-04-02 19:33:23.209+00 https://www.pharmasalmanac.com/articles/gsk-to-support-manufacture-of-novavax-covid-19-vaccine 2021-04-01 14:20:41.015+00 https://www.pharmasalmanac.com/articles/pyxis-oncology-closes-152-million-series-b-financing-to-further-advance-portfolio-of-biologics 2021-04-01 14:17:04.845+00 https://www.pharmasalmanac.com/articles/piramal-pharma-ltd.-to-acquire-100-stake-in-hemmo-pharmaceuticals-a-leading-indian-manufacturer-of-peptide-apis 2021-03-31 15:41:55.941+00 https://www.pharmasalmanac.com/articles/brainscope-launches-next-gen-medical-device-for-concussion-detection 2021-03-30 16:26:06.193+00 https://www.pharmasalmanac.com/articles/celonic-and-curevac-announce-agreement-to-manufacture-over-100-million-doses-of-curevacs-covid-19-vaccine-candidate-cvncov 2021-03-30 15:30:19.188+00 https://www.pharmasalmanac.com/articles/exploring-the-natural-pharmacopeia-and-incubating-a-biotech-company 2021-03-30 11:22:26.882+00 https://www.pharmasalmanac.com/articles/shorten-time-to-market-with-new-data-driven-lyophilization-process 2021-03-30 11:17:10.428+00 https://www.pharmasalmanac.com/articles/blockchain-increasing-efficiency-and-transparency 2021-03-29 19:03:57.641+00 https://www.pharmasalmanac.com/articles/gea-introduces-single-use-disc-stack-separator-kytero-for-cell-harvesting-at-achema-pulse 2021-03-25 16:36:03.844+00 https://www.pharmasalmanac.com/articles/reducing-the-risk-during-cell-and-gene-therapy-development-and-manufacturing 2021-03-24 14:20:56.059+00 https://www.pharmasalmanac.com/articles/avoiding-costly-and-time-consuming-mistakes-in-gene-therapy-process-development 2021-03-23 16:33:46.953+00 https://www.pharmasalmanac.com/articles/grifols-reinforces-its-innovation-strategy-after-completing-the-acquisition-of-gigagen-to-boost-a-novel-method-to-generate-a-wide-range-of-immunoglobulins 2021-03-22 17:13:43.319+00 https://www.pharmasalmanac.com/articles/innovative-strategies-to-maintain-product-integrity-in-biologic-and-biosimilar-clinical-studies 2021-03-22 10:00:00.763+00 https://www.pharmasalmanac.com/articles/phasebio-pharmaceuticals-and-biovectra-enter-into-supply-agreement-to-support-development-and-commercialization-of-bentracimab 2021-03-19 16:22:58.619+00 https://www.pharmasalmanac.com/articles/tevogen-bio-announces-partnership-with-biocentriq-to-enhance-tevogens-development-capacity-of-its-proprietary-targeted-t-cell-therapy-for-covid-19 2021-03-17 17:57:28.877+00 https://www.pharmasalmanac.com/articles/hovione-completes-its-phase-ii-clinical-trial-of-the-first-minocycline-ophthalmic-showing-promise-in-dry-eye-disease-associated-with-inflamed-meibomian-1616003490706 2021-03-17 17:55:21.683+00 https://www.pharmasalmanac.com/articles/beyond-2020-looking-into-the-crystal-ball-for-gene-therapy 2021-03-15 18:43:20.882+00 https://www.pharmasalmanac.com/articles/transport-system-in-the-human-brain-studied-in-new-dissertation 2021-03-12 14:08:23.881+00 https://www.pharmasalmanac.com/articles/bridging-the-biopharmaceutical-manufacturing-digital-divide 2021-03-12 11:00:00.797+00 https://www.pharmasalmanac.com/articles/cell-therapy-facility-design-synopsis-horizontal-vs.-vertical 2021-03-11 20:40:19.592+00 https://www.pharmasalmanac.com/articles/developing-a-robust-in-vitro-intestinal-model-for-preclinical-candidate-screening-of-gi-toxicity 2021-03-11 18:44:44.207+00 https://www.pharmasalmanac.com/articles/factory-of-the-future-will-be-a-convergence-of-digital-and-bioprocessing-technologies 2021-03-11 18:44:01.958+00 https://www.pharmasalmanac.com/articles/supporting-drug-manufacturers-with-emprove-nitrosamine-declarations 2021-03-11 18:43:33.761+00 https://www.pharmasalmanac.com/articles/accurately-recapitulating-environmental-niches-in-in-vitro-models-of-the-intestine 2021-03-11 11:00:00.787+00 https://www.pharmasalmanac.com/articles/evolve-biologics-provides-business-update-on-progress-toward-commercialization-of-innovative-plasmacap-eba-technology 2021-03-10 15:18:53.095+00 https://www.pharmasalmanac.com/articles/ubc-announces-initiative-to-accelerate-covid-19-vaccine-real-world-evidence-generation 2021-03-09 21:36:30.176+00 https://www.pharmasalmanac.com/articles/nu-tek-biosciences-to-build-dedicated-animal-free-peptone-manufacturing-facility-to-service-growing-biologics-supply-chain-demands 2021-03-09 14:10:21.044+00 https://www.pharmasalmanac.com/articles/tempus-announces-sequencing-and-computational-biology-collaboration-with-kronos-bio-to-support-the-development-of-cdk9-inhibitor-kb-0742 2021-03-09 14:05:34.314+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-completes-acquisition-of-oxgene-to-further-strengthen-cell-and-gene-therapy-service-offerings-for-global-customers 2021-03-02 14:38:47.228+00 https://www.pharmasalmanac.com/articles/phase-appropriate-cmc-activities-facilitate-the-transition-from-early-development-through-commercialization 2021-02-16 16:15:54.519+00 https://www.pharmasalmanac.com/articles/preparing-for-the-adc-explosion-with-end-to-end-support 2021-02-05 20:44:50.591+00 https://www.pharmasalmanac.com/articles/allogeneic-t-cell-therapies-efficient-commercial-manufacturing-readiness-using-manufacturing-by-design-methodology 2021-02-04 15:07:14.159+00 https://www.pharmasalmanac.com/articles/a-successful-approach-for-managing-unexpected-increases-in-potency-for-hpapis 2021-02-04 15:06:55.905+00 https://www.pharmasalmanac.com/articles/economically-viable-same-day-autologous-cell-therapies 2021-02-04 15:05:26.433+00 https://www.pharmasalmanac.com/articles/recapitulating-the-multifaceted-inflammatory-environment-of-the-intestine-in-vitro 2021-02-04 15:04:58.073+00 https://www.pharmasalmanac.com/articles/good-laboratory-practices-lead-to-good-manufacturing-in-cdmos 2021-02-04 00:28:50.435+00 https://www.pharmasalmanac.com/articles/nesos-announces-peer-reviewed-validation-of-its-first-of-its-kind-wireless-earbud-for-the-treatment-of-rheumatoid-arthritis 2021-02-03 16:59:05.514+00 https://www.pharmasalmanac.com/articles/patent-on-improved-particle-size-testing-method-granted-to-hovione-will-impact-market 2021-02-03 16:56:51.012+00 https://www.pharmasalmanac.com/articles/colliers-completes-new-headquarters-search-for-rapidly-growing-gene-therapy-firm-spirovant 2021-01-27 18:00:46.023+00 https://www.pharmasalmanac.com/articles/tecans-first-virtual-genomics-symposium 2021-01-19 17:48:47.955+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-acquires-viral-vector-manufacturing-business-from-novasep 2021-01-15 17:34:12.839+00 https://www.pharmasalmanac.com/articles/enabling-pharma-researchers-to-think-differently-with-effective-data-manipulation 2021-01-14 13:38:32.842+00 https://www.pharmasalmanac.com/articles/hovione-launches-asd-hipros-the-most-advanced-screening-service-for-optimal-spray-dried-dispersions-formulation 2021-01-13 14:43:42.495+00 https://www.pharmasalmanac.com/articles/increasing-the-efficiency-of-drug-development-with-preclinical-testing-using-human-intestinal-stem-cells 2021-01-04 22:59:40.625+00 https://www.pharmasalmanac.com/articles/nationalism-and-the-pharmaceutical-supply-chain 2020-12-17 18:25:04.886+00 https://www.pharmasalmanac.com/articles/how-does-altis-biosystems-envision-the-future-of-the-pharma/biopharma-industry 2020-12-15 17:26:59.557+00 https://www.pharmasalmanac.com/articles/combating-cancer-and-other-diseases-with-supercharged-nkt-cells 2020-12-11 23:58:52.922+00 https://www.pharmasalmanac.com/articles/q-although-there-is-no-such-thing-as-a-truly-crisis-proof-organization-how-are-you-working-to-mitigate-risks-for-future-crises-like-the-covid-19-pandemic 2020-12-11 23:57:46.858+00 https://www.pharmasalmanac.com/articles/targeting-retinal-diseases-with-an-ophthalmic-formulation-of-bevacizumab 2020-12-11 21:21:07.472+00 https://www.pharmasalmanac.com/articles/what-do-you-think-is-the-greatest-lesson-learned-from-the-covid-19-pandemic-and-what-lasting-impacts-do-you-foresee-over-the-next-5-10-years 2020-12-11 20:43:23.022+00 https://www.pharmasalmanac.com/articles/expanding-laboratory-access-to-gene-sequencing 2020-12-11 19:48:50.786+00 https://www.pharmasalmanac.com/articles/pharmablock-enters-strategic-partnership-with-ascentage-pharma 2020-12-11 16:36:19.637+00 https://www.pharmasalmanac.com/articles/halix-signs-agreement-with-astrazeneca-for-commercial-manufacture-of-covid-19-vaccine 2020-12-11 15:39:50.266+00 https://www.pharmasalmanac.com/articles/bayer-and-atara-biotherapeutics-enter-strategic-collaboration-for-mesothelin-targeted-car-t-cell-therapies-for-solid-tumors 2020-12-11 15:37:55.813+00 https://www.pharmasalmanac.com/articles/how-an-agile-company-addressed-the-pandemic-moving-from-psychiatric-medicines-to-a-covid-19-therapeutic 2020-12-11 14:25:23.358+00 https://www.pharmasalmanac.com/articles/delivering-vaccines-during-a-pandemic 2020-12-09 18:47:27.592+00 https://www.pharmasalmanac.com/articles/shaping-the-future-of-biopharma-through-next-generation-contract-drug-manufacturing 2020-12-09 18:44:17.875+00 https://www.pharmasalmanac.com/articles/solving-solubility-challenges-with-a-polyvinyl-alcohol-excipient-and-hot-melt-extrusion 2020-12-09 18:40:32.165+00 https://www.pharmasalmanac.com/articles/how-covid-19-is-reshaping-vaccine-development-innovations-in-vaccine-technology-and-partnerships 2020-12-09 18:37:48.007+00 https://www.pharmasalmanac.com/articles/disruptive-technologies-in-life-sciences-personalized-medicines 2020-12-09 18:34:22.791+00 https://www.pharmasalmanac.com/articles/life-imitating-science-arranta-bios-commitment-to-corporate-social-responsibility-and-diversity 2020-12-09 18:23:14.805+00 https://www.pharmasalmanac.com/articles/aiding-material-qualification-and-risk-assessment-for-single-use-biomanufacturing 2020-12-09 18:21:49.504+00 https://www.pharmasalmanac.com/articles/meeting-the-challenges-of-the-pandemic-through-virtual-trade-shows 2020-12-09 18:19:09.353+00 https://www.pharmasalmanac.com/articles/the-importance-of-a-global-leader-in-small-molecule-manufacturing-during-the-covid-19-pandemic 2020-12-09 18:17:38.938+00 https://www.pharmasalmanac.com/articles/creating-quality-content-for-effective-digital-marketing 2020-12-09 18:16:00.803+00 https://www.pharmasalmanac.com/articles/preparing-for-covid-19-vaccine-distribution-despite-tight-shipping-capacity 2020-12-09 18:12:45.313+00 https://www.pharmasalmanac.com/articles/mobile-research-nursing-evolving-to-meet-pandemic-challenges 2020-12-09 18:11:22.653+00 https://www.pharmasalmanac.com/articles/wearable-technology-innovation-adherence-and-clinical-outcomes 2020-12-09 18:10:14.358+00 https://www.pharmasalmanac.com/articles/wearable-technology-targeting-a-range-of-uses-and-indications 2020-12-09 18:08:38.67+00 https://www.pharmasalmanac.com/articles/wearable-technology-their-future-in-clinical-trials-and-the-real-world 2020-12-09 18:07:19.889+00 https://www.pharmasalmanac.com/articles/changing-the-paradigm-of-stem-cell-technology 2020-12-09 17:56:56.887+00 https://www.pharmasalmanac.com/articles/increasing-predictability-with-aav-platform-technologies 2020-12-09 17:53:51.203+00 https://www.pharmasalmanac.com/articles/how-does-sanaclis-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 16:19:34.527+00 https://www.pharmasalmanac.com/articles/how-does-polpharma-biologics-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 16:18:57.227+00 https://www.pharmasalmanac.com/articles/how-does-inceptor-bio-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 16:15:59.798+00 https://www.pharmasalmanac.com/articles/how-does-pii-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 16:15:13.931+00 https://www.pharmasalmanac.com/articles/how-does-arranta-bio-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 16:01:27.091+00 https://www.pharmasalmanac.com/articles/how-does-globyz-biopharma-services-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 15:59:33.094+00 https://www.pharmasalmanac.com/articles/how-does-spi-pharma-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 15:49:37.004+00 https://www.pharmasalmanac.com/articles/how-does-dynamk-capital-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 15:35:51.789+00 https://www.pharmasalmanac.com/articles/how-does-evolve-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 15:33:46.611+00 https://www.pharmasalmanac.com/articles/how-does-ecri-envision-the-future-of-the-pharma/biopharma-industry 2020-12-09 15:31:52.504+00 https://www.pharmasalmanac.com/articles/blueprint-medicines-announces-fda-approval 2020-12-03 16:58:47.381+00 https://www.pharmasalmanac.com/articles/babson-diagnostics-receives-fda-emergency-use-authorization-for-its-sars-cov-2-igg-antibody-test 2020-12-03 16:57:50.122+00 https://www.pharmasalmanac.com/articles/this-ancient-aztec-medicine-could-be-a-gamechanger-for-mental-health 2020-12-01 20:17:31.212+00 https://www.pharmasalmanac.com/articles/lillys-neutralizing-antibody-bamlanivimab-ly-cov555-receives-fda-emergency-use-authorization-for-the-treatment-of-recently-diagnosed-covid-19 2020-12-01 20:17:04.121+00 https://www.pharmasalmanac.com/articles/enhancing-human-gut-tissue-models-through-gene-editing 2020-11-30 16:31:33.144+00 https://www.pharmasalmanac.com/articles/iron-oxides-enhance-protection-against-skin-damage 2020-11-23 22:20:40.492+00 https://www.pharmasalmanac.com/articles/cues-molecular-point-of-care-covid-19-tests-deployed-to-five-states-in-hhs-and-dod-pilot-program 2020-11-23 21:19:13.882+00 https://www.pharmasalmanac.com/articles/successful-drug-development-with-synthetic-lipids-critical-aspects-and-strategies 2020-11-20 20:53:29.512+00 https://www.pharmasalmanac.com/articles/abcellera-expands-technology-stack-with-acquisition-of-trianni-for-90-million 2020-11-20 17:25:09.123+00 https://www.pharmasalmanac.com/articles/wuxi-advanced-therapies-expands-philadelphia-campus-with-new-state-of-the-art-testing-laboratory 2020-11-19 21:50:43.864+00 https://www.pharmasalmanac.com/articles/syncona-founds-purespring-with-a-45m-series-a-financing 2020-11-19 17:16:14.314+00 https://www.pharmasalmanac.com/articles/seqens-invests-in-new-technologies 2020-11-19 16:55:50.909+00 https://www.pharmasalmanac.com/articles/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy-endpoint-in-the-first-interim-analysis-of-the-phase-3-cove-study 2020-11-16 21:24:38.889+00 https://www.pharmasalmanac.com/articles/rafael-pharmaceuticals-receives-fda-fast-track-designation-for-cpi-613-devimistat-for-the-treatment-of-pancreatic-cancer 2020-11-12 21:41:12.57+00 https://www.pharmasalmanac.com/articles/wuxi-advanced-therapies-expands-services-to-include-high-quality-and-cost-effective-rd-and-gmp-plasmid-dna 2020-11-12 18:22:13.512+00 https://www.pharmasalmanac.com/articles/biomedican-announces-successful-biosynthesis-and-large-scale-production-of-rare-cannabinoids-cbg/cbga 2020-11-12 15:00:01.093+00 https://www.pharmasalmanac.com/articles/moderna-announces-clinical-updates-on-personalized-cancer-vaccine-program 2020-11-11 16:46:26.106+00 https://www.pharmasalmanac.com/articles/novavax-covid-19-vaccine-granted-fast-track-designation-by-u.s.-fda 2020-11-10 19:15:59.635+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-announce-vaccine-candidate-against-covid-19-achieved-success-in-first-interim-analysis-from-phase-3-study 2020-11-10 19:07:07.119+00 https://www.pharmasalmanac.com/articles/novartis-announces-collaboration-with-molecular-partners-to-develop-two-darpin-therapies-for-potential-use-against-covid-19 2020-11-06 15:50:29.168+00 https://www.pharmasalmanac.com/articles/proteonic-announces-licensing-of-its-2g-unic-technology-platform-for-production-of-biologics-to-gilead-sciences 2020-11-06 15:37:37.573+00 https://www.pharmasalmanac.com/articles/100-remission-rate-reported-in-third-dose-cohort-of-actimab-a-clag-m-phase-1-combination-trial-in-patients-with-relapsed-or-refractory-aml 2020-11-04 21:55:07.683+00 https://www.pharmasalmanac.com/articles/disteks-new-ezfill-dissolution-media-preparation-system-now-offers-data-integrity-support 2020-11-02 21:59:46.749+00 https://www.pharmasalmanac.com/articles/sanofi-and-gsk-to-support-covax-with-200-million-doses-of-covid-19-vaccine 2020-10-30 17:42:41.087+00 https://www.pharmasalmanac.com/articles/covid-19-and-the-growing-need-for-dual-source-supply-chains 2020-10-28 12:56:24.906+00 https://www.pharmasalmanac.com/articles/qualifying-odt-excipient-systems-beyond-disintegration-performance 2020-10-27 20:35:56.381+00 https://www.pharmasalmanac.com/articles/retrophin-announces-agreement-to-acquire-orphan-technologies 2020-10-27 17:33:57.329+00 https://www.pharmasalmanac.com/articles/bayer-acquires-askbio-to-broaden-innovation-base-in-cell-and-gene-therapy 2020-10-27 17:27:32.834+00 https://www.pharmasalmanac.com/articles/the-application-of-mannitol-in-wet-granulation 2020-10-23 17:57:43.745+00 https://www.pharmasalmanac.com/articles/therapeutic-potential-of-novel-plasma-protein-production-technology 2020-10-22 17:03:27.453+00 https://www.pharmasalmanac.com/articles/evaluating-microbiome-therapies-with-intestinal-cell-models 2020-10-22 13:00:00.806+00 https://www.pharmasalmanac.com/articles/aridis-pharmaceuticals-reports-positive-preclinical-efficacy-data-of-an-inhaled-treatment-for-self-administered-covid-19-therapy 2020-10-19 21:00:35.706+00 https://www.pharmasalmanac.com/articles/standardizing-best-practices-for-transporting-cell-and-gene-therapies 2020-10-16 21:09:10.65+00 https://www.pharmasalmanac.com/articles/spi-pharma-appoints-scott-thomson-as-ceo 2020-10-15 16:51:03.953+00 https://www.pharmasalmanac.com/articles/lilly-statement-on-the-niaid-decision-to-pause-enrollment-in-activ-3-clinical-trial 2020-10-15 16:49:49.121+00 https://www.pharmasalmanac.com/articles/innovation-and-flexibility-drive-success-during-the-covid-19-pandemic 2020-10-15 13:03:58.082+00 https://www.pharmasalmanac.com/articles/arranta-bio-announces-mechanical-completion-of-commercial-ready-capacity-for-advanced-biologics 2020-10-14 19:27:30.933+00 https://www.pharmasalmanac.com/articles/covid-19-long-acting-antibody-laab-combination-azd7442-rapidly-advances-into-phase-iii-clinical-trials 2020-10-13 16:22:55.718+00 https://www.pharmasalmanac.com/articles/abzena-invests-60m-into-cgmp-manufacturing-capacity 2020-10-13 16:20:28.016+00 https://www.pharmasalmanac.com/articles/avail-medsystems-raises-100-million-in-series-b-funding-led-by-d1-capital-to-meet-demand-for-procedural-telemedicine-technology-for-the-operating-room 2020-10-09 17:35:59.95+00 https://www.pharmasalmanac.com/articles/how-is-dynamk-capital-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-10-04 18:41:12.115+00 https://www.pharmasalmanac.com/articles/lucid-scientific-secures-3-million-in-series-seed-financing-led-by-dynamk-capital-1 2020-10-03 14:46:11.748+00 https://www.pharmasalmanac.com/articles/farxiga-granted-breakthrough-therapy-designation-in-u.s.-for-chronic-kidney-disease 2020-10-02 13:50:21.579+00 https://www.pharmasalmanac.com/articles/extensive-experience-is-crucial-to-speed-to-the-clinic-and-market-for-live-biotherapeutic-products 2020-10-02 13:42:06.904+00 https://www.pharmasalmanac.com/articles/anticipating-the-logistics-of-a-covid-19-vaccination-effort 2020-10-01 15:21:23.643+00 https://www.pharmasalmanac.com/articles/reshoring-a-nations-api-and-pharmaceutical-production 2020-10-01 15:20:15.49+00 https://www.pharmasalmanac.com/articles/celyad-oncology-announces-clinical-trial-collaboration-to-evaluate-cyad-101-with-keytruda 2020-10-01 14:44:51.48+00 https://www.pharmasalmanac.com/articles/georgia-state-researchers-developing-tool-to-predict-medication-response-in-mental-health-patients 2020-09-30 16:15:44.706+00 https://www.pharmasalmanac.com/articles/iliad-biotechnologies-reports-positive-topline-results-from-phase-2b-trial-for-pertussis-vaccine-candidate-bpze1 2020-09-30 16:07:10.869+00 https://www.pharmasalmanac.com/articles/sgd-pharma-extends-industry-leading-ready-to-use-molded-glass-vial-range-with-introduction-of-easylyo-and-iso20mm-50ml-sizes-in-tray 2020-09-30 16:00:46.287+00 https://www.pharmasalmanac.com/articles/the-benefits-of-expanding-osd-capacity 2020-09-29 20:33:17.601+00 https://www.pharmasalmanac.com/articles/better-together-collaborating-to-simplify-complexities-in-drug-development 2020-09-29 20:32:14.835+00 https://www.pharmasalmanac.com/articles/introduction-the-evolving-pharmaceutical-supply 2020-09-29 20:31:56.904+00 https://www.pharmasalmanac.com/articles/rethinking-the-global-pharmaceutical-supply-chain-post-covid-19 2020-09-29 18:40:42.436+00 https://www.pharmasalmanac.com/articles/trends-shaping-the-dynamic-market-for-parenterals 2020-09-29 16:17:19.844+00 https://www.pharmasalmanac.com/articles/organ-on-a-chip-technology-aims-to-disrupt-traditional-drug-testing-models 2020-09-29 16:12:39.638+00 https://www.pharmasalmanac.com/articles/how-bioanalysis-supports-the-development-of-new-cell-and-gene-therapies 2020-09-29 16:12:12.026+00 https://www.pharmasalmanac.com/articles/data-driven-decision-making-throughout-the-pharma-life-cycle 2020-09-29 16:11:42.703+00 https://www.pharmasalmanac.com/articles/crispr-rnps-and-the-future-of-cell-and-gene-therapy 2020-09-29 16:10:26.381+00 https://www.pharmasalmanac.com/articles/the-covid-19-pandemic-magnifies-pharmaceutical-supply-chain-issues 2020-09-29 16:09:06.061+00 https://www.pharmasalmanac.com/articles/the-growing-importance-of-local-manufacturing-and-nearby-outsourcing-partners 2020-09-29 16:08:20.156+00 https://www.pharmasalmanac.com/articles/experience-to-solve-your-microbiome-challenges 2020-09-29 16:06:05.629+00 https://www.pharmasalmanac.com/articles/an-economic-update-on-natural-health-and-cannabis-products-during-covid-19 2020-09-29 16:05:22.335+00 https://www.pharmasalmanac.com/articles/how-is-spi-pharma-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-09-29 16:04:10.751+00 https://www.pharmasalmanac.com/articles/how-is-sanaclis-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-09-29 16:03:41.301+00 https://www.pharmasalmanac.com/articles/how-is-polpharma-biologics-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-09-29 16:03:08.361+00 https://www.pharmasalmanac.com/articles/how-is-globyz-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-09-29 15:59:54.479+00 https://www.pharmasalmanac.com/articles/how-is-pii-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-09-29 15:59:14.881+00 https://www.pharmasalmanac.com/articles/how-is-arranta-bio-evolving-its-business-model-to-meet-the-future-of-healthcare 2020-09-29 15:57:41.066+00 https://www.pharmasalmanac.com/articles/the-precarious-pharmaceutical-supply-chain-to-reshore-or-not-to-reshore-part-1 2020-09-29 15:53:53.854+00 https://www.pharmasalmanac.com/articles/accelerating-drug-development-with-microphysiological-systems-mps 2020-09-29 15:50:51.276+00 https://www.pharmasalmanac.com/articles/lessons-learned-from-the-ground-floor-of-life-science-advising 2020-09-29 15:50:07.065+00 https://www.pharmasalmanac.com/articles/the-business-of-a-pandemic-mergers-and-acquisitions-during-covid-19 2020-09-29 15:49:33.04+00 https://www.pharmasalmanac.com/articles/approved-therapeutics-for-a-novel-pandemic-drug-repurposing-to-treat-covid-19 2020-09-29 15:47:19.599+00 https://www.pharmasalmanac.com/articles/overcoming-skin-assay-challenges-with-living-human-models 2020-09-29 15:46:17.223+00 https://www.pharmasalmanac.com/articles/investing-with-a-focus-on-medical-devices-and-digital-health 2020-09-29 15:45:25.013+00 https://www.pharmasalmanac.com/articles/getting-your-biologic-to-clinic-faster-and-more-efficiently 2020-09-29 15:44:43.684+00 https://www.pharmasalmanac.com/articles/realizing-the-promise-of-therapeutics-targeting-the-endocannabinoid-system 2020-09-29 15:43:55.82+00 https://www.pharmasalmanac.com/articles/the-advantages-of-implementing-plant-based-vaccines 2020-09-29 15:43:17.976+00 https://www.pharmasalmanac.com/articles/transforming-the-treatment-of-ocular-diseases-and-cancer-with-peptide-drugs 2020-09-29 15:38:38.319+00 https://www.pharmasalmanac.com/articles/enhancing-drug-delivery-with-thin-film-freezing-technology 2020-09-29 15:37:44.372+00 https://www.pharmasalmanac.com/articles/preventative-nasal-spray-shown-to-reduce-viral-replication-by-up-to-96-in-covid-19-challenge-study 2020-09-28 15:14:24.091+00 https://www.pharmasalmanac.com/articles/reflexion-and-sofinnova-partners-recognized-with-salus-excellence-award-at-the-convergence-in-oncology-summit 2020-09-25 14:08:58.016+00 https://www.pharmasalmanac.com/articles/biontech-to-acquire-gmp-manufacturing-site-to-expand-covid-19-vaccine-production-capacity-in-first-half-2021 2020-09-24 16:40:20.327+00 https://www.pharmasalmanac.com/articles/johnson-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate 2020-09-24 16:25:24.539+00 https://www.pharmasalmanac.com/articles/hovione-announces-partnership-to-support-manufacturing-of-antiviral-veklury-for-covid-19 2020-09-23 15:48:05.914+00 https://www.pharmasalmanac.com/articles/alaxia-breaks-new-ground-with-lead-compound-alx-009-as-virucidal-agent 2020-09-22 14:44:47.535+00 https://www.pharmasalmanac.com/articles/olive-adds-106mm-to-transform-healthcare-payments-with-ai-workforce 2020-09-22 14:42:13.699+00 https://www.pharmasalmanac.com/articles/come-home-to-biovectra 2020-09-21 22:53:36.481+00 https://www.pharmasalmanac.com/articles/reyvow-demonstrated-pain-freedom-from-migraine-attacks-at-60-minutes-and-up-to-48-hours-in-new-phase-study 2020-09-18 16:54:36.345+00 https://www.pharmasalmanac.com/articles/novigenix-presents-new-immuno-transcriptomic-data-for-prediction-of-response-to-immunotherapy-in-metastatic-urothelial-cancer-patients 2020-09-17 16:47:37.102+00 https://www.pharmasalmanac.com/articles/sgd-pharma-introduces-ensiemo-the-new-complete-child-resistant-packaging-solution-for-cbd-oils 2020-09-16 13:33:21.915+00 https://www.pharmasalmanac.com/articles/paradigm4-launches-reveal-single-cell-app-for-analyzing-large-scale-data-sets 2020-09-16 13:14:24.303+00 https://www.pharmasalmanac.com/articles/novavax-announces-covid-19-vaccine-manufacturing-agreement-with-serum-institute-of-india 2020-09-15 17:10:21.96+00 https://www.pharmasalmanac.com/articles/vaxart-announces-fda-clearance-of-ind-application-for-oral-covid-19-vaccine 2020-09-15 16:59:43.46+00 https://www.pharmasalmanac.com/articles/gilead-sciences-to-acquire-immunomedics 2020-09-15 16:49:04.575+00 https://www.pharmasalmanac.com/articles/what-is-your-perspective-on-how-the-pharma-industry-has-responded-to-the-covid-19-pandemic-what-lessons-have-been-learned 2020-09-14 22:15:57.985+00 https://www.pharmasalmanac.com/articles/design-of-complex-biopharmaceutical-facilities-considering-options-and-alternatives 2020-09-14 22:14:23.889+00 https://www.pharmasalmanac.com/articles/what-do-you-see-as-being-the-most-innovative-technologies-introduced-in-2017 2020-09-14 22:13:23.758+00 https://www.pharmasalmanac.com/articles/new-manufacturing-paradigms-in-an-evolving-pharma-industry 2020-09-14 22:12:17.12+00 https://www.pharmasalmanac.com/articles/the-introduction-of-robotics-creating-a-truly-sterile-environment 2020-09-14 22:09:54.68+00 https://www.pharmasalmanac.com/articles/astrazeneca-oxford-sars-cov-2-vaccine-trials-temporarily-paused 2020-09-09 23:51:08.544+00 https://www.pharmasalmanac.com/articles/labcorp-launches-first-combined-test-for-covid-19-flu-and-rsv-in-time-for-flu-season 2020-09-09 19:37:07.604+00 https://www.pharmasalmanac.com/articles/ibm-watson-health-and-orbitalrx-to-launch-integrated-solution-to-assist-hospital-pharmacy-providers-in-managing-drug-shortages 2020-09-09 18:41:25.709+00 https://www.pharmasalmanac.com/articles/abbvie-and-i-mab-enter-into-global-strategic-partnership-for-differentiated-immuno-oncology-therapy 2020-09-04 15:42:09.185+00 https://www.pharmasalmanac.com/articles/q2-roundtable-bioavailability-roundtable-what-are-your-thoughts-on-enhancing-bioavailability-with-novel-technologies 2020-09-02 17:56:11.668+00 https://www.pharmasalmanac.com/articles/luina-bio-announces-new-bio-manufacturing-gmp-and-development-facility-expansion 2020-09-02 14:27:20.641+00 https://www.pharmasalmanac.com/articles/bilim-pharmaceuticals-ht-presspart-and-hovione-technology-unveil-collaboration-for-new-asthma-product-ventofor-combi-fix-delivered-by-powdair-plus 2020-09-01 13:01:31.823+00 https://www.pharmasalmanac.com/articles/hackensack-meridian-health-enrolling-individuals-for-covid-19-vaccine-clinical-trial 2020-08-31 21:47:19.979+00 https://www.pharmasalmanac.com/articles/gileads-remdesivir-receives-fda-emergency-use-authorization-for-the-treatment-of-patients-with-moderate-covid-19 2020-08-31 18:41:14.362+00 https://www.pharmasalmanac.com/articles/seqens-inaugurates-hpapi-unit 2020-08-28 15:59:40.611+00 https://www.pharmasalmanac.com/articles/regeneron-adds-400-jobs-in-ireland 2020-08-28 15:55:39.187+00 https://www.pharmasalmanac.com/articles/bayer-and-northpond-ventures-lead-usd-55-million-series-a-financing-round-for-triumvira-immunologics 2020-08-28 15:25:40.508+00 https://www.pharmasalmanac.com/articles/synthego-raises-100-million-to-accelerate-crispr-platform-scale-up-in-response-to-growing-demand 2020-08-28 15:06:04.226+00 https://www.pharmasalmanac.com/articles/tff-pharmaceuticals-enters-into-worldwide-licensing-agreement-with-union-therapeutics-for-covid-19-treatment 2020-08-26 19:25:04.076+00 https://www.pharmasalmanac.com/articles/moderna-confirms-advanced-discussions-with-european-commission-to-supply-europe-with-80-million-doses-of-mrna-vaccine-against-covid-19 2020-08-26 18:37:16.541+00 https://www.pharmasalmanac.com/articles/catalent-signs-agreement-with-astrazeneca-to-expand-manufacturing-support-for-covid-19-vaccine-azd1222 2020-08-26 18:31:08.908+00 https://www.pharmasalmanac.com/articles/astrazeneca-initiates-phase-i-clinical-trial-initiated-for-monoclonal-antibody-combination-for-covid-19 2020-08-25 18:00:31.549+00 https://www.pharmasalmanac.com/articles/qiagen-to-launch-digital-sars-cov-2-antibody-test 2020-08-25 17:51:00.998+00 https://www.pharmasalmanac.com/articles/dragonfly-therapeutics-and-bristol-myers-squibb-announce-exclusive-global-license-for-dragonflys-il-12-investigational-immunotherapy-program 2020-08-20 18:44:41.034+00 https://www.pharmasalmanac.com/articles/trevena-announces-fda-approval-of-olinvyk-injection 2020-08-20 17:29:25.844+00 https://www.pharmasalmanac.com/articles/rome-therapeutics-appoints-drug-discovery-veteran-dennis-zaller-ph.d.-as-chief-scientific-officer 2020-08-20 17:01:10.143+00 https://www.pharmasalmanac.com/articles/takeda-to-sell-otc-drug-unit-to-blackstone-for-2.3bn 2020-08-20 16:58:59.127+00 https://www.pharmasalmanac.com/articles/mobilion-closes-35m-series-b-financing-round 2020-08-20 16:48:32.34+00 https://www.pharmasalmanac.com/articles/fda-accepts-application-for-xolair-prefilled-syringe-for-self-administration-across-all-indications 2020-08-19 19:22:41.173+00 https://www.pharmasalmanac.com/articles/aeronabs-promise-powerful-inhalable-protection-against-covid-19-inspired-by-llamas 2020-08-18 15:16:17.574+00 https://www.pharmasalmanac.com/articles/hyperfine-research-receives-510k-clearance-from-us-fda-for-market-ready-swoop-portable-mri-system 2020-08-18 14:46:38.208+00 https://www.pharmasalmanac.com/articles/tff-pharmaceuticals-enters-into-worldwide-licensing-agreement-with-union-therapeutics-for-its-thin-film-freezing-technology-in-combination-with-niclosamide 2020-08-14 16:52:17.174+00 https://www.pharmasalmanac.com/articles/ajinomoto-bio-pharma-services-expands-small-molecule-manufacturing-capabilities-at-its-india-facility 2020-08-14 09:00:00.491+00 https://www.pharmasalmanac.com/articles/european-commission-concludes-further-talks-to-secure-jj-covid-19-vaccine 2020-08-14 09:00:00.489+00 https://www.pharmasalmanac.com/articles/astrazeneca-ships-flumist-quadrivalent-vaccine-in-the-u.s.-for-2020-2021-flu-season 2020-08-14 09:00:00.474+00 https://www.pharmasalmanac.com/articles/mylan-and-sesame-workshop-partner-to-provide-socio-emotional-support-resources-to-families-impacted-by-covid-19 2020-08-14 09:00:00.465+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-announces-results-of-offer-to-acquire-qiagen-lapse-of-offer-and-termination-of-acquisition-agreement 2020-08-13 17:34:57.397+00 https://www.pharmasalmanac.com/articles/novavax-and-sk-bioscience-announce-collaboration-for-novavax-covid-19-vaccine-candidate 2020-08-13 17:25:45.462+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-and-the-bristol-myers-squibb-foundation-commit-300-million-to-accelerate-and-expand-health-equity-and-diversity-and-inclusion-efforts 2020-08-13 17:25:23.764+00 https://www.pharmasalmanac.com/articles/altis-biosystems-announces-completion-of-a-3.1-million-seed-investment-led-by-venturesouth 2020-08-11 14:22:42.057+00 https://www.pharmasalmanac.com/articles/seres-therapeutics-shares-positive-top-line-results 2020-08-10 20:44:44.208+00 https://www.pharmasalmanac.com/articles/neutrolis-announces-development-of-first-in-class-treatment-targeting-neutrophil-extracellular-traps-nets-for-patients-with-severe-covid-19 2020-08-10 20:33:07.75+00 https://www.pharmasalmanac.com/articles/catalent-adds-potent-manufacturing-capabilities-at-its-buenos-aires-argentina-site 2020-08-07 06:51:15.937+00 https://www.pharmasalmanac.com/articles/astrazeneca-signs-covid-19-vaccine-deal-with-chinese-company 2020-08-07 06:43:41.927+00 https://www.pharmasalmanac.com/articles/applying-a-synthetic-approach-to-the-development-of-a-new-generation-of-antibiotics 2020-08-06 16:49:20.986+00 https://www.pharmasalmanac.com/articles/sk-pharmteco-announces-general-manager-to-sk-biotek-ireland 2020-08-06 15:11:22.809+00 https://www.pharmasalmanac.com/articles/the-renaissance-of-microbial-fermentation 2020-08-06 07:26:27.058+00 https://www.pharmasalmanac.com/articles/clinical-ink-announces-its-acquisition-by-gi-partners 2020-08-04 17:32:50.926+00 https://www.pharmasalmanac.com/articles/pmv-pharma-closes-70-million-in-series-d-financing 2020-08-04 16:37:42.564+00 https://www.pharmasalmanac.com/articles/biontech-announces-strategic-collaboration-with-regeneron-to-advance-fixvac-and-libtayo-combination-in-melanoma 2020-07-31 19:02:08.102+00 https://www.pharmasalmanac.com/articles/sanofi-and-gsk-selected-for-operation-warp-speed-to-supply-united-states-government-with-100-million-doses-of-covid-19-vaccine 2020-07-31 18:44:02.722+00 https://www.pharmasalmanac.com/articles/allovir-announces-pricing-of-upsized-initial-public-offering 2020-07-31 18:26:12.635+00 https://www.pharmasalmanac.com/articles/dfc-to-sign-letter-of-interest-for-investment-in-kodaks-expansion-into-pharmaceuticals 2020-07-30 15:10:34.768+00 https://www.pharmasalmanac.com/articles/intravacc-and-celonic-to-develop-and-produce-a-novel-covid-19-vaccine 2020-07-30 15:06:56.007+00 https://www.pharmasalmanac.com/articles/sterling-signs-deal-to-produce-potential-covid-19-drug-candidate-for-moleculin 2020-07-30 14:57:19.177+00 https://www.pharmasalmanac.com/articles/accelerating-the-development-of-viral-vector-manufacturing-processes 2020-07-28 14:37:55.967+00 https://www.pharmasalmanac.com/articles/astrazeneca-and-daiichi-sankyo-enter-collaboration-to-develop-and-commercialize-new-antibody-drug-conjugate 2020-07-27 22:01:11.5+00 https://www.pharmasalmanac.com/articles/moderna-begins-phase-3-cove-study-of-mrna-vaccine-against-covid-19 2020-07-27 21:39:37.422+00 https://www.pharmasalmanac.com/articles/moderna-announces-expansion-of-barda-agreement-to-support-larger-phase-3-program-for-covid-19-vaccine 2020-07-27 21:32:12.1+00 https://www.pharmasalmanac.com/articles/sandoz-announces-plans-for-joint-investment-to-help-strengthen-future-of-antibiotics-manufacturing-in-europe 2020-07-27 21:10:58.469+00 https://www.pharmasalmanac.com/articles/astrazenecas-breztri-aerosphere-approved-in-the-us-for-the-maintenance-treatment-of-copd 2020-07-24 16:54:48.391+00 https://www.pharmasalmanac.com/articles/new-rapid-molecular-test-for-tuberculosis-can-simultaneously-detect-resistance-to-first-and-second-line-drugs 2020-07-24 16:39:22.409+00 https://www.pharmasalmanac.com/articles/novartis-launches-first-of-its-kind-not-for-profit-portfolio-of-medicines-for-symptomatic-treatment-of-covid-19 2020-07-24 16:23:05.166+00 https://www.pharmasalmanac.com/articles/bioaegis-therapeutics-receives-approval-to-proceed-with-phase-2-trial-of-its-gelsolin-covid-19-treatment 2020-07-24 15:46:45.823+00 https://www.pharmasalmanac.com/articles/merck-and-irbm-announce-pioneering-collaboration-to-advance-peptide-therapeutics 2020-07-23 13:41:55.564+00 https://www.pharmasalmanac.com/articles/common-fda-approved-drug-may-effectively-neutralize-virus-that-causes-covid-19 2020-07-23 13:19:50.382+00 https://www.pharmasalmanac.com/articles/synairgen-announces-positive-results-from-trial-of-sng001-in-hospitalised-covid-19-patients 2020-07-21 15:32:40.764+00 https://www.pharmasalmanac.com/articles/sgs-signs-analytical-testing-agreement-with-astrazeneca-for-covid-19-vaccine-candidate 2020-07-17 18:46:11.715+00 https://www.pharmasalmanac.com/articles/polpharma-biologics-building-on-early-achievements 2020-07-17 14:33:28.245+00 https://www.pharmasalmanac.com/articles/how-is-polpharma-biologics-innovating-through-the-integration_of_advanced_cell_line 2020-07-17 14:30:13.418+00 https://www.pharmasalmanac.com/articles/applying-the-principles-of-immunotherapy-to-infectious-diseases 2020-07-17 14:20:26.559+00 https://www.pharmasalmanac.com/articles/johnson-johnson-and-its-partners-mark-a-milestone-in-the-quest-for-a-global-preventive-hiv-vaccine-with-the-imbokodo-study 2020-07-17 13:08:52.143+00 https://www.pharmasalmanac.com/articles/astrazenecas-drug-significantly-reduces-the-rate-of-the-composite-of-stroke-and-death-in-patients 2020-07-16 19:25:47.016+00 https://www.pharmasalmanac.com/articles/ai-startup-deep-longevity-launches-with-series-a-financing-and-new-ai-system-to-tackle-aging-related-diseases 2020-07-16 18:40:03.536+00 https://www.pharmasalmanac.com/articles/blueprint-medicines-announces-global-collaboration-with-roche-to-develop-and-commercialize-pralsetinib-for-patients-with-ret-altered-cancers 2020-07-16 17:53:58.326+00 https://www.pharmasalmanac.com/articles/how-is-sanaclis-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2020-07-16 16:20:01.239+00 https://www.pharmasalmanac.com/articles/gilead-sciences-and-arcus-biosciences-complete-closing-of-their-10-year-partnership-to-co-develop-and-co-commercialize-next-generation-cancer-immunotherapies 2020-07-15 19:33:13.905+00 https://www.pharmasalmanac.com/articles/new-data-from-phase-iiib-study-reinforces-safety-profile-of-roches-hemlibra-in-people-with-haemophilia-a 2020-07-13 21:28:56.013+00 https://www.pharmasalmanac.com/articles/foundational-research-published-in-nature-biotechnology-showcases-auxolytics-approach-to-developing-nutrient-based-cell-therapy-control-switches 2020-07-13 21:21:51.385+00 https://www.pharmasalmanac.com/articles/genome-medical-raises-14-million-to-expand-virtual-clinical-genetics-care-and-accelerate-telemedicine-technology-development 2020-07-13 21:05:33.46+00 https://www.pharmasalmanac.com/articles/the-essentiality-of-transportation-to-the-pharma-industry 2020-07-13 18:16:00.214+00 https://www.pharmasalmanac.com/articles/how-is-pii-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2020-07-13 17:21:12.073+00 https://www.pharmasalmanac.com/articles/how-is-olon-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2020-07-10 17:06:39.25+00 https://www.pharmasalmanac.com/articles/redesigning_organisms_as_metabolism_architects 2020-07-10 16:31:20.761+00 https://www.pharmasalmanac.com/articles/gilead-presents-additional-data-on-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19 2020-07-10 15:42:41.513+00 https://www.pharmasalmanac.com/articles/haima-therapeutics-receives-phase-ii-tvsf-award-from-the-state-of-ohio-to-develop-its-synthoplate-product-for-veterinary-use 2020-07-10 15:31:34.676+00 https://www.pharmasalmanac.com/articles/kymera-therapeutics-and-sanofi-enter-into-strategic-partnership-to-advance-novel-protein-degrader-therapies-to-patients 2020-07-10 15:20:59.194+00 https://www.pharmasalmanac.com/articles/blackstone-announces-4.6-billion-final-close-of-life-sciences-fund 2020-07-10 15:14:00.724+00 https://www.pharmasalmanac.com/articles/essentials-of-an-industry-leading-cdmo-partner-for-highly-potent-projects 2020-07-10 14:03:09.666+00 https://www.pharmasalmanac.com/articles/robust-harvest-clarification-for-adeno-associated-viral-vectors-via-depth-filtration 2020-07-09 18:52:50.587+00 https://www.pharmasalmanac.com/articles/evolving-needs-for-comprehensive-clinical-comparator-sourcing-strategies 2020-07-09 18:48:07.231+00 https://www.pharmasalmanac.com/articles/driving-more-effective-medicine-by-listening-to-patients 2020-07-09 18:45:49.887+00 https://www.pharmasalmanac.com/articles/how-is-spi-pharma-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2020-07-09 18:40:21.85+00 https://www.pharmasalmanac.com/articles/exploring-the-future-of-healthcare-in-25-countries-in-25-days 2020-07-09 18:28:18.777+00 https://www.pharmasalmanac.com/articles/leveraging-the-cell-cytoskeleton-for-the-treatment-of-cancer-and-neurodegenerative-diseases 2020-07-09 18:24:03.184+00 https://www.pharmasalmanac.com/articles/developing-transformative-treatments-for-rare-endocrine-diseases 2020-07-09 18:21:44.185+00 https://www.pharmasalmanac.com/articles/epigenetic-regulation-to-treat-acute-organ-injury-and-chronic-liver-diseases 2020-07-09 18:20:30.474+00 https://www.pharmasalmanac.com/articles/osivax-receives-over-eur-30m-in-public-funding-to-support-development-of-universal-coronavirus-and-influenza-vaccines 2020-07-09 15:45:31.483+00 https://www.pharmasalmanac.com/articles/gsk-and-medicago-announce-collaboration-to-develop-a-novel-adjuvanted-covid-19-candidate-vaccine 2020-07-09 15:36:07.482+00 https://www.pharmasalmanac.com/articles/drug-prices-increase-in-july 2020-07-09 15:30:21.526+00 https://www.pharmasalmanac.com/articles/regeneron-awarded-a-450-million-contract-to-manufacture-regn-cov2 2020-07-07 16:58:28.104+00 https://www.pharmasalmanac.com/articles/emergent-biosolutions-signs-five-year-agreement-for-large-scale-drug-substance-manufacturing-for-johnson-johnsons-lead-covid-19-vaccine-candidate 2020-07-07 15:39:25.728+00 https://www.pharmasalmanac.com/articles/novavax-announces-1.6-billion-funding-from-operation-warp-speed 2020-07-07 15:20:41.023+00 https://www.pharmasalmanac.com/articles/a-personalized-cell-therapy-chain-management-platform 2020-07-07 13:29:49.387+00 https://www.pharmasalmanac.com/articles/the-key-to-tackling-drug-development-complexity-collaboration 2020-07-07 13:00:00.527+00 https://www.pharmasalmanac.com/articles/applying-rapid-countermeasure-preparedness-to-development-of-a-novel-covid-19-vaccine 2020-07-06 14:54:44.943+00 https://www.pharmasalmanac.com/articles/labcorp-introduces-xcellerate-covid-19-clinical-study-solution 2020-07-03 09:00:00.409+00 https://www.pharmasalmanac.com/articles/hansa-biopharma-announces-exclusive-agreement-with-sarepta-therapeutics-to-develop-imlifidase-as-pre-treatment-ahead-of-gene-therapy 2020-07-03 09:00:00.4+00 https://www.pharmasalmanac.com/articles/massachusetts-eye-and-ear-enters-licensing-agreement-with-biogen-to-develop-treatment-for-inherited-retinal-disorder 2020-07-03 09:00:00.397+00 https://www.pharmasalmanac.com/articles/addressing-the-challenges-of-comparator-drug-sourcing-for-clinical-trials 2020-07-02 19:55:51.975+00 https://www.pharmasalmanac.com/articles/fujifilm-partners-with-dr.-reddys-and-global-response-aid-for-deployment-of-a-covid-19-treatment-drug-outside-of-japan 2020-07-02 18:01:31.958+00 https://www.pharmasalmanac.com/articles/humana-to-offer-labcorp-at-home-covid-19-test-collection-and-collaborate-with-walmart-and-quest-diagnostics-to-offer-drive-thru-testing-for-humana-members 2020-07-02 17:26:13.45+00 https://www.pharmasalmanac.com/articles/aseptic-manufacturing-with-state-of-the-art-technologies 2020-07-02 17:09:03.278+00 https://www.pharmasalmanac.com/articles/what-two-or-three-drug-molecules-do-you-identify-as-having-had-the-greatest-impact-on-society-what-about-on-the-pharmaceutical-industry 2020-07-02 15:07:40.131+00 https://www.pharmasalmanac.com/articles/molecules-that-changed-medicine 2020-07-02 01:04:18.336+00 https://www.pharmasalmanac.com/articles/drug-approval-trends-significant-acceleration-in-recent-years 2020-07-02 01:03:16.38+00 https://www.pharmasalmanac.com/articles/in-conversation-novel-off-the-shelf-targeted-cell-therapies 2020-07-02 01:00:33.42+00 https://www.pharmasalmanac.com/articles/investing-at-the-intersection-of-industrial-manufacturing-and-healthcare 2020-07-02 00:54:44.699+00 https://www.pharmasalmanac.com/articles/leveraging-innovative-technologies-to-access-better-data-more-efficiently-and-cost-effectively 2020-07-02 00:49:22.774+00 https://www.pharmasalmanac.com/articles/creating-value-through-best-practices-across-a-global-integrated-service-provider 2020-07-02 00:48:58.421+00 https://www.pharmasalmanac.com/articles/selecting-a-microbiome-cdmo-partner-for-the-long-term 2020-07-02 00:48:26.826+00 https://www.pharmasalmanac.com/articles/common-challenges-and-solutions-of-equipment-ownership-and-use 2020-07-02 00:47:36.831+00 https://www.pharmasalmanac.com/articles/positioning-a-cdmo-to-meet-future-needs 2020-07-02 00:46:58.066+00 https://www.pharmasalmanac.com/articles/delivering-breakthrough-medicines-for-rare-hematologic-diseases-and-cancers 2020-07-02 00:44:48.985+00 https://www.pharmasalmanac.com/articles/covid-19-and-europe-driving-nationalism-rather-than-solidarity 2020-07-02 00:37:42.524+00 https://www.pharmasalmanac.com/articles/innovative-biomaterials-facilitate-novel-medical-devices 2020-07-02 00:37:14.352+00 https://www.pharmasalmanac.com/articles/how-is-globyz-biopharma-services-innovating-through-the-pandemic-and-beyond-to-define-the-future-of-healthcare 2020-07-02 00:35:18.971+00 https://www.pharmasalmanac.com/articles/covid-19-understanding-the-virus-the-pandemic-and-the-path-forward 2020-07-02 00:27:33.715+00 https://www.pharmasalmanac.com/articles/linking-novel-medicines-to-patients-with-hard-to-treat-cancers-for-improved-quality-of-life 2020-07-01 15:08:53.148+00 https://www.pharmasalmanac.com/articles/solving-unmet-clinical-needs-by-harnessing-the-science-of-aging 2020-07-01 15:07:19.639+00 https://www.pharmasalmanac.com/articles/computational-discoveries-for-clinical-development-of-novel-cancer-therapies 2020-07-01 15:05:42.152+00 https://www.pharmasalmanac.com/articles/a-therapeutic-strategy-for-neurological-disorders 2020-07-01 15:02:14.731+00 https://www.pharmasalmanac.com/articles/leveraging-the-native-immune-response-to-fight-cancer 2020-07-01 15:00:48.441+00 https://www.pharmasalmanac.com/articles/whats-next-for-the-supply-chain-post-pandemic 2020-07-01 13:40:03.288+00 https://www.pharmasalmanac.com/articles/regulating-clinical-trials-in-pandemic-times 2020-07-01 13:16:28.435+00 https://www.pharmasalmanac.com/articles/inovio-announces-positive-interim-phase-1-data-for-ino-4800-vaccine-for-covid-19 2020-06-30 17:55:27.004+00 https://www.pharmasalmanac.com/articles/goldfinch-bio-secures-100-million-in-series-b-financing 2020-06-30 17:52:52.522+00 https://www.pharmasalmanac.com/articles/gene-therapy-in-mice-builds-muscle-reduces-fat 2020-06-30 16:59:32.416+00 https://www.pharmasalmanac.com/articles/one-time-treatment-generates-new-neurons-eliminates-parkinsons-disease-in-mice 2020-06-30 16:40:15.877+00 https://www.pharmasalmanac.com/articles/sygnature-discovery-boosts-senior-management-team-with-appointment-of-dr.-paul-overton 2020-06-25 13:52:28.544+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-announces-acquisition-of-solid-oral-dosage-drug-product-facility-in-sellersville-pennsylvania-from-gw-laboratories-inc 2020-06-25 13:35:32.418+00 https://www.pharmasalmanac.com/articles/cyclica-raises-cad23-million-in-a-series-b-financing-to-create-the-biotech-pipeline-of-the-future 2020-06-25 13:01:01.445+00 https://www.pharmasalmanac.com/articles/sanofi-and-translate-bio-expand-collaboration-to-develop-mrna-vaccines-across-all-infectious-disease-areas 2020-06-23 17:03:07.197+00 https://www.pharmasalmanac.com/articles/gilead-sciences-secures-exclusive-option-to-acquire-pionyr-immunotherapeutics 2020-06-23 16:39:27.702+00 https://www.pharmasalmanac.com/articles/emergent-biosolutions-to-invest-75-million-in-canton-site-and-expand-viral-vector-and-gene-therapy-capability 2020-06-23 16:37:45.531+00 https://www.pharmasalmanac.com/articles/supernus-completes-acquisition-of-cns-portfolio-from-us-worldmeds 2020-06-19 17:02:46.762+00 https://www.pharmasalmanac.com/articles/naari-completes-acquisition-of-andas-from-intas-pharmaceuticals 2020-06-19 16:39:14.398+00 https://www.pharmasalmanac.com/articles/cepheid-announces-development-of-four-in-one-combination-test-for-sars-cov-2-flu-a-flu-b-and-rsv 2020-06-18 16:57:32.022+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-co-develop-a-global-companion-diagnostic-for-low-grade-glioma-with-agios-pharmaceuticals 2020-06-18 16:48:48.451+00 https://www.pharmasalmanac.com/articles/latam-cargo-expands-its-pharma-network-to-satisfy-latin-american-markets-demand 2020-06-16 17:31:57.693+00 https://www.pharmasalmanac.com/articles/eli-lilly-drug-significantly-reduces-the-risk-of-breast-cancer-returning 2020-06-16 16:30:25.653+00 https://www.pharmasalmanac.com/articles/low-cost-dexamethasone-reduces-death-in-patients-with-severe-respiratory-complications-of-covid-19 2020-06-16 15:54:02.679+00 https://www.pharmasalmanac.com/articles/vertex-announces-new-clinical-data-for-investigational-gene-editing-therapy-ctx001-in-severe-hemoglobinopathies 2020-06-12 16:23:22.361+00 https://www.pharmasalmanac.com/articles/moderna-advances-late-stage-development-of-its-vaccine-mrna-1273-against-covid-19 2020-06-12 16:15:33.253+00 https://www.pharmasalmanac.com/articles/braeburn-submits-request-for-final-approval-of-brixadi-for-the-treatment-of-opioid-use-disorder 2020-06-11 16:12:33.78+00 https://www.pharmasalmanac.com/articles/fda-clears-ind-for-inkt-cells-to-treat-covid-19-patients 2020-06-11 15:45:49.986+00 https://www.pharmasalmanac.com/articles/pii-and-its-partners-received-fda-market-approval-for-seven-products-and-commercially-launched-6-products-in-2017 2020-06-10 20:20:50.461+00 https://www.pharmasalmanac.com/articles/sio2-materials-science-receives-143-million-contract-from-u.s.-government 2020-06-09 18:38:33.268+00 https://www.pharmasalmanac.com/articles/archerdx-announces-strategic-collaboration-with-astrazeneca-to-develop-personalized-cancer-monitoring-assays-for-minimal-residual-disease 2020-06-08 18:29:47.959+00 https://www.pharmasalmanac.com/articles/alnylam-presents-positive-phase-3-results-from-illuminate-a-study-of-lumasiran-an-investigational-rnai-therapeutic-for-treatment-of-primary-hyperoxaluria-type-1 2020-06-08 16:53:31.011+00 https://www.pharmasalmanac.com/articles/novavax-selects-agc-biologics-to-manufacture-matrix-m-adjuvant-for-novel-covid-19-vaccine 2020-06-05 14:14:46.121+00 https://www.pharmasalmanac.com/articles/athira-pharma-closes-85-million-series-b-financing 2020-06-04 22:10:25.908+00 https://www.pharmasalmanac.com/articles/spectrum-pharmaceuticals-appoints-lyndah-k.-dreiling-m.d.-mba-as-senior-vice-president-clinical-development 2020-06-04 21:49:49.266+00 https://www.pharmasalmanac.com/articles/astrazeneca-to-discover-and-develop-novel-therapies-targeting-rna-modifying-proteins-in-oncology-collaboration-with-accent-therapeutics 2020-06-04 21:44:02.039+00 https://www.pharmasalmanac.com/articles/hillhouse-capital-leads-160m-series-b-round-in-genor-biopharma 2020-06-02 17:30:29.757+00 https://www.pharmasalmanac.com/articles/sun-pharma-receives-approval-from-dcgi-to-initiate-clinical-trial-with-nafamostat-in-covid-19-patients 2020-06-02 17:01:47.837+00 https://www.pharmasalmanac.com/articles/fda-issues-emergency-use-authorization-for-impella-rp-as-therapy-for-covid-19-patients-with-right-heart-failure 2020-06-02 16:18:56.177+00 https://www.pharmasalmanac.com/articles/astrazeneca-collaborates-with-archerdx-to-use-personalized-cancer-assays-to-detect-minimal-residual-disease-in-lung-cancer-trials 2020-05-29 16:38:58.821+00 https://www.pharmasalmanac.com/articles/novavax-expands-large-scale-global-manufacturing-capacity-for-covid-19-vaccine 2020-05-29 09:00:00.368+00 https://www.pharmasalmanac.com/articles/montefiore-einstein-scientists-lead-two-trials-of-leronlimab-for-covid-19 2020-05-29 09:00:00.338+00 https://www.pharmasalmanac.com/articles/gilead-sciences-and-arcus-biosciences-establish-10-year-partnership-to-co-develop-and-co-commercialize-next-generation-cancer-immunotherapies 2020-05-28 15:57:49.88+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-and-csl-enter-strategic-partnership 2020-05-28 15:43:22.517+00 https://www.pharmasalmanac.com/articles/rentschler-biopharma-extends-collaboration-with-genmab-to-u.s.-facility 2020-05-27 15:12:26.346+00 https://www.pharmasalmanac.com/articles/biomed-x-institute-launches-rapid-antiviral-response-platform-to-prevent-future-pandemics 2020-05-26 15:53:31.297+00 https://www.pharmasalmanac.com/articles/philips-launches-healthsuite-clinical-trial-accelerator 2020-05-22 15:30:57.215+00 https://www.pharmasalmanac.com/articles/astrazeneca-advances-response-to-covid-19-after-receiving-first-commitments-for-oxfords-potential-new-vaccine 2020-05-21 20:49:45.991+00 https://www.pharmasalmanac.com/articles/apple-and-google-launch-exposure-notification-api-to-support-public-health-agencies 2020-05-20 20:57:02.887+00 https://www.pharmasalmanac.com/articles/phlow-corporation-awarded-354-million-hhs/aspr/barda-contract-to-manufacture-essential-medicines-in-shortage 2020-05-20 16:08:43.948+00 https://www.pharmasalmanac.com/articles/continuously-tracking-fear-response-could-improve-mental-health-treatment 2020-05-19 15:13:44.949+00 https://www.pharmasalmanac.com/articles/sti-1499-a-potent-anti-sars-cov-2-antibody-demonstrates-ability-to-completely-inhibit-in-vitro-virus-infection-in-preclinical-studies 2020-05-19 15:08:16.426+00 https://www.pharmasalmanac.com/articles/moderna-announces-positive-interim-phase-1-data-for-its-mrna-vaccine-mrna-1273-against-novel-coronavirus 2020-05-18 18:54:41.639+00 https://www.pharmasalmanac.com/articles/wuxi-advanced-therapies-launches-new-closed-process-car-t-cell-therapy-platform 2020-05-18 16:33:01.109+00 https://www.pharmasalmanac.com/articles/myokardia-announces-primary-and-all-secondary-endpoints-met-in-phase-3-clinical-trial-for-the-treatment-of-obstructive-hypertrophic-cardiomyopathy 2020-05-15 17:19:44.841+00 https://www.pharmasalmanac.com/articles/hkbu-led-research-team-develops-novel-anti-viral-targeted-drug-for-nasopharyngeal-cancer-treatment 2020-05-15 16:00:01.924+00 https://www.pharmasalmanac.com/articles/abbot-receives-fda-authorization-for-covid-19-antibody-blood-test-system 2020-05-15 15:50:33.124+00 https://www.pharmasalmanac.com/articles/usp-launches-trust-accelerated-program-to-speed-development-of-covid-19-treatments-and-vaccines 2020-05-14 16:32:31.412+00 https://www.pharmasalmanac.com/articles/astrazeneca-completes-recovery-of-global-rights-to-brazikumab-from-allergan 2020-05-14 16:20:52.802+00 https://www.pharmasalmanac.com/articles/mylan-to-supply-investigational-antiviral-remdesivir-for-the-potential-treatment-of-covid-19 2020-05-14 16:01:17.654+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-response-to-covid-19-expands-to-include-new-serology-test 2020-05-13 19:36:56.767+00 https://www.pharmasalmanac.com/articles/fda-accepts-for-priority-review-bristol-myers-squibbs-application-for-cc-486-for-maintenance-treatment-of-adult-patients-in-remission-with-acute-myeloid-leukemia 2020-05-08 13:15:56.334+00 https://www.pharmasalmanac.com/articles/farxiga-approved-in-the-us-for-the-treatment-of-heart-failure-in-patients 2020-05-08 13:13:03.819+00 https://www.pharmasalmanac.com/articles/fda-approves-gsks-zejula 2020-05-08 12:53:00.963+00 https://www.pharmasalmanac.com/articles/ptc-therapeutics-to-acquire-censa-pharmaceuticals 2020-05-07 17:39:33.712+00 https://www.pharmasalmanac.com/articles/first-cell-and-gene-therapy-manufacturing-center-located-on-a-u.s.-university-campus-is-named 2020-05-05 17:47:13.813+00 https://www.pharmasalmanac.com/articles/seqens-mobilizes-its-innovation-to-support-the-unprecedented-research-on-covid-19 2020-05-05 16:52:11.385+00 https://www.pharmasalmanac.com/articles/vir-and-alnylam-identify-rnai-therapeutic-development-candidate-targeting-sars-cov-2 2020-05-05 16:35:35.59+00 https://www.pharmasalmanac.com/articles/hovione-announces-the-appointment-of-jean-luc-herbeaux-as-chief-operating-officer 2020-05-04 14:27:53.453+00 https://www.pharmasalmanac.com/articles/iceland-provides-a-picture-of-the-early-spread-of-covid-19-in-a-population-with-a-cohesive-public-health-response 2020-05-01 19:43:50.776+00 https://www.pharmasalmanac.com/articles/wyss-designed-swabs-enter-human-trials-for-covid-19 2020-05-01 17:59:15.675+00 https://www.pharmasalmanac.com/articles/interphex-postponed-until-2021 2020-05-01 17:08:02.309+00 https://www.pharmasalmanac.com/articles/moderna-and-lonza-announce-worldwide-strategic-collaboration-to-manufacture-modernas-vaccine-against-novel-coronavirus 2020-05-01 16:55:50.747+00 https://www.pharmasalmanac.com/articles/fujifilm-diosynth-biotechnologies-reserve-manufacturing-capacity-for-covid-19 2020-04-30 17:41:27.338+00 https://www.pharmasalmanac.com/articles/astrazeneca-and-oxford-university-announce-landmark-agreement-for-covid-19-vaccine 2020-04-30 15:49:33.235+00 https://www.pharmasalmanac.com/articles/what-technology-do-you-foresee-leading-the-industry-over-the-coming-decade-both-in-terms-of-real-approvals-and-general-impact 2020-04-28 21:59:18.54+00 https://www.pharmasalmanac.com/articles/novartis-acquires-amblyotech 2020-04-28 20:15:00.014+00 https://www.pharmasalmanac.com/articles/pneumagen-ltd-announces-positive-anti-viral-activity-for-novel-glycan-approach-in-preventing-coronavirus-infections 2020-04-28 20:13:06.046+00 https://www.pharmasalmanac.com/articles/fda-approves-new-meningococcal-vaccination 2020-04-28 19:39:05.847+00 https://www.pharmasalmanac.com/articles/sanofi-and-regeneron-provide-update-on-u.s.-phase-2/3-adaptive-designed-trial-in-hospitalized-covid-19-patients 2020-04-28 16:33:34.228+00 https://www.pharmasalmanac.com/articles/askbio-acquires-brainvectis-to-expand-its-clinical-pipeline-for-neurodegenerative-diseases 2020-04-24 15:56:12.356+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-doses-first-patients-with-acute-lung-injury-caused-by-covid-19 2020-04-24 15:44:24.19+00 https://www.pharmasalmanac.com/articles/n4-pharma-explores-how-nuvec-can-fight-covid-19 2020-04-23 17:22:47.226+00 https://www.pharmasalmanac.com/articles/roche-receives-fda-approval-for-cobas-hpv-test-to-identify-women-at-risk-for-cervical-cancer 2020-04-23 16:14:15.541+00 https://www.pharmasalmanac.com/articles/simplifying-the-supply-chain-with-large-volume-western-cdmo-partners 2020-04-22 21:52:10.519+00 https://www.pharmasalmanac.com/articles/sanofi-and-luminostics-to-join-forces-on-developing-covid-19-smartphone-based-self-testing-solution 2020-04-21 16:44:24.749+00 https://www.pharmasalmanac.com/articles/novartis-to-sponsor-large-clinical-trial-of-hydroxychloroquine-in-hospitalized-covid-19-patients 2020-04-20 21:32:28.614+00 https://www.pharmasalmanac.com/articles/seattle-genetics-announces-fda-approval-of-tukysa-for-breast-cancer 2020-04-20 21:18:12.002+00 https://www.pharmasalmanac.com/articles/mylan-board-appoints-robert-j.-coury-as-executive-chairman 2020-04-17 15:52:27.299+00 https://www.pharmasalmanac.com/articles/fda-accepts-for-priority-review-biologics-license-application-for-regn-eb3-to-treat-ebola 2020-04-17 15:45:04.01+00 https://www.pharmasalmanac.com/articles/roivant-doses-first-patient-in-pivotal-breathe-clinical-trial-evaluating-gimsilumab-in-covid-19-patients 2020-04-17 15:26:41.402+00 https://www.pharmasalmanac.com/articles/leo-pharma-enters-license-agreement-with-oneness-biotech-and-microbio-shanghai-for-fb825-a-novel-atopic-dermatitis-and-asthma-drug-candidate 2020-04-15 21:54:32.635+00 https://www.pharmasalmanac.com/articles/zotefoams-plastazote-polyethylene-foam-helps-global-response-to-covid-19 2020-04-15 21:27:04.355+00 https://www.pharmasalmanac.com/articles/sanofi-and-gsk-to-join-forces-in-covid-19-vaccine-collaboration 2020-04-14 16:31:58.23+00 https://www.pharmasalmanac.com/articles/moderna-highlights-opportunity-of-mrna-vaccines 2020-04-14 16:22:59.224+00 https://www.pharmasalmanac.com/articles/lilly-begins-clinical-testing-of-therapies-for-covid-19 2020-04-13 21:11:11.186+00 https://www.pharmasalmanac.com/articles/bd-biomedomics-announce-launch-of-rapid-serology-test-to-detect-exposure-to-covid-19 2020-04-10 14:33:10.851+00 https://www.pharmasalmanac.com/articles/novartis-announces-plans-to-initiate-clinical-study-of-jakavi-in-severe-covid-19-patients 2020-04-10 14:18:06.672+00 https://www.pharmasalmanac.com/articles/ibio-expands-covid-19-vaccine-collaboration-to-include-the-infectious-disease-research-institute 2020-04-09 18:17:56.063+00 https://www.pharmasalmanac.com/articles/covid-19-a-look-at-the-virus-its-epidemiology-therapeutic-and-vaccine-development-efforts-and-impacts-of-the-pandemic 2020-04-07 21:25:50.217+00 https://www.pharmasalmanac.com/articles/covid-19-vaccine-delivered-by-skin-patch-shows-promise 2020-04-07 15:51:47.435+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-expands-patient-support-programs-to-help-newly-uninsured-patients-in-the-u.s 2020-04-07 15:37:23.234+00 https://www.pharmasalmanac.com/articles/gsks-asthma-biologic-approved 2020-04-07 15:15:01.754+00 https://www.pharmasalmanac.com/articles/servier-acquires-symphogen 2020-04-07 15:14:20.919+00 https://www.pharmasalmanac.com/articles/medical-professionals-across-merck-pfizer-and-eli-lilly-volunteer-amid-covid-19-pandemic 2020-04-07 15:13:23.825+00 https://www.pharmasalmanac.com/articles/gilead-sciences-statement-on-access-to-remdesivir-outside-of-clinical-trials 2020-04-02 17:14:00.396+00 https://www.pharmasalmanac.com/articles/caidr-intuitive-app-to-help-people-better-understand-impact-of-social-distancing 2020-04-02 16:06:08.637+00 https://www.pharmasalmanac.com/articles/lux-research-predicts-synthetic-biology-has-high-potential-as-an-alternative-production-method-for-chemicals 2020-04-02 15:19:45.187+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-receives-ce-mark-for-its-diagnostic-test-to-detect-covid-19 2020-03-31 18:43:49.011+00 https://www.pharmasalmanac.com/articles/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19 2020-03-31 18:28:10.01+00 https://www.pharmasalmanac.com/articles/mylan-and-pfizer-provide-update-regarding-proposed-combination-of-mylan-and-upjohn 2020-03-27 14:40:10.891+00 https://www.pharmasalmanac.com/articles/beigene-announces-supply-update-for-abraxane-in-china 2020-03-25 22:14:08.469+00 https://www.pharmasalmanac.com/articles/pharma-equipment-auction-alert-federal-equipment-company-hosts-auction-of-pharmaceutical-equipment-excess-to-future-needs-of-upm-pharmaceuticals 2020-03-24 16:04:09.289+00 https://www.pharmasalmanac.com/articles/vaccitech-and-oxford-university-announce-promising-phase-2a-data-on-prostate-cancer-immunotherapy 2020-03-23 19:00:11.439+00 https://www.pharmasalmanac.com/articles/pharma-facility-opportunity-alert-pharmaceutical-grade-facility-available-for-sale-or-lease 2020-03-20 20:21:56.05+00 https://www.pharmasalmanac.com/articles/ge-healthcare-increases-production-to-aid-coronavirus-patients 2020-03-20 18:53:14.949+00 https://www.pharmasalmanac.com/articles/fda-grants-bellerophon-emergency-expanded-access-for-inopulse-for-the-treatment-of-covid-19-virus 2020-03-20 18:21:49.361+00 https://www.pharmasalmanac.com/articles/pfizer-and-biontech-to-co-develop-potential-covid-19-vaccine 2020-03-20 18:00:40.008+00 https://www.pharmasalmanac.com/articles/how-would-you-characterize-the-current-landscape-of-ma-activity-in-the-pharmaceutical/biopharmaceutical-industry 2020-03-19 18:29:46.544+00 https://www.pharmasalmanac.com/articles/fda-urges-remote-clinical-trials 2020-03-19 17:25:14.798+00 https://www.pharmasalmanac.com/articles/roche-ships-400000-coronavirus-test-kits-to-u.s 2020-03-19 16:57:13.621+00 https://www.pharmasalmanac.com/articles/jj-cites-lack-of-evidence-for-hiv-treatment-against-covid-19 2020-03-17 19:44:59.762+00 https://www.pharmasalmanac.com/articles/moderna-announces-first-participant-dosed-in-phase-1-study-of-mrna-vaccine-against-novel-coronavirus 2020-03-17 19:08:01.366+00 https://www.pharmasalmanac.com/articles/pneumagen-ltd-leverages-its-novel-glycan-approach-to-target-coronavirus-covid-19-infections 2020-03-17 16:30:58.752+00 https://www.pharmasalmanac.com/articles/plant-based-protein-expression-for-rapid-green-bioprocessing 2020-03-16 01:45:13.32+00 https://www.pharmasalmanac.com/articles/federal-equipment-company-hosts-four-consecutive-auctions-of-cannabis-and-pharmaceutical-equipment 2020-03-12 21:33:37.9+00 https://www.pharmasalmanac.com/articles/company-founder-ingmar-hoerr-succeeds-daniel-menichella-as-ceo-of-curevac-ag 2020-03-12 21:21:59.987+00 https://www.pharmasalmanac.com/articles/increasing-the-potency-of-antibody-drug-conjugates 2020-03-12 19:54:53.431+00 https://www.pharmasalmanac.com/articles/lilly-statement-on-novel-coronavirus-and-the-reliable-supply-of-the-companys-medicines 2020-03-12 15:25:55.223+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-completes-weather-tight-seal-of-its-biologics-manufacturing-facility-in-ireland 2020-03-12 15:21:49.453+00 https://www.pharmasalmanac.com/articles/bora-pharmaceuticals-to-acquire-gsk-mississauga-based-facility 2020-03-12 15:07:25.325+00 https://www.pharmasalmanac.com/articles/toxys-raises-2-million-financing-for-global-expansion-of-its-unique-animal-free-chemical-safety-tests 2020-03-12 14:58:21.755+00 https://www.pharmasalmanac.com/articles/njiis-biopharma-division-announces-its-advisory-committee 2020-03-11 21:39:42.465+00 https://www.pharmasalmanac.com/articles/evolution-research-group-acquires-richmond-behavioral-associates 2020-03-10 19:47:02.223+00 https://www.pharmasalmanac.com/articles/beroni-group-advances-research-and-development-of-medical-solution-for-coronavirus-covid-19 2020-03-10 19:27:00.109+00 https://www.pharmasalmanac.com/articles/interphex-postponed-due-to-covid-19 2020-03-10 19:22:30.186+00 https://www.pharmasalmanac.com/articles/voluntis-and-bristol-myers-squibb-to-co-develop-digital-therapeutics-for-oncology 2020-03-06 17:50:52.905+00 https://www.pharmasalmanac.com/articles/quest-diagnostics-to-launch-coronavirus-disease-2019-covid-19-test 2020-03-06 17:44:32.918+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-acquire-qiagen-n.v 2020-03-06 16:32:26.736+00 https://www.pharmasalmanac.com/articles/cellectis-and-servier-execute-the-amendment-confirming-the-expansion-of-their-collaboration-on-ucart19-products 2020-03-05 16:00:07.179+00 https://www.pharmasalmanac.com/articles/michael-j.-reilly-promoted-to-ceo-of-integrity-bio 2020-03-05 15:54:09.296+00 https://www.pharmasalmanac.com/articles/biopharma-services-inc.-donates-its-clinical-resources-and-scientific-expertise-in-the-pursuit-of-coronavirus-covid-19-vaccine-research 2020-03-05 15:37:20.006+00 https://www.pharmasalmanac.com/articles/australian-study-expands-health-potential-for-seaweed-extract 2020-03-05 15:28:40.139+00 https://www.pharmasalmanac.com/articles/gilead-to-acquire-forty-seven-for-4.9-billion 2020-03-02 20:42:43.931+00 https://www.pharmasalmanac.com/articles/abbott-and-insulet-partner-to-integrate-next-generation-glucose-sensing-and-automated-insulin-delivery-technologies-for-seamless-diabetes-care 2020-02-27 22:33:49.694+00 https://www.pharmasalmanac.com/articles/perrigo-and-catalent-announce-fda-approval-of-perrigos-ab-rated-generic-version-of-proair-hfa 2020-02-27 22:18:04.688+00 https://www.pharmasalmanac.com/articles/its-7-pm-did-you-pick-up-your-prescription 2020-02-27 19:58:17.528+00 https://www.pharmasalmanac.com/articles/gilead-sciences-initiates-two-phase-3-studies-of-investigational-antiviral-remdesivir-for-the-treatment-of-covid-19 2020-02-27 19:41:33.643+00 https://www.pharmasalmanac.com/articles/nowrx-pharmacy-saves-california-customers-over-1-million-in-less-than-8-months 2020-02-27 19:38:20.97+00 https://www.pharmasalmanac.com/articles/fda-issues-statement-on-ensuring-safety-of-foreign-products-during-coronavirus-outbreak 2020-02-25 16:30:11.623+00 https://www.pharmasalmanac.com/articles/dipharma-francis-s.r.l.-completes-construction-of-new-cgmp-suite-in-usa 2020-02-25 15:55:38.351+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-vir-biotechnology-announce-collaboration-for-global-development-of-antibodies-to-treat-covid-19 2020-02-25 15:48:01.028+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-congratulates-immutep-on-positive-interim-data-for-imp-321 2020-02-24 15:01:50.061+00 https://www.pharmasalmanac.com/articles/eli-lilly-and-company-to-partner-in-support-of-the-olympic-and-paralympic-games-tokyo-2020 2020-02-21 19:38:02.939+00 https://www.pharmasalmanac.com/articles/alku-expands-its-pharmaceutical-services-to-have-a-niche-focus-on-analytical-research-and-development 2020-02-21 18:57:48.364+00 https://www.pharmasalmanac.com/articles/missouri-st-researchers-create-organ-tissue-with-bioactive-glass-stem-cells-and-3d-printer 2020-02-20 17:53:40.139+00 https://www.pharmasalmanac.com/articles/everest-medicines-appoints-kerry-blanchard-m.d.-ph.d.-as-director-and-chief-executive-officer 2020-02-20 16:38:51.436+00 https://www.pharmasalmanac.com/articles/immatics-and-gsk-partner-to-develop-novel-adoptive-cell-therapies 2020-02-20 16:34:25.287+00 https://www.pharmasalmanac.com/articles/regulus-therapeutics-reinitiates-multiple-ascending-dose-study-of-rgls4326-for-the-treatment-of-adpkd 2020-02-18 20:48:03.7+00 https://www.pharmasalmanac.com/articles/eyepoint-pharmaceuticals-and-vision-center-network-of-america-sign-purchase-agreement-for-dexycu 2020-02-18 20:33:57.15+00 https://www.pharmasalmanac.com/articles/medicinova-receives-notice-of-allowance-for-new-patent-covering-mn-001-and-mn-002-for-the-treatment-of-advanced-nash-in-japan 2020-02-18 20:19:35.294+00 https://www.pharmasalmanac.com/articles/fda-grants-soligenix-fast-track-designation-for-rivax-in-the-prevention-of-ricin-poisoning 2020-02-14 18:18:10.257+00 https://www.pharmasalmanac.com/articles/avenue-therapeutics-announces-new-drug-application-for-iv-tramadol-accepted-for-review-by-fda 2020-02-14 18:12:03.842+00 https://www.pharmasalmanac.com/articles/johnson-johnson-announces-collaboration-with-u.s.-department-of-health-human-services-to-accelerate-development-of-a-potential-novel-coronavirus-vaccine 2020-02-14 17:52:13.963+00 https://www.pharmasalmanac.com/articles/astrazeneca-singapore-establish-strategic-partnerships-to-improve-health-through-innovation 2020-02-13 15:38:33.862+00 https://www.pharmasalmanac.com/articles/catalent-completes-acquisition-of-masthercell 2020-02-13 15:25:01.785+00 https://www.pharmasalmanac.com/articles/bayer-and-nuvisan-create-new-research-unit-in-berlin 2020-02-13 15:14:01.68+00 https://www.pharmasalmanac.com/articles/enterprise-therapeutics-appoints-dr-david-morris-md-as-chief-medical-officer 2020-02-11 20:31:47.884+00 https://www.pharmasalmanac.com/articles/kalvista-pharmaceuticals-provides-update-on-diabetic-macular-edema-programs 2020-02-11 20:26:52.29+00 https://www.pharmasalmanac.com/articles/novartis-lung-cancer-drug-granted-priority-fda-review 2020-02-11 20:21:29.92+00 https://www.pharmasalmanac.com/articles/yale-innovation-summit-announces-media-partnership-with-pharmas-almanac 2020-02-05 22:23:04.766+00 https://www.pharmasalmanac.com/articles/olympus-announces-fda-clearance-of-the-tjf-q190v-duodenoscope 2020-02-04 15:36:56.315+00 https://www.pharmasalmanac.com/articles/abcam-expands-cell-engineering-capabilities-through-asset-purchase-of-applied-stemcells-gene-editing-platform-and-oncology-product-portfolio 2020-02-04 15:32:01.611+00 https://www.pharmasalmanac.com/articles/novacyt-launches-test-for-coronavirus 2020-02-04 15:26:53.827+00 https://www.pharmasalmanac.com/articles/synteract-expands-into-asia-pacific-and-south-africa-through-acquisition-of-specialty-biometrics-cro 2020-02-04 15:07:39.12+00 https://www.pharmasalmanac.com/articles/cepi-and-gsk-collaborate-to-develop-a-vaccine-for-coronavirus 2020-02-04 10:00:00.336+00 https://www.pharmasalmanac.com/articles/gilead-sciences-begins-trial-on-treatment-for-coronavirus-2019-ncov 2020-02-04 10:00:00.274+00 https://www.pharmasalmanac.com/articles/boston-pharmaceuticals-appoints-dr.-craig-t.-basson-m.d.-ph.d.-as-chief-medical-officer 2020-02-04 10:00:00.261+00 https://www.pharmasalmanac.com/articles/sony-announces-fda-clearance-for-nucleus-the-smart-operating-room-platform-for-sale-in-the-u.s 2020-02-04 10:00:00.261+00 https://www.pharmasalmanac.com/articles/insmed-announces-positive-top-line-results-from-phase-2-willow-study-of-ins1007-in-patients-with-non-cystic-fibrosis-bronchiectasis 2020-02-03 21:44:07.202+00 https://www.pharmasalmanac.com/articles/vgxi-to-manufacture-vaccine-against-novel-coronavirus-under-cepi-funded-collaboration 2020-02-03 21:33:51.576+00 https://www.pharmasalmanac.com/articles/catalent-acquires-orgenesis-cell-therapy-unit 2020-02-03 20:08:47.508+00 https://www.pharmasalmanac.com/articles/cynbiose-receives-2.1-million-to-launch-cynbiome-for-preclinical-services-for-the-microbiome 2020-01-29 16:04:52.643+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-enables-development-of-multiple-neutralizing-antibodies-for-novel-coronavirus 2020-01-29 15:00:05.727+00 https://www.pharmasalmanac.com/articles/the-health-plan-serving-over-200000-covered-lives-selects-nanthealths-navinet-open-to-drive-provider-engagement-strategy 2020-01-28 15:44:10.501+00 https://www.pharmasalmanac.com/articles/kintai-therapeutics-advances-anti-obesity-agent-after-demonstrating-sustained-weight-loss 2020-01-28 15:28:04.364+00 https://www.pharmasalmanac.com/articles/2020-21-blavatnik-fellowship-at-yale-applications-are-now-being-accepted 2020-01-27 17:49:24.817+00 https://www.pharmasalmanac.com/articles/adhering-to-delivery-milestones 2020-01-24 15:43:47.522+00 https://www.pharmasalmanac.com/articles/crispr-cas9-milestones-the-first-in-vivo-clinical-trial-is-now-underway 2020-01-23 20:29:43.493+00 https://www.pharmasalmanac.com/articles/roches-risdiplam-meets-primary-endpoint-in-pivotal-firefish-trial 2020-01-23 20:22:54.857+00 https://www.pharmasalmanac.com/articles/the-center-for-breakthrough-medicines-to-build-a-cell-and-gene-therapy-cdmo-in-king-of-prussia-pa 2020-01-23 20:18:01.912+00 https://www.pharmasalmanac.com/articles/governor-cooper-announces-over-460-jobs-in-durham-as-eli-lilly-and-company-selects-north-carolina-for-major-pharmaceutical-plant 2020-01-23 20:04:26.251+00 https://www.pharmasalmanac.com/articles/samsung-biologics-and-ucb-sign-third-drug-manufacturing-deal 2020-01-22 17:07:09.625+00 https://www.pharmasalmanac.com/articles/lilly-announces-agreement-to-acquire-dermira 2020-01-21 16:35:50.941+00 https://www.pharmasalmanac.com/articles/dozens-of-non-oncology-drugs-can-kill-cancer-cells 2020-01-21 16:10:35.527+00 https://www.pharmasalmanac.com/articles/numedii-inc.-announces-pharmaceutical-discovery-collaboration-for-ulcerative-colitis 2020-01-20 14:47:28.164+00 https://www.pharmasalmanac.com/articles/insilico-enters-into-artificial-intelligence-collaboration-with-pfizer 2020-01-17 17:42:41.834+00 https://www.pharmasalmanac.com/articles/lilly-expands-insulin-affordability-options 2020-01-17 17:35:31.125+00 https://www.pharmasalmanac.com/articles/civica-rx-partners-with-thermo-fisher-scientific-to-develop-and-manufacture-drugs-with-a-history-of-drug-shortages 2020-01-17 17:29:03.526+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-and-bayer-enter-into-an-acquisition-agreement-on-a-drug-product-plant-in-germany 2020-01-16 16:45:14.471+00 https://www.pharmasalmanac.com/articles/popularity-of-generic-drugs-poised-to-overshadow-atherosclerosis-drugs-market-growth 2020-01-15 17:07:42.597+00 https://www.pharmasalmanac.com/articles/abbvie-announces-leadership-team-and-creation-of-new-business-allergan-aesthetics-upon-completion-of-acquisition 2020-01-09 22:24:32.595+00 https://www.pharmasalmanac.com/articles/supporting-commercialization-of-live-biotherapeutic-products-for-microbiome-based-therapies 2020-01-09 17:44:21.746+00 https://www.pharmasalmanac.com/articles/bc-platforms-partners-with-dante-labs-to-build-europes-largest-next-generation-sequencing-laboratory-for-private-and-public-customers 2020-01-08 20:22:48.096+00 https://www.pharmasalmanac.com/articles/phillips-medisize-expands-clinical-manufacturing-capabilities-to-serve-growing-drug-delivery-device-market 2020-01-08 20:13:40.207+00 https://www.pharmasalmanac.com/articles/building-the-foundation-of-japans-premier-cdmo 2020-01-07 21:27:28.604+00 https://www.pharmasalmanac.com/articles/lonza-and-allevi-collaborate-to-advance-3d-bioprinting 2020-01-07 17:26:15.951+00 https://www.pharmasalmanac.com/articles/yseop-and-litera-partner-to-fast-track-regulation-submission-processes-for-life-sciences-companies 2020-01-07 17:22:27.236+00 https://www.pharmasalmanac.com/articles/wuxi-sta-opens-oligonucleotide-large-scale-manufacturing-facility 2020-01-07 17:22:13.303+00 https://www.pharmasalmanac.com/articles/lnc-therapeutics-chooses-luina-bio-for-the-development-and-gmp-manufacturing-of-its-first-live-biotherapeutic-product-based-on-the-gut-microbiome 2020-01-06 16:32:08.983+00 https://www.pharmasalmanac.com/articles/what-breakthrough-technologies-have-had-a-transformative-effect-on-your-business-this-year 2020-01-03 19:59:03.531+00 https://www.pharmasalmanac.com/articles/melinta-therapeutics-announces-restructuring-and-files-bankruptcy 2020-01-03 15:29:29.332+00 https://www.pharmasalmanac.com/articles/llumina-and-pacific-biosciences-announce-termination-of-merger-agreement 2020-01-03 15:21:10.702+00 https://www.pharmasalmanac.com/articles/astellas-strengthens-immuno-oncology-pipeline-with-acquisition-of-xyphos-biosciences-inc 2020-01-03 15:17:22.427+00 https://www.pharmasalmanac.com/articles/ucb-to-build-new-biotech-manufacturing-plant-in-belgium 2020-01-02 20:01:05.784+00 https://www.pharmasalmanac.com/articles/joinn-biologics-inc.-receives-60-million-series-a-financing 2019-12-20 17:20:42.173+00 https://www.pharmasalmanac.com/articles/agenus-commences-combination-trial-of-its-next-gen-ctla-4-with-its-pd-1-antibody 2019-12-20 17:02:13.577+00 https://www.pharmasalmanac.com/articles/averitas-pharma-announces-fda-acceptance-for-neuropathic-pain-treatment 2019-12-20 17:01:17.486+00 https://www.pharmasalmanac.com/articles/vistagen-and-baylor-college-of-medicine-announce-successful-results-of-study-treating-suicidal-ideation-in-veterans 2019-12-20 16:50:12.675+00 https://www.pharmasalmanac.com/articles/agc-biologics-expands-plasmid-dna-offering 2019-12-20 16:45:42.83+00 https://www.pharmasalmanac.com/articles/trump-administration-proposes-new-rules-to-increase-accountability-and-availability-of-the-organ-supply 2019-12-18 18:25:18.011+00 https://www.pharmasalmanac.com/articles/federal-trade-commission-closes-investigation-of-roche-holding-ags-proposed-acquisition-of-spark-therapeutics-inc 2019-12-18 18:12:39.5+00 https://www.pharmasalmanac.com/articles/ftc-challenges-illuminas-proposed-acquisition-of-pacbio 2019-12-18 18:11:57.001+00 https://www.pharmasalmanac.com/articles/grail-appoints-gautam-kollu-as-chief-commercial-officer 2019-12-18 18:08:51.312+00 https://www.pharmasalmanac.com/articles/biohaven-achieves-positive-topline-results-for-intranasal-migraine-treatment 2019-12-17 19:29:33.423+00 https://www.pharmasalmanac.com/articles/immuneering-completes-17-million-series-a-financing 2019-12-16 16:44:47.847+00 https://www.pharmasalmanac.com/articles/vote-expected-on-democratic-drug-pricing-bill 2019-12-13 17:38:49.687+00 https://www.pharmasalmanac.com/articles/janssen-reports-positive-results-for-darzalex-in-multiple-myeloma 2019-12-13 17:29:43.851+00 https://www.pharmasalmanac.com/articles/sanofi-to-exit-diabetes-and-cardiovascular-research 2019-12-13 17:24:58.718+00 https://www.pharmasalmanac.com/articles/analysis-finds-big-pharma-does-not-develop-most-new-drugs 2019-12-13 17:16:20.417+00 https://www.pharmasalmanac.com/articles/simultaneous-rna-and-dna-testing-is-more-effective-than-dna-testing-alone 2019-12-13 17:15:50.247+00 https://www.pharmasalmanac.com/articles/abbvie-and-scripps-research-announce-collaboration-to-develop-a-broad-range-of-new-therapeutics 2019-12-12 20:41:52.333+00 https://www.pharmasalmanac.com/articles/reducing-fill-finish-wait-times 2019-12-12 15:25:54.1+00 https://www.pharmasalmanac.com/articles/amgen-selects-location-for-rd-facility-in-the-south-san-francisco-biotechnology-hub 2019-12-10 20:29:10.338+00 https://www.pharmasalmanac.com/articles/sanofi-to-acquire-synthorx-to-bolster-its-immuno-oncology-pipeline-for-2.5-billion 2019-12-10 20:16:58.186+00 https://www.pharmasalmanac.com/articles/flagship-pioneering-unveils-cygnal-therapeutics 2019-12-10 20:12:53.165+00 https://www.pharmasalmanac.com/articles/fujifilm-toyama-chemical-announces-completion-of-japans-first-manufacturing-facility-for-commercial-liposome-formulations 2019-12-10 19:58:56.404+00 https://www.pharmasalmanac.com/articles/advancing-commercial-manufacturing-from-orphan-drugs-to-blockbusters 2019-12-10 16:34:50.343+00 https://www.pharmasalmanac.com/articles/four-technology-trends-bringing-personalized-medicine-to-life 2019-12-10 15:45:24.671+00 https://www.pharmasalmanac.com/articles/introduction-the-promise-challenge-of-gene-therapy 2019-12-10 15:13:13.838+00 https://www.pharmasalmanac.com/articles/solving-process-challenges-requires-flexibility-to-explore-alternative-analytical-methods 2019-12-09 20:49:41.579+00 https://www.pharmasalmanac.com/articles/facilitating-3d-organ-printing-with-plant-based-bioinks 2019-12-09 20:01:47.471+00 https://www.pharmasalmanac.com/articles/what-developing-technologies-do-you-believe-will-have-the-greatest-impact-on-the-biopharma-industry-in-2020-and-beyond 2019-12-07 22:18:50.345+00 https://www.pharmasalmanac.com/articles/bringing-novel-delivery-technologies-to-the-north-american-market 2019-12-06 22:56:37.232+00 https://www.pharmasalmanac.com/articles/the-pivotal-role-of-plasmid-dna 2019-12-06 22:55:52.075+00 https://www.pharmasalmanac.com/articles/driving-drug-discovery-using-patients-immune-response 2019-12-06 22:54:23.393+00 https://www.pharmasalmanac.com/articles/cd34-cell-therapy-in-clinical-trials 2019-12-06 22:53:58.134+00 https://www.pharmasalmanac.com/articles/the-self-protein-challenge 2019-12-06 22:53:26.644+00 https://www.pharmasalmanac.com/articles/why-the-industry-is-moving-toward-blockchain-technology 2019-12-06 22:53:06.503+00 https://www.pharmasalmanac.com/articles/fast-tracking-adc-development-and-commercialization 2019-12-06 22:52:40.35+00 https://www.pharmasalmanac.com/articles/challenges-of-manufacturing-the-expanding-range-of-bimultispecific-modalities 2019-12-06 22:49:38.819+00 https://www.pharmasalmanac.com/articles/fast-tracking-design-and-construction-to-save-more-lives 2019-12-06 22:48:55.824+00 https://www.pharmasalmanac.com/articles/giving-structure-to-a-long-term-csr-strategy 2019-12-06 22:48:13.007+00 https://www.pharmasalmanac.com/articles/how-a-quality-culture-contributes-to-global-compliance 2019-12-06 22:47:51.637+00 https://www.pharmasalmanac.com/articles/small-batch-drug-development-and-production-requires-flexible-repeatable-fill-finish-systems 2019-12-06 22:45:44.059+00 https://www.pharmasalmanac.com/articles/proprietary-protein-therapeutics-with-clinically-improved-profiles 2019-12-06 22:45:18.096+00 https://www.pharmasalmanac.com/articles/supporting-rapid-equipment-procurement-for-fast-tracked-projects 2019-12-06 22:44:41.836+00 https://www.pharmasalmanac.com/articles/innovating-the-approach-to-neurological-disease-treatment 2019-12-06 22:44:17.915+00 https://www.pharmasalmanac.com/articles/advances-in-the-oral-delivery-of-peptides 2019-12-06 22:43:57.429+00 https://www.pharmasalmanac.com/articles/slow-progress-and-a-shaky-start-whats-next-for-gene-therapy 2019-12-06 22:43:19.538+00 https://www.pharmasalmanac.com/articles/high-productivity-membrane-chromatography-to-enable-next-generation-purification-of-monoclonal-antibodies 2019-12-06 22:43:02.857+00 https://www.pharmasalmanac.com/articles/innovative-therapies-to-treat-rare-and-underserved-eye-diseases 2019-12-06 22:42:45.742+00 https://www.pharmasalmanac.com/articles/gene-therapy-rd-accelerates 2019-12-06 22:40:50.142+00 https://www.pharmasalmanac.com/articles/developing-a-potential-cure-for-bladder-cancer 2019-12-06 22:40:31.204+00 https://www.pharmasalmanac.com/articles/overcoming-the-manufacturing-roadblock 2019-12-06 22:40:10.636+00 https://www.pharmasalmanac.com/articles/promise-amid-challenges-logistics-of-the-cell-and-gene-therapy-supply-chain 2019-12-06 22:39:46.862+00 https://www.pharmasalmanac.com/articles/tackling-genetic-eye-diseases-with-novel-rna-therapies 2019-12-06 22:39:26.073+00 https://www.pharmasalmanac.com/articles/leveraging-natural-killer-cells-as-car-t-therapies 2019-12-06 22:39:07.737+00 https://www.pharmasalmanac.com/articles/akoya-biosciences-raises-50-million-in-new-financing 2019-12-06 19:45:17.631+00 https://www.pharmasalmanac.com/articles/reducing-project-timelines-with-integrated-cleanroom-solutions 2019-12-06 18:43:58.667+00 https://www.pharmasalmanac.com/articles/acadia-pharmaceuticals-presents-positive-top-line-results-from-dementia-related-psychosis-trial 2019-12-06 18:41:44.454+00 https://www.pharmasalmanac.com/articles/gavi-board-approves-new-ebola-vaccine-program 2019-12-06 18:37:00.62+00 https://www.pharmasalmanac.com/articles/takeda-and-enzyre-to-develop-diagnostic-device-allowing-hemophilia-patients-to-determine-their-coagulation-status-at-home 2019-12-06 18:23:17.478+00 https://www.pharmasalmanac.com/articles/alternative-vial-designs-to-reduce-lyo-breakage-risk 2019-12-06 17:58:39.379+00 https://www.pharmasalmanac.com/articles/horizon-therapeutics-plc-opens-new-manufacturing-and-rd-facility-in-south-san-francisco 2019-12-05 17:41:10.462+00 https://www.pharmasalmanac.com/articles/leo-pharma-and-portal-instruments-announce-collaboration-to-develop-needle-free-drug-delivery-device 2019-12-05 17:37:44.779+00 https://www.pharmasalmanac.com/articles/piramal-pharma-solutions-announces-collaboration-with-bergenbio-on-the-development-of-fda-fast-track-designated-leukemia-treatment 2019-12-05 17:27:26.108+00 https://www.pharmasalmanac.com/articles/how-does-your-company-manage-to-provide-local-services-support-while-still-efficiently-managing-global-compliance 2019-12-04 21:23:45.469+00 https://www.pharmasalmanac.com/articles/science-37-names-david-coman-chief-executive-officer 2019-11-29 10:00:00.325+00 https://www.pharmasalmanac.com/articles/merz-forms-fully-focused-global-medical-aesthetics-business-merz-aesthetics 2019-11-29 10:00:00.324+00 https://www.pharmasalmanac.com/articles/crb-on-the-road-to-bio-making-your-facility-a-future-facility 2019-11-26 18:58:24.489+00 https://www.pharmasalmanac.com/articles/upm-pharmaceuticals-on-the-road-to-bio-anticipating-whats-around-the-bend 2019-11-26 18:57:48.31+00 https://www.pharmasalmanac.com/articles/biovectra-on-the-road-to-bio-bridging-microbial-demand-with-expanded-capacity 2019-11-26 18:55:08.303+00 https://www.pharmasalmanac.com/articles/celanese-on-the-road-to-bio-excipients-in-biologics 2019-11-26 18:54:55.192+00 https://www.pharmasalmanac.com/articles/abzena-on-the-road-to-bio-fueling-biopharmaceutical-development 2019-11-26 18:54:43.365+00 https://www.pharmasalmanac.com/articles/calquence-approved-in-the-us-for-adult-patients-with-chronic-lymphocytic-leukemia 2019-11-25 20:23:01.719+00 https://www.pharmasalmanac.com/articles/nations-business-groups-call-for-full-repeal-of-medical-device-tax 2019-11-25 20:11:03.981+00 https://www.pharmasalmanac.com/articles/alcami-on-the-road-to-bio-creating-differentiated-value-for-biotechs 2019-11-25 20:02:39.083+00 https://www.pharmasalmanac.com/articles/medtronic-drug-coated-balloon-receives-u.s.-fda-approval-to-treat-arteriovenous-fistula-lesions 2019-11-25 18:45:29.799+00 https://www.pharmasalmanac.com/articles/novartis-to-acquire-the-medicines-company-for-9.7-billion 2019-11-25 18:42:42.897+00 https://www.pharmasalmanac.com/articles/ferring-and-blackstone-life-sciences-invest-over-570-million-usd-in-novel-gene-therapy-for-bladder-cancer-patients 2019-11-25 18:41:39.021+00 https://www.pharmasalmanac.com/articles/kristine-senft-on-the-road-to-bio-driving-growth-through-communication-transparency-agility 2019-11-23 20:42:39.423+00 https://www.pharmasalmanac.com/articles/icagen-on-the-road-to-bio-early-stage-planning-for-end-stage-success 2019-11-23 20:42:08.471+00 https://www.pharmasalmanac.com/articles/unither-pharmaceuticals-on-the-road-to-bio-innovation-in-delivery 2019-11-23 20:41:30.362+00 https://www.pharmasalmanac.com/articles/mw-r2b 2019-11-23 20:39:01.608+00 https://www.pharmasalmanac.com/articles/emory-university-on-the-road-to-bio-drug-innovation-ventures-at-emory-drive 2019-11-23 20:38:08.038+00 https://www.pharmasalmanac.com/articles/envigo-on-the-road-to-bio-staying-the-course-with-a-credible-partner 2019-11-23 20:37:34.755+00 https://www.pharmasalmanac.com/articles/bio-rad-on-the-road-to-bio-accelerating-discovery-to-improve-lives 2019-11-23 20:37:00.836+00 https://www.pharmasalmanac.com/articles/g-con-on-the-road-to-bio-managing-mobility-flexibility-risk-with-modular-design 2019-11-23 20:36:24.867+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-1-massachusetts-/-new-york 2019-11-23 18:51:08.373+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-2-new-york-/-pennsylvania 2019-11-23 18:50:29.193+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-3-pennsylvania-/-tennessee 2019-11-23 18:49:27.453+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-4-tennessee-/-south-carolina 2019-11-23 18:48:18.621+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-5-south-carolina-/-georgia 2019-11-23 18:47:32.746+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-6-georgia-/-mississippi 2019-11-23 18:46:37.299+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-7-texas 2019-11-23 18:45:36.71+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-8-texas 2019-11-23 18:44:48.63+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-10-texas-/-arizona 2019-11-23 18:43:34.111+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-9-texas 2019-11-23 18:42:46.622+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-11-arizona-/-california 2019-11-23 18:39:59.361+00 https://www.pharmasalmanac.com/articles/the-road-to-bio-day-12-california 2019-11-23 18:38:51.461+00 https://www.pharmasalmanac.com/articles/kronos-bio-appoints-biopharma-industry-veteran-jorge-f.-dimartino-m.d.-ph.d.-as-chief-medical-officer 2019-11-20 18:43:11.11+00 https://www.pharmasalmanac.com/articles/lilly-announces-400-million-capital-investment-in-manufacturing-facilities-in-indianapolis 2019-11-20 18:36:42.439+00 https://www.pharmasalmanac.com/articles/tissium-closes-39m-series-b-funding-round 2019-11-20 18:25:46.128+00 https://www.pharmasalmanac.com/articles/werewolf-therapeutics-launches-with-56m-series-a-financing-to-develop-transformative-immuno-stimulatory-cancer-medicines 2019-11-20 18:15:44.992+00 https://www.pharmasalmanac.com/articles/crispr-therapeutics-and-vertex-announce-positive-safety-and-efficacy-data-from-first-two-patients-treated-with-investigational-crispr/cas9-gene-editing-1574272694075 2019-11-20 18:00:00.386+00 https://www.pharmasalmanac.com/articles/rising-demand-for-novel-cancer-treatment-approaches-to-propel-cell-line-development-market-through-2024 2019-11-20 15:46:06.558+00 https://www.pharmasalmanac.com/articles/qtrilmet-approved-in-the-eu-for-the-treatment-of-type-2-diabetes 2019-11-19 15:52:08.999+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-congratulates-tychan-on-the-worlds-first-yellow-fever-antibody-tested-safe-and-efficacious-in-human-volunteers 2019-11-19 15:46:34.051+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-invests-nearly-50-million-to-expand-plant-in-puerto-rico 2019-11-15 16:35:27.758+00 https://www.pharmasalmanac.com/articles/kayentis-opens-japanese-subsidiary-to-support-growth-of-asia-pacific-clinical-trials-sector 2019-11-15 16:19:42.163+00 https://www.pharmasalmanac.com/articles/ge-healthcare-life-sciences-and-akeso-pharmaceuticals-to-speed-up-novel-therapy-manufacturing-in-china 2019-11-15 15:54:59.302+00 https://www.pharmasalmanac.com/articles/fujifilm-diosynth-biotechnologies-announces-55-million-investment-to-expand-gene-therapy-development-capabilities 2019-11-15 15:42:43.264+00 https://www.pharmasalmanac.com/articles/analytical-methodologies-utilized-in-therapeutic-viral-vector-manufacturing 2019-11-15 15:06:37.179+00 https://www.pharmasalmanac.com/articles/dr.-kerklaan-therapeutics-doctor-created-and-tested-cbd-wellness-line-expands-into-global-retailers 2019-11-13 20:43:13.988+00 https://www.pharmasalmanac.com/articles/invitae-to-acquire-clear-genetics 2019-11-13 19:25:09.266+00 https://www.pharmasalmanac.com/articles/sandoz-announces-agreement-to-acquire-aspens-japanese-operations 2019-11-13 17:46:33.339+00 https://www.pharmasalmanac.com/articles/leveraging-effective-partnering-models 2019-11-12 17:51:09.997+00 https://www.pharmasalmanac.com/articles/enhancing-responsiveness-with-embedded-flexibility 2019-11-12 17:50:50.377+00 https://www.pharmasalmanac.com/articles/servier-offers-quality-service 2019-11-12 17:24:22.811+00 https://www.pharmasalmanac.com/articles/benefitting-from-embedded-quality-for-end-to-end-success 2019-11-12 17:23:48.544+00 https://www.pharmasalmanac.com/articles/risk-minimization-with-an-integrated-global-network 2019-11-12 17:23:27.955+00 https://www.pharmasalmanac.com/articles/aligning-the-outsourcing-relationship 2019-11-12 17:22:44.29+00 https://www.pharmasalmanac.com/articles/major-shift-to-digital-ads-expected-in-2020 2019-11-12 16:19:26.209+00 https://www.pharmasalmanac.com/articles/abbvie-issues-large-bond-to-finance-allergan-merger 2019-11-12 15:58:19.737+00 https://www.pharmasalmanac.com/articles/gene-therapy-payment-questions-linger 2019-11-12 15:29:27.161+00 https://www.pharmasalmanac.com/articles/sandoz-receives-fda-approval-for-oncology-supportive-care-biosimilar-ziextenzo 2019-11-08 16:52:23.097+00 https://www.pharmasalmanac.com/articles/stryker-announces-definitive-agreement-to-acquire-wright-medical 2019-11-08 16:49:02.886+00 https://www.pharmasalmanac.com/articles/several-candidates-are-contending-for-the-top-fda-job 2019-11-06 17:31:16.877+00 https://www.pharmasalmanac.com/articles/new-bill-proposes-to-lower-drug-costs 2019-11-06 17:30:05.24+00 https://www.pharmasalmanac.com/articles/rna-repressor-switches-off-protein-production 2019-11-06 17:29:35.543+00 https://www.pharmasalmanac.com/articles/revolution-medicines-and-amgen-partner-on-phase-1b-study-to-evaluate-combination-of-rmc-4630-and-amg-510 2019-11-05 19:25:36.953+00 https://www.pharmasalmanac.com/articles/compugen-announces-fda-clearance-of-ind-application-for-com902 2019-11-05 19:22:53.337+00 https://www.pharmasalmanac.com/articles/ichnos-sciences-announces-completion-of-enrollment-of-phase-2b-trials-for-two-investigational-therapies-isb-830-and-isc-27864 2019-11-05 19:19:43.54+00 https://www.pharmasalmanac.com/articles/t3d-therapeutics-closes-15m-financing-to-advance-phase-2-development-of-t3d-959-in-a-new-approach-to-treating-alzheimers-disease 2019-11-05 19:16:40.148+00 https://www.pharmasalmanac.com/articles/sanifit-announces-the-phase-2b-calipso-trial-of-snf472-met-endpoint-in-slowing-the-cardiovascular-calcification-in-patients-on-hemodialysis 2019-11-01 19:29:07.091+00 https://www.pharmasalmanac.com/articles/amgen-enters-into-strategic-collaboration-with-beigene-to-expand-oncology-presence-in-china 2019-11-01 19:19:21.181+00 https://www.pharmasalmanac.com/articles/seranovo-enters-into-license-agreement-with-carna-biosciences-for-development-of-oral-formulation-of-carnas-kinase-inhibitor 2019-10-30 15:09:00.324+00 https://www.pharmasalmanac.com/articles/arranta-bio-announces-82m-in-new-funding-and-a-strategic-partnership-with-thermo-fisher-scientific 2019-10-30 14:52:28.638+00 https://www.pharmasalmanac.com/articles/supporting-customers-with-an-integrated-fermentation-offering-1 2019-10-30 13:35:06.879+00 https://www.pharmasalmanac.com/articles/tg-therapeutics-announces-positive-results-from-the-unity-nhl-phase-2b-pivotal-trial-evaluating-umbralisib-monotherapy-in-patients-with-relapsed 2019-10-29 16:55:55.041+00 https://www.pharmasalmanac.com/articles/mirati-therapeutics-presents-first-clinical-data-of-phase-1/2-trial-of-mrtx849 2019-10-29 16:41:09.778+00 https://www.pharmasalmanac.com/articles/disc-medicine-expands-pipeline-focused-on-hepcidin-pathway 2019-10-29 16:28:48.779+00 https://www.pharmasalmanac.com/articles/gsk-candidate-vaccine-demonstrates-sustained-level-of-protection-against-active-pulmonary-tuberculosis 2019-10-29 16:22:06.961+00 https://www.pharmasalmanac.com/articles/impacts-of-glocalization-on-the-pharmaceutical-industry 2019-10-29 13:12:42.608+00 https://www.pharmasalmanac.com/articles/production-of-aav-vectors-using-suspension-mammalian-and-insect-cell-systems 2019-10-29 00:12:22.707+00 https://www.pharmasalmanac.com/articles/what-do-you-identify-as-the-greatest-advances-that-have-been-achieved-in-recent-years-with-respect-to-harmonization-of-pharmaceutical-regulations 2019-10-28 23:24:46.737+00 https://www.pharmasalmanac.com/articles/glocalization-introduction 2019-10-28 22:54:28.423+00 https://www.pharmasalmanac.com/articles/from-regulatory-convergence-to-global-regulatory-harmonization 2019-10-28 22:01:45.251+00 https://www.pharmasalmanac.com/articles/the-relevance-of-global-clinical-trials 2019-10-28 22:00:39.433+00 https://www.pharmasalmanac.com/articles/northway-biotechpharma-celebrates-15-years-of-growth-and-success-1 2019-10-28 21:50:35.752+00 https://www.pharmasalmanac.com/articles/choosing-the-right-expression-platform-for-biologics 2019-10-28 21:48:50.48+00 https://www.pharmasalmanac.com/articles/creating-a-global-cdmo-focused-on-quality-innovation-and-happiness 2019-10-28 21:48:37.368+00 https://www.pharmasalmanac.com/articles/achieving-rapid-success-with-a-flexible-client-centric-approach 2019-10-28 21:47:09.965+00 https://www.pharmasalmanac.com/articles/living-in-canadas-coastal-paradise 2019-10-28 21:46:10.704+00 https://www.pharmasalmanac.com/articles/facilitating-pharmaceutical-and-biotech-facility-acquisitions 2019-10-28 21:45:48.948+00 https://www.pharmasalmanac.com/articles/updating-ethical-guidelines-for-cancer-clinical-trials 2019-10-28 21:45:28.664+00 https://www.pharmasalmanac.com/articles/strategizing-for-international-business-development 2019-10-28 21:44:59.695+00 https://www.pharmasalmanac.com/articles/expanding-access-to-oral-thin-film-technology 2019-10-28 21:44:21.771+00 https://www.pharmasalmanac.com/articles/stabilizing-and-protecting-biologic-formulations 2019-10-28 21:43:53.236+00 https://www.pharmasalmanac.com/articles/facilitating-modern-bioprocessing-with-real-time-protein-titer-monitoring 2019-10-28 21:42:40.046+00 https://www.pharmasalmanac.com/articles/focusing-on-the-tumor-microenvironment-leads-to-novel-drug-targets 2019-10-28 21:42:08.164+00 https://www.pharmasalmanac.com/articles/looking-beyond-current-treatments-for-cns-diseases-and-disorders 2019-10-28 21:41:49.071+00 https://www.pharmasalmanac.com/articles/leveraging-biosynthetic-expertise-to-access-a-wide-portfolio-of-cannabinoids 2019-10-28 21:41:16.623+00 https://www.pharmasalmanac.com/articles/personalizing-cancer-treatment-with-genomics-technology 2019-10-28 21:40:56.993+00 https://www.pharmasalmanac.com/articles/developing-a-microbiome-based-treatment-for-food-allergies 2019-10-28 21:40:36.369+00 https://www.pharmasalmanac.com/articles/mimicking-environmental-enrichment-for-migraine-therapy 2019-10-28 21:40:13.437+00 https://www.pharmasalmanac.com/articles/harnessing-the-gut-brain-axis-to-treat-neurological-disorders 2019-10-28 21:39:57.189+00 https://www.pharmasalmanac.com/articles/meeting-the-need-for-higher-containment 2019-10-28 21:39:30.196+00 https://www.pharmasalmanac.com/articles/internationalization-of-a-european-cdmo 2019-10-28 21:38:58.217+00 https://www.pharmasalmanac.com/articles/rigorous-quality-controls-for-cold-chain-drug-shipments 2019-10-28 21:38:36.738+00 https://www.pharmasalmanac.com/articles/supporting-commercial-manufacturing-of-semisolid-dosage-forms 2019-10-28 21:35:52.793+00 https://www.pharmasalmanac.com/articles/executive-compensation-essential-factor-in-private-equity-transactions 2019-10-28 21:34:33.714+00 https://www.pharmasalmanac.com/articles/tech-transfer-and-scale-up-for-custom-apis-driven-by-a-collaborative-culture 2019-10-28 21:33:54.456+00 https://www.pharmasalmanac.com/articles/growing-with-a-flexible-collaborative-cdmo 2019-10-28 21:32:59.216+00 https://www.pharmasalmanac.com/articles/amgen-to-make-repatha-evolocumab-available-exclusively-at-its-lower-list-price-option-in-2020 2019-10-25 17:44:00.818+00 https://www.pharmasalmanac.com/articles/novartis-gets-european-approval-to-update-cosentyx-label-to-include-dosing-flexibility-in-ankylosing-spondylitis 2019-10-25 17:32:11.702+00 https://www.pharmasalmanac.com/articles/gsk-agrees-to-divest-rabies-and-tick-borne-encephalitis-vaccines-to-bavarian-nordic 2019-10-25 17:27:46.064+00 https://www.pharmasalmanac.com/articles/supporting-customers-with-an-integrated-fermentation-offering 2019-10-25 17:10:01.562+00 https://www.pharmasalmanac.com/articles/gsk-announces-u.s.-food-and-drug-administration-approval-of-additional-indication-for-zejula-niraparib-for-late-line-treatment-for-women 2019-10-24 14:48:26.377+00 https://www.pharmasalmanac.com/articles/trialspark-announces-collaboration-with-limbix-on-conducting-an-end-to-end-clinical-trial-on-limbixs-digital-therapeutic-for-adolescent-depression 2019-10-24 14:30:38.804+00 https://www.pharmasalmanac.com/articles/nih-launches-new-collaboration-to-develop-gene-based-cures-for-sickle-cell-disease-and-hiv-on-global-scale 2019-10-24 14:07:41.183+00 https://www.pharmasalmanac.com/articles/sigrid-therapeutics-takes-another-step-towards-a-treatment-for-prevention-of-type-2-diabetes 2019-10-24 13:57:31.798+00 https://www.pharmasalmanac.com/articles/biogen-plans-regulatory-filing-for-aducanumab-in-alzheimers-disease-based-on-new-analysis-of-larger-dataset-from-phase-3-studies 2019-10-22 14:51:06.264+00 https://www.pharmasalmanac.com/articles/sartorius-stedim-biotech-launches-new-sartocheck-5-plus-filter-tester 2019-10-22 14:42:43.574+00 https://www.pharmasalmanac.com/articles/farxiga-approved-in-the-us-to-reduce-the-risk-of-hospitalization-for-heart-failure-in-patients-with-type-2-diabetes 2019-10-22 14:33:06.844+00 https://www.pharmasalmanac.com/articles/tripharm-services-announces-creation-of-pharmaceutical-manufacturing-center 2019-10-17 15:47:20.462+00 https://www.pharmasalmanac.com/articles/sofinnova-partners-raises-333-million-capital-ix-early-stage-healthcare-fund 2019-10-17 15:40:26.653+00 https://www.pharmasalmanac.com/articles/syros-announces-update-on-selective-cdk7-inhibitor-portfolio 2019-10-17 15:35:27.595+00 https://www.pharmasalmanac.com/articles/fam-trastuzumab-deruxtecan-granted-fda-priority-review-for-treatment-of-patients-with-her2-positive-metastatic-breast-cancer 2019-10-17 15:31:33.973+00 https://www.pharmasalmanac.com/articles/cabaletta-bio-announces-presentation-of-preclinical-data-showing-specific-caar-t-activity-against-anti-musk-expressing-b-cells 2019-10-15 16:44:36.654+00 https://www.pharmasalmanac.com/articles/new-capsule-can-orally-deliver-drugs-that-usually-have-to-be-injected 2019-10-15 16:34:50.793+00 https://www.pharmasalmanac.com/articles/akcea-and-pfizer-inc.-announce-licensing-agreement-for-investigative-antisense-therapy-akcea-angptl3-lrx 2019-10-11 18:15:10.888+00 https://www.pharmasalmanac.com/articles/viagra-helps-mobilize-bone-marrow-stem-cells-for-transplantation-in-mice 2019-10-11 18:05:17.735+00 https://www.pharmasalmanac.com/articles/gilead-and-galapagos-announce-efficacy-and-safety-results-of-filgotinib-through-52-weeks-in-finch-1-and-finch-3-studies-in-rheumatoid-arthritis 2019-10-11 17:59:30.71+00 https://www.pharmasalmanac.com/articles/transient-transfection-at-a-large-scale-for-flexibility-in-clinical-and-commercial-vector-manufacturing 2019-10-11 16:51:23.007+00 https://www.pharmasalmanac.com/articles/challenges-for-next-generation-biological-therapeutics-discovery-and-development 2019-10-10 21:01:41.83+00 https://www.pharmasalmanac.com/articles/new-facility-presents-manufacturing-solutions-for-recombinant-proteins 2019-10-10 20:20:10.714+00 https://www.pharmasalmanac.com/articles/biotechnology-innovation-organization-announces-2021-leadership-transition 2019-10-10 17:16:38.554+00 https://www.pharmasalmanac.com/articles/labcorp-announces-new-leadership-roles-for-its-two-business-segments-and-selects-new-chief-human-resources-office 2019-10-10 17:05:46.724+00 https://www.pharmasalmanac.com/articles/parexel-and-datavant-enter-multi-year-strategic-partnership-to-enable-the-connection-of-real-world-data-across-all-parexel-clinical-trials 2019-10-10 16:13:09.547+00 https://www.pharmasalmanac.com/articles/lyophilization-cycle-development-optimization-a-hands-on-laboratory-course 2019-10-09 21:06:15.726+00 https://www.pharmasalmanac.com/articles/ani-announces-positive-clinical-results-from-cortrophin-gel-cortisol-response-study 2019-10-07 15:13:54.888+00 https://www.pharmasalmanac.com/articles/regen-biopharma-successfully-treats-rheumatoid-arthritis-using-cannabidiol-cbd-based-immune-modulatory-treatments 2019-10-07 15:09:32.358+00 https://www.pharmasalmanac.com/articles/fda-approves-second-drug-to-prevent-hiv-infection-as-part-of-ongoing-efforts-to-end-the-hiv-epidemic 2019-10-07 15:05:47.273+00 https://www.pharmasalmanac.com/articles/novartis-and-microsoft-announce-collaboration-to-transform-medicine-with-artificial-intelligence 2019-10-07 14:44:01.337+00 https://www.pharmasalmanac.com/articles/cellectis-and-lonza-enter-cgmp-manufacturing-service-agreement-for-cellectis-allogeneic-ucart-product-candidates 2019-10-07 14:43:27.78+00 https://www.pharmasalmanac.com/articles/fda-encourages-inclusion-of-male-patients-in-breast-cancer-clinical-trials 2019-10-07 14:43:04.393+00 https://www.pharmasalmanac.com/articles/poorly-reported-placebos-may-lead-to-mistaken-estimates-of-benefits 2019-10-07 14:42:38.265+00 https://www.pharmasalmanac.com/articles/new-data-reinforces-benefits-of-spiolto-respimat-in-improving-patient-outcomes 2019-10-07 14:40:26.909+00 https://www.pharmasalmanac.com/articles/managing-the-risks-associated-with-orphan-drug-development-and-manufacturing 2019-10-07 14:27:43.825+00 https://www.pharmasalmanac.com/articles/what-truly-novel-therapies-in-the-earliest-stages-of-discovery-and-development-do-you-believe-will-have-a-significant-impact-in-the-future 2019-10-03 17:10:14.984+00 https://www.pharmasalmanac.com/articles/mylan-finalizes-previously-disclosed-settlement-with-u.s.-securities-and-exchange-commission 2019-09-30 18:45:03.865+00 https://www.pharmasalmanac.com/articles/blood-test-can-replace-invasive-biopsy-for-more-patients-with-lung-cancer 2019-09-30 18:42:20.919+00 https://www.pharmasalmanac.com/articles/grail-announces-positive-new-data-with-multi-cancer-early-detection-blood-test-from-ccga-study 2019-09-30 18:38:34.045+00 https://www.pharmasalmanac.com/articles/echopixel-introduces-first-ever-intraoperative-software-to-provide-3d-holographic-experience-to-support-structural-heart-procedures 2019-09-30 18:32:50.116+00 https://www.pharmasalmanac.com/articles/dataarts-healthcare-life-sciences-practice-launches-skincareai-prototype-app-for-early-melanoma-detection 2019-09-30 18:19:24.857+00 https://www.pharmasalmanac.com/articles/amgen-announces-positive-results-from-two-phase-3-blincyto-studies-in-pediatric-patients 2019-09-27 17:59:50.239+00 https://www.pharmasalmanac.com/articles/gsk-invests-120-million-in-next-generation-us-biopharmaceutical-manufacturing-facility 2019-09-26 16:14:45.256+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-partners-with-inflammasome-therapeutics-to-develop-novel-therapies-for-patients-with-retinal-disease 2019-09-26 15:55:27.018+00 https://www.pharmasalmanac.com/articles/fda-announces-voluntary-recall-of-sandoz-ranitidine-capsules-following-detection-of-an-impurity 2019-09-26 15:44:10.415+00 https://www.pharmasalmanac.com/articles/a-triplex-approach-to-bacteria-engineering 2019-09-20 16:39:18.556+00 https://www.pharmasalmanac.com/articles/novartis-pledges-5-day-response-regarding-future-data-integrity-issues 2019-09-20 16:36:22.334+00 https://www.pharmasalmanac.com/articles/astellas-takes-patient-centricity-to-the-next-level 2019-09-20 16:30:48.146+00 https://www.pharmasalmanac.com/articles/turning-back-the-epigenetic-clock 2019-09-20 16:27:21.421+00 https://www.pharmasalmanac.com/articles/fda-cder-head-castigates-pharma-industry 2019-09-20 16:24:46.809+00 https://www.pharmasalmanac.com/articles/cerevel-gets-new-ceo 2019-09-20 16:21:26.92+00 https://www.pharmasalmanac.com/articles/arial-halts-trial-for-first-drug-to-treat-drp-early 2019-09-20 16:19:15.207+00 https://www.pharmasalmanac.com/articles/hovione-announces-successful-end-of-phase-2-meeting-with-the-fda-and-outlines-phase-3-program-for-minocycline-topical-gel 2019-09-20 14:04:46.756+00 https://www.pharmasalmanac.com/articles/fda-grants-fast-track-designation-for-farxiga-in-heart-failure 2019-09-16 21:09:53.562+00 https://www.pharmasalmanac.com/articles/vertex-announces-new-access-agreement-with-scottish-government-for-orkambi-lumacaftor/ivacaftor-and-symkevi-tezacaftor/ivacaftor 2019-09-12 20:04:32.817+00 https://www.pharmasalmanac.com/articles/moderna-announces-positive-phase-1-results-for-the-first-systemic-messenger-rna-therapeutic-encoding-a-secreted-protein-mrna-1944 2019-09-12 19:59:36.556+00 https://www.pharmasalmanac.com/articles/covance-unveils-new-rd-center-in-shanghai 2019-09-12 19:43:27.794+00 https://www.pharmasalmanac.com/articles/new-vision-system-for-tracking-eye-movement-gets-fda-clearance 2019-09-11 19:18:44.728+00 https://www.pharmasalmanac.com/articles/could-preventing-the-development-of-amyloid-beta-lesions-in-the-brain-stop-alzheimers 2019-09-11 19:04:38.109+00 https://www.pharmasalmanac.com/articles/patient-deaths-lead-to-fda-safety-warning-on-hepatitis-c-medication 2019-09-11 19:00:45.005+00 https://www.pharmasalmanac.com/articles/current-players-could-face-competition-in-the-pcsk9-space 2019-09-11 18:46:36.663+00 https://www.pharmasalmanac.com/articles/mallinckrodt-agrees-to-sell-biovectra-inc.-to-h.i.g.-capital-for-250-million 2019-09-11 18:33:40.96+00 https://www.pharmasalmanac.com/articles/acadia-pharmaceuticals-announces-meets-the-primary-phase-3-endpoint-in-patients-with-dementia-related-psychosis 2019-09-11 18:26:24.347+00 https://www.pharmasalmanac.com/articles/avalon-ventures-and-coi-pharmaceuticals-announce-acquisition-of-sitari-pharmaceuticals-by-gsk 2019-09-11 18:14:45.122+00 https://www.pharmasalmanac.com/articles/biontech-announces-new-collaboration-to-develop-hiv-and-tuberculosis-programs 2019-09-11 18:05:29.295+00 https://www.pharmasalmanac.com/articles/lexicon-pharmaceuticals-announces-termination-of-alliance-and-settlement-with-sanofi 2019-09-11 17:57:17.08+00 https://www.pharmasalmanac.com/articles/sengine-precision-medicine-and-atomwise-announce-strategic-joint-venture-to-accelerate-novel-drug-discovery 2019-09-11 17:40:40.938+00 https://www.pharmasalmanac.com/articles/apple-announces-three-groundbreaking-health-studies 2019-09-11 17:35:40.478+00 https://www.pharmasalmanac.com/articles/pharvaris-announces-66-million-series-b-financing-to-advance-the-clinical-development-of-an-oral-therapy-for-hereditary-angioedema 2019-09-10 18:15:30.66+00 https://www.pharmasalmanac.com/articles/inhibrx-announces-enrollment-of-first-patient-in-phase-1-study-of-inbrx-101-a-modified-recombinant-human-aat-fc-fusion-protein 2019-09-06 20:27:57.111+00 https://www.pharmasalmanac.com/articles/zyversa-therapeutics-advances-development-of-lead-inflammasome-inhibitor-candidate-ic-100 2019-09-06 19:11:51.108+00 https://www.pharmasalmanac.com/articles/stryker-announces-definitive-agreement-to-acquire-mobius-imaging-cardan-robotics 2019-09-06 19:04:10.511+00 https://www.pharmasalmanac.com/articles/ultragenyx-announces-positive-data-from-phase-1/2-study-of-dtx401-gene-therapy-in-glycogen-storage-disease-type-ia 2019-09-05 21:55:29.845+00 https://www.pharmasalmanac.com/articles/zhejiang-jiuzhou-to-acquire-suzhou-unit-of-novartis-ag-for-cny790-million 2019-09-05 21:30:52.508+00 https://www.pharmasalmanac.com/articles/startup-navega-therapeutics-aims-to-develop-a-crispr-treatment-for-pain 2019-09-05 21:20:47.365+00 https://www.pharmasalmanac.com/articles/batavia-biosciences-to-deploy-horizon-discoverys-cho-cell-technology-to-develop-anti-zika-biotherapeutic 2019-09-05 21:06:37.179+00 https://www.pharmasalmanac.com/articles/strides-acquires-us-fda-approved-manufacturing-facility-in-the-us 2019-09-05 20:56:17.933+00 https://www.pharmasalmanac.com/articles/new-gs1-us-implementation-guideline-to-help-pharmaceutical-industry-prepare-for-upcoming-dscsa-verified-returns-deadline 2019-09-05 20:45:20.879+00 https://www.pharmasalmanac.com/articles/q2-tn-biopharmas-ascendent-supply-chain-reveals-its-present-potential-future-promise-chapter-2 2019-09-05 14:36:46.144+00 https://www.pharmasalmanac.com/articles/peptide-hydrogels-could-help-heal-traumatic-brain-injuries 2019-09-05 13:52:31.087+00 https://www.pharmasalmanac.com/articles/uniqure-announces-achievement-of-planned-enrollment-in-hope-b-pivotal-trial-of-amt-061-etranacogene-dezaparvovec-in-patients-with-hemophilia-b 2019-09-05 13:47:20.641+00 https://www.pharmasalmanac.com/articles/pci-strengthens-position-in-europe-with-investment-in-ireland 2019-09-05 13:46:58.97+00 https://www.pharmasalmanac.com/articles/trump-urges-va-to-use-spravato 2019-09-04 21:27:36.712+00 https://www.pharmasalmanac.com/articles/studies-in-primates-reveal-potential-new-target-for-anxiety-treatments 2019-09-04 21:25:13.201+00 https://www.pharmasalmanac.com/articles/new-brain-modeling-data-now-available 2019-09-04 21:13:04.845+00 https://www.pharmasalmanac.com/articles/rebalancing-the-autonomic-nervous-system-with-a-mild-electrical-current 2019-09-04 21:03:59.307+00 https://www.pharmasalmanac.com/articles/using-a-scorpion-toxin-to-study-pain-and-inflammation 2019-09-04 19:45:02.177+00 https://www.pharmasalmanac.com/articles/rumors-suggest-amgen-is-interested-in-alexion 2019-09-04 19:42:36.877+00 https://www.pharmasalmanac.com/articles/q2-biovectra-establishing-specialized-cdmo-capabilities-for-the-production-of-advanced-therapies 2019-09-04 17:54:45.89+00 https://www.pharmasalmanac.com/articles/hovione-technology-signs-collaboration-agreement-with-kiel-university 2019-09-03 21:35:48.031+00 https://www.pharmasalmanac.com/articles/vertex-to-acquire-semma-therapeutics-with-a-goal-of-developing-curative-cell-based-treatments-for-type-1-diabetes 2019-09-03 18:43:25.619+00 https://www.pharmasalmanac.com/articles/syncona-cornerstones-100-million-financing-in-achilles 2019-09-03 18:41:09.498+00 https://www.pharmasalmanac.com/articles/soligenix-announces-positive-recommendation-on-its-phase-3-clinical-trial-for-the-treatment-of-oral-mucositis 2019-08-29 21:30:26.794+00 https://www.pharmasalmanac.com/articles/ajinomoto-bio-pharma-services-acquires-remaining-interest-in-granules-omnichem-joint-venture-in-india 2019-08-29 21:16:19.604+00 https://www.pharmasalmanac.com/articles/presage-announces-collaboration-with-bristol-myers-squibb-for-phase-o-studies-of-novel-cancer-agents-utilizing-civo-technology 2019-08-29 16:01:33.06+00 https://www.pharmasalmanac.com/articles/immatics-and-celgene-enter-strategic-collaboration-to-develop-novel-adoptive-cell-therapies 2019-08-29 15:36:21.494+00 https://www.pharmasalmanac.com/articles/lilly-announces-top-line-phase-3-results-for-oral-jak-inhibitor-baricitinib-for-moderate-to-severe-atopic-dermatitis 2019-08-28 21:59:42.65+00 https://www.pharmasalmanac.com/articles/medtronic-announces-planned-leadership-succession 2019-08-28 21:59:08.576+00 https://www.pharmasalmanac.com/articles/pneumagen-appoints-scientific-advisory-board 2019-08-28 21:16:16.305+00 https://www.pharmasalmanac.com/articles/first-ever-fda-clears-biobeats-wearable-watch-and-patch-for-non-invasive-cuffless-monitoring-of-blood-pressure 2019-08-28 21:07:19.125+00 https://www.pharmasalmanac.com/articles/hifibio-therapeutics-closes-67-million-series-c-financing-to-build-on-recent-success-and-advance-pipeline-of-novel-antibody-drugs-for-cancer-and-autoimmune-disorders 2019-08-28 21:02:57.918+00 https://www.pharmasalmanac.com/articles/ibio-and-cc-pharming-expand-business-collaboration-in-china 2019-08-27 20:25:01.005+00 https://www.pharmasalmanac.com/articles/novartis-ceo-says-company-could-have-handled-data-manipulation-issue-more-effectively 2019-08-27 18:47:21.558+00 https://www.pharmasalmanac.com/articles/are-ema-and-fda-decisions-diverging 2019-08-27 18:45:14.236+00 https://www.pharmasalmanac.com/articles/new-nanoelectronics-designed-to-facilitate-tissue-wide-electrophysiology 2019-08-27 18:34:13.644+00 https://www.pharmasalmanac.com/articles/editing-many-sites-at-once-with-crispr-cas 2019-08-27 18:25:33.117+00 https://www.pharmasalmanac.com/articles/index-pharmaceuticals-meets-primary-endpoint-in-the-phase-iib-study-conduct-with-cobitolimod-in-ulcerative-colitis 2019-08-27 17:12:05.585+00 https://www.pharmasalmanac.com/articles/ionis-licenses-hepatitis-b-program-to-gsk 2019-08-27 17:08:08.981+00 https://www.pharmasalmanac.com/articles/fda-grants-fast-track-designation-for-farxiga-in-chronic-kidney-disease 2019-08-27 17:04:36.301+00 https://www.pharmasalmanac.com/articles/amgen-to-acquire-otezla-for-13.4-billion-in-cash-or-approximately-11.2-billion-net-of-anticipated-future-cash-tax-benefits 2019-08-27 17:01:21.402+00 https://www.pharmasalmanac.com/articles/blue-cross-and-blue-shield-of-minnesota-to-cover-insulin-costs-at-no-charge-next-year 2019-08-26 21:30:40.565+00 https://www.pharmasalmanac.com/articles/mission-bios-tapestri-platform-can-now-identify-both-mutations-and-copy-number-variants-from-the-same-cells 2019-08-23 21:49:26.96+00 https://www.pharmasalmanac.com/articles/finch-therapeutics-raises-53-million-to-advance-microbiome-based-therapies-for-recurrent-c.-difficile-autism-and-other-disease-areas 2019-08-23 21:13:07.778+00 https://www.pharmasalmanac.com/articles/innovent-enters-a-licensing-agreement-with-lilly-to-develop-commercialize-a-novel-diabetes-medicine-in-china 2019-08-23 20:46:39.006+00 https://www.pharmasalmanac.com/articles/gsk-announces-positive-headline-results-from-the-pivotal-dreamm-2-study-for-multiple-myeloma 2019-08-23 20:43:40.2+00 https://www.pharmasalmanac.com/articles/abbvie-receives-fda-approval-of-rinvoq-upadacitinib-an-oral-jak-inhibitor-for-the-treatment-of-moderate-to-severe-rheumatoid-arthritis 2019-08-23 20:37:58.882+00 https://www.pharmasalmanac.com/articles/viiv-healthcare-reports-positive-phase-iii-study-results-of-investigational-long-acting-injectable-hiv-treatment-regimen-administered-every-two-months 2019-08-23 20:10:18.819+00 https://www.pharmasalmanac.com/articles/the-pfizer-foundation-invests-in-20-organizations-tackling-infectious-diseases-and-antimicrobial-resistance 2019-08-23 15:34:17.73+00 https://www.pharmasalmanac.com/articles/eiger-announces-fda-breakthrough-therapy-designation-for-peginterferon-lambda-for-treatment-of-hepatitis-delta-virus-infection 2019-08-23 15:24:04.68+00 https://www.pharmasalmanac.com/articles/biomaterials-smarten-up-with-crispr 2019-08-23 09:00:11.843+00 https://www.pharmasalmanac.com/articles/glenmark-receives-approval-for-combination-of-remogliflozin-etabonate-and-metformin-hydrochloride-for-adults-with-type-2-diabetes-in-india 2019-08-22 21:20:15.686+00 https://www.pharmasalmanac.com/articles/researchers-are-investigating-smart-cell-therapies 2019-08-22 18:50:51.902+00 https://www.pharmasalmanac.com/articles/editing-adult-blood-stem-cells-could-treat-blood-disorders 2019-08-22 18:46:42.588+00 https://www.pharmasalmanac.com/articles/roche-acquisition-of-spark-therapeutics-delayed-again 2019-08-22 18:43:36.779+00 https://www.pharmasalmanac.com/articles/hybrid-human/monkey-embryos-created-by-salk-researchers-in-china 2019-08-22 18:40:46.694+00 https://www.pharmasalmanac.com/articles/amgen-reports-further-success-with-new-kras-inhibitor 2019-08-22 18:26:03.321+00 https://www.pharmasalmanac.com/articles/genomic-health-to-be-acquired-by-exact-sciences 2019-08-22 18:21:25.368+00 https://www.pharmasalmanac.com/articles/genecentric-therapeutics-acquires-select-immunogenomics 2019-08-21 21:44:43.875+00 https://www.pharmasalmanac.com/articles/boston-scientific-closes-acquisition-of-btg-plc 2019-08-21 21:40:10.897+00 https://www.pharmasalmanac.com/articles/barentz-strengthens-its-position-in-south-africa-through-a-joint-venture-with-sk-chemtrade-services 2019-08-20 14:41:52.64+00 https://www.pharmasalmanac.com/articles/bloomfield-hills-teen-awarded-25000-for-developing-method-to-create-universal-influenza-vaccine 2019-08-20 14:07:59.954+00 https://www.pharmasalmanac.com/articles/aldevron-breaks-ground-on-14-acre-campus-expansion 2019-08-20 13:59:23.643+00 https://www.pharmasalmanac.com/articles/ibio-inks-3d-bioprinting-agreement 2019-08-20 13:55:29.929+00 https://www.pharmasalmanac.com/articles/araris-biotech-ag-closes-seed-financing-round-of-chf-2.5-million 2019-08-20 13:39:04.557+00 https://www.pharmasalmanac.com/articles/lighting-up-proteins-with-immuno-saber 2019-08-19 22:01:51.645+00 https://www.pharmasalmanac.com/articles/alcon-to-launch-precision1-daily-disposable-contact-lenses-as-it-continues-to-deliver-on-vision-care-pipeline 2019-08-19 21:54:27.427+00 https://www.pharmasalmanac.com/articles/announcing-expansion-for-enhanced-capabilities 2019-08-19 18:22:01.787+00 https://www.pharmasalmanac.com/articles/flexible-biologics-manufacturing-in-lithuiana 2019-08-19 13:55:09.672+00 https://www.pharmasalmanac.com/articles/formulating-biologics-for-thermal-stability 2019-08-19 13:54:32.661+00 https://www.pharmasalmanac.com/articles/uniting_innovation_and_customer 2019-08-19 13:52:19.657+00 https://www.pharmasalmanac.com/articles/accelerating_innovation_for_gene_therapy 2019-08-19 13:50:11.321+00 https://www.pharmasalmanac.com/articles/expanding_gmp_gene_therapy_manufacturing 2019-08-19 13:49:35.08+00 https://www.pharmasalmanac.com/articles/building_upon_an_integrated_biologics_offering 2019-08-19 13:49:04.117+00 https://www.pharmasalmanac.com/articles/cmo_services_built_on_a_culture_of_agility 2019-08-19 13:48:38.274+00 https://www.pharmasalmanac.com/articles/innovation_supported_by_a_global_footprint 2019-08-19 13:47:43.778+00 https://www.pharmasalmanac.com/articles/fastpharming_for_speed_to_market 2019-08-19 13:46:57.703+00 https://www.pharmasalmanac.com/articles/mice-avoid-gaining-weight-when-certain-gut-bacteria-are-present 2019-08-16 16:22:37.463+00 https://www.pharmasalmanac.com/articles/questions-about-robotic-surgery-emerge 2019-08-16 16:16:47.331+00 https://www.pharmasalmanac.com/articles/using-crispr-to-treat-muscular-dystrophy 2019-08-15 21:33:41.186+00 https://www.pharmasalmanac.com/articles/pact-pharma-believes-it-can-develop-car-t-cell-therapies-for-solid-tumors 2019-08-15 21:25:16.509+00 https://www.pharmasalmanac.com/articles/gilead-licenses-antiviral-candidates-from-novartis 2019-08-15 21:20:50.731+00 https://www.pharmasalmanac.com/articles/inflammatory-disease-candidate-reaches-end-of-the-line 2019-08-15 21:12:20.713+00 https://www.pharmasalmanac.com/articles/parp-inhibitors-may-be-useful-for-treating-more-cancers 2019-08-15 21:02:20.639+00 https://www.pharmasalmanac.com/articles/ultragenyx-announces-partnership-with-genetx-to-advance-treatment-for-angelman-syndrome 2019-08-15 18:44:37.17+00 https://www.pharmasalmanac.com/articles/leo-pharma-a/s-acquires-rights-to-develop-and-market-brodalumab-for-moderate-to-severe-psoriasis-outside-of-europe 2019-08-15 18:32:52.828+00 https://www.pharmasalmanac.com/articles/regeneron-announces-positive-topline-results-from-phase-3-trial-of-evinacumab-in-patients-with-severe-inherited-form-of-high-cholesterol 2019-08-15 18:22:21.357+00 https://www.pharmasalmanac.com/articles/tagrisso-significantly-improves-overall-survival-in-the-phase-iii-flaura-trial-for-1st-line-egfr-mutated-non-small-cell-lung-cancer 2019-08-15 09:00:07.755+00 https://www.pharmasalmanac.com/articles/gsk-announces-leadership-changes-in-the-us 2019-08-13 19:13:47.784+00 https://www.pharmasalmanac.com/articles/relief-therapeutics-holding-sa-announces-divestment-of-its-subsidiary-relief-therapeutics-sa-to-sonnet-biotherapeutics-inc 2019-08-13 19:09:15.343+00 https://www.pharmasalmanac.com/articles/heart-on-a-chip-mimics-drug-response-seen-in-humans-in-vitro-approach-provides-predictive-platform-for-human-based-drug-discovery 2019-08-13 18:59:33.685+00 https://www.pharmasalmanac.com/articles/prellis-biologics-raises-8.7-million-reports-progress-in-3d-holographic-tissue-printing 2019-08-13 18:44:28.2+00 https://www.pharmasalmanac.com/articles/dynacure-receives-orphan-drug-designation-from-the-us-fda-for-dyn101-an-antisense-medicine-to-treat-rare-disease-centronuclear-myopathies 2019-08-13 18:25:02.302+00 https://www.pharmasalmanac.com/articles/glaukos-and-avedro-announce-definitive-acquisition-agreement 2019-08-13 18:18:40.285+00 https://www.pharmasalmanac.com/articles/graphpad-software-acquires-snapgene-forms-insightful-science 2019-08-13 18:10:05.237+00 https://www.pharmasalmanac.com/articles/applying-chemistry-and-engineering-expertise-to-continuous-processing 2019-08-12 18:19:47.697+00 https://www.pharmasalmanac.com/articles/cleave-therapeutics-appoints-amy-burroughs-chief-executive-officer-and-completes-12-million-equity-financing 2019-08-09 21:16:17.498+00 https://www.pharmasalmanac.com/articles/editas-medicine-appoints-cynthia-collins-as-president-and-chief-executive-officer 2019-08-09 20:50:03.141+00 https://www.pharmasalmanac.com/articles/melinta-therapeutics-names-david-gill-as-chairman-and-announces-ceo-succession-plan 2019-08-09 20:41:01.479+00 https://www.pharmasalmanac.com/articles/lilly-evidation-health-and-apple-study-shows-personal-digital-devices-may-help-in-the-identification-of-dementia 2019-08-09 20:30:01.594+00 https://www.pharmasalmanac.com/articles/gilead-continues-to-mix-things-up-at-the-executive-level 2019-08-07 19:35:33.477+00 https://www.pharmasalmanac.com/articles/analysis-of-government-data-reveals-main-players-in-opioid-market 2019-08-07 19:32:30.221+00 https://www.pharmasalmanac.com/articles/could-a-gene-therapy-prevent-sudden-cardiac-death 2019-08-07 19:29:26.705+00 https://www.pharmasalmanac.com/articles/takeda-looks-to-sell-european-assets 2019-08-07 19:21:03.48+00 https://www.pharmasalmanac.com/articles/china-welcomes-indian-competition-in-push-to-lower-drug-costs 2019-08-07 19:19:44.184+00 https://www.pharmasalmanac.com/articles/rhythm-pharmaceuticals-announces-positive-topline-results-from-pivotal-phase-3-clinical-trials-evaluating-setmelanotide-in-pomc-and-lepr-deficiency-obesities 2019-08-07 18:39:17.115+00 https://www.pharmasalmanac.com/articles/genentechs-tecentriq-atezolizumab-reduced-the-risk-of-disease-worsening-or-death-in-advanced-bladder-cancer 2019-08-07 18:33:09.893+00 https://www.pharmasalmanac.com/articles/taconic-biosciences-releases-first-off-the-shelf-nash-animal-model 2019-08-07 18:25:58.746+00 https://www.pharmasalmanac.com/articles/xylocor-therapeutics-names-rickey-reinhardt-md-phd-chief-medical-officer 2019-08-07 18:20:21.287+00 https://www.pharmasalmanac.com/articles/caprion-biosciences-and-histogenex-unite-businesses-to-create-global-leader-in-immune-monitoring-and-biomarker-development 2019-08-07 18:14:33.504+00 https://www.pharmasalmanac.com/articles/tryon-medical-partners-announces-partnership-with-javara-to-offer-clinical-trials-to-patients 2019-08-07 18:10:53.161+00 https://www.pharmasalmanac.com/articles/aptars-nasal-unidose-device-approved-by-us-fda-for-first-needle-free-rescue-treatment-for-severe-hypoglycemia 2019-08-07 18:05:34.612+00 https://www.pharmasalmanac.com/articles/novartis-stands-behind-zolgensma-onasemnogene-abeparvovec-xioi-for-the-treatment-of-children-less-than-2-years-of-age-with-spinal-muscular-atrophy 2019-08-07 17:51:20.412+00 https://www.pharmasalmanac.com/articles/neogenomics-announces-grand-opening-of-new-pharma-services-laboratory-in-singapore 2019-08-07 17:37:20.694+00 https://www.pharmasalmanac.com/articles/brain-stimulation-for-ptsd-patients 2019-08-07 13:42:59.323+00 https://www.pharmasalmanac.com/articles/aquinox-pharmaceuticals-and-neoleukin-therapeutics-announce-merger-agreement 2019-08-06 19:33:40.13+00 https://www.pharmasalmanac.com/articles/uganda-starts-its-largest-ever-ebola-vaccine-trial 2019-08-06 19:20:04.024+00 https://www.pharmasalmanac.com/articles/forxiga-label-updated-in-the-eu-in-type-2-diabetes 2019-08-06 14:08:15.927+00 https://www.pharmasalmanac.com/articles/new-executive-team-announced-at-adaptimmune 2019-08-02 16:03:30.093+00 https://www.pharmasalmanac.com/articles/transgene-provides-update-on-phocus-study-of-pexa-vec-in-liver-cancer-following-planned-interim-futility-analysis 2019-08-02 15:58:54.831+00 https://www.pharmasalmanac.com/articles/rakuten-medical-secures-additional-investment-from-rakuten-to-further-develop-its-photoimmunotherapy-platform-capabilities 2019-08-02 15:35:36.477+00 https://www.pharmasalmanac.com/articles/sensyne-health-signs-collaboration-agreement-with-bayer-to-accelerate-the-treatments-for-cardiovascular-disease-using-clinical-artificial-intelligence 2019-08-01 19:04:48.968+00 https://www.pharmasalmanac.com/articles/amicus-announces-positive-interim-clinical-data-for-aav-gene-therapy-in-children-with-cln6-batten-disease 2019-08-01 19:04:07.285+00 https://www.pharmasalmanac.com/articles/american-dream-becomes-reality-for-talented-young-scots 2019-08-01 19:03:07.272+00 https://www.pharmasalmanac.com/articles/gsk-completes-transaction-with-pfizer-to-form-new-consumer-healthcare-joint-venture 2019-08-01 19:02:41.121+00 https://www.pharmasalmanac.com/articles/lonza-partners-with-vineti-across-its-cell-and-gene-therapy-manufacturing-network-to-optimize-vein-to-vein-delivery-service 2019-08-01 19:01:38.674+00 https://www.pharmasalmanac.com/articles/celgene-to-pay-mylan-62-million-to-resolve-cancer-drug-antitrust-case 2019-08-01 19:01:07.07+00 https://www.pharmasalmanac.com/articles/tackling-solid-tumors-with-engineered-bacteria 2019-08-01 16:40:24.461+00 https://www.pharmasalmanac.com/articles/livia-group-announces-the-acquisition-of-prime-european-therapeuticals-s.p.a.-from-almany-molecular-research-inc 2019-08-01 16:29:07.665+00 https://www.pharmasalmanac.com/articles/fda-says-no-to-farxiga-for-type-1-diabetes 2019-08-01 15:35:16.308+00 https://www.pharmasalmanac.com/articles/china-eases-generic-drug-market-shake-up 2019-08-01 14:59:06.7+00 https://www.pharmasalmanac.com/articles/wellington-partners-raises-eur-210-million-life-science-fund 2019-07-31 14:22:35.57+00 https://www.pharmasalmanac.com/articles/fda-approves-bayers-nubeqa-darolutamide-for-prostate-cancer 2019-07-31 14:19:18.711+00 https://www.pharmasalmanac.com/articles/eqt-to-acquire-majority-interest-in-aldevron-the-leading-global-supplier-of-plasmid-dna-used-in-cell-and-gene-therapies 2019-07-31 14:12:04.068+00 https://www.pharmasalmanac.com/articles/new-approach-to-treating-pancreatic-cancer-being-explored 2019-07-30 15:15:13.073+00 https://www.pharmasalmanac.com/articles/smart-brain-stimulators-next-gen-parkinsons-disease-therapy 2019-07-30 09:00:03.827+00 https://www.pharmasalmanac.com/articles/exact-sciences-and-genomic-health-to-combine-creating-leading-global-cancer-diagnostics-company 2019-07-29 17:49:16.398+00 https://www.pharmasalmanac.com/articles/vertex-announces-dr.-jeffrey-leiden-to-transition-to-role-of-executive-chairman-and-dr.-reshma-kewalramani-appointed-as-new-ceo 2019-07-26 16:52:40.887+00 https://www.pharmasalmanac.com/articles/genscript-biotechs-biologics-rd-and-production-center-is-formally-put-into-operation 2019-07-26 16:38:13.718+00 https://www.pharmasalmanac.com/articles/zambon-completes-transformational-acquisition-of-breath-therapeutics 2019-07-26 16:27:31.469+00 https://www.pharmasalmanac.com/articles/lonza-on-track-to-deliver-full-year-2019-results-driven-by-pharma-biotech-business 2019-07-25 19:20:01.043+00 https://www.pharmasalmanac.com/articles/sage-therapeutics-announces-clinical-updates-and-progress-across-neuroscience-pipeline-during-sage-futurecast 2019-07-24 19:20:50.207+00 https://www.pharmasalmanac.com/articles/jounce-therapeutics-announces-update-on-strategic-collaboration-with-celgene-corporation 2019-07-24 19:17:26.062+00 https://www.pharmasalmanac.com/articles/yellow-wood-partners-to-acquire-iconic-dr.-scholls-brand-from-bayer 2019-07-24 19:11:15.579+00 https://www.pharmasalmanac.com/articles/bayer-statement-on-voluntary-recall-of-two-lots-of-kogenate-fs-antihemophilic-factor-recombinant-in-the-united-states 2019-07-23 19:16:16.504+00 https://www.pharmasalmanac.com/articles/sanofi-signs-strategic-deal-for-exclusive-us-over-the-counter-rights-to-tamiflu-in-flu-care 2019-07-23 19:13:26.599+00 https://www.pharmasalmanac.com/articles/revisiting-the-global-serialization-landscape 2019-07-23 17:36:53.774+00 https://www.pharmasalmanac.com/articles/navigating-the-road-to-successful-orphan-drug-commercialization-and-launch 2019-07-23 17:36:07.916+00 https://www.pharmasalmanac.com/articles/celltrion-and-nan-fung-group-to-establish-vcell-healthcare-limited-to-develop-and-commercialize-biosimilars-in-china 2019-07-22 20:18:22.608+00 https://www.pharmasalmanac.com/articles/jj-awaits-judges-decision-in-lawsuit-filed-by-oklahoma-over-the-opioid-crisis 2019-07-22 14:29:44.868+00 https://www.pharmasalmanac.com/articles/genentechs-xofluza-flu-treatment-effective-in-children 2019-07-22 14:01:34.589+00 https://www.pharmasalmanac.com/articles/car-t-cell-therapy-price-sets-record-in-switzerland 2019-07-22 13:58:10.068+00 https://www.pharmasalmanac.com/articles/immusoft-announces-the-appointment-of-robert-hayes-ph.d.-as-chief-scientific-officer 2019-07-19 13:45:45.398+00 https://www.pharmasalmanac.com/articles/astellas-and-seattle-genetics-announce-submission-of-biologics-license-application-to-fda-for-enfortumab-vedotin 2019-07-19 13:37:01.013+00 https://www.pharmasalmanac.com/articles/orum-therapeutics-announces-30-million-series-b-financing-to-advance-cell-penetrating-cell-specific-antibody-technology-for-novel-therapeutics 2019-07-19 13:33:19.778+00 https://www.pharmasalmanac.com/articles/compugen-expands-intellectual-property-portfolio-for-com701-with-new-u.s.-patent-covering-combination-use-with-anti-pd-1-antibody 2019-07-19 13:28:32.561+00 https://www.pharmasalmanac.com/articles/polsky-center-for-entrepreneurship-and-innovation-supports-university-of-chicago-professor-in-founding-immuno-oncology-startup 2019-07-17 21:45:08.22+00 https://www.pharmasalmanac.com/articles/fda-accepts-file-and-accelerates-review-of-novartis-sickle-cell-disease-medicine-crizanlizumab-seg101 2019-07-17 21:38:26.588+00 https://www.pharmasalmanac.com/articles/gilead-and-galapagos-enter-into-transformative-research-and-development-collaboration 2019-07-17 21:21:00.423+00 https://www.pharmasalmanac.com/articles/kite-announces-plans-to-bolster-industry-leading-cell-therapy-manufacturing-capabilities-with-new-viral-vector-facility 2019-07-16 20:35:11.511+00 https://www.pharmasalmanac.com/articles/groninger-opens-a-new-showroom-at-its-headquarters-in-germany 2019-07-16 20:30:48.682+00 https://www.pharmasalmanac.com/articles/recordati-to-acquire-worldwide-rights-to-signifor-and-osilodrostat-lci699 2019-07-15 20:23:02.363+00 https://www.pharmasalmanac.com/articles/fda-approves-bayers-gadavist-gadobutrol-injection-as-the-first-and-only-contrast-agent-for-use-in-cardiac-mr-for-coronary-artery-disease 2019-07-15 20:18:16.661+00 https://www.pharmasalmanac.com/articles/gsk-announces-positive-headline-results-in-phase-3-prima-study-of-zejula-niraparib-for-patients-with-ovarian-cancer 2019-07-15 20:12:27.037+00 https://www.pharmasalmanac.com/articles/abbvie-enhances-early-stage-oncology-pipeline-with-acquisition-of-mavupharma 2019-07-15 20:07:21.999+00 https://www.pharmasalmanac.com/articles/lilly-announces-changes-in-senior-leadership 2019-07-11 21:51:35.932+00 https://www.pharmasalmanac.com/articles/altaire-pharmaceuticals-inc.-issues-voluntary-recall-of-multiple-ophthalmic-products 2019-07-11 21:48:14.634+00 https://www.pharmasalmanac.com/articles/sandoz-extends-symjepi-epinephrine-injection-launch-to-u.s.-pharmacies-to-help-improve-patient-access 2019-07-11 21:45:30.471+00 https://www.pharmasalmanac.com/articles/revolution-medicines-closes-100-million-financing-to-advance-pipeline-of-novel-therapies-addressing-frontier-targets-in-ras-dependent-cancers 2019-07-11 21:41:30.386+00 https://www.pharmasalmanac.com/articles/positive-results-for-colon-cancer-drug-drove-pfizers-purchase-of-array-biopharma 2019-07-11 20:20:48.687+00 https://www.pharmasalmanac.com/articles/opioid-abuse-is-linked-to-a-rise-in-infectious-diseases 2019-07-10 18:53:31.355+00 https://www.pharmasalmanac.com/articles/esperion-raises-an-additional-200-million 2019-07-10 18:48:21.374+00 https://www.pharmasalmanac.com/articles/fda-grants-additional-myeloma-approval-to-jjs-darzalex 2019-07-10 18:46:17.517+00 https://www.pharmasalmanac.com/articles/gottlieb-joins-pfizer-board-of-directors 2019-07-10 18:44:11.806+00 https://www.pharmasalmanac.com/articles/lonza-will-purchase-a-sterile-fill-finish-site-from-novartis 2019-07-10 18:40:43.874+00 https://www.pharmasalmanac.com/articles/change-in-leadership-at-ubiome 2019-07-10 18:35:51.375+00 https://www.pharmasalmanac.com/articles/preclinical-studies-bode-well-for-diabetes-drug-from-semma-therapeutics 2019-07-10 18:26:45.453+00 https://www.pharmasalmanac.com/articles/emergex-signs-an-rd-agreement-with-imcb-to-develop-a-vaccine-for-the-emerging-threat-of-hand-foot-mouth-disease 2019-07-10 15:02:10.085+00 https://www.pharmasalmanac.com/articles/adc-therapeutics-announces-final-close-of-series-e-financing-expansion 2019-07-10 14:48:18.355+00 https://www.pharmasalmanac.com/articles/igm-biosciences-announces-102-million-series-c-financing-to-advance-its-igm-antibody-platform-and-pipeline 2019-07-10 14:47:54.937+00 https://www.pharmasalmanac.com/articles/nimbus-therapeutics-and-celgene-expand-alliance-to-immunotherapy-in-oncology 2019-07-10 14:47:24.38+00 https://www.pharmasalmanac.com/articles/celsius-therapeutics-signs-collaboration-agreement-with-janssen-to-identify-response-biomarkers-for-ulcerative-colitis 2019-07-10 14:46:55.298+00 https://www.pharmasalmanac.com/articles/biontech-raises-usd-325-million-in-an-upsized-series-b-financing-to-further-advance-individualized-immuno-oncology-pipeline 2019-07-09 15:56:11.486+00 https://www.pharmasalmanac.com/articles/neurovive-initiates-second-part-of-its-ongoing-kl1333-phase-ia/b-clinical-study 2019-07-09 15:50:12.088+00 https://www.pharmasalmanac.com/articles/intra-cellular-therapies-announces-positive-top-line-results-from-a-phase-3-trial-of-lumateperone-in-patients-with-bipolar-depression 2019-07-09 15:44:23.956+00 https://www.pharmasalmanac.com/articles/prestige-biopharma-and-pharmapark-announce-license-and-supply-agreement-to-commercialize-prestiges-trastuzumab-biosimilar-in-the-russian-federation 2019-07-08 19:45:46.285+00 https://www.pharmasalmanac.com/articles/prestige-biopharma-releases-positive-results-from-phase-i-study-of-hd204-biosimilar-candidate-to-bevacizumab 2019-07-08 19:02:12.214+00 https://www.pharmasalmanac.com/articles/grifols-announces-fda-approval-of-xembify-20-subcutaneous-immunoglobulin-for-primary-immunodeficiencies 2019-07-08 18:59:09.816+00 https://www.pharmasalmanac.com/articles/domain-therapeutics-appoints-xavier-leroy-as-chief-technology-officer 2019-07-08 18:58:12.424+00 https://www.pharmasalmanac.com/articles/membrane-based-reverse-osmosis-systems-for-wfi-production 2019-07-08 13:16:40.218+00 https://www.pharmasalmanac.com/articles/iovance-biotherapeutics-provides-cervical-cancer-program-updates-following-end-of-phase-2-meeting-with-u.s.-food-and-drug-administration-fda 2019-07-03 15:35:57.258+00 https://www.pharmasalmanac.com/articles/amicus-therapeutics-and-catalent-biologics-enter-strategic-partnership-for-gene-therapy-development-and-manufacturing 2019-07-03 15:23:33.456+00 https://www.pharmasalmanac.com/articles/lonza-to-acquire-sterile-fill-and-finish-facility-from-novartis 2019-07-02 15:44:15.258+00 https://www.pharmasalmanac.com/articles/bayer-supervisory-board-takes-action-to-address-the-glyphosate-litigation-and-welcomes-the-appointment-of-ken-feinberg-as-mediator 2019-07-02 15:40:29.467+00 https://www.pharmasalmanac.com/articles/flamma-acquires-tevas-philadelphia-cgmp-facility-marking-entry-into-the-us-marketplace-with-labs-pilot-plant 2019-07-02 09:00:03.112+00 https://www.pharmasalmanac.com/articles/printing-3d-lungs-using-food-dyes 2019-07-01 21:15:00.641+00 https://www.pharmasalmanac.com/articles/spotlight-on-p2x3-antagonists 2019-07-01 21:10:01.982+00 https://www.pharmasalmanac.com/articles/fda-considering-drug-designed-to-improve-sexual-desire 2019-07-01 21:02:08.405+00 https://www.pharmasalmanac.com/articles/fda-provides-guidance-on-increasing-clinical-trial-diversity 2019-07-01 20:55:03.203+00 https://www.pharmasalmanac.com/articles/analysis-of-medicare-prescriptions-uncovers-role-surgeons-played-in-opioid-crisis 2019-07-01 20:52:40.727+00 https://www.pharmasalmanac.com/articles/mirum-pharmaceuticals-files-for-ipo 2019-07-01 20:44:07.049+00 https://www.pharmasalmanac.com/articles/esperion-and-oberland-capital-announce-200-million-funding-agreement 2019-07-01 16:44:22.977+00 https://www.pharmasalmanac.com/articles/carrick-therapeutics-announces-plan-to-establish-us-operations-and-appointment-of-tim-pearson-as-ceo 2019-07-01 16:39:15.662+00 https://www.pharmasalmanac.com/articles/novavax-and-catalent-biologics-enter-strategic-partnershipto-expand-gene-therapy-footprint 2019-06-27 21:58:41.121+00 https://www.pharmasalmanac.com/articles/daytwo-secures-31-million-in-series-b-financing-to-scale-microbiome-research-platform-to-address-chronic-health-conditions 2019-06-27 19:27:25.332+00 https://www.pharmasalmanac.com/articles/bridgebio-pharma-announces-pricing-of-its-initial-public-offering 2019-06-27 16:40:31.987+00 https://www.pharmasalmanac.com/articles/u.s.-fda-grants-fast-track-designation-to-empagliflozin-for-the-treatment-of-chronic-heart-failure 2019-06-27 16:24:51.42+00 https://www.pharmasalmanac.com/articles/mile-high-labs-acquires-state-of-the-art-pharmaceutical-facility-in-broomfield-colorado 2019-06-27 16:20:25.243+00 https://www.pharmasalmanac.com/articles/pr-m06-19-ni-055 2019-06-26 18:10:49.999+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-to-expand-integrated-biologics-conjugation-solution-center-to-include-commercial-manufacturing 2019-06-26 17:59:39.526+00 https://www.pharmasalmanac.com/articles/daiichi-sankyo-provides-update-on-fda-review-of-quizartinib-for-the-treatment-of-patients-with-relapsed/refractory-flt3-itd-aml 2019-06-25 13:51:07.056+00 https://www.pharmasalmanac.com/articles/abbvie-to-acquire-allergan-for-63-billion 2019-06-25 13:50:10.079+00 https://www.pharmasalmanac.com/articles/sensyne-health-evotec-osi-and-the-university-of-oxford-create-new-partnership-called-lab10x-to-accelerate-data-driven-drug-discovery-powered-by-ai 2019-06-25 13:43:23.636+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-provides-update-on-pending-merger-with-celgene 2019-06-24 21:59:06.923+00 https://www.pharmasalmanac.com/articles/labcorp-and-mount-sinai-health-system-collaborate-to-establish-digital-and-ai-enabled-pathology-center-of-excellence 2019-06-24 21:55:17.773+00 https://www.pharmasalmanac.com/articles/statement-on-agencys-efforts-to-increase-transparency-in-medical-device-reporting 2019-06-24 21:45:35.978+00 https://www.pharmasalmanac.com/articles/krystal-biotech-announces-positive-results-from-phase-2-clinical-trial-and-receives-regenerative-medicine-advanced-therapy-designation 2019-06-24 21:33:19.429+00 https://www.pharmasalmanac.com/articles/kymab-and-lifearc-enter-strategic-partnership-to-discover-new-medicines-using-kymabs-intelliselect-technologies 2019-06-24 21:29:18.666+00 https://www.pharmasalmanac.com/articles/subjectwell-raises-10m-to-expand-its-risk-free-patient-recruitment-marketplace 2019-06-21 16:46:28.862+00 https://www.pharmasalmanac.com/articles/fda-approves-botox-onabotulinumtoxina-for-pediatric-patients-with-upper-limb-spasticity 2019-06-21 16:43:54.323+00 https://www.pharmasalmanac.com/articles/verastem-oncology-announces-leadership-changes 2019-06-21 16:40:11.931+00 https://www.pharmasalmanac.com/articles/tangen-biosciences-announces-9-million-series-a-financing-to-accelerate-development-of-disruptive-molecular-diagnostic-platform 2019-06-21 16:36:31.888+00 https://www.pharmasalmanac.com/articles/high-price-of-zynteglo-lentiglobin-impacts-bluebirds-stock-price 2019-06-21 15:08:51.826+00 https://www.pharmasalmanac.com/articles/crispr-gene-editing-of-babies-could-take-place-in-russia 2019-06-21 15:06:29.55+00 https://www.pharmasalmanac.com/articles/drug-companies-fight-back-on-tv-ad-pricing 2019-06-21 15:01:53.439+00 https://www.pharmasalmanac.com/articles/pfizer-acquires-array-biopharma-for-11.4-billion 2019-06-21 14:59:27.141+00 https://www.pharmasalmanac.com/articles/herceptin-biosimilar-approved-in-the-u.s 2019-06-21 14:56:00.795+00 https://www.pharmasalmanac.com/articles/pushing-the-bounds-of-memory-by-unraveling-secret-conversations-via-signaling-in-cells 2019-06-21 14:32:22.886+00 https://www.pharmasalmanac.com/articles/using-immune-markers-to-identify-precancerous-cells 2019-06-20 18:05:14.288+00 https://www.pharmasalmanac.com/articles/the-lives-of-many-cells-are-longer-than-expected 2019-06-20 17:59:47.968+00 https://www.pharmasalmanac.com/articles/common-glycemic-control-drug-could-have-other-significant-positive-effects-for-type-2-diabetes-patients 2019-06-20 17:35:34.279+00 https://www.pharmasalmanac.com/articles/emflaza-now-approved-for-treatment-of-young-children 2019-06-20 17:30:56.233+00 https://www.pharmasalmanac.com/articles/mill-creek-life-sciences-receives-grant-for-development-of-dendritic-cell-vaccine 2019-06-19 21:20:48.856+00 https://www.pharmasalmanac.com/articles/cognizant-to-acquire-zenith-technologies-a-leader-in-life-sciences-manufacturing-technology-services 2019-06-19 21:09:50.865+00 https://www.pharmasalmanac.com/articles/iveric-bio-enters-into-strategic-manufacturing-relationship-with-catalents-paragon-gene-therapy-for-orphan-inherited-retinal-diseases 2019-06-19 20:15:30.706+00 https://www.pharmasalmanac.com/articles/voyager-therapeutics-announces-restructured-gene-therapy-relationship-with-sanofi-genzyme-and-portfolio-update 2019-06-19 19:56:57.104+00 https://www.pharmasalmanac.com/articles/cambrex-adds-new-lab-space 2019-06-17 21:57:19.399+00 https://www.pharmasalmanac.com/articles/fda-approves-new-cochlear-implant-with-easier-access-to-mri-and-expanded-connectivity-ready-for-googles-direct-streaming-to-android-smartphones 2019-06-17 16:53:46.92+00 https://www.pharmasalmanac.com/articles/fda-grants-breakthrough-device-designation-to-bio-technes-exodx-prostate-intelliscore-epi-test 2019-06-17 16:46:18.487+00 https://www.pharmasalmanac.com/articles/enanta-pharmaceuticals-announces-positive-topline-results-in-healthy-adults-infected-with-respiratory-syncytial-virus-rsv 2019-06-17 16:41:20.795+00 https://www.pharmasalmanac.com/articles/pfizer-to-acquire-array-biopharma 2019-06-17 16:32:05.463+00 https://www.pharmasalmanac.com/articles/seqens-to-unveil-new-innovation-and-development-center-of-excellence 2019-06-17 09:00:03.885+00 https://www.pharmasalmanac.com/articles/gbt-announces-efficacy-data-from-all-patients-enrolled-in-phase-3-study-sustained-improvements-in-hemoglobin-with-voxelotor 2019-06-14 19:51:17.875+00 https://www.pharmasalmanac.com/articles/novartis-announces-new-leader-of-pharmaceuticals-business-unit 2019-06-14 19:45:07.495+00 https://www.pharmasalmanac.com/articles/lilly-presents-positive-results-for-taltz-vs.-humirain-patients-with-active-psoriatic-arthritis 2019-06-14 19:37:33.194+00 https://www.pharmasalmanac.com/articles/industry-leader-insight-dedicated-cdmo-services-meet-customer-needs-in-the-dynamic-biopharma-sector 2019-06-14 14:46:35.776+00 https://www.pharmasalmanac.com/articles/purigen-biosystems-raises-26.4-million-series-b-financing-to-accelerate-commercialization-of-automated-sample-preparation-platform 2019-06-14 14:36:46.914+00 https://www.pharmasalmanac.com/articles/novartis-cosentyx-first-to-show-efficacy-in-all-key-manifestations-of-psoriatic-arthritis 2019-06-14 14:24:46.245+00 https://www.pharmasalmanac.com/articles/gsk-joins-forces-with-the-university-of-california-to-advance-genomic-research-and-improve-drug-discovery 2019-06-13 21:08:04.569+00 https://www.pharmasalmanac.com/articles/abcellera-announces-therapeutic-antibody-discovery-collaboration-with-gilead-in-infectious-disease 2019-06-13 21:01:32.239+00 https://www.pharmasalmanac.com/articles/polar-speed-and-marken-join-forces-in-the-uk 2019-06-13 20:48:47.21+00 https://www.pharmasalmanac.com/articles/drug-affordability-review-board-created-in-maryland 2019-06-13 19:58:00.902+00 https://www.pharmasalmanac.com/articles/oklahoma-vs.-johnson-johnson-opioid-crisis-trial 2019-06-13 19:50:15.74+00 https://www.pharmasalmanac.com/articles/iovance-announces-plans-to-build-cell-therapy-production-plant-in-u.s 2019-06-13 19:45:44.035+00 https://www.pharmasalmanac.com/articles/mallinckrodt-modifies-specialty-generics-spinout-portfolio-composition 2019-06-13 19:43:19.83+00 https://www.pharmasalmanac.com/articles/over-1000-cancer-cell-therapies-in-development 2019-06-13 19:39:34.33+00 https://www.pharmasalmanac.com/articles/whole-biome-raises-35-million-in-series-b-financing 2019-06-13 19:35:13.846+00 https://www.pharmasalmanac.com/articles/aptar-acquires-nanopharm-and-gateway-analytical-broadening-pharma-services-platform-to-accelerate-customer-drug-development 2019-06-12 21:08:15.361+00 https://www.pharmasalmanac.com/articles/trialassure-launches-trialresults.com-for-clinical-trial-sponsors-to-publicly-post-plain-language-summaries 2019-06-12 20:20:13.098+00 https://www.pharmasalmanac.com/articles/saga-raises-40-million-sek-3.7-million-to-advance-ultrasensitive-cancer-liquid-biopsies 2019-06-12 20:07:13.849+00 https://www.pharmasalmanac.com/articles/changes-in-roches-board-of-directors-and-corporate-executive-committee 2019-06-11 21:59:10.021+00 https://www.pharmasalmanac.com/articles/genmab-signs-agreement-with-janssen-for-next-generation-cd38-antibody-hexabody-cd38 2019-06-11 21:49:50.615+00 https://www.pharmasalmanac.com/articles/gene-editing-solutions-with-off-the-shelf-gmp-crispr-cas9-nucleases 2019-06-11 20:28:39.201+00 https://www.pharmasalmanac.com/articles/the-link-between-a-robust-company-culture-and-quality 2019-06-11 16:40:35.196+00 https://www.pharmasalmanac.com/articles/the-advantage-of-plant-based-expression-solutions-around-the-globe 2019-06-07 17:25:01.517+00 https://www.pharmasalmanac.com/articles/aldevron-to-build-14-acre-gene-therapy-manufacturing-campus 2019-06-03 14:08:50.144+00 https://www.pharmasalmanac.com/articles/tracelink-gets-fda-approval-for-participation-in-the-pilot-project-program 2019-05-31 20:48:52.128+00 https://www.pharmasalmanac.com/articles/eli-lilly-acquires-rights-to-non-opioid-pain-treatment 2019-05-31 20:44:11.941+00 https://www.pharmasalmanac.com/articles/liver-model-shows-function-of-mutated-liver-genes 2019-05-31 20:26:59.267+00 https://www.pharmasalmanac.com/articles/new-model-of-mitosis-could-facilitate-cancer-research 2019-05-31 20:22:08.292+00 https://www.pharmasalmanac.com/articles/fda-approves-sma-gene-therapy 2019-05-31 20:17:57.343+00 https://www.pharmasalmanac.com/articles/boehringer-ingelheim-investing-in-mexico 2019-05-31 20:13:39.7+00 https://www.pharmasalmanac.com/articles/scynexis-reports-completion-of-chronic-nonclinical-toxicology-studies-supporting-long-term-administration-of-ibrexafungerp 2019-05-31 17:01:31.353+00 https://www.pharmasalmanac.com/articles/edward-brennan-jr.-m.d.-facs-to-lead-fsd-pharma-biosciences-division 2019-05-30 18:11:10.773+00 https://www.pharmasalmanac.com/articles/harbour-biomed-enters-multi-year-hcab-technology-licensing-agreement-with-a-top-ten-global-pharma-for-next-generation-human-antibody-discovery 2019-05-30 18:06:46.766+00 https://www.pharmasalmanac.com/articles/cytonus-therapeutics-to-present-ca-il12-breast-cancer-data-at-the-2019-bio-international-convention 2019-05-30 17:44:07.134+00 https://www.pharmasalmanac.com/articles/gsk-announces-changes-to-their-sales-representative-incentive-program 2019-05-29 21:32:50.462+00 https://www.pharmasalmanac.com/articles/iovance-biotherapeutics-announces-new-facility-to-support-u.s.-production-of-tumor-infiltrating-lymphocyte-cell-therapy-products 2019-05-29 21:24:32.395+00 https://www.pharmasalmanac.com/articles/gilead-sciences-appoints-johanna-mercier-as-chief-commercial-officer 2019-05-29 20:48:23.96+00 https://www.pharmasalmanac.com/articles/u.s.-fda-grants-priority-review-for-vascepa-icosapent-ethyl-supplemental-new-drug-application-seeking-cardiovascular-risk-reduction-indication 2019-05-29 20:22:37.469+00 https://www.pharmasalmanac.com/articles/bayer-and-foundation-medicine-announce-global-collaboration-to-develop-next-generation-sequencing-ngs-based-companion-diagnostics-in-oncology 2019-05-29 19:31:25.465+00 https://www.pharmasalmanac.com/articles/state-lawsuit-charges-generic-makers-with-price-fixing 2019-05-29 17:31:03.865+00 https://www.pharmasalmanac.com/articles/china-to-introduce-regulations-on-gene-editing 2019-05-29 17:29:00.104+00 https://www.pharmasalmanac.com/articles/drug-delivery-tech-based-on-sea-lamprey-immune-system-could-facilitate-treatment-of-brain-disorders 2019-05-29 17:24:18.49+00 https://www.pharmasalmanac.com/articles/triple-combination-treatments-for-multiple-myeloma-approved-in-europe 2019-05-29 17:13:09.356+00 https://www.pharmasalmanac.com/articles/cumulus-oncology-licenses-chk1-kinase-inhibitor-candidate-from-ligand 2019-05-29 17:07:58.793+00 https://www.pharmasalmanac.com/articles/what-advances-in-manufacturing-technology-are-most-enabling-the-scale-up-and-commercialization-of-next-generation-therapies 2019-05-29 14:46:23.376+00 https://www.pharmasalmanac.com/articles/social-networking-and-information-exchange-at-china-pharma-week 2019-05-28 18:10:47.76+00 https://www.pharmasalmanac.com/articles/bioprocess-of-the-future-whats-in-it-for-biomanufacturers 2019-05-28 16:43:05.668+00 https://www.pharmasalmanac.com/articles/where-do-orphan-drugs-go-from-here 2019-05-28 16:36:18.26+00 https://www.pharmasalmanac.com/articles/painting-tumors-is-a-promising-approach-to-improve-surgical-outcomes 2019-05-28 16:25:45.15+00 https://www.pharmasalmanac.com/articles/an-expanding-orphan-drug-market 2019-05-28 16:07:50.231+00 https://www.pharmasalmanac.com/articles/catering-to-a-growing-demand-for-small-volume-parenteral-manufacturing 2019-05-28 15:15:05.556+00 https://www.pharmasalmanac.com/articles/rentschler-expands-capabilities-in-biologics-contract-manufacturing 2019-05-28 14:49:17.362+00 https://www.pharmasalmanac.com/articles/designing-a-customer-centric-cdmo 2019-05-24 18:08:57.212+00 https://www.pharmasalmanac.com/articles/following-the-tobacco-road 2019-05-24 18:07:39.287+00 https://www.pharmasalmanac.com/articles/advanced-therapies-landscape-the-road-forward-and-ma 2019-05-24 18:06:05.144+00 https://www.pharmasalmanac.com/articles/leveraging-gmp-grade-human-serum-albumin-for-pharmaceutical-manufacturing 2019-05-24 18:05:23.035+00 https://www.pharmasalmanac.com/articles/speeding-up-adc-development-with-the-right-partner-organization 2019-05-24 18:04:29.44+00 https://www.pharmasalmanac.com/articles/taking-extra-care-with-formulation 2019-05-24 18:01:52.4+00 https://www.pharmasalmanac.com/articles/oral-solid-dose-manufacturing-for-customers-now-and-into-the-future 2019-05-24 18:01:30.151+00 https://www.pharmasalmanac.com/articles/supporting-aav-and-lentiviral-vector-development-and-commercialization 2019-05-24 18:00:45.792+00 https://www.pharmasalmanac.com/articles/applying-enzymatic-synthesis-for-chiral-molecules 2019-05-24 18:00:15.607+00 https://www.pharmasalmanac.com/articles/exploring-the-efficacy-of-stem-cells-in-reversing-age-related-frailty 2019-05-24 17:57:08.654+00 https://www.pharmasalmanac.com/articles/managing-the-complexity-of-the-supply-chain-for-cell-and-gene-therapies 2019-05-24 17:56:22.918+00 https://www.pharmasalmanac.com/articles/supporting-small-and-emerging-pharma-through-collaboration-and-specialized-expertise 2019-05-24 17:55:30.799+00 https://www.pharmasalmanac.com/articles/integrated-outsourcing-from-rsms-to-apis 2019-05-24 17:53:33.752+00 https://www.pharmasalmanac.com/articles/driving-innovation-to-support-strategic-client-partnerships 2019-05-24 16:11:02.687+00 https://www.pharmasalmanac.com/articles/reducing-waste-with-lean-delivery-in-facility-design-and-construction 2019-05-24 16:08:24.86+00 https://www.pharmasalmanac.com/articles/supporting-commercialization-with-specialized-technologies 2019-05-24 15:57:34.062+00 https://www.pharmasalmanac.com/articles/a-promising-step-forward-for-predicting-lung-cancer-from-google 2019-05-22 21:30:36.507+00 https://www.pharmasalmanac.com/articles/respivant-sciences-announces-dosing-of-first-patient-in-phase-2b-trial-of-rvt-1601-for-the-treatment-of-persistent-cough-due-to-idiopathic-pulmonary-fibrosis 2019-05-22 21:29:31.769+00 https://www.pharmasalmanac.com/articles/inovio-first-to-advance-lassa-fever-candidate-vaccine-into-a-clinical-trial 2019-05-22 20:54:13.226+00 https://www.pharmasalmanac.com/articles/altasciences-and-wuxi-apptec-enter-into-collaboration-for-wind-projects 2019-05-21 21:20:39.827+00 https://www.pharmasalmanac.com/articles/bbk-worldwide-opens-latest-subsidiary-strengthening-global-clinical-trial-patient-support-initiatives 2019-05-21 21:13:00.06+00 https://www.pharmasalmanac.com/articles/catalent-completes-acquisition-of-gene-therapy-leader-paragon-bioservices-inc.-for-1.2-billion 2019-05-21 20:54:53.906+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-signed-letter-of-intent-for-long-term-vaccine-manufacturing-contract 2019-05-21 20:27:33.095+00 https://www.pharmasalmanac.com/articles/array-biopharma-announces-braftovi-mektovi-cetuximab-meet-primary-endpoints-in-metastatic-colorectal-cancer 2019-05-21 19:39:10.102+00 https://www.pharmasalmanac.com/articles/lyonbiopole-cluster-showcases-its-members-at-bio-2019-17-innovative-entities-will-attend 2019-05-21 16:36:16.796+00 https://www.pharmasalmanac.com/articles/second-generation-on-the-go-ecg-device-gets-fda-approval 2019-05-21 16:05:51.111+00 https://www.pharmasalmanac.com/articles/janssen-iktos-collaborate-on-in-silico-drug-design 2019-05-21 16:02:24.726+00 https://www.pharmasalmanac.com/articles/vertiflex-acquired-by-boston-scientific 2019-05-21 15:58:17.29+00 https://www.pharmasalmanac.com/articles/successful-results-reported-for-another-rituximab-biosimilar 2019-05-21 15:53:46.325+00 https://www.pharmasalmanac.com/articles/takeda-slimming-down 2019-05-21 14:16:51.567+00 https://www.pharmasalmanac.com/articles/new-regulation-requires-pricing-info-in-tv-pharma-ads 2019-05-21 14:14:02.006+00 https://www.pharmasalmanac.com/articles/morphosys-ag-primary-endpoint-of-l-mind-a-combination-study-of-tafasitamab-mor208-and-lenalidomide-has-been-met-confirming-previously-published-activity 2019-05-20 21:35:38.432+00 https://www.pharmasalmanac.com/articles/new-long-term-data-show-that-twice-a-year-dosing-with-inclisiran-results-in-persistent-lowering-of-ldl-cholesterol 2019-05-20 21:28:09.888+00 https://www.pharmasalmanac.com/articles/actuate-therapeutics-completes-21.7-million-series-b-financing 2019-05-17 20:39:18.865+00 https://www.pharmasalmanac.com/articles/dbv-technologies-announces-departure-of-deputy-ceo-david-schilansky 2019-05-17 20:26:20.453+00 https://www.pharmasalmanac.com/articles/takeda-and-frazier-healthcare-partners-announce-collaboration-to-launch-phathom-pharmaceuticals 2019-05-17 20:19:52.17+00 https://www.pharmasalmanac.com/articles/abbvie-resolves-humira-adalimumab-u.s.-patent-litigation-with-boehringer-ingelheim 2019-05-17 18:54:58.412+00 https://www.pharmasalmanac.com/articles/pfizer-announces-positive-top-line-results-from-phase-3-study-in-patients-with-moderate-to-severe-atopic-dermatitis 2019-05-17 14:48:02.881+00 https://www.pharmasalmanac.com/articles/abbvie-provides-update-on-depatuxizumab-mafodotin-depatux-m-an-investigational-medicine-for-newly-diagnosed-glioblastoma-an-aggressive-form-of-brain-cancer 2019-05-17 14:39:49.194+00 https://www.pharmasalmanac.com/articles/ginkgo-bioworks-acquires-warp-drive-bios-genome-mining-platform-for-discovery-and-development-of-novel-classes-of-antibiotics 2019-05-16 19:18:04.598+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-acquire-manufacturing-site-in-cork-ireland-from-gsk 2019-05-16 19:13:29.105+00 https://www.pharmasalmanac.com/articles/genentech-announces-fda-approval-for-venclexta-plus-gazyva-for-people-with-previously-untreated-chronic-lymphocytic-leukemia 2019-05-16 19:07:57.562+00 https://www.pharmasalmanac.com/articles/ross-prize-awarded-to-nih-scientific-director 2019-05-15 18:38:24.67+00 https://www.pharmasalmanac.com/articles/know-bio-announces-closing-of-30-million-in-equity-financing 2019-05-15 18:34:52.289+00 https://www.pharmasalmanac.com/articles/fengate-exceeds-fundraising-target-and-closes-core-infrastructure-fund-iii-with-1.1-billion-in-capital-commitments 2019-05-15 18:28:11.998+00 https://www.pharmasalmanac.com/articles/leapfrog-breaks-impact-investing-record-with-700m-emerging-markets-fund 2019-05-14 15:22:25.979+00 https://www.pharmasalmanac.com/articles/labcorp-announces-availability-of-new-qiagen-therascreen-fgfr-mutation-analysis-companion-diagnostic-for-bladder-cancer 2019-05-14 15:12:26.7+00 https://www.pharmasalmanac.com/articles/moderna-announces-publication-of-phase-1-data-for-mrna-vaccines-against-two-potential-pandemic-influenza-strains 2019-05-14 15:07:14.235+00 https://www.pharmasalmanac.com/articles/bayer-invests-150-million-to-build-new-cell-culture-technology-center-in-berkeley-to-spur-innovation-of-biotech-therapies 2019-05-14 15:03:49.461+00 https://www.pharmasalmanac.com/articles/gilead-sciences-to-provide-free-truvada-for-prep-to-support-u.s.-initiative-to-end-the-hiv-epidemic 2019-05-14 14:57:42.63+00 https://www.pharmasalmanac.com/articles/top-execs-at-opioid-maker-insys-therapeutics-found-guilty-of-paying-bribes 2019-05-10 20:49:54.184+00 https://www.pharmasalmanac.com/articles/the-fda-changes-the-drug-approval-process 2019-05-10 20:46:22.236+00 https://www.pharmasalmanac.com/articles/gsk-has-hopes-for-trelegy-in-asthma 2019-05-10 20:31:12.944+00 https://www.pharmasalmanac.com/articles/novartis-to-acquire-xiidra-expanding-front-of-eye-portfolio 2019-05-10 15:00:05.173+00 https://www.pharmasalmanac.com/articles/gene-therapy-costs-discussed-by-insurance-company-heads 2019-05-10 14:09:07.784+00 https://www.pharmasalmanac.com/articles/merck-undergoes-restructuring 2019-05-10 14:06:40.957+00 https://www.pharmasalmanac.com/articles/elligo-health-research-raises-20m-to-connect-more-physicians-and-their-patients-to-clinical-research-as-a-care-option 2019-05-09 16:04:45.215+00 https://www.pharmasalmanac.com/articles/alector-opts-for-lonzas-ibex-develop-to-secure-future-manufacturing-for-neurodegeneration-therapies 2019-05-09 15:57:29.518+00 https://www.pharmasalmanac.com/articles/kiyatec-announces-3-million-initial-closing-of-series-b2-preferred-stock-financing-and-new-investor-labcorp 2019-05-09 15:47:18.509+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-acquires-pharmapace-to-enhance-biometrics-services-for-clinical-development 2019-05-09 15:41:18.916+00 https://www.pharmasalmanac.com/articles/new-research-on-the-kerecis-fish-skin-grafts-wound-treatment-to-be-presented-at-the-symposium-on-advanced-wound-care 2019-05-07 21:06:48.373+00 https://www.pharmasalmanac.com/articles/heron-therapeutics-partners-with-the-national-academy-of-medicine-to-counter-the-opioid-epidemic-in-the-united-states 2019-05-07 21:02:07.741+00 https://www.pharmasalmanac.com/articles/invitae-reports-47-growth-in-quarterly-revenue-and-volume-year-over-year 2019-05-07 20:58:01.315+00 https://www.pharmasalmanac.com/articles/fda-grants-breakthrough-device-designation-to-nateras-signatera-test 2019-05-06 22:01:12.927+00 https://www.pharmasalmanac.com/articles/chop-anesthesiologist-appointed-to-fda-advisory-committee 2019-05-06 21:56:42.836+00 https://www.pharmasalmanac.com/articles/inovio-receives-european-medicines-agency-certification-for-quality-and-non-clinical-data-for-its-phase-3-product-vgx-3100 2019-05-06 21:27:53.484+00 https://www.pharmasalmanac.com/articles/insulet-reports-first-quarter-2019-revenue 2019-05-06 20:26:27.301+00 https://www.pharmasalmanac.com/articles/overcoming-analytical-compliance-challenges 2019-05-06 15:28:34.633+00 https://www.pharmasalmanac.com/articles/novus-therapeutics-announces-closing-of-10.7-million-registered-direct-offering-priced-at-the-market 2019-05-03 21:43:40.057+00 https://www.pharmasalmanac.com/articles/abbott-receives-who-prequalification-approval-for-breakthrough-hiv-point-of-care-test 2019-05-03 16:48:09.423+00 https://www.pharmasalmanac.com/articles/amgen-and-syapse-enter-precision-medicine-collaboration-in-oncology 2019-05-03 16:28:04.044+00 https://www.pharmasalmanac.com/articles/arrakis-therapeutics-developing-oral-drugs-that-target-rna 2019-05-02 20:39:27.487+00 https://www.pharmasalmanac.com/articles/bms-celgene-merger-still-on 2019-05-02 20:35:50.425+00 https://www.pharmasalmanac.com/articles/study-finds-genetics-do-impact-weight 2019-05-02 20:30:48.949+00 https://www.pharmasalmanac.com/articles/first-generic-nalaxone-nasal-spray-approved-by-fda 2019-05-02 20:26:49.305+00 https://www.pharmasalmanac.com/articles/first-medical-device-cleared-by-fda-to-treat-childhood-adhd 2019-05-02 17:06:58.059+00 https://www.pharmasalmanac.com/articles/fda-approved-keytruda-for-kidney-cancer-sooner-than-expected 2019-05-02 16:20:05.797+00 https://www.pharmasalmanac.com/articles/fda-purchases-bundle-of-admet-predictor-licenses 2019-04-30 20:53:40.137+00 https://www.pharmasalmanac.com/articles/cerevance-achieves-key-endpoints-in-phase-1-clinical-trial-of-novel-parkinsons-disease-drug-cvn424 2019-04-30 20:49:42.604+00 https://www.pharmasalmanac.com/articles/aluf-holdings-inc.-announces-closing-of-interaqt-corporation-colotraq-acquisition 2019-04-30 20:18:51.409+00 https://www.pharmasalmanac.com/articles/global-vaccines-market-to-2027-focus-on-influenza-hepatitis-respiratory-syncytial-virus-and-other-disease 2019-04-30 19:53:49.06+00 https://www.pharmasalmanac.com/articles/synteract-bolsters-its-oncology-neuro-degenerative-and-rare-disease-centers-of-development-with-two-new-executives 2019-04-30 18:09:04.695+00 https://www.pharmasalmanac.com/articles/mymetics-receives-hiv-vaccine-funding-from-the-nih 2019-04-29 21:51:52.391+00 https://www.pharmasalmanac.com/articles/new-england-biolabs-launches-nebnext-enzymatic-methyl-seq-em-seq-for-bisulfite-free-methylation-analysis 2019-04-29 21:48:32.397+00 https://www.pharmasalmanac.com/articles/mayo-clinic-researchers-say-fecal-transplants-show-promise-for-treating-antibiotic-resistant-bacteria 2019-04-29 21:39:49.89+00 https://www.pharmasalmanac.com/articles/gencove-announces-phase-i-sbir-grant-to-validate-polygenic-risk-score-estimation-from-low-pass-sequencing 2019-04-26 21:46:41.657+00 https://www.pharmasalmanac.com/articles/sirnaomics-closes-47-million-series-c-financing-to-develop-rnai-therapeutics-for-treatment-of-cancer-and-fibrotic-diseases 2019-04-26 21:45:45.185+00 https://www.pharmasalmanac.com/articles/perrigo-increases-its-dividend-by-11 2019-04-26 21:43:32.215+00 https://www.pharmasalmanac.com/articles/u.s.-court-of-appeals-rules-in-favor-of-lilly-in-alimta-vitamin-regimen-patent-lawsuit 2019-04-26 21:24:24.445+00 https://www.pharmasalmanac.com/articles/measles-mumps-rubella-vaccine-available-at-rite-aid-pharmacies-in-los-angeles-california 2019-04-26 19:50:53.818+00 https://www.pharmasalmanac.com/articles/samsung-demonstrates-viability-of-lower-dose-digital-radiography-algorithm-for-pediatric-patients 2019-04-23 21:16:27.279+00 https://www.pharmasalmanac.com/articles/iqvia-institute-for-human-data-science-study-record-59-new-u.s.-drugs-launched-in-2018-success-rates-fall-rd-trends-could-improve-productivity-by-2023 2019-04-23 20:51:44.919+00 https://www.pharmasalmanac.com/articles/grant-thornton-launches-eu-mdr-and-ivdr-tools-for-medical-device-and-diagnostics-industry 2019-04-22 22:12:15.177+00 https://www.pharmasalmanac.com/articles/catalent-makes-moves-to-enter-gene-therapy-market-with-the-purchase-of-paragon-bioservices 2019-04-18 18:51:46.762+00 https://www.pharmasalmanac.com/articles/jj-believes-its-diabetes-drug-invokana-is-a-game-changer 2019-04-18 18:45:15.487+00 https://www.pharmasalmanac.com/articles/jjs-bladder-cancer-drug-gets-accelerated-fda-approval 2019-04-18 18:36:04.176+00 https://www.pharmasalmanac.com/articles/final-rule-published-by-the-fda-on-consumer-hand-sanitizers 2019-04-18 18:30:57.13+00 https://www.pharmasalmanac.com/articles/pharma-company-tax-savings-went-to-investors-and-stock-buybacks 2019-04-18 18:28:24.671+00 https://www.pharmasalmanac.com/articles/researchers-use-gene-editing-with-crispr-to-treat-lethal-lung-diseases-before-birth 2019-04-17 21:36:47.274+00 https://www.pharmasalmanac.com/articles/amgen-foundation-launches-amgen-biotech-experience-in-tampa-florida 2019-04-17 21:33:04.53+00 https://www.pharmasalmanac.com/articles/the-heart-valve-repair-and-replacement-devices-market-will-register-a-cagr-of-nearly-16-by-2023 2019-04-17 21:29:04.006+00 https://www.pharmasalmanac.com/articles/united-biopharma-announces-publication-of-breakthrough-hiv-clinical-trial-data-in-the-new-england-journal-of-medicine 2019-04-17 21:23:38.02+00 https://www.pharmasalmanac.com/articles/i-mab-biopharma-and-wuxi-biologics-announce-long-term-strategic-manufacturing-partnership-for-five-clinical-and-one-commercial-programs 2019-04-16 20:44:37.986+00 https://www.pharmasalmanac.com/articles/common-sensing-gocap-reveals-insulin-adherence-effects-on-glycemic-control 2019-04-16 20:38:21.953+00 https://www.pharmasalmanac.com/articles/orthos-vitros-high-sensitivity-troponin-i-assay-for-the-diagnosis-of-heart-attack-now-ce-marked-available-in-eu-countries 2019-04-16 20:30:25.921+00 https://www.pharmasalmanac.com/articles/new-publication-validates-clinical-performance-of-signatera-for-recurrence-monitoring-and-mrd-assessment-in-breast-cancer 2019-04-16 20:23:49.179+00 https://www.pharmasalmanac.com/articles/zymo-research-corp.-partners-with-the-uci-microbiome-initiative 2019-04-16 20:16:38.199+00 https://www.pharmasalmanac.com/articles/fiu-scientists-discover-new-arsenic-based-broad-spectrum-antibiotic 2019-04-16 19:14:31.114+00 https://www.pharmasalmanac.com/articles/to-protect-stem-cells-plants-have-diverse-genetic-backup-plans 2019-04-16 16:14:38.809+00 https://www.pharmasalmanac.com/articles/alchem-international-solves-stability-dilemma-for-micronized-digoxin-and-files-patent-for-novel-production-process 2019-04-16 16:10:55.156+00 https://www.pharmasalmanac.com/articles/evenity-romosozumab-aqqg-now-available-in-the-united-states-for-the-treatment-of-osteoporosis-in-postmenopausal-women-at-high-risk-for-fracture 2019-04-16 16:05:47.356+00 https://www.pharmasalmanac.com/articles/biotechpharma-to-expand-process-development-and-gmp-manufacturing-capacity-to-5000-l 2019-04-16 14:13:49.541+00 https://www.pharmasalmanac.com/articles/novartis-announces-fda-filing-acceptance-and-priority-review-of-brolucizumab-rth258-for-patients-with-wet-amd 2019-04-15 21:59:46.331+00 https://www.pharmasalmanac.com/articles/immunic-therapeutics-and-vital-therapies-complete-transaction-creating-nasdaq-listed-company-targeting-chronic-inflammatory-and-autoimmune-diseases 2019-04-12 21:49:57.594+00 https://www.pharmasalmanac.com/articles/investing-in-form-fill-seal-technology 2019-04-12 15:46:46.82+00 https://www.pharmasalmanac.com/articles/takara-bio-submits-drug-master-file-to-us-fda-for-retronectin-gmp-grade-liquid-format 2019-04-11 21:45:19.386+00 https://www.pharmasalmanac.com/articles/bayer-announces-results-of-sub-group-analysis-for-vitrakvi-larotrectinib-in-patients-with-ntrk-gene-fusion-positive-metastatic-non-small-cell-lung-cancer-nsclc 2019-04-11 21:41:36.988+00 https://www.pharmasalmanac.com/articles/ai-powered-virtual-healthcare-available-to-canadians 2019-04-11 21:29:54.871+00 https://www.pharmasalmanac.com/articles/amgen-looking-to-exit-migraine-collaboration-with-novartis 2019-04-10 21:53:13.028+00 https://www.pharmasalmanac.com/articles/expanded-collaboration-around-companion-diagnostics 2019-04-10 21:49:30.095+00 https://www.pharmasalmanac.com/articles/regeneron-expands-partnership-with-rnai-drug-developer-alnylam 2019-04-10 21:45:51.703+00 https://www.pharmasalmanac.com/articles/failed-depression-drug-could-be-opioid-addiction-treatment 2019-04-10 21:42:37.989+00 https://www.pharmasalmanac.com/articles/par-pharmaceutical-begins-offering-generic-albuterol-sulfate 2019-04-10 21:35:44.827+00 https://www.pharmasalmanac.com/articles/hpv-treatment-may-also-fight-rare-respiratory-disease 2019-04-10 21:32:34.697+00 https://www.pharmasalmanac.com/articles/study-finds-correlation-between-specific-epigenetic-molecules-and-autism-traits 2019-04-09 20:10:56.437+00 https://www.pharmasalmanac.com/articles/researchers-report-sx-682-could-enhance-multiple-forms-of-t-cell-based-immunotherapies-in-solid-tumors 2019-04-09 18:55:14.55+00 https://www.pharmasalmanac.com/articles/abk-biomedical-raises-30m-in-series-b-financing 2019-04-09 18:48:31.428+00 https://www.pharmasalmanac.com/articles/dante-labs-launches-genomel-the-first-commercial-long-reads-human-whole-genome-sequencing 2019-04-08 20:39:26.929+00 https://www.pharmasalmanac.com/articles/bayer-only-life-science-company-named-as-a-most-reputable-company-in-biggest-ever-corporate-reputation-study-in-u.s 2019-04-04 21:47:15.109+00 https://www.pharmasalmanac.com/articles/new-22-million-project-targets-deadly-viruses 2019-04-04 21:33:23.736+00 https://www.pharmasalmanac.com/articles/dr.-gustavo-mahler-resigns-as-chief-executive-officer-of-agc-biologics-patricio-massera-to-succeed-as-ceo-effective-may-1st-2019 2019-04-04 12:44:41.811+00 https://www.pharmasalmanac.com/articles/dps-group-and-tria-congratulate-moderna-on-ispe-2019-facility-of-the-future-category-award 2019-04-03 18:59:51.094+00 https://www.pharmasalmanac.com/articles/fda-clears-the-ind-for-ucartcs1-the-first-allogeneic-car-t-to-treat-multiple-myeloma-patients 2019-04-03 16:37:01.516+00 https://www.pharmasalmanac.com/articles/ucb-given-fda-okay-for-anti-arthritis-drug 2019-04-02 20:50:10.222+00 https://www.pharmasalmanac.com/articles/janssen-aims-for-supplemental-u.s.-fda-approval-for-invokana 2019-04-02 20:41:35.333+00 https://www.pharmasalmanac.com/articles/actinium-pharma-and-astellas-move-to-third-phase-of-their-collaboration 2019-04-02 20:36:28.723+00 https://www.pharmasalmanac.com/articles/autologous-gene-therapy-receives-positive-opinion-from-ema-committee 2019-04-02 20:24:11.239+00 https://www.pharmasalmanac.com/articles/novartis-acquires-ifm-tre 2019-04-02 20:15:52.347+00 https://www.pharmasalmanac.com/articles/u.s.-fda-commissioner-gottlieb-appears-before-the-senate-appropriations-committee 2019-04-02 20:12:45.932+00 https://www.pharmasalmanac.com/articles/using-genetic-data-to-fight-depression 2019-04-02 19:59:15.264+00 https://www.pharmasalmanac.com/articles/hum-nutrition-introduces-pre-and-probiotic-supplement-formulated-for-acne-prone-non-cystic-and-dry-skin-after-concluding-consumer-study 2019-04-01 16:55:09.081+00 https://www.pharmasalmanac.com/articles/heron-announces-european-medicines-agency-validation-of-marketing-authorisation-application-for-htx-011-for-postoperative-pain-management 2019-04-01 16:45:01.11+00 https://www.pharmasalmanac.com/articles/genomes.io-joins-tachyon-2.0-consensys-ventures-blockchain-focused-accelerator 2019-04-01 16:37:59.311+00 https://www.pharmasalmanac.com/articles/citius-announces-5.3-million-registered-direct-offering-priced-at-the-market 2019-04-01 16:32:46.654+00 https://www.pharmasalmanac.com/articles/pulmatrix-enters-into-binding-term-sheet-with-cipla-technologies-llc-for-the-development-and-commercialization-of-pulmazol 2019-04-01 16:27:51.686+00 https://www.pharmasalmanac.com/articles/kazia-presents-positive-cantrixil-phase-i-data-at-aacr-conference 2019-04-01 16:14:20.733+00 https://www.pharmasalmanac.com/articles/study-shows-how-light-therapy-might-help-premature-babies-avoid-vision-problems 2019-04-01 16:04:46.426+00 https://www.pharmasalmanac.com/articles/glycuron-2.78-able-to-enhance-measurable-positive-image-perception 2019-04-01 15:28:14.42+00 https://www.pharmasalmanac.com/articles/seqens-cosmetics-functional-care-formerly-chemoxy-launches-chemoxycare-6-12-hexanediol-with-best-in-class-quality-profile 2019-04-01 15:11:17.165+00 https://www.pharmasalmanac.com/articles/megabiotic-44-a-pre-and-postbiotics-complex-from-lactobacillus-bulgaricus-glb44-microorganism-able-to-enhance-pore-refinement 2019-04-01 15:10:50.434+00 https://www.pharmasalmanac.com/articles/transcenta-holding-announces-licensing-agreement-with-lilly 2019-03-29 17:14:09.561+00 https://www.pharmasalmanac.com/articles/dogs-prove-there-is-a-scent-associated-to-epileptic-seizures 2019-03-29 16:59:19.385+00 https://www.pharmasalmanac.com/articles/cimzia-certolizumab-pegol-is-now-the-first-and-only-u.s.-fda-approved-treatment-for-non-radiographic-axial-spondyloarthritis 2019-03-29 16:56:07.726+00 https://www.pharmasalmanac.com/articles/sangamo-therapeutics-presents-new-preclinical-data-demonstrating-significant-reduction-in-tau-expression-with-gene-regulation-technology 2019-03-29 16:50:42.748+00 https://www.pharmasalmanac.com/articles/barc-lab-and-owl-metabolomics-announce-strategic-partnership-on-deploying-metabolomic-technology-in-clinical-trials 2019-03-29 16:44:33.923+00 https://www.pharmasalmanac.com/articles/actinium-successfully-completes-second-module-of-collaborative-research-program-with-astellas-third-module-initiated 2019-03-29 16:38:32.309+00 https://www.pharmasalmanac.com/articles/first-patient-treated-for-severe-emphysema-with-the-fda-approved-spiration-valve-system 2019-03-29 16:34:11.656+00 https://www.pharmasalmanac.com/articles/amygdala-neurosciences-announces-dosing-the-first-patients-in-the-12.4-million-nih-heal-initiative-funded-search-program-of-clinical-studies-with-ans-6637 2019-03-28 21:55:05.818+00 https://www.pharmasalmanac.com/articles/caris-life-sciences-identifies-a-splicing-complex-on-the-surface-of-non-hodgkins-lymphoma-cells-that-is-a-potential-anti-tumor-drug-target 2019-03-28 21:25:58.633+00 https://www.pharmasalmanac.com/articles/asimov-selected-by-darpa-to-develop-artificial-intelligence-design-engine-for-synthetic-biology 2019-03-28 21:17:28.002+00 https://www.pharmasalmanac.com/articles/lilly-and-immunext-announce-licensing-and-research-collaboration 2019-03-28 19:50:51.607+00 https://www.pharmasalmanac.com/articles/new-blood-cancer-drug-shows-promise 2019-03-28 16:03:57.929+00 https://www.pharmasalmanac.com/articles/alcon-going-on-its-own 2019-03-28 16:01:57.067+00 https://www.pharmasalmanac.com/articles/possible-connection-between-dengue-virus-exposure-and-zika-virus-infection 2019-03-28 15:56:06.549+00 https://www.pharmasalmanac.com/articles/a-new-approach-to-preserving-fertility-for-cancer-patients 2019-03-28 15:50:18.412+00 https://www.pharmasalmanac.com/articles/imago-biosciences-completes-successful-funding-round 2019-03-28 15:32:45.154+00 https://www.pharmasalmanac.com/articles/brexit-protestors-include-scientists 2019-03-28 15:23:31.078+00 https://www.pharmasalmanac.com/articles/brammer-bio-purchased-by-thermo-fisher-scientific 2019-03-28 15:03:11.442+00 https://www.pharmasalmanac.com/articles/jazz-pharmaceuticals-announces-positive-top-line-results-from-phase-3-study-of-jzp-258-in-adult-narcolepsy-patients-with-cataplexy-and-excessive-daytime-sleepiness 2019-03-27 22:01:18.456+00 https://www.pharmasalmanac.com/articles/overcoming-raw-material-and-supply-chain-challenges-in-viral-vector-manufacturing 2019-03-27 20:54:42.177+00 https://www.pharmasalmanac.com/articles/grifols-announces-the-opening-of-its-new-plasma-donor-center-in-russellville-ar 2019-03-25 20:04:05.521+00 https://www.pharmasalmanac.com/articles/propanc-biopharma-initiates-development-of-bio-analytical-assay-in-preparation-for-human-trials 2019-03-25 19:32:08.667+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-announces-ampreloxetine-td-9855-phase-2-study-results-selected-for-oral-presentation-at-32nd-european-neurology-congress 2019-03-25 19:25:43.675+00 https://www.pharmasalmanac.com/articles/crispr-chip-enables-digital-detection-of-dna-without-amplification 2019-03-25 19:19:30.753+00 https://www.pharmasalmanac.com/articles/successful-us-fda-inspection-of-asymchem-tianjin-1-hpapi-development-and-manufacturing-facility 2019-03-25 19:17:56.036+00 https://www.pharmasalmanac.com/articles/guerbet-announces-transition-from-temporary-importation-to-regular-supply-for-lipiodol-ethiodized-oil-injection-also-introduces-new-glass-vial-container 2019-03-25 19:09:35.032+00 https://www.pharmasalmanac.com/articles/aducanumab-failure-selectivity-for-the-toxic-oligomer-is-essential-to-treating-root-cause-of-alzheimers-disease 2019-03-25 09:00:08.307+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-receives-ema-gmp-certificates 2019-03-22 09:00:09.175+00 https://www.pharmasalmanac.com/articles/enzyvants-investigational-farber-disease-enzyme-replacement-therapy-rvt-801-receives-fda-fast-track-and-rare-pediatric-disease-designations 2019-03-21 21:25:35.55+00 https://www.pharmasalmanac.com/articles/inovios-ebola-vaccine-delivered-intradermally-demonstrates-100-immunogenicity-in-a-clinical-study-published-in-the-journal-of-infectious-diseases 2019-03-21 21:21:34.338+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-instruments-recognized-by-selectscience 2019-03-21 21:17:56.558+00 https://www.pharmasalmanac.com/articles/agenus-announces-clinical-appointments 2019-03-21 21:14:38.68+00 https://www.pharmasalmanac.com/articles/health-quest-sets-out-to-boost-participation-in-clinical-trials-with-ibm-watson 2019-03-21 21:09:37.194+00 https://www.pharmasalmanac.com/articles/abbvie-donates-40-million-to-rebuild-north-chicago-middle-school 2019-03-21 21:02:25.254+00 https://www.pharmasalmanac.com/articles/distek-inc.-releases-dual-impeller-bione-single-use-bioreactor-system 2019-03-21 14:57:27.444+00 https://www.pharmasalmanac.com/articles/alcon-buys-powervision-for-285-million 2019-03-20 16:42:25.503+00 https://www.pharmasalmanac.com/articles/medical-implants-to-receive-fda-review 2019-03-20 16:37:02.674+00 https://www.pharmasalmanac.com/articles/apple-watch-to-be-tested-in-clinical-trial 2019-03-20 15:53:08.103+00 https://www.pharmasalmanac.com/articles/fda-announces-modernization-strategies-for-clinical-trials-of-precision-medicines 2019-03-20 15:44:36.238+00 https://www.pharmasalmanac.com/articles/global-robotic-arm-market-is-forecast-to-exhibit-a-cagr-of-over-13.8-during-the-forecast-period-growing-from-17.9-billion-in-2018-to-39.2-billion-by-2024 2019-03-20 15:20:40.703+00 https://www.pharmasalmanac.com/articles/milliporesigma-opens-first-m-lab-collaboration-center-in-europe 2019-03-20 15:00:58.665+00 https://www.pharmasalmanac.com/articles/amgen-cytokinetics-and-servier-announce-continuation-of-galactic-hf-following-planned-interim-analysis 2019-03-20 14:55:26.856+00 https://www.pharmasalmanac.com/articles/takeda-and-hemoshear-therapeutics-extend-exclusive-drug-discovery-partnership-in-liver-diseases 2019-03-20 14:54:55.044+00 https://www.pharmasalmanac.com/articles/syntrix-announces-first-patient-cohort-dosed-in-phase-2-study-of-desmetramadol-in-diabetic-neuropathic-pain 2019-03-20 14:40:00.966+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-to-invest-150-million-to-expand-pharma-services-capabilities 2019-03-20 09:00:08.734+00 https://www.pharmasalmanac.com/articles/in-vitro-adme-testing-services-market-2019-2030 2019-03-20 09:00:08.388+00 https://www.pharmasalmanac.com/articles/allergan-announces-fda-approval-of-avycaz-ceftazidime-and-avibactam-for-pediatric-patients 2019-03-20 09:00:07.632+00 https://www.pharmasalmanac.com/articles/alligator-bioscience-new-preclinical-data-demonstrate-strong-anti-tumor-effects-for-the-4-1bb-antibody-ator-1017 2019-03-18 21:18:48.881+00 https://www.pharmasalmanac.com/articles/astellas-launches-prograf-granules-tacrolimus-for-oral-suspension-in-the-u.s.-for-pediatric-liver-heart-and-kidney-transplant-patients 2019-03-18 20:35:03.908+00 https://www.pharmasalmanac.com/articles/mylan-institutional-llc-initiates-voluntary-nationwide-recall-of-levoleucovorin-injection-due-to-the-presence-of-particulate-matter 2019-03-18 20:21:13.155+00 https://www.pharmasalmanac.com/articles/highly-potent-api-and-sterile-capabilities-key-to-dcat-week-19-company-announcements 2019-03-18 19:42:58.408+00 https://www.pharmasalmanac.com/articles/special-focus-innovation-creating-solutions-for-healthcares-ambitious-agenda 2019-03-14 17:11:16.099+00 https://www.pharmasalmanac.com/articles/university-of-california-granted-new-crispr-cas9-patent-extending-its-patent-portfolio-for-genome-editing 2019-03-14 09:00:04.311+00 https://www.pharmasalmanac.com/articles/gencove-raises-3m-investment-led-by-spero-ventures-to-expand-genome-sequencing-platform 2019-03-13 18:11:05.92+00 https://www.pharmasalmanac.com/articles/fujifilm-to-acquire-large-scale-biologics-manufacturing-site-from-biogen-to-accelerate-growth-of-its-bio-cdmo-business 2019-03-13 17:42:01.215+00 https://www.pharmasalmanac.com/articles/biocept-expands-its-pathology-partnership-offering-for-liquid-biopsy-with-the-addition-of-several-key-services 2019-03-13 16:10:12.142+00 https://www.pharmasalmanac.com/articles/scientists-clarify-what-probiotics-are 2019-03-13 16:03:29.961+00 https://www.pharmasalmanac.com/articles/agenus-milestone-triggers-7.5m-payment-from-gilead 2019-03-13 15:50:18.615+00 https://www.pharmasalmanac.com/articles/lilly-announces-final-results-of-elanco-exchange-offer 2019-03-13 15:45:40.817+00 https://www.pharmasalmanac.com/articles/q-given-the-ongoing-evolution-of-the-pharma-industry-today-how-does-your-organization-incorporate-ethical-concerns-into-your-business-practices 2019-03-13 15:25:45.239+00 https://www.pharmasalmanac.com/articles/pharma-makes-moves-to-leverage-artificial-intelligence 2019-03-13 15:15:34.673+00 https://www.pharmasalmanac.com/articles/factors-driving-consolidation-in-the-cdmo-space 2019-03-13 15:10:38.85+00 https://www.pharmasalmanac.com/articles/selecting-the-right-private-equity-partner-to-build-a-leading-outsourcing-provider 2019-03-13 15:09:11.753+00 https://www.pharmasalmanac.com/articles/rentschler-biopharma-se-sets-foot-in-the-u.s.-to-strengthen-its-world-class-cdmo-position 2019-03-13 14:56:35.164+00 https://www.pharmasalmanac.com/articles/digital-droplet-pcr-for-viral-vector-analysis 2019-03-13 14:50:38.535+00 https://www.pharmasalmanac.com/articles/speed-and-customized-support-from-gene-to-gmp-manufacturing 2019-03-13 13:54:30.875+00 https://www.pharmasalmanac.com/articles/pharma-tackles-the-big-issues 2019-03-12 22:34:18.761+00 https://www.pharmasalmanac.com/articles/q-what-do-you-believe-the-role-of-artificial-intelligence-and-other-advanced-technologies-will-be-over-the-next-decade 2019-03-12 21:20:30.974+00 https://www.pharmasalmanac.com/articles/understanding-the-fdas-approach-to-real-world-evidence 2019-03-12 21:19:39.155+00 https://www.pharmasalmanac.com/articles/rapid-growth-in-the-adc-market-drives-strategic-partnership-interest 2019-03-12 21:19:15.781+00 https://www.pharmasalmanac.com/articles/award-winning-performance-driven-by-an-award-winning-workplace-culture 2019-03-12 21:18:47.081+00 https://www.pharmasalmanac.com/articles/collaborating-for-immunotherapy-development 2019-03-12 21:18:21.858+00 https://www.pharmasalmanac.com/articles/pharmas-almanac-most-impactful-thought-leadership-of-2018 2019-03-12 21:17:22.802+00 https://www.pharmasalmanac.com/articles/a-research-partner-with-proven-results 2019-03-12 21:05:15.004+00 https://www.pharmasalmanac.com/articles/accelerating-biosimilar-development 2019-03-12 21:03:59.383+00 https://www.pharmasalmanac.com/articles/twin-screw-melt-granulation-as-a-platform-technology-for-continuous-manufacturing 2019-03-12 21:03:20.443+00 https://www.pharmasalmanac.com/articles/overcoming-challenges-in-microbial-process-development 2019-03-12 21:02:58.81+00 https://www.pharmasalmanac.com/articles/a-world-class-partner-for-todays-market 2019-03-12 20:59:54.014+00 https://www.pharmasalmanac.com/articles/the-value-triangle-risk-management-for-rmats 2019-03-12 20:58:29.129+00 https://www.pharmasalmanac.com/articles/u.k.-healthcare-firms-creating-value-worldwide 2019-03-12 20:58:02.766+00 https://www.pharmasalmanac.com/articles/similar-different-and-constantly-varied 2019-03-12 20:56:46.931+00 https://www.pharmasalmanac.com/articles/quality-of-earnings-the-most-important-term-you-probably-dont-know 2019-03-12 20:56:03.37+00 https://www.pharmasalmanac.com/articles/machine-learning-may-benefit-future-alzheimers-patients 2019-03-12 20:55:26.503+00 https://www.pharmasalmanac.com/articles/setting-expectations-for-facility-and-business-sales-in-the-cdmo-sector 2019-03-12 20:55:20.132+00 https://www.pharmasalmanac.com/articles/preparing-middle-market-firms-to-attract-investment 2019-03-12 20:54:07.825+00 https://www.pharmasalmanac.com/articles/reprioritizing-to-bring-fy2020-into-focus 2019-03-12 20:53:33.923+00 https://www.pharmasalmanac.com/articles/evolving-ethical-conduct-concerns-in-clinical-trials 2019-03-12 20:53:17.707+00 https://www.pharmasalmanac.com/articles/balancing-ethical-and-fiduciary-responsibilities-in-drug-pricing 2019-03-12 20:52:58.901+00 https://www.pharmasalmanac.com/articles/developing-and-characterizing-dpi-formulations-for-biologics 2019-03-12 20:52:40.062+00 https://www.pharmasalmanac.com/articles/pfizer-licenses-antolrx-type-1-diabetes-candidate 2019-03-12 20:51:24.748+00 https://www.pharmasalmanac.com/articles/adjusting-internal-structure-to-better-meet-demands-of-unmet-business 2019-03-12 20:50:20.417+00 https://www.pharmasalmanac.com/articles/entyvio-outperforms-humira-as-an-ulcerative-colitis-therapy 2019-03-12 20:45:30.048+00 https://www.pharmasalmanac.com/articles/cellectis-moves-forward-with-plans-for-internal-manufacturing-capability 2019-03-12 20:39:46.375+00 https://www.pharmasalmanac.com/articles/fda-grants-priority-review-to-dupixent-for-treatment-of-adults-with-severe-chronic-rhinosinusitis 2019-03-12 20:31:45.11+00 https://www.pharmasalmanac.com/articles/axovant-reports-early-results-for-gene-therapies 2019-03-12 20:27:39.557+00 https://www.pharmasalmanac.com/articles/how-agile-investment-drives-innovation 2019-03-12 18:52:04.589+00 https://www.pharmasalmanac.com/articles/preclinical-to-nearly-commercial-virus-and-viral-vector-manufacturing 2019-03-12 18:49:54.832+00 https://www.pharmasalmanac.com/articles/investing-in-the-future-of-potent-compounds 2019-03-12 18:49:22.8+00 https://www.pharmasalmanac.com/articles/leveraging-operational-simulations-to-design-cell-therapy-facilities 2019-03-12 18:48:36.335+00 https://www.pharmasalmanac.com/articles/a-world-of-opportunity-what-to-expect-from-cphi-p-mec-china 2019-03-12 18:48:22.689+00 https://www.pharmasalmanac.com/articles/driving-growth-of-the-cell-and-gene-therapy-sector 2019-03-12 18:46:09.443+00 https://www.pharmasalmanac.com/articles/finding-the-right-product-platform-a-personal-perspective 2019-03-12 18:39:45.379+00 https://www.pharmasalmanac.com/articles/facilitating-complex-clinical-trials-for-rare-diseases 2019-03-12 18:36:02.121+00 https://www.pharmasalmanac.com/articles/fill/finish-increasing-investment-and-flexibility-for-effective-manufacturing 2019-03-12 18:35:42.259+00 https://www.pharmasalmanac.com/articles/supporting-client-projects-for-cdmo-success 2019-03-12 18:31:37.102+00 https://www.pharmasalmanac.com/articles/process-understanding-central-to-successful-drug-synthesis 2019-03-12 18:30:47.667+00 https://www.pharmasalmanac.com/articles/the-global-human-microbiome-market-is-expected-to-reach-us-1197.08-mn-in-2025-from-us-257.30-mn-in-2017 2019-03-12 15:09:42.689+00 https://www.pharmasalmanac.com/articles/lillys-cyramza-phase-3-relay-trial-met-primary-endpoint-in-first-line-treatment-of-patients-with-metastatic-egfr-mutated-non-small-cell-lung-cancer 2019-03-12 14:34:27.976+00 https://www.pharmasalmanac.com/articles/lipocines-lpcn-1144-for-nash-demonstrates-substantial-fatty-liver-resolution-and-meaningful-liver-fat-reduction-in-nafld-population 2019-03-12 14:27:18.48+00 https://www.pharmasalmanac.com/articles/galmed-reports-positive-results-from-pharmacokinetic-split-dose-study-of-aramchol 2019-03-12 14:21:44.725+00 https://www.pharmasalmanac.com/articles/fortebio-introduces-new-product-for-high-throughput-glycan-screening 2019-03-12 14:14:13.485+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-announces-first-patient-dosed-in-phase-2b/3-study-of-td-1473-in-patients-with-ulcerative-colitis 2019-03-12 14:10:51.803+00 https://www.pharmasalmanac.com/articles/long-acting-injectable-hiv-treatment-regimen-of-rilpivirine-and-cabotegravir-demonstrated-comparable-safety-and-efficacy-to-daily-oral-hiv-therapy 2019-03-07 22:33:00.255+00 https://www.pharmasalmanac.com/articles/global-healthcare-robotics-market-2023-market-was-estimated-at-5.40-billion-in-2017-and-is-anticipated-to-reach-11.44-billion-by-2023 2019-03-07 22:25:00.203+00 https://www.pharmasalmanac.com/articles/fda-releases-final-classification-for-natural-cycles-the-first-and-only-birth-control-app-in-the-u.s 2019-03-07 22:17:03.812+00 https://www.pharmasalmanac.com/articles/facilitating-drug-repositioning-with-artificial-intelligence 2019-03-07 16:20:53.089+00 https://www.pharmasalmanac.com/articles/nasal-drug-delivery-systems-market-worth-67.99-billion-by-2025-grand-view-research-inc 2019-03-07 14:02:28.726+00 https://www.pharmasalmanac.com/articles/real-world-evidence-on-use-of-halaven-eribulin-mesylate-injection-following-cdk-4/6-inhibitor-to-be-presented-at-36th-annual-miami-breast-cancer-conference 2019-03-06 17:47:45.481+00 https://www.pharmasalmanac.com/articles/lilly-to-introduce-lower-priced-insulin 2019-03-06 17:28:52.997+00 https://www.pharmasalmanac.com/articles/bioivt-launches-its-xpressway-profile-safety-package-a-gene-expression-reference-guide-designed-to-improve-drug-safety-analyses 2019-03-06 17:13:03.729+00 https://www.pharmasalmanac.com/articles/bausch-health-completes-acquisition-of-certain-assets-of-synergy-pharmaceuticals-inc 2019-03-06 17:10:05.365+00 https://www.pharmasalmanac.com/articles/aobiome-doses-first-patient-in-phase-1b-clinical-trial-of-b244-for-the-treatment-of-pediatric-atopic-dermatitis 2019-03-06 17:05:04.111+00 https://www.pharmasalmanac.com/articles/bimekizumab-demonstrated-long-term-maintenance-of-complete-or-almost-complete-skin-disease-resolution-for-psoriasis-patients-in-be-able-2-extension-study 2019-03-06 15:21:48.806+00 https://www.pharmasalmanac.com/articles/perrigo-confirms-patent-challenge-for-generic-version-of-nascobal 2019-03-06 15:20:53.239+00 https://www.pharmasalmanac.com/articles/nkmax-america-announces-fda-approval-of-ind-for-phase-1-trial-of-snk01-in-patients-with-refractory-cancer 2019-03-06 15:20:26.664+00 https://www.pharmasalmanac.com/articles/biogen-moves-into-gene-therapy-with-nightstar-buy 2019-03-05 23:04:09.432+00 https://www.pharmasalmanac.com/articles/how-do-you-classify-fecal-microbiota 2019-03-05 22:56:41.574+00 https://www.pharmasalmanac.com/articles/big-deals-already-begun-for-biotechs-in-2019 2019-03-05 22:53:25.962+00 https://www.pharmasalmanac.com/articles/clinical-trials-bot-matches-patients-to-studies 2019-03-05 22:38:02.763+00 https://www.pharmasalmanac.com/articles/lilly-receives-fda-priority-review-designation-for-emgality-galcanezumab-gnlm-injection-for-the-preventive-treatment-of-episodic-cluster-headache-in-adults 2019-03-05 22:05:24.579+00 https://www.pharmasalmanac.com/articles/over-the-counter-drugs-market-to-hit-185-billion-by-2025-global-market-insights-inc 2019-03-05 21:32:53.868+00 https://www.pharmasalmanac.com/articles/novartis-licenses-first-in-class-heart-disease-drug 2019-03-05 17:07:36.789+00 https://www.pharmasalmanac.com/articles/senate-finance-committee-holds-hearing-on-pharma-pricing 2019-03-05 16:30:06.18+00 https://www.pharmasalmanac.com/articles/roche-moves-into-the-gene-therapy-space 2019-03-05 16:26:51.441+00 https://www.pharmasalmanac.com/articles/generic-suboxone-sublingual-film-launched 2019-03-05 16:00:53.749+00 https://www.pharmasalmanac.com/articles/cholangiocarcinoma-drug-receives-orphan-drug-designation-from-fda 2019-03-05 15:57:09.38+00 https://www.pharmasalmanac.com/articles/spain-tops-bloombergs-list-of-healthiest-countries 2019-03-05 15:12:46.317+00 https://www.pharmasalmanac.com/articles/preparative-chromatography 2019-03-05 14:16:49.715+00 https://www.pharmasalmanac.com/articles/new-look-same-unwavering-patient-commitment-0 2019-03-05 14:16:49.596+00 https://www.pharmasalmanac.com/articles/new-look-same-unwavering-patient-commitment 2019-03-05 14:16:49.483+00 https://www.pharmasalmanac.com/articles/jj-in-talks-to-close-scottish-medical-sutures-site 2019-03-05 14:13:44.314+00 https://www.pharmasalmanac.com/articles/spending-trends-in-the-cmo-and-cro-market 2019-03-05 14:13:22.269+00 https://www.pharmasalmanac.com/articles/inovio-initiates-reveal-2-global-phase-3-clinical-study-for-the-treatment-of-hpv-related-cervical-pre-cancer 2019-03-04 17:59:36.579+00 https://www.pharmasalmanac.com/articles/chandelier-neuron-requires-velcro-like-molecule-to-form-connections 2019-03-04 16:59:03.485+00 https://www.pharmasalmanac.com/articles/biomarin-receives-positive-chmp-opinion-in-europe-for-palynziq-pegvaliase-injection-for-treatment-of-patients-with-phenylketonuria-pku-aged-16-and-older 2019-03-01 20:49:47.799+00 https://www.pharmasalmanac.com/articles/novo-nordisk-files-for-a-label-update-for-fiasp-to-the-ema-and-the-fda-seeking-approval-for-use-in-children-and-adolescents 2019-03-01 20:42:23.771+00 https://www.pharmasalmanac.com/articles/compugen-presents-update-on-com701-phase-1-trial-at-asco-sitc-clinical-immuno-oncology-symposium 2019-03-01 20:37:44.582+00 https://www.pharmasalmanac.com/articles/allergan-presents-data-from-seven-abstracts-at-the-2019-american-academy-of-dermatology-aad-in-washington-d.c 2019-03-01 20:14:46.819+00 https://www.pharmasalmanac.com/articles/ilumya-tildrakizumab-asmn-3-year-data-demonstrates-sustained-skin-clearance-in-patients-with-moderate-to-severe-plaque-psoriasis 2019-03-01 20:08:55.442+00 https://www.pharmasalmanac.com/articles/meeting-consumer-demand-for-vegetarian-capsules 2019-02-26 20:45:46.105+00 https://www.pharmasalmanac.com/articles/abl-bio-expands-strategic-collaboration-with-wuxi-biologics-and-licenses-wuxibodytm-platform-for-novel-immune-check-point-bispecifics-for-220-million 2019-02-26 19:47:12.238+00 https://www.pharmasalmanac.com/articles/fresenius-medical-care-completes-acquisition-of-nxstage-medical 2019-02-26 19:42:39.881+00 https://www.pharmasalmanac.com/articles/pcma-statement-on-senate-finance-committee-hearing-on-drug-prices 2019-02-26 18:26:21.465+00 https://www.pharmasalmanac.com/articles/regeneron-and-sanofi-strongly-disagree-with-verdict-upholding-three-of-five-amgen-u.s.-patent-claims-relating-to-pcsk9-antibodies 2019-02-26 18:22:07.342+00 https://www.pharmasalmanac.com/articles/the-global-population-health-management-market-size-is-expected-to-reach-usd-101.0-billion-by-2025 2019-02-26 18:16:16.195+00 https://www.pharmasalmanac.com/articles/astellas-and-wisercare-announce-collaboration-to-improve-patient-experience 2019-02-26 18:11:28.028+00 https://www.pharmasalmanac.com/articles/hemocue-announces-fda-510k-clearance-and-u.s.-launch-of-its-latest-point-of-care-hemoglobin-test-the-hemocue-hb-801-system 2019-02-25 10:00:06.635+00 https://www.pharmasalmanac.com/articles/new-study-in-mice-reveals-unexpected-place-for-learning-memory-in-the-brain 2019-02-22 17:30:18.675+00 https://www.pharmasalmanac.com/articles/patientpoint-and-antidote-team-up-to-drive-clinical-trial-recruitment-at-the-point-of-care 2019-02-22 17:22:19.291+00 https://www.pharmasalmanac.com/articles/the-immuno-oncology-assays-market-is-expected-to-grow-from-usd-2.9-billion-in-2018-to-usd-5.9-billion-by-2024-at-a-cagr-of-12.7 2019-02-22 17:16:48.848+00 https://www.pharmasalmanac.com/articles/amgen-cytokinetics-and-servier-announce-start-of-meteoric-hf-the-second-phase-3-clinical-trial-of-omecamtiv-mecarbil-in-patients-with-heart-failure 2019-02-21 20:41:00.512+00 https://www.pharmasalmanac.com/articles/bpsa-releases-guide-to-production-of-cell-and-gene-therapies 2019-02-21 20:31:22.696+00 https://www.pharmasalmanac.com/articles/aivita-completes-treatment-of-first-patient-in-phase-2-ovarian-cancer-trial 2019-02-21 20:28:44.136+00 https://www.pharmasalmanac.com/articles/insulin-pricing-suit-goes-to-court 2019-02-21 19:53:32.691+00 https://www.pharmasalmanac.com/articles/roche-counters-generic-competition-with-new-cancer-treatments 2019-02-21 19:51:01.027+00 https://www.pharmasalmanac.com/articles/fda-warns-about-claims-of-aging-and-memory-loss-prevention-with-infusions-of-young-donor-plasma 2019-02-21 19:48:34.99+00 https://www.pharmasalmanac.com/articles/second-study-with-induced-pluripotent-stem-cells-is-approved-in-japan 2019-02-21 19:43:34.216+00 https://www.pharmasalmanac.com/articles/new-nash-treatment-achieves-positive-phase-iii-results 2019-02-21 19:38:24.17+00 https://www.pharmasalmanac.com/articles/late-stage-positive-results-reported-for-nerve-growth-factor-inhibitor 2019-02-21 19:34:59.138+00 https://www.pharmasalmanac.com/articles/allergan-responds-to-public-shareholder-letter 2019-02-19 22:51:14.238+00 https://www.pharmasalmanac.com/articles/sandoz-inc.-launches-authorized-generic-version-of-buprenorphine-and-naloxone-sublingual-film 2019-02-19 22:49:19.768+00 https://www.pharmasalmanac.com/articles/diabetes-research-institute-scientists-engineer-suicide-genes-to-safely-grow-insulin-producing-beta-cells-from-stem-cells 2019-02-19 22:32:54.804+00 https://www.pharmasalmanac.com/articles/medimmune-neotx-to-study-combination-treatment 2019-02-19 21:56:33.278+00 https://www.pharmasalmanac.com/articles/fda-moves-against-companies-claiming-treatments-for-alzheimers-disease 2019-02-19 21:45:03.744+00 https://www.pharmasalmanac.com/articles/the-global-cold-plasma-market-size-is-expected-to-reach-usd-198.50-million-by-2026-at-a-strong-cagr-of-15.2 2019-02-15 20:38:41.689+00 https://www.pharmasalmanac.com/articles/stealth-biotherapeutics-announces-pricing-of-initial-public-offering 2019-02-15 20:23:44.701+00 https://www.pharmasalmanac.com/articles/bayer-to-obtain-full-rights-to-global-development-and-commercialization-of-oncology-compounds-vitrakvi-larotrectinib-and-bay-2731954-loxo-195 2019-02-15 20:16:26.605+00 https://www.pharmasalmanac.com/articles/lilly-completes-acquisition-of-loxo-oncology 2019-02-15 20:13:19.213+00 https://www.pharmasalmanac.com/articles/avapritinib-receives-phase-iii-clinical-trial-approval-for-gist-in-china 2019-02-15 20:05:37.937+00 https://www.pharmasalmanac.com/articles/johnson-johnson-announces-agreement-to-acquire-auris-health-inc 2019-02-15 10:00:12.551+00 https://www.pharmasalmanac.com/articles/researchers-may-have-found-method-for-detecting-consciousness 2019-02-14 19:36:27.503+00 https://www.pharmasalmanac.com/articles/putting-mosquitoes-on-a-diet 2019-02-14 19:21:39.05+00 https://www.pharmasalmanac.com/articles/abilita-bio-and-amgen-enter-into-a-multi-target-collaboration 2019-02-13 22:37:00.834+00 https://www.pharmasalmanac.com/articles/discovery-life-sciences-launches-major-european-expansion 2019-02-13 22:23:20.958+00 https://www.pharmasalmanac.com/articles/aivita-identifies-mechanism-to-enhance-patient-response-rate-to-next-generation-cancer-stem-cell-immunotherapy 2019-02-13 21:37:49.484+00 https://www.pharmasalmanac.com/articles/cure-rate-exceeds-97-percent-in-retrospective-study-of-sensus-healthcares-srt-100-for-treating-basal-and-squamous-cell-carcinomas-of-the-lower-extremities 2019-02-13 21:14:34.721+00 https://www.pharmasalmanac.com/articles/price-lowered-on-cholesterol-drugs 2019-02-12 22:35:16.685+00 https://www.pharmasalmanac.com/articles/global-cancer-immunotherapy-market-focus-on-pharmaceutical-products-therapeutic-indication-competitive-landscape-and-region-analysis-and-forecast-2018-202 2019-02-11 22:51:14.059+00 https://www.pharmasalmanac.com/articles/sangamo-announces-interim-results-of-phase-1/2-champions-study-showing-preliminary-evidence-of-in-vivo-genome-editing-in-patients-with-mps-ii-treated-with-sb-913 2019-02-11 10:00:01.731+00 https://www.pharmasalmanac.com/articles/proposed-u.s.-rules-would-eliminate-rebate-deals-between-drug-makers-and-pharmacy-benefit-managers 2019-02-07 20:55:38.023+00 https://www.pharmasalmanac.com/articles/bhb-therapeutics-launched-to-develop-medicines-to-prevent-age-related-diseases 2019-02-07 20:50:21.402+00 https://www.pharmasalmanac.com/articles/u.s.-fda-approves-botox-competitor 2019-02-07 20:44:07.493+00 https://www.pharmasalmanac.com/articles/soligenix-announces-publication-demonstrating-thermostabilization-of-an-ebola-subunit-vaccine-candidate 2019-02-07 19:20:20.922+00 https://www.pharmasalmanac.com/articles/pulmatrix-receives-ind-approval-for-pulmazole-phase-2-clinical-study 2019-02-07 19:05:47.945+00 https://www.pharmasalmanac.com/articles/kensci-raises-22-million-in-series-b-funding-to-fuel-growth 2019-02-07 19:01:44.463+00 https://www.pharmasalmanac.com/articles/antidote-therapeutics-announces-collaboration-with-national-cancer-institute-to-develop-ati-1013-a-novel-nicotine-binding-antibody 2019-02-07 18:54:02.41+00 https://www.pharmasalmanac.com/articles/sangamo-announces-interim-results-of-phase-1/2-empowers-study-evaluating-sb-318-zinc-finger-nuclease-zfn-in-vivo-genome-editing 2019-02-07 18:50:05.63+00 https://www.pharmasalmanac.com/articles/grifols-receives-fda-approval-for-procleix-babesia-assay-for-donor-screening-on-procleix-panther-system 2019-02-07 18:43:12.71+00 https://www.pharmasalmanac.com/articles/optimapharm-acquires-swiss-denothex-and-becomes-a-leading-european-mid-size-clinical-research-organization 2019-02-07 18:22:12.085+00 https://www.pharmasalmanac.com/articles/3m-board-increases-dividend-6-percent 2019-02-06 22:34:51.842+00 https://www.pharmasalmanac.com/articles/embleema-closes-3.7m-series-a-funding-round-and-joins-techstars-alchemist-blockchain-accelerator-program 2019-02-06 22:24:11.419+00 https://www.pharmasalmanac.com/articles/ema-committee-recommends-approval-of-tevas-anti-cgrp-treatment-for-migraines 2019-02-06 21:33:26.962+00 https://www.pharmasalmanac.com/articles/argenx-licenses-halozyme-subcutaneous-delivery-tech 2019-02-06 21:32:52.22+00 https://www.pharmasalmanac.com/articles/ema-will-soon-operate-from-amsterdam 2019-02-06 21:31:59.392+00 https://www.pharmasalmanac.com/articles/invo-bioscience-appoints-michael-j.-campbell-as-coo-vp-of-business-development 2019-02-06 10:15:04.709+00 https://www.pharmasalmanac.com/articles/sanofi-ceo-olivier-brandicourt-becomes-phrma-board-chairman 2019-02-05 22:10:39.716+00 https://www.pharmasalmanac.com/articles/mylan-announces-fda-approval-of-wixela-inhub-first-generic-of-advair-diskus 2019-02-05 16:15:07.468+00 https://www.pharmasalmanac.com/articles/altamont-capital-partners-acquires-publicis-healthcare-solutions 2019-02-05 10:15:04.428+00 https://www.pharmasalmanac.com/articles/selectivity-for-the-toxic-oligomer-essential-to-treating-root-cause-of-alzheimers-disease 2019-02-04 10:15:05.159+00 https://www.pharmasalmanac.com/articles/innovaccer-releases-healthcares-first-ever-research-on-social-determinants-of-health-with-zip-code-level-insights-across-the-us 2019-02-04 10:15:04.202+00 https://www.pharmasalmanac.com/articles/clinical-trials-planned-for-iris-recognition-based-patient-identification-software 2019-02-04 10:15:04.201+00 https://www.pharmasalmanac.com/articles/lilly-and-loxo-oncology-announce-expiration-of-hsr-act-waiting-period-in-connection-with-proposed-transaction 2019-02-04 10:15:04.169+00 https://www.pharmasalmanac.com/articles/perrigo-to-receive-milestone-payment-of-250-million-from-rpi-finance-trust 2019-02-01 10:15:04.465+00 https://www.pharmasalmanac.com/articles/aldeyra-therapeutics-expands-retinal-disease-pipeline-with-acquisition-of-helio-vision 2019-02-01 10:15:04.442+00 https://www.pharmasalmanac.com/articles/phynd-technologies-inc.-announces-completion-of-series-b-funding 2019-02-01 10:15:04.404+00 https://www.pharmasalmanac.com/articles/medipines-announces-fda-clearance-of-breakthrough-respiratory-device-the-medipines-gas-exchange-monitor 2019-01-31 10:15:31.927+00 https://www.pharmasalmanac.com/articles/computer-aided-drug-design-leads-to-real-candidate-and-new-biotech-startup 2019-01-30 19:13:13.031+00 https://www.pharmasalmanac.com/articles/johnson-johnson-is-latest-pharma-company-to-raise-u.s.-prices 2019-01-30 19:09:57.237+00 https://www.pharmasalmanac.com/articles/device-prints-anti-aging-product-on-the-skin 2019-01-30 18:58:35.627+00 https://www.pharmasalmanac.com/articles/epa-finalizes-rule-to-streamline-hazardous-waste-management-in-the-healthcare-sector 2019-01-30 18:46:52.171+00 https://www.pharmasalmanac.com/articles/new-bioproduction-system-for-vaccines-launched-by-univercells 2019-01-30 18:41:38.822+00 https://www.pharmasalmanac.com/articles/anti-aging-drug-development-company-applies-artificial-intelligence 2019-01-30 18:38:38.768+00 https://www.pharmasalmanac.com/articles/bioinvent-receives-fda-orphan-designation-for-bi-1206-for-mantle-cell-lymphoma 2019-01-30 15:11:52.084+00 https://www.pharmasalmanac.com/articles/ampersand-health-and-mediquire-announce-partnership-to-move-providers-to-value-based-care 2019-01-30 15:09:24.598+00 https://www.pharmasalmanac.com/articles/senecio-robotics-has-shipped-an-ai-based-robotic-machine-to-an-international-partner-in-support-of-global-efforts-to-combat-mosquito-borne-diseases 2019-01-30 10:15:23.582+00 https://www.pharmasalmanac.com/articles/addressing-the-challenges-and-opportunities-presented-by-advanced-therapies 2019-01-29 19:58:16.982+00 https://www.pharmasalmanac.com/articles/nyu-langone-launches-center-to-study-environmental-exposures-their-effects-on-health 2019-01-29 18:24:10.01+00 https://www.pharmasalmanac.com/articles/lilly-to-spend-8-billion-on-loxo-oncology 2019-01-29 17:55:50.887+00 https://www.pharmasalmanac.com/articles/i-mab-receives-ind-approval-from-the-us-fda-to-initiate-clinical-trials-for-its-proprietary-tjc4-a-potential-global-best-in-class-anti-cd47-monoclonal-antibody 2019-01-29 10:15:23.247+00 https://www.pharmasalmanac.com/articles/bio-techne-launches-cell-and-gene-therapy-portfolio 2019-01-29 10:15:21.312+00 https://www.pharmasalmanac.com/articles/bio-techne-introduces-ce-sds-plus-for-maurice-system 2019-01-29 10:15:21.273+00 https://www.pharmasalmanac.com/articles/hovione-issues-50-million-bond 2019-01-28 15:10:21.064+00 https://www.pharmasalmanac.com/articles/amgen-and-allergan-announce-positive-top-line-results-from-phase-1/-phase-3-study-of-abp-798-biosimilar-candidate-to-rituximab 2019-01-28 10:15:12.722+00 https://www.pharmasalmanac.com/articles/computational-drug-discovery-company-confirms-investment 2019-01-25 15:49:31.415+00 https://www.pharmasalmanac.com/articles/depression-drug-shows-early-positive-results 2019-01-25 15:45:51.838+00 https://www.pharmasalmanac.com/articles/gene-expression-profiling-raises-costs-for-cancer-care-without-improving-outcomes-for-low-risk-breast-cancer-patients-according-to-researchers 2019-01-25 10:15:10.976+00 https://www.pharmasalmanac.com/articles/philogen-announces-collaboration-with-celgene 2019-01-25 10:15:10.919+00 https://www.pharmasalmanac.com/articles/novant-health-selects-genesis-automation-for-enterprise-supply-chain 2019-01-25 10:15:07.964+00 https://www.pharmasalmanac.com/articles/biorem-announces-orders-totalling-3.6-million 2019-01-24 10:15:26.136+00 https://www.pharmasalmanac.com/articles/fda-approves-use-of-0.5-ml-dose-of-fluzone-quadrivalent-influenza-vaccine-in-children-as-young-as-6-months-of-age 2019-01-24 10:15:23.188+00 https://www.pharmasalmanac.com/articles/rmdy-health-selected-by-mobe-to-deliver-one-to-one-participant-engagement-across-digital-channels 2019-01-24 10:15:22.124+00 https://www.pharmasalmanac.com/articles/the-probiotics-market-is-estimated-to-be-valued-at-45.64-billion-in-2017-and-projected-to-grow-at-a-cagr-of-7.0 2019-01-23 10:15:12.037+00 https://www.pharmasalmanac.com/articles/lilly-reports-results-of-phase-3-soft-tissue-sarcoma-study-of-lartruvo 2019-01-23 10:15:12.016+00 https://www.pharmasalmanac.com/articles/imaginab-enrolls-first-patient-in-phase-ii-clinical-trial 2019-01-23 10:15:12.014+00 https://www.pharmasalmanac.com/articles/biocept-announces-pricing-of-2.2-million-registered-direct-offering 2019-01-23 10:15:12.008+00 https://www.pharmasalmanac.com/articles/new-study-shows-physician-targeted-marketing-is-associated-with-increase-in-opioid-overdose-deaths 2019-01-22 10:15:26.46+00 https://www.pharmasalmanac.com/articles/abbvie-provides-update-on-phase-3-study-of-ibrutinib-imbruvica-in-metastatic-pancreatic-cancer 2019-01-22 10:15:26.458+00 https://www.pharmasalmanac.com/articles/bayer-introduces-versatile-new-option-for-heartworm-prevention-and-intestinal-parasite-control 2019-01-22 10:15:20.418+00 https://www.pharmasalmanac.com/articles/gaylord-specialty-healthcare-announces-sonja-labarbera-as-president-and-ceo 2019-01-22 10:15:19.457+00 https://www.pharmasalmanac.com/articles/nx-prenatal-and-milu-labs-announce-strategic-collaboration-to-commercialize-exosome-based-preterm-birth-risk-test-in-asia 2019-01-21 10:15:12.297+00 https://www.pharmasalmanac.com/articles/acurx-receives-fda-fast-track-designation-for-acx-362e-for-the-treatment-of-c.-difficile-infection 2019-01-21 10:15:12.29+00 https://www.pharmasalmanac.com/articles/first-light-diagnostics-closes-8.25-million-series-a-2-financing 2019-01-21 10:15:12.289+00 https://www.pharmasalmanac.com/articles/longeveron-recruiting-for-stem-cell-alzheimers-trial-in-south-florida 2019-01-18 10:15:18.814+00 https://www.pharmasalmanac.com/articles/experimental-treatment-approach-shows-potential-against-staphylococcus-aureus 2019-01-18 10:15:18.811+00 https://www.pharmasalmanac.com/articles/longeveron-receives-prestigious-nih-small-business-innovation-research-grant 2019-01-18 10:15:13.782+00 https://www.pharmasalmanac.com/articles/aivita-biomedical-receives-ind-clearance-for-phase-1b-melanoma-trial 2019-01-18 10:15:12.783+00 https://www.pharmasalmanac.com/articles/new-analytic-model-to-better-identify-patients-likely-to-develop-ptsd 2019-01-17 10:15:19.57+00 https://www.pharmasalmanac.com/articles/genscript-launches-novel-technology-licensed-from-amgen-for-accelerating-protein-and-antibody-purification 2019-01-17 10:15:18.612+00 https://www.pharmasalmanac.com/articles/fda-approves-worlds-first-device-for-treatment-of-premature-babies-and-newborns-with-an-opening-in-their-hearts-a-common-congenital-defect 2019-01-17 10:15:17.624+00 https://www.pharmasalmanac.com/articles/cvs-health-announces-100-million-community-commitment-following-acquisition-of-aetna 2019-01-16 10:15:21.408+00 https://www.pharmasalmanac.com/articles/flow-sciences-inc.-partners-with-three-companies-to-contain-lyophilization-process-of-new-hpapi 2019-01-15 22:10:35.909+00 https://www.pharmasalmanac.com/articles/sanofi-and-regeneron-immuno-oncology-collaboration-ending 2019-01-15 22:06:28.433+00 https://www.pharmasalmanac.com/articles/the-global-wearable-robotic-exoskeleton-market-is-projected-to-reach-5.4-billion-by-2028 2019-01-15 19:49:05.618+00 https://www.pharmasalmanac.com/articles/fujifilm-announces-the-launch-of-its-next-generation-apollo-x-advanced-mammalian-expression-system 2019-01-15 10:15:03.141+00 https://www.pharmasalmanac.com/articles/pillar-biosciences-enters-strategic-partnership-with-china-biotech-services-holdings-to-deliver-precision-diagnostics-to-markets-in-asia 2019-01-15 10:15:03.125+00 https://www.pharmasalmanac.com/articles/sightglass-vision-multicenter-trial-to-study-novel-eyeglasses-to-control-nearsightedness-for-fda-approval 2019-01-15 10:15:03.083+00 https://www.pharmasalmanac.com/articles/a-path-forward-for-increasing-kidney-transplantation 2019-01-14 10:15:04.432+00 https://www.pharmasalmanac.com/articles/abbott-and-malaria-no-more-work-together-to-end-malaria-in-odisha-india 2019-01-14 10:15:04.417+00 https://www.pharmasalmanac.com/articles/the-eva-system-colposcope-fulfills-promise-of-the-ave-algorithm-to-change-future-of-cervical-cancer-detection 2019-01-14 10:15:04.385+00 https://www.pharmasalmanac.com/articles/biogen-and-skyhawk-therapeutics-announce-agreement-to-develop-novel-small-molecule-rna-splicing-modifiers-for-neurological-disease-targets 2019-01-11 14:43:24.842+00 https://www.pharmasalmanac.com/articles/blood-cancer-therapeutics-global-markets-to-2023 2019-01-11 10:15:06.012+00 https://www.pharmasalmanac.com/articles/sosei-heptares-to-receive-us15-million-milestone-payment-from-astrazeneca-with-first-partnered-program-moving-towards-phase-2 2019-01-10 18:01:45.549+00 https://www.pharmasalmanac.com/articles/deltarex-g-generates-significant-interest-in-a-commentary-published-in-molecular-therapy-family-of-journals 2019-01-10 17:25:59.986+00 https://www.pharmasalmanac.com/articles/lakepharma-announces-its-cgmp-microbiomanufacturing-center-is-now-operational 2019-01-10 17:24:52.773+00 https://www.pharmasalmanac.com/articles/novel-intrasaccular-aneurysm-treatment-device-receives-fda-pma-approval 2019-01-10 10:15:12.264+00 https://www.pharmasalmanac.com/articles/regeneron-and-sanofi-restructure-immuno-oncology-collaboration-for-discovery-and-development-programs 2019-01-10 10:15:11.354+00 https://www.pharmasalmanac.com/articles/astrazeneca-announces-organizational-changes 2019-01-10 10:15:11.344+00 https://www.pharmasalmanac.com/articles/swiss-ai-firm-raises-funds-for-entry-into-u.s 2019-01-09 19:54:22.069+00 https://www.pharmasalmanac.com/articles/allergan-establishes-rd-group-in-massachusetts 2019-01-09 19:47:28.439+00 https://www.pharmasalmanac.com/articles/fda-approves-first-inhaler-with-built-in-sensors 2019-01-09 19:42:01.096+00 https://www.pharmasalmanac.com/articles/ces-2019-omron-healthcare-launches-first-wearable-blood-pressure-monitor-previews-breakthrough-monitor-with-ekg-and-new-digital-health-services 2019-01-09 10:15:12.548+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-announces-alignment-of-workforce-with-focus-on-key-strategic-priorities 2019-01-09 10:15:12.505+00 https://www.pharmasalmanac.com/articles/primevax-immuno-oncology-receives-ind-permission-from-fda 2019-01-09 10:15:12.505+00 https://www.pharmasalmanac.com/articles/antengene-benefits-from-second-round-financing 2019-01-08 16:25:50.331+00 https://www.pharmasalmanac.com/articles/initial-positive-results-lead-to-expanded-cancer-trial 2019-01-08 16:15:43.023+00 https://www.pharmasalmanac.com/articles/new-assays-for-detecting-genomic-mutations-launched-by-contextual-genomics 2019-01-08 16:13:34.514+00 https://www.pharmasalmanac.com/articles/vedanta-increases-investment 2019-01-08 16:10:29.064+00 https://www.pharmasalmanac.com/articles/drug-companies-raise-prices-to-start-new-year 2019-01-08 16:06:10.59+00 https://www.pharmasalmanac.com/articles/grace-therapeutics-to-present-at-the-37th-annual-j.p.-morgan-healthcare-conference 2019-01-08 10:00:04.584+00 https://www.pharmasalmanac.com/articles/innovent-announces-first-patient-dosed-in-a-phase-iii-clinical-trial-of-anti-pd-1-antibody-tyvyt-sintilimab-injection 2019-01-08 10:00:04.57+00 https://www.pharmasalmanac.com/articles/neogen-acquires-canadian-animal-genomics-laboratory 2019-01-08 10:00:04.523+00 https://www.pharmasalmanac.com/articles/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2019 2019-01-08 10:00:04.001+00 https://www.pharmasalmanac.com/articles/ge-healthcare-vanderbilt-university-medical-center-partner-for-safer-more-precise-immunotherapy-cancer-treatment 2019-01-07 20:35:22.358+00 https://www.pharmasalmanac.com/articles/polarityte-registers-osteote-with-u.s.-food-and-drug-administration 2019-01-07 10:15:06.716+00 https://www.pharmasalmanac.com/articles/baltimore-biotech-earns-international-recognition-for-advanced-development-and-manufacturing-facility 2019-01-04 15:24:48.364+00 https://www.pharmasalmanac.com/articles/brammer-bolsters-leadership-team-and-announces-chief-quality-officer 2019-01-04 15:16:12.93+00 https://www.pharmasalmanac.com/articles/locus-biosciences-enters-a-collaboration-and-license-agreement-with-johnson-johnson-innovation-to-develop-crispr-cas3-bacteriophage-therapeutics 2019-01-04 15:02:26.363+00 https://www.pharmasalmanac.com/articles/gilead-invests-in-immuno-oncology 2019-01-03 22:10:01.634+00 https://www.pharmasalmanac.com/articles/bristol-myers-squibb-to-acquire-celgene-to-create-a-premier-innovative-biopharma-company 2019-01-03 14:55:28.634+00 https://www.pharmasalmanac.com/articles/connect-biopharmaceuticals-completes-55-million-series-b-financing-to-accelerate-clinical-development-of-novel-immune-modulators 2019-01-03 10:15:09.674+00 https://www.pharmasalmanac.com/articles/china-sxt-pharmaceuticals-inc.-announces-first-closing-of-initial-public-offering 2019-01-03 10:15:09.671+00 https://www.pharmasalmanac.com/articles/heron-therapeutics-to-present-at-the-37th-annual-j.p.-morgan-healthcare-conference 2019-01-03 10:15:08.695+00 https://www.pharmasalmanac.com/articles/amgen-submits-biologics-license-application-for-abp-710-biosimilar-infliximab-to-us-food-and-drug-administration 2019-01-02 10:15:07.479+00 https://www.pharmasalmanac.com/articles/launch-of-generic-lialda-delayed-release-tablets-expands-mylans-gastroenterology-product-offering 2019-01-02 10:15:07.415+00 https://www.pharmasalmanac.com/articles/bayer-updates-betaseron-interferon-beta-1b-prescribing-information-in-accordance-with-the-fda 2019-01-02 10:15:07.243+00 https://www.pharmasalmanac.com/articles/abbvie-announces-executive-leadership-changes 2019-01-02 10:15:07.132+00 https://www.pharmasalmanac.com/articles/lilly-announces-publication-of-analyses-showing-benefit-of-the-addition-of-verzenioabemaciclib-in-multiple-subgroups-of-patients-with-advanced-breast-cancer 2018-12-28 10:15:13.045+00 https://www.pharmasalmanac.com/articles/pneumatic-nebulizers-market-will-surge-at-5.3-cagr-to-hit-875-mn-by-2024-global-market-insights-inc 2018-12-28 10:15:13.012+00 https://www.pharmasalmanac.com/articles/biohaven-announces-closing-of-144m-public-offering-of-common-shares-including-full-exercise-of-underwriters-option-to-purchase-additional-shares 2018-12-28 10:15:11.968+00 https://www.pharmasalmanac.com/articles/entrada-therapeutics-raises-59-million-series-a-to-advance-intracellular-biologics-platform 2018-12-27 10:15:07.67+00 https://www.pharmasalmanac.com/articles/bruker-completes-the-acquisition-of-alicona-imaging-gmbh 2018-12-27 10:15:07.296+00 https://www.pharmasalmanac.com/articles/pall-opens-center-of-excellence-in-shanghai 2018-12-27 10:15:07.128+00 https://www.pharmasalmanac.com/articles/kymera-therapeutics-announces-expansion-of-scientific-advisory-board-to-advance-pre-clinical-molecules-toward-the-clinic 2018-12-27 10:15:06.702+00 https://www.pharmasalmanac.com/articles/biocept-and-prognos-enter-into-partnership-to-apply-artificial-intelligence-to-optimize-commercialization-of-biomarker-targeted-therapies-in-oncology 2018-12-24 10:15:13.172+00 https://www.pharmasalmanac.com/articles/ifm-therapeutics-announces-newly-discovered-mechanism-of-inflammatory-processes-in-the-body 2018-12-21 10:15:10.471+00 https://www.pharmasalmanac.com/articles/could-the-opioid-epidemic-be-relieved-by-a-vaccine 2018-12-19 17:33:16.921+00 https://www.pharmasalmanac.com/articles/sanofi-to-consolidate-massachusetts-activities 2018-12-19 17:12:53.091+00 https://www.pharmasalmanac.com/articles/astrazeneca-and-fibrogen-receive-first-approval-for-anemia-drug-in-china 2018-12-19 17:07:14.97+00 https://www.pharmasalmanac.com/articles/partnership-initiates-fight-to-regulate-lawsuit-ads-targeting-bad-drugs 2018-12-19 17:05:07.19+00 https://www.pharmasalmanac.com/articles/agc-triples-u.s.-biopharmaceutical-production-capacity 2018-12-18 18:50:02.018+00 https://www.pharmasalmanac.com/articles/sempre-health-and-upmc-health-plan-expand-program-that-improves-affordability-and-adherence-for-critical-medications 2018-12-18 18:36:48.829+00 https://www.pharmasalmanac.com/articles/marken-and-trakcel-collaborate-to-serve-cell-and-gene-trials 2018-12-18 18:34:56.207+00 https://www.pharmasalmanac.com/articles/amgen-and-lazarex-cancer-foundation-team-up-to-allow-more-diversity-in-clinical-trials 2018-12-18 10:15:13.037+00 https://www.pharmasalmanac.com/articles/cell-expansion-market-to-reach-us-26-billion-by-2024-says-tmr 2018-12-18 10:15:13.009+00 https://www.pharmasalmanac.com/articles/the-global-surgical-robots-market-is-projected-to-reach-6.5-billion-by-2023-from-usd-3.9-billion-in-2018-at-a-cagr-of-10.4 2018-12-18 10:15:13.004+00 https://www.pharmasalmanac.com/articles/world-first-approval-for-multiple-myeloma-drug-aplidinr 2018-12-17 10:15:12.596+00 https://www.pharmasalmanac.com/articles/oxford-biotherapeutics-expands-strategic-collaboration-with-wuxi-biologics-and-licenses-wuxibody-platform-for-five-bispecific-antibody-programs-for-up-to-450-million 2018-12-17 10:15:12.5+00 https://www.pharmasalmanac.com/articles/genedit-closes-8.5-million-series-seed-financing 2018-12-17 10:15:12.499+00 https://www.pharmasalmanac.com/articles/roche-to-develop-companion-diagnostic-test-to-help-identify-patients-eligible-for-anti-pd-1-therapy-based-on-biomarker-expression-not-location-of-solid-tumors 2018-12-14 15:53:57.979+00 https://www.pharmasalmanac.com/articles/abbott-to-present-at-j.p.-morgan-healthcare-conference 2018-12-14 10:15:12.121+00 https://www.pharmasalmanac.com/articles/biomx-appoints-sailaja-puttagunta-as-chief-medical-officer 2018-12-14 10:15:12.121+00 https://www.pharmasalmanac.com/articles/fda-approves-roches-tecentriq-in-combination-with-avastin-and-chemotherapy-for-the-initial-treatment-of-people-with-a-specific-type-of-metastatic-lung-cancer 2018-12-13 19:14:50.915+00 https://www.pharmasalmanac.com/articles/xospata-gilteritinib-available-at-biologics-by-mckesson 2018-12-13 10:15:08.248+00 https://www.pharmasalmanac.com/articles/nycedc-grants-1m-to-quentis-therapeutics-for-expansion-of-lifesci-space-in-west-harlem 2018-12-13 10:15:08.186+00 https://www.pharmasalmanac.com/articles/impel-neuropharma-closes-67.5-million-series-d-financing 2018-12-12 10:15:08.07+00 https://www.pharmasalmanac.com/articles/amgen-announces-10-percent-increase-in-2019-first-quarter-dividend 2018-12-12 10:15:07.426+00 https://www.pharmasalmanac.com/articles/immuno-oncology-development-trends-and-opportunities 2018-12-12 10:15:07.097+00 https://www.pharmasalmanac.com/articles/genentech-receives-additional-approval-for-tecentriq 2018-12-11 17:46:18.882+00 https://www.pharmasalmanac.com/articles/roche-exec-moves-to-gilead 2018-12-11 17:41:17.119+00 https://www.pharmasalmanac.com/articles/fda-issues-draft-guidance-for-companion-diagnostics 2018-12-11 17:37:57.524+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-plans-for-growth 2018-12-11 17:14:02.32+00 https://www.pharmasalmanac.com/articles/usrm-announces-u.s.-stem-cell-clinic-expansion-of-products-and-services 2018-12-11 10:15:09.146+00 https://www.pharmasalmanac.com/articles/ablexis-announces-licensing-agreement-with-allogene-therapeutics 2018-12-10 10:15:02.423+00 https://www.pharmasalmanac.com/articles/olympus-spiration-valve-system-is-fda-approved-for-the-endobronchial-treatment-of-emphysema 2018-12-10 10:15:02.407+00 https://www.pharmasalmanac.com/articles/sartorius-supervisory-board-appoints-two-new-executive-board-members 2018-12-10 10:15:02.4+00 https://www.pharmasalmanac.com/articles/the-anti-obesity-drugs-market-will-register-a-cagr-of-almost-8-by-2023 2018-12-07 17:44:46.754+00 https://www.pharmasalmanac.com/articles/isothrive-study-reveals-novel-bacterial-microfood-may-relieve-acid-reflux-by-restoring-the-distal-esophageal-microbiome 2018-12-07 10:15:13.853+00 https://www.pharmasalmanac.com/articles/mylan-expands-gastroenterology-portfolio-with-launch-of-generic-for-prevacid-solutab-delayed-release-orally-disintegrating-tablets 2018-12-07 10:15:11.757+00 https://www.pharmasalmanac.com/articles/imbruvica-ibrutinib-combination-regimen-significantly-improved-survival-versus-the-chemoimmunotherapy-fcr 2018-12-06 10:15:12.264+00 https://www.pharmasalmanac.com/articles/new-phase-3-cassini-data-presented-on-the-use-of-xarelto-rivaroxaban-for-venous-thromboembolism-vte-prevention-in-high-risk-cancer-patients 2018-12-06 10:15:12.261+00 https://www.pharmasalmanac.com/articles/cutbacks-and-divestitures-planned-at-bayer 2018-12-05 17:25:34.337+00 https://www.pharmasalmanac.com/articles/fda-gives-novartis-gene-replacement-therapy-application-priority-review 2018-12-05 17:22:21.909+00 https://www.pharmasalmanac.com/articles/regenerons-bispecific-antibody-candidate-shows-positive-results-in-early-clinical-studies 2018-12-05 17:15:54.041+00 https://www.pharmasalmanac.com/articles/pfizer-to-license-abbvies-humira-ip 2018-12-05 17:14:15.38+00 https://www.pharmasalmanac.com/articles/pfizers-rituximab-biosimilar-achieves-positive-study-results 2018-12-05 17:09:25.56+00 https://www.pharmasalmanac.com/articles/ocular-technology-provides-early-detection-of-alzheimers-disease 2018-12-05 10:15:06.719+00 https://www.pharmasalmanac.com/articles/immunotherapy-pioneers-a-unveil-updated-efficacy-data-of-tisagenlecleucel-plus 2018-12-05 10:15:04.75+00 https://www.pharmasalmanac.com/articles/ajinomoto-bio-pharma-services-introduces-ajicap-bioconjugation-technology-for-adc-manufacturing 2018-12-04 10:15:13.995+00 https://www.pharmasalmanac.com/articles/platelets-grown-from-stem-cells-may-be-alternative-to-donated-platelets 2018-12-04 10:15:13.906+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-receives-2018-global-integrated-drug-rd-services-competitive-strategy-innovation-leadership-award-from-frost-sullivan 2018-12-04 10:15:13.882+00 https://www.pharmasalmanac.com/articles/cvs-health-completes-acquisition-of-aetna-marking-the-start-of-transforming-the-consumer-health-experience 2018-12-03 10:15:07.422+00 https://www.pharmasalmanac.com/articles/researchers-regrow-hair-on-wounded-skin 2018-12-03 10:15:05.394+00 https://www.pharmasalmanac.com/articles/the-global-cell-therapy-market-size-is-expected-to-reach-usd-7.92-billion-by-2025 2018-11-30 10:15:03.375+00 https://www.pharmasalmanac.com/articles/tactiva-therapeutics-announces-license-to-oncolytic-vaccinia-virus-armed-with-cxcr4-antagonist-for-treatment-of-ovarian-cancer 2018-11-30 10:15:03.356+00 https://www.pharmasalmanac.com/articles/perrigo-announces-tentative-fda-approval-for-the-first-to-file-generic-version-of-ultravate-lotion-0.05 2018-11-30 10:15:02.416+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-announces-first-subject-dosed-in-phase-1-clinical-trial-of-td-8236-a-novel-inhaled-pan-jak-inhibitor 2018-11-29 10:15:11.043+00 https://www.pharmasalmanac.com/articles/fda-approves-vitrakvi-larotrectinib-the-first-ever-trk-inhibitor-for-patients-with-advanced-solid-tumors-harboring-an-ntrk-gene-fusion12 2018-11-29 10:15:10.137+00 https://www.pharmasalmanac.com/articles/interventional-medicine-maker-btg-will-be-purchased-by-boston-scientific 2018-11-28 20:33:01.624+00 https://www.pharmasalmanac.com/articles/clinical-study-explores-the-efficacy-of-numerous-ebola-therapies 2018-11-28 20:28:55.515+00 https://www.pharmasalmanac.com/articles/researchers-discover-potential-cause-for-alzheimers-disease 2018-11-28 20:25:38.25+00 https://www.pharmasalmanac.com/articles/wuxi-biologics-breaks-ground-on-innovation-center-in-china 2018-11-28 20:19:57.076+00 https://www.pharmasalmanac.com/articles/fda-approves-new-bone-cancer-drug 2018-11-28 20:17:07.284+00 https://www.pharmasalmanac.com/articles/crispr-used-to-edit-genes-in-human-embryos 2018-11-28 20:12:04.945+00 https://www.pharmasalmanac.com/articles/cannabis-market-worth-39.4-billion-by-2023-exclusive-report-by-marketsandmarkets 2018-11-28 10:15:08.263+00 https://www.pharmasalmanac.com/articles/qps-expands-u.s.-based-phase-i-clinical-trial-capabilities-to-support-the-growing-needs-of-its-pharmaceutical-biotechnology-and-cro-partners 2018-11-28 10:15:07.303+00 https://www.pharmasalmanac.com/articles/newfound-mechanism-may-yield-ways-to-counter-mistaken-immune-attack-on-body 2018-11-28 10:15:07.297+00 https://www.pharmasalmanac.com/articles/ge-healthcare-to-open-biotechnology-manufacturing-center-in-uk 2018-11-28 10:15:07.297+00 https://www.pharmasalmanac.com/articles/mylan-statement-in-response-to-fda-warning-letter-relating-to-morgantown-plant 2018-11-27 10:15:08.323+00 https://www.pharmasalmanac.com/articles/fresenius-leases-space-at-enterprise-business-park 2018-11-27 10:15:08.318+00 https://www.pharmasalmanac.com/articles/mylan-initiates-voluntary-nationwide-recall-due-to-the-detection-of-trace-amounts-of-ndea 2018-11-26 10:15:08.28+00 https://www.pharmasalmanac.com/articles/amgen-receives-chmp-positive-opinion-to-expand-use-of-blincyto-blinatumomab 2018-11-23 10:15:05.56+00 https://www.pharmasalmanac.com/articles/casi-pharmaceuticals-to-build-gmp-manufacturing-site-in-wuxi-china 2018-11-23 10:15:05.542+00 https://www.pharmasalmanac.com/articles/promentis-pharmaceuticals-announces-successful-completion-of-phase-1-studies-for-sxc-2023-targeting-novel-glutamatergic-mechanism 2018-11-23 10:15:05.538+00 https://www.pharmasalmanac.com/articles/new-study-makes-important-step-toward-treatment-of-deadly-brain-cancer 2018-11-23 10:15:05.495+00 https://www.pharmasalmanac.com/articles/auritec-pharmaceuticals-completes-enrollment-for-its-sustained-release-depot-tacrolimus-clinical-trial 2018-11-23 10:15:05.487+00 https://www.pharmasalmanac.com/articles/us-tax-savings-help-abbvie 2018-11-21 21:11:53.495+00 https://www.pharmasalmanac.com/articles/radiotherapy-makes-a-comeback 2018-11-20 17:38:01.424+00 https://www.pharmasalmanac.com/articles/patient-weight-can-impact-the-effectiveness-of-cancer-immunotherapies 2018-11-20 17:33:08.12+00 https://www.pharmasalmanac.com/articles/phase-iii-study-results-for-peanut-allergy-therapy-are-a-mixed-bag 2018-11-20 17:29:23.921+00 https://www.pharmasalmanac.com/articles/ema-recommends-approval-of-the-first-oral-drug-for-sleeping-sickness 2018-11-20 17:15:48.612+00 https://www.pharmasalmanac.com/articles/more-price-hikes-coming-from-pfizer-next-year 2018-11-20 17:07:21.03+00 https://www.pharmasalmanac.com/articles/immunocore-expands-partnership-with-roche 2018-11-20 17:05:16.764+00 https://www.pharmasalmanac.com/articles/sandoz-issues-voluntary-recall-of-losartan 2018-11-20 17:02:30.641+00 https://www.pharmasalmanac.com/articles/dnatrix-to-present-interim-phase-2-results-of-dnx-2401-with-pembrolizumab-for-glioblastoma 2018-11-20 16:02:29.822+00 https://www.pharmasalmanac.com/articles/theranica-announces-results-from-pivotal-study-of-device-for-treating-acute-migraine 2018-11-20 10:15:11.334+00 https://www.pharmasalmanac.com/articles/cervical-cancer-treatment-cure-is-possible-if-patients-receive-brachytherapy 2018-11-19 10:15:13.086+00 https://www.pharmasalmanac.com/articles/pulmatrix-to-present-results-from-the-pulmazole-pur1900-phase-1/1b-study-at-the-2018-annual-scientific-meeting 2018-11-19 10:15:13.075+00 https://www.pharmasalmanac.com/articles/published-study-pycnogenol-measurably-improved-symptoms-related-to-enlarged-prostate-within-60-days 2018-11-19 10:15:13.052+00 https://www.pharmasalmanac.com/articles/synteract-acquires-pediatric-cro-kinderpharm-to-further-strengthen-its-pediatric-center-of-development 2018-11-19 10:15:10.234+00 https://www.pharmasalmanac.com/articles/nih-1.4m-grant-supports-study-into-precision-bioelectronic-medicine 2018-11-16 10:15:06.548+00 https://www.pharmasalmanac.com/articles/dermatological-drugs-worldwide-market-analysis-outlook-to-2022-the-emergence-of-improved-diagnostic-modalities-is-driving-growth 2018-11-16 10:15:06.525+00 https://www.pharmasalmanac.com/articles/newly-published-feeding-trial-showed-cranberries-reduced-the-negative-impact-of-a-low-fiber-animal-based-diet-on-gut-health 2018-11-15 16:22:34.729+00 https://www.pharmasalmanac.com/articles/a-new-pd-l1-bond-ready-to-use-antibody-providing-you-with-the-freedom-and-flexibility-to-develop-the-tests-you-need 2018-11-14 10:15:05.41+00 https://www.pharmasalmanac.com/articles/researchers-eye-mental-health-impacts-of-hurricane-harvey 2018-11-14 10:15:05.404+00 https://www.pharmasalmanac.com/articles/for-eyes-launches-foundation-to-provide-greater-access-to-eye-care 2018-11-14 10:15:04.879+00 https://www.pharmasalmanac.com/articles/shire-is-hoping-takhzyro-sales-will-allay-investor-concerns-about-its-62-billion-acquisition-by-takeda 2018-11-13 17:38:22.243+00 https://www.pharmasalmanac.com/articles/us-fda-approves-third-pfizer-cancer-drug-in-two-months 2018-11-13 17:29:08.771+00 https://www.pharmasalmanac.com/articles/high-price-for-first-cannabis-drug 2018-11-13 17:24:47.091+00 https://www.pharmasalmanac.com/articles/cvs-health-acquisition-of-aetna-to-close-before-thanksgiving 2018-11-13 17:06:30.14+00 https://www.pharmasalmanac.com/articles/sanofi-and-denali-therapeutics-enter-new-collaboration 2018-11-13 17:03:25.926+00 https://www.pharmasalmanac.com/articles/boston-scientific-to-participate-in-2018-canaccord-genuity-medical-technologies-diagnostics-forum 2018-11-13 10:15:06.709+00 https://www.pharmasalmanac.com/articles/california-research-team-publishes-promising-results-from-peptide-based-universal-cancer-vaccine 2018-11-13 10:15:06.146+00 https://www.pharmasalmanac.com/articles/visiongain-report-researches-growth-opportunities-within-the-59bn-global-probiotics-market 2018-11-09 15:59:06.151+00 https://www.pharmasalmanac.com/articles/hpapis-and-two-piece-liquid-fill-capsules-the-perfect-match 2018-11-09 15:12:27.599+00 https://www.pharmasalmanac.com/articles/enesi-pharma-and-sementis-sign-rd-collaboration-focused-on-needle-free-solid-dose-vaccines-for-peanut-allergy-and-chikungunya/zika-infection 2018-11-09 10:15:08.711+00 https://www.pharmasalmanac.com/articles/initial-results-from-emprise-real-world-evidence-study-show-jardiance-was-associated-with-reduced-risk-for-hospitalization-for-heart-failure 2018-11-09 10:15:08.198+00 https://www.pharmasalmanac.com/articles/oxurion-and-beta-therapeutics-to-develop-new-heparanase-inhibitors-for-treatment-of-dry-amd 2018-11-09 10:15:08.189+00 https://www.pharmasalmanac.com/articles/sharp-announces-preferred-partner-agreement-with-berkshire-sterile-manufacturing 2018-11-09 10:15:08.187+00 https://www.pharmasalmanac.com/articles/mei-pharma-and-kyowa-hakko-kirin-announce-license-agreement-to-develop-and-commercialize-me-401-in-japan 2018-11-08 10:15:11.903+00 https://www.pharmasalmanac.com/articles/regenxbio-and-abeona-therapeutics-announce-worldwide-exclusive-licenses-for-the-treatment-of-four-rare-lysosomal-storage-disorders-using-nav-aav9-vector 2018-11-08 10:15:11.836+00 https://www.pharmasalmanac.com/articles/sysmex-inostics-oncobea-circulating-tumor-dna-technology-demonstrates-superior-response-prediction-for-advanced-pancreatic-cancer-over-standard 2018-11-08 10:15:11.832+00 https://www.pharmasalmanac.com/articles/cellect-receives-multiple-patent-grants 2018-11-07 10:15:09.742+00 https://www.pharmasalmanac.com/articles/the-medical-cannabis-market-is-set-to-expand-as-north-american-continues-to-grow 2018-11-07 10:15:09.729+00 https://www.pharmasalmanac.com/articles/lipocine-announces-completion-of-enrollment-in-lpcn-1144-liver-imaging-study-in-subjects-at-risk-for-nash 2018-11-07 10:15:09.704+00 https://www.pharmasalmanac.com/articles/curevo-announces-fda-advancement-of-ind-application-for-crv-101-new-shingles-vaccine-candidate 2018-11-07 10:15:09.172+00 https://www.pharmasalmanac.com/articles/gala-enrolls-first-subjects-in-an-early-feasibility-study-of-rheox-for-chronic-bronchitis-in-the-united-states 2018-11-07 10:15:09.168+00 https://www.pharmasalmanac.com/articles/abzena-announces-20m-investment-into-expansion-of-integrated-biotherapeutics-offering-biologics-drug-substance-and-adc-and-makes-key-executive-appointment 2018-11-06 17:33:28.422+00 https://www.pharmasalmanac.com/articles/acelrx-announces-fda-approval-of-dsuvia 2018-11-06 17:29:26.934+00 https://www.pharmasalmanac.com/articles/amgen-and-provention-bio-announce-co-development-collaboration-in-celiac-disease 2018-11-06 17:28:27.171+00 https://www.pharmasalmanac.com/articles/galderma-announces-fda-approval-of-restylane-lyft-for-midface-injection-via-cannula 2018-11-06 10:15:05.617+00 https://www.pharmasalmanac.com/articles/gsk-opens-new-facility-in-scotland 2018-11-05 18:11:19.101+00 https://www.pharmasalmanac.com/articles/third-pcsk9-inhibitor-for-lowering-cholesterol-moves-into-phase-iii-trials 2018-11-05 17:56:51.36+00 https://www.pharmasalmanac.com/articles/neuroscience-company-created-by-bain-capital-and-pfizer 2018-11-05 17:53:32.413+00 https://www.pharmasalmanac.com/articles/high-valued-start-up-announces-positive-results-for-osteoarthritis-drug 2018-11-05 17:48:48.782+00 https://www.pharmasalmanac.com/articles/more-positive-results-for-novartis-eye-drug-brolucizumab 2018-11-05 17:31:36.542+00 https://www.pharmasalmanac.com/articles/abbvie-reports-third-quarter-2018-financial-results 2018-11-05 10:15:03.568+00 https://www.pharmasalmanac.com/articles/aquestive-therapeutics-announces-u.s.-food-and-drug-administration-fda-approval-for-sympazan-clobazam-oral-film 2018-11-05 10:15:03.067+00 https://www.pharmasalmanac.com/articles/migraine-drugs-market-rising-at-steady-3.5-during-2017-2025-abortive-treatment-generates-maximum-revenue-tmr 2018-11-05 10:15:03.023+00 https://www.pharmasalmanac.com/articles/osteoremedies-announces-the-first-fda-cleared-dual-antibiotic-spacer-and-bone-cement-with-gentamicin-and-vancomycin 2018-11-05 10:15:01.963+00 https://www.pharmasalmanac.com/articles/australis-finalizes-definitive-agreement-to-acquire-rthm-technologies-inc 2018-11-02 09:15:11.246+00 https://www.pharmasalmanac.com/articles/jazz-pharmaceuticals-announces-fda-approval-of-xyrem-sodium-oxybate-for-the-treatment-of-cataplexy-or-excessive-daytime-sleepiness-in-pediatric-narcolepsy-patients 2018-11-02 09:15:11.233+00 https://www.pharmasalmanac.com/articles/invitae-expands-work-with-alnylam-pharmaceuticals-to-provide-access-to-genetic-testing-for-primary-hyperoxaluria 2018-11-02 09:15:10.705+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-announces-collaboration-to-simplify-analysis-of-complex-therapeutic-proteins 2018-11-01 09:15:04.111+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-opens-new-expanded-facility-in-frederick-md 2018-11-01 09:15:04.111+00 https://www.pharmasalmanac.com/articles/green-science-alliance-co.-ltd.-has-started-production-of-chitin-nanofiber-chitosan-nanofiber 2018-11-01 09:15:03.468+00 https://www.pharmasalmanac.com/articles/actobio-therapeutics-doses-first-patient-in-phase-ib/iia-clinical-study-of-ag019-for-the-treatment-of-type-1-diabetes 2018-10-31 09:15:11.391+00 https://www.pharmasalmanac.com/articles/diabetes-medication-may-protect-against-a-common-cause-of-blindness 2018-10-31 09:15:11.389+00 https://www.pharmasalmanac.com/articles/myr-pharma-announces-presentation-of-interim-results-of-myr-203-a-phase-2-study-of-myrcludex-in-combination-with-pegylated-interferon-in-chronic-hepatitis-delta 2018-10-31 09:15:10.869+00 https://www.pharmasalmanac.com/articles/thermo-fisher-scientific-opens-newly-expanded-facility-in-frederick-md 2018-10-30 17:00:13.567+00 https://www.pharmasalmanac.com/articles/amo-pharma-reports-positive-data-from-investigator-led-tide-study-of-amo-02-in-autism-spectrum-disorder 2018-10-30 09:15:01.142+00 https://www.pharmasalmanac.com/articles/big-data-in-drug-packaging-and-distribution 2018-10-29 17:42:52.572+00 https://www.pharmasalmanac.com/articles/oxford-nanopore-technologies-attracts-amgen-investment 2018-10-29 17:37:27.113+00 https://www.pharmasalmanac.com/articles/castle-creek-pharma-raises-funding-to-repurpose-diacerein 2018-10-29 17:34:54.244+00 https://www.pharmasalmanac.com/articles/gsks-viiv-healthcare-seeks-fda-approval-for-combination-hiv-therapy 2018-10-29 17:31:57.413+00 https://www.pharmasalmanac.com/articles/positive-results-for-keytruda-in-kidney-cancer 2018-10-29 17:27:53.214+00 https://www.pharmasalmanac.com/articles/fda-looking-for-way-to-facilitate-simultaneous-generic-approvals 2018-10-29 17:24:20.394+00 https://www.pharmasalmanac.com/articles/new-tumor-dna-assay-will-be-used-to-assess-response-to-a-new-cancer-vaccine 2018-10-29 17:21:54.603+00 https://www.pharmasalmanac.com/articles/positive-opinion-announced-in-eu-for-new-dengue-fever-vaccine 2018-10-29 17:17:41.24+00 https://www.pharmasalmanac.com/articles/herceptin-biosimilar-gets-positive-opinion-in-europe 2018-10-29 17:10:29.554+00 https://www.pharmasalmanac.com/articles/the-evolution-of-pharma-depends-on-data-integration-and-application 2018-10-29 15:30:50.179+00 https://www.pharmasalmanac.com/articles/novel-combination-therapy-promotes-wound-healing 2018-10-29 09:15:12.868+00 https://www.pharmasalmanac.com/articles/perrigo-to-release-third-quarter-calendar-year-2018-financial-results-on-november-8-2018 2018-10-29 09:15:12.401+00 https://www.pharmasalmanac.com/articles/global-interventional-cardiology-market-to-reach-24.96-billion-by-2027 2018-10-29 09:15:12.326+00 https://www.pharmasalmanac.com/articles/alcami-helps-medicines-development-for-global-health-secure-fda-approval-of-moxidectin-for-river-blindness 2018-10-29 09:15:11.339+00 https://www.pharmasalmanac.com/articles/looking-forward-what-new-technologies-/paradigms-do-you-anticipate-having-the-greatest-impact-next-year-digitalization-and-industry-4.0-serialization-etc 2018-10-26 19:54:03.882+00 https://www.pharmasalmanac.com/articles/q-what-innovative-technologies-had-the-greatest-impact-on-your-company-this-year-what-were-the-impacts 2018-10-26 19:47:37.773+00 https://www.pharmasalmanac.com/articles/the-coming-of-age-of-amorphous-solid-dispersions 2018-10-26 15:01:10.455+00 https://www.pharmasalmanac.com/articles/knowledge-and-experience-equal-successful-technology-transfer 2018-10-26 14:57:54.347+00 https://www.pharmasalmanac.com/articles/a-turnkey-solution-sourcing-equipment-and-empowering-operators 2018-10-26 14:56:34.698+00 https://www.pharmasalmanac.com/articles/designing-effective-facilities-to-meet-the-growing-demand-for-oligonucleotide-drugs 2018-10-26 14:54:46.065+00 https://www.pharmasalmanac.com/articles/big-data-in-drug-manufacturing 2018-10-26 14:52:45.504+00 https://www.pharmasalmanac.com/articles/big-data-in-drug-development-and-discovery 2018-10-26 14:52:20.581+00 https://www.pharmasalmanac.com/articles/fda-delays-enforcement-of-serialization-mandate 2018-10-26 14:51:17.079+00 https://www.pharmasalmanac.com/articles/preparing-clinical-trial-logistics-for-a-no-deal-brexit 2018-10-26 14:42:42.195+00 https://www.pharmasalmanac.com/articles/regulatory-approval-brings-sirna-into-the-rare-disease-toolbox 2018-10-26 14:27:11.439+00 https://www.pharmasalmanac.com/articles/chinese-capital-backs-u.s.-biotech 2018-10-26 14:25:22.781+00 https://www.pharmasalmanac.com/articles/biondvax-receives-8m-from-the-european-investment-bank-eib-in-support-of-manufacturing-facility-and-ongoing-phase-3-clinical-trial 2018-10-26 13:38:14.905+00 https://www.pharmasalmanac.com/articles/regenxbio-announces-exclusive-worldwide-license-with-ultragenyx-for-the-treatment-of-cdkl5-deficiency-disorder-using-nav-vectors 2018-10-26 09:15:04.853+00 https://www.pharmasalmanac.com/articles/mallinckrodt-presents-data-on-h.p.-acthar-gel-repository-corticotropin-injection-in-rheumatoid-arthritis-ra-at-the-2018-acr/arhp-annual-meeting 2018-10-26 09:15:04.814+00 https://www.pharmasalmanac.com/articles/medicenna-presented-insights-from-the-phase-2b-clinical-trial-of-mdna55-at-the-european-society-for-medical-oncology-2018-congress 2018-10-26 09:15:04.298+00 https://www.pharmasalmanac.com/articles/medisafe-partners-with-merck-kgaa-darmstadt-germany-to-improve-adherence-for-patients-with-cardiometabolic-disorders-in-russia-mexico-and-brazil 2018-10-25 16:55:45.857+00 https://www.pharmasalmanac.com/articles/qpex-biopharma-announces-closing-of-33-million-series-a-financing-and-launch-of-company-to-address-worldwide-problem-of-drug-resistant-infections 2018-10-25 16:43:47.077+00 https://www.pharmasalmanac.com/articles/tairx-inc.-and-biohealth-innovation-inc.-form-tairx-us-to-develop-and-commercialize-therapeutics-and-precision-medicine-diagnostics 2018-10-25 09:15:07.92+00 https://www.pharmasalmanac.com/articles/fda-approves-asthma-indication-for-dupixent-dupilumab 2018-10-25 09:15:06.471+00 https://www.pharmasalmanac.com/articles/nxt-id-issues-shareholder-update 2018-10-24 09:15:03.574+00 https://www.pharmasalmanac.com/articles/halozyme-provides-summary-results-of-data-for-pegph20-combination-treatments-presented-at-esmo-2018-congress 2018-10-24 09:15:03.574+00 https://www.pharmasalmanac.com/articles/cellect-announces-a-major-technological-breakthrough-for-industrialization-of-apotainer-stem-cell-product-line 2018-10-24 09:15:03.052+00 https://www.pharmasalmanac.com/articles/nccn-awarded-2-million-in-research-funding-from-taiho-oncology-to-study-trifluridine-and-tipiracil-in-various-cancers 2018-10-23 09:15:09.652+00 https://www.pharmasalmanac.com/articles/reistone-biopharma-a-new-chinese-biotech-company-ready-to-initiate-its-ulcerative-colitis-phase-ii-clinical-trial-globally 2018-10-23 09:15:09.579+00 https://www.pharmasalmanac.com/articles/quest-diagnostics-acquires-hurley-medical-centers-outreach-laboratory-services-operation-in-central-michigan 2018-10-23 09:15:09.575+00 https://www.pharmasalmanac.com/articles/real-world-study-shows-sequencing-of-gilotrif-followed-by-osimertinib-delivered-a-combined-median-time-on-treatment 2018-10-23 09:15:09.575+00 https://www.pharmasalmanac.com/articles/allergan-bags-another-body-contouring-approval 2018-10-22 16:16:27.312+00 https://www.pharmasalmanac.com/articles/pharmas-big-spending-on-tv-ads-continues-in-2018 2018-10-22 16:08:37.601+00 https://www.pharmasalmanac.com/articles/humira-patent-disputes-between-novartis-and-abbvie-settled 2018-10-22 15:57:04.563+00 https://www.pharmasalmanac.com/articles/new-fund-to-focus-on-india 2018-10-22 15:54:41.519+00 https://www.pharmasalmanac.com/articles/xarelto-gets-approval-for-additional-indication 2018-10-22 15:52:00.229+00 https://www.pharmasalmanac.com/articles/another-biosimilar-gets-nod-from-independent-fda-panel 2018-10-22 15:43:25.32+00 https://www.pharmasalmanac.com/articles/cell-based-flu-vaccines-appear-to-be-more-effective-than-egg-based-strains 2018-10-22 15:24:11.48+00 https://www.pharmasalmanac.com/articles/almac-grows-in-north-carolina 2018-10-22 15:20:54.63+00 https://www.pharmasalmanac.com/articles/janssen-announces-new-three-year-tremfya-guselkumab-data-demonstrates-stably-maintained-rates-of-skin-clearance-in-patients-with-moderate-to-severe-plaque-psoriasis 2018-10-22 09:15:09.055+00 https://www.pharmasalmanac.com/articles/mylan-and-biocon-announce-positive-chmp-opinion-for-ogivri-biosimilar-trastuzumab 2018-10-22 09:15:08.388+00 https://www.pharmasalmanac.com/articles/abbotts-heartmate-3-heart-pump-now-fda-approved-for-advanced-heart-failure-patients-not-eligible-for-a-heart-transplant 2018-10-22 09:15:08.365+00 https://www.pharmasalmanac.com/articles/polypid-begins-phase-2-study-to-assess-safety-and-efficacy-of-d-plex100-in-prevention-of-abdominal-surgical-site-infections 2018-10-19 14:30:39.056+00 https://www.pharmasalmanac.com/articles/eclipse-medcorp-acquires-transformative-technology-in-regenerative-medicine 2018-10-19 14:27:07.701+00 https://www.pharmasalmanac.com/articles/bausch-healths-ortho-dermatologics-business-to-present-new-scientific-data-during-the-fall-clinical-dermatology-conference 2018-10-19 09:15:08.169+00 https://www.pharmasalmanac.com/articles/cronos-group-inc.-partners-with-technion-research-development-foundation-for-cannabinoid-based-skin-care-treatments 2018-10-19 09:15:07.733+00 https://www.pharmasalmanac.com/articles/a-vision-for-growth-tailored-to-our-partners-needs 2018-10-18 16:39:41.288+00 https://www.pharmasalmanac.com/articles/sysmex-inostics-oncobeam-liquid-biopsy-technology-demonstrates-utility-for-clinical-management-of-melanoma-patients-undergoing-treatment 2018-10-18 09:15:11.906+00 https://www.pharmasalmanac.com/articles/united-nations-chooses-leading-marketplace-builder-arcadier-to-defeat-non-communicable-diseases-around-the-world 2018-10-17 09:15:02.355+00 https://www.pharmasalmanac.com/articles/new-study-examines-how-pharmaceutical-industry-is-embracing-digital-patient-engagement-programs 2018-10-17 09:15:01.906+00 https://www.pharmasalmanac.com/articles/theraps-dashboard-analytics-tool-offers-aggregate-health-care-data-insight-for-improved-health-outcomes 2018-10-17 09:15:01.408+00 https://www.pharmasalmanac.com/articles/gsk-funds-british-biotech-sitryx 2018-10-16 16:30:36.747+00 https://www.pharmasalmanac.com/articles/fda-gives-de-novo-clearance-to-first-over-the-counter-hearing-aid 2018-10-16 16:14:50.082+00 https://www.pharmasalmanac.com/articles/new-collaboration-aimed-at-improving-cancer-diagnostics-in-the-uk 2018-10-16 16:12:19.909+00 https://www.pharmasalmanac.com/articles/uk-hospital-to-get-command-center-driven-by-ai-and-real-time-analytics 2018-10-16 16:08:40.134+00 https://www.pharmasalmanac.com/articles/sutros-stro-001-receives-u.s.-fda-orphan-drug-designation-for-treatment-of-multiple-myeloma 2018-10-16 16:04:50.069+00 https://www.pharmasalmanac.com/articles/new-diabetes-drug-shows-promise-in-phase-2-study 2018-10-16 16:01:31.581+00 https://www.pharmasalmanac.com/articles/soligenix-announces-positive-recommendation-by-independent-data-monitoring-committee-on-its-phase-3-clinical-trial-of-sgx301 2018-10-16 09:15:02.422+00 https://www.pharmasalmanac.com/articles/oncosec-initiates-keynote-890-a-phase-2-clinical-trial-of-tavo-in-combination-with-mercks-keytruda 2018-10-16 09:15:02.363+00 https://www.pharmasalmanac.com/articles/alliqua-biomedical-inc.-and-adynxx-inc.-announce-merger-agreement-to-create-nasdaq-listed-clinical-stage-pharmaceutical-company-with-a-focus-on-pain-and-inflammation 2018-10-15 09:15:02.239+00 https://www.pharmasalmanac.com/articles/the-menarini-group-announces-commercial-agreement-for-vabomere-orbactiv-and-minocin-in-68-countries 2018-10-15 09:15:02.205+00 https://www.pharmasalmanac.com/articles/u.s.-department-of-veterans-affairs-signs-contract-with-merck-for-its-remicade-biosimilar 2018-10-12 18:58:36.185+00 https://www.pharmasalmanac.com/articles/new-clinical-trial-will-evaluate-biomarkers-as-predictors-of-treatment-response-in-ibd 2018-10-12 18:37:42.43+00 https://www.pharmasalmanac.com/articles/tissue-analytics-launches-3d-wound-imaging-for-smartphones 2018-10-12 09:15:04.48+00 https://www.pharmasalmanac.com/articles/abbvie-to-present-new-data-for-upadacitinib-and-humira-adalimumab-at-the-2018-acr/arhp-annual-meeting 2018-10-12 09:15:03.892+00 https://www.pharmasalmanac.com/articles/janssen-collaborates-on-rna-therapy 2018-10-11 18:43:39.231+00 https://www.pharmasalmanac.com/articles/theravance-biopharma-and-mylan-to-present-new-data-from-studies-of-yupelri-revefenacin-at-the-2018-chest-annual-meeting 2018-10-11 09:15:09.881+00 https://www.pharmasalmanac.com/articles/myovant-sciences-and-flo-health-partner-to-develop-digital-tool-to-screen-women-for-heavy-menstrual-bleeding 2018-10-11 09:15:09.328+00 https://www.pharmasalmanac.com/articles/atlas-genetics-announces-company-rebranding-changes-name-to-binx-health 2018-10-11 09:15:08.963+00 https://www.pharmasalmanac.com/articles/fda-grants-coordination-pharmaceuticals-ind-approval-for-cpi-100-a-novel-antitumor-nanomedicine 2018-10-10 09:15:02.974+00 https://www.pharmasalmanac.com/articles/strykers-advanced-guidance-technologies-announces-partnerships-with-synaptive-medical-and-ziehm-imaging 2018-10-09 15:36:36.707+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-group-and-mayo-clinic-receive-2018-medtech-insight-award-for-best-alliance 2018-10-09 09:15:08.049+00 https://www.pharmasalmanac.com/articles/allergan-launches-personalized-study-approach-for-clinical-research-programs-in-inflammatory-bowel-disease 2018-10-08 09:15:08.747+00 https://www.pharmasalmanac.com/articles/tracelink-unveils-smart-rx-manager-a-flexible-pharmacy-solution-for-eu-falsified-medicines-directive-fmd-compliance 2018-10-08 09:15:08.19+00 https://www.pharmasalmanac.com/articles/increasing-customer-successes-through-enhanced-qc-agility-and-flexibility 2018-10-05 15:07:23.508+00 https://www.pharmasalmanac.com/articles/proposed-opioid-bill-includes-new-payment-disclosures 2018-10-04 15:27:30.264+00 https://www.pharmasalmanac.com/articles/roche-collaborates-in-digital-health 2018-10-04 15:17:45.609+00 https://www.pharmasalmanac.com/articles/new-treatment-option-for-migraine-suffers 2018-10-04 15:15:23.885+00 https://www.pharmasalmanac.com/articles/another-pd-1/l1-drug-gets-priority-approval-from-the-us-fda 2018-10-04 15:11:09.786+00 https://www.pharmasalmanac.com/articles/promising-phase-2b-results-for-new-gsk-tuberculosis-vaccine 2018-10-04 15:08:24.983+00 https://www.pharmasalmanac.com/articles/gilead-makes-move-to-launch-early-generics 2018-10-04 15:06:38.2+00 https://www.pharmasalmanac.com/articles/nobel-prize-in-medicine-goes-to-immunotherapy-developers 2018-10-04 15:06:09.59+00 https://www.pharmasalmanac.com/articles/seven-trends-impacting-chemical-process-development 2018-10-04 14:43:54.692+00 https://www.pharmasalmanac.com/articles/the-future-of-viral-vector-manufacturing-market 2018-10-04 14:43:29.036+00 https://www.pharmasalmanac.com/articles/fda-approves-libtayo-cemiplimab-rwlc-as-first-and-only-treatment-for-advanced-cutaneous-squamous-cell-carcinoma 2018-10-04 09:15:07.727+00 https://www.pharmasalmanac.com/articles/china-sxt-pharmaceuticals-inc.-announces-effectiveness-of-registration-statement-on-form-f-1 2018-10-04 09:15:07.717+00 https://www.pharmasalmanac.com/articles/gi-partners-completes-acquisition-and-merger-of-california-cryobank-and-cord-blood-registry 2018-10-03 21:50:17.526+00 https://www.pharmasalmanac.com/articles/vista-equity-partners-to-acquire-leading-consumer-directed-healthcare-firm-alegeus 2018-10-03 21:48:57.002+00 https://www.pharmasalmanac.com/articles/boston-scientific-announces-agreement-to-acquire-veniti-inc 2018-10-03 21:47:27.01+00 https://www.pharmasalmanac.com/articles/ligand-makes-offer-to-acquire-vernalis-a-leader-in-structure-based-drug-discovery-for-approximately-43-million-in-cash 2018-10-03 21:45:49.604+00 https://www.pharmasalmanac.com/articles/emergent-biosolutions-to-acquire-paxvax-from-cerberus-capital-management 2018-10-03 21:42:47.943+00 https://www.pharmasalmanac.com/articles/nuvo-pharmaceuticals-announces-letter-of-intent-to-acquire-commercial-products-and-infrastructure-from-aralez-pharmaceuticals 2018-10-03 21:41:22.559+00 https://www.pharmasalmanac.com/articles/catalent-completes-tender-offer-for-all-outstanding-shares-of-juniper-pharmaceuticals-inc 2018-10-03 21:38:38.534+00 https://www.pharmasalmanac.com/articles/accelerating-time-to-market-with-integrated-preparative-chromatography-support 2018-10-03 20:26:36.714+00 https://www.pharmasalmanac.com/articles/patient-centricity-and-the-pharmaceutical-supply-chain-an-evolving-dynamic 2018-10-03 20:25:52.477+00 https://www.pharmasalmanac.com/articles/fda-grants-profounda-inc.-competitive-generic-therapy-cgt-designation-for-planned-anda-filing-of-minocycline-hydrochloride-microspheres1-mg 2018-10-03 09:15:02.662+00 https://www.pharmasalmanac.com/articles/world-heart-day-nearly-one-in-five-deaths-from-cardiovascular-disease-are-caused-by-air-pollution-a-total-of-3-million-deaths-globally-every-year 2018-10-03 09:15:01.622+00 https://www.pharmasalmanac.com/articles/bio-techne-announces-cell-and-gene-therapy-initiative 2018-10-03 09:15:01.619+00 https://www.pharmasalmanac.com/articles/remember-the-user-incorporating-patient-centricity-into-drug-design 2018-10-02 20:55:03.431+00 https://www.pharmasalmanac.com/articles/pursuing-patient-centricity-from-start-to-finish 2018-10-02 20:54:15.996+00 https://www.pharmasalmanac.com/articles/the-impact-of-patients-as-consumersnew-fill/finish-and-packaging-solutions 2018-10-02 20:52:07.491+00 https://www.pharmasalmanac.com/articles/optimizing-profitability-in-drug-product-manufacturing-with-hard-shell-capsules 2018-10-02 20:40:44.899+00 https://www.pharmasalmanac.com/articles/aspects-to-consider-on-the-way-to-a-tailored-manufacturing-strategy 2018-10-02 20:34:46.198+00 https://www.pharmasalmanac.com/articles/people-expertise-and-dedication-are-key-to-successful-strategic-partnerships 2018-10-02 20:33:35.957+00 https://www.pharmasalmanac.com/articles/leveraging-offsite-fabrication-in-the-pharma-industry 2018-10-02 20:26:08.011+00 https://www.pharmasalmanac.com/articles/understanding-the-uniquedesign-and-engineering-needs-for-gene-therapy-production 2018-10-02 20:12:17.665+00 https://www.pharmasalmanac.com/articles/creating-value-with-tailored-odt-solutions 2018-10-02 19:36:52.219+00 https://www.pharmasalmanac.com/articles/personalized-logistics-solutions-for-virtual-and-hybrid-clinical-trials 2018-10-02 19:26:31.286+00 https://www.pharmasalmanac.com/articles/competitive-generic-therapy-a-new-patient-centric-fda-pathway 2018-10-02 19:25:26.089+00 https://www.pharmasalmanac.com/articles/aligning-with-sponsors-for-strategic-growth 2018-10-02 19:12:33.108+00 https://www.pharmasalmanac.com/articles/terminal-sterilization-for-parenteral-drugs-finding-the-right-cdmo-partner 2018-10-02 19:11:23.744+00 https://www.pharmasalmanac.com/articles/meeting-regulatory-requirements-rising-to-the-challenge-with-a-trusted-equipment-partner 2018-10-02 19:09:01.97+00 https://www.pharmasalmanac.com/articles/the-biotech-boom 2018-10-02 18:48:10.542+00 https://www.pharmasalmanac.com/articles/sandoz-inc.-announces-us-fda-approval-of-pediatric-dose-of-symjepi-epinephrine 2018-10-02 09:15:06.847+00 https://www.pharmasalmanac.com/articles/sir-william-castell-joins-the-board-of-phoenix-solutions-as-a-private-norwegian-biotechnology-company-harnessing-the-power-of-ultrasound-for-targeted-drug-delivery 2018-10-02 09:15:05.495+00 https://www.pharmasalmanac.com/articles/capsugel-evolving-a-strong-brand 2018-10-01 21:43:12.587+00 https://www.pharmasalmanac.com/articles/bain-capital-private-equity-acquires-dsm-sinochem-pharmaceuticals 2018-10-01 20:52:22.73+00 https://www.pharmasalmanac.com/articles/ampac-fine-chemicals-to-be-acquired-by-sk-holdings 2018-10-01 20:52:03.815+00 https://www.pharmasalmanac.com/articles/breakthrough-treatment-helps-prolong-life-for-people-with-metastatic-lung-cancer 2018-10-01 09:15:01.579+00 https://www.pharmasalmanac.com/articles/titan-pharmaceuticals-prices-9500000-public-offering 2018-09-28 09:15:06.738+00 https://www.pharmasalmanac.com/articles/novartis-announces-positive-chmp-opinion-for-one-time-gene-therapy-luxturnar-to-treat-children-and-adults-with-rare-inherited-retinal-disease 2018-09-28 09:15:06.215+00 https://www.pharmasalmanac.com/articles/boston-scientific-launches-lithovue-empower-retrieval-deployment-device 2018-09-28 09:15:06.214+00 https://www.pharmasalmanac.com/articles/lilly-receives-positive-chmp-opinion-for-emgality-galcanezumab-for-the-prophylaxis-of-migraine-in-adult 2018-09-28 09:15:05.218+00 https://www.pharmasalmanac.com/articles/abbvie-announces-5-million-donation-to-family-reach-to-support-children-battling-cancer-and-their-families 2018-09-27 09:15:04.763+00 https://www.pharmasalmanac.com/articles/cancer-immunotherapy-treatment-market-on-the-rise-as-rd-increases 2018-09-27 09:15:03.771+00 https://www.pharmasalmanac.com/articles/mylan-and-biocon-announce-positive-chmp-opinion-for-fulphila-biosimilar-pegfilgrastim 2018-09-27 09:15:03.766+00 https://www.pharmasalmanac.com/articles/mylan-launches-authorized-generic-of-ampyra-tablets 2018-09-27 09:15:03.723+00 https://www.pharmasalmanac.com/articles/brammer-bio-announces-progress-on-200-million-program-to-advance-gene-therapies 2018-09-26 14:30:08.899+00 https://www.pharmasalmanac.com/articles/oramed-receives-fda-clearance-for-ind-application-for-its-oral-glp-1-analog-capsule 2018-09-26 09:15:06.451+00 https://www.pharmasalmanac.com/articles/obi-pharma-granted-fda-orphan-drug-designation-for-obi-3424-for-the-treatment-of-acute-lymphoblastic-leukemia-all 2018-09-26 09:15:05.912+00 https://www.pharmasalmanac.com/articles/fda-clears-augmented-reality-visualization-solution-glow800 2018-09-26 09:15:05.91+00 https://www.pharmasalmanac.com/articles/stem-cell-research-may-lead-to-treatments-for-gastrointestinal-diseases 2018-09-25 18:44:47.873+00 https://www.pharmasalmanac.com/articles/fish-oil-drug-shows-dramatic-results-in-cardiovascular-study 2018-09-25 17:11:49.908+00 https://www.pharmasalmanac.com/articles/fda-removes-partial-clinical-hold-on-epizyme-tazemetostat-clinical-trials 2018-09-25 17:08:57.5+00 https://www.pharmasalmanac.com/articles/new-evidence-suggests-the-brain-and-stomach-are-in-direct-communication 2018-09-25 17:04:56.471+00 https://www.pharmasalmanac.com/articles/new-blood-test-from-roche-detects-common-gene-mutations 2018-09-25 17:01:32.756+00 https://www.pharmasalmanac.com/articles/cancer-drug-candidate-attracts-big-pharma-attention 2018-09-25 16:56:20.561+00 https://www.pharmasalmanac.com/articles/new-small-molecule-drugs-could-enhance-immune-responses-to-cancer 2018-09-25 16:50:32.751+00 https://www.pharmasalmanac.com/articles/gene-that-helps-cells-resist-zika-infection-identified 2018-09-25 16:44:34.713+00 https://www.pharmasalmanac.com/articles/safety-risks-associated-with-crushing-or-altering-medication 2018-09-25 09:15:05.914+00 https://www.pharmasalmanac.com/articles/european-commission-approves-braftovi-encorafenib-in-combination-with-mektovi-binimetinib-for-advanced-braf-mutant-melanoma 2018-09-25 09:15:05.408+00 https://www.pharmasalmanac.com/articles/synthetic-biology-making-strides-in-key-applications-finds-idtechex 2018-09-25 09:15:05.354+00 https://www.pharmasalmanac.com/articles/ziylo-acquired-by-novo-nordisk-in-deal-that-could-exceed-us800m 2018-09-24 09:15:03.538+00 https://www.pharmasalmanac.com/articles/tolero-pharmaceuticals-announces-clinical-research-collaboration-with-abbvie-for-acute-myeloid-leukemia-trial 2018-09-24 09:15:03.528+00 https://www.pharmasalmanac.com/articles/new-genetic-understanding-could-lead-to-brain-cancer-treatments 2018-09-21 15:14:38.854+00 https://www.pharmasalmanac.com/articles/patients-with-rare-leukemia-disease-will-have-new-treatment-option 2018-09-21 15:12:13.221+00 https://www.pharmasalmanac.com/articles/fight-against-duchenne-muscular-dystrophy-gets-major-funding-boost 2018-09-21 09:15:05.099+00 https://www.pharmasalmanac.com/articles/veristat-congratulates-agios-pharmaceuticals-on-the-fda-approval-of-tibsovo 2018-09-21 09:15:04.515+00 https://www.pharmasalmanac.com/articles/u.s.-food-and-drug-administration-approves-opdivonivolumab 2018-09-21 09:15:04.086+00 https://www.pharmasalmanac.com/articles/elysium-health-announces-exclusive-license-for-use-of-nicotinamide-riboside 2018-09-21 09:15:03.954+00 https://www.pharmasalmanac.com/articles/regeneron-and-teva-announce-positive-topline-phase-3-fasinumab-results-in-patients-with-chronic-pain-from-osteoarthritis-of-the-knee-or-hip 2018-09-20 18:45:15.763+00 https://www.pharmasalmanac.com/articles/neurocrine-biosciences-to-present-data-on-ingrezza-valbenazine-and-opicapone-at-the-2018-world-congress-on-parkinsons-disease-and-related-disorders 2018-09-20 09:15:13.811+00 https://www.pharmasalmanac.com/articles/allergan-makes-neurotoxin-buy-with-acquisition-of-bonti-inc 2018-09-19 20:30:43.289+00 https://www.pharmasalmanac.com/articles/jj-anticipates-growth 2018-09-19 20:22:28.187+00 https://www.pharmasalmanac.com/articles/ortho-dermatologics-resubmits-u.s.-new-drug-application-for-duobrii-halobetasol-propionate-and-tazarotene-lotion 2018-09-19 09:15:08.691+00 https://www.pharmasalmanac.com/articles/wuxi-apptec-research-service-division-and-cyclica-collaborate-to-drive-polypharmacology-in-drug-discovery-through-ai-augmented-technologies 2018-09-19 09:15:07.199+00 https://www.pharmasalmanac.com/articles/peptide-logic-awarded-a-grant-to-develop-peripherally-restricted-and-long-acting-kappa-opioid-receptor-la-kor-agonists 2018-09-19 09:15:07.164+00 https://www.pharmasalmanac.com/articles/preparing-for-hurricane-florence-in-pharma 2018-09-18 19:26:56.024+00 https://www.pharmasalmanac.com/articles/latest-apple-watch-gets-fda-approval-as-a-class-ii-device 2018-09-18 19:23:22.297+00 https://www.pharmasalmanac.com/articles/rxi-pharmaceuticals-and-karolinska-institutet-enter-into-collaboration-to-develop-sd-rxrna-compounds-to-improve-functionality-and-persistence-of-t-cells-and-nk-cells 2018-09-18 09:15:13.914+00 https://www.pharmasalmanac.com/articles/trovagene-receives-usan-approval-for-onvansertib-as-nonproprietary-name-for-first-in-class-3rd-generation-plk1-inhibitor-drug-candidate-pcm-075 2018-09-18 09:15:12.888+00 https://www.pharmasalmanac.com/articles/biontech-signs-collaboration-agreement-with-pfizer-to-develop-mrna-based-vaccines-for-prevention-of-influenza 2018-09-18 09:15:12.888+00 https://www.pharmasalmanac.com/articles/transforming-with-an-equipment-partner-preparing-the-industry-for-serialization 2018-09-17 10:00:04.674+00 https://www.pharmasalmanac.com/articles/actinium-to-provide-update-on-pivotal-phase-3-sierra-trial-following-positive-data-monitoring-committee-meeting 2018-09-17 09:15:12.389+00 https://www.pharmasalmanac.com/articles/milliporesigma-awarded-australian-crispr-nickase-patent-for-foundational-genome-editing-technology 2018-09-17 09:15:11.48+00 https://www.pharmasalmanac.com/articles/genenews-and-lifex-partner-to-deliver-proprietary-liquid-biopsy-molecular-diagnostics-to-health-systems-to-detect-cancer-at-earliest-stages 2018-09-17 09:15:11.433+00 https://www.pharmasalmanac.com/articles/perlara-announces-glycogen-storage-diseases-perlquest-with-the-university-of-notre-dame 2018-09-17 09:15:11.431+00 https://www.pharmasalmanac.com/articles/novartis-unloads-sandoz-us-components 2018-09-14 17:32:21.807+00 https://www.pharmasalmanac.com/articles/ophthalmic-drug-developer-kodiak-biosciences-files-for-ipo 2018-09-14 17:30:11.144+00 https://www.pharmasalmanac.com/articles/eu-gives-nod-to-keytruda-and-chemotherapy-combination-treatment 2018-09-14 17:27:26.686+00 https://www.pharmasalmanac.com/articles/cel-sci-reports-recent-data-review-by-the-independent-data-monitoring-committee-for-its-pivotal-phase-3-head-and-neck-cancer-study 2018-09-14 09:15:04.723+00 https://www.pharmasalmanac.com/articles/leadiant-biosciences-to-collaborate-with-national-institutes-of-health-on-therapy-in-late-stage-development-for-gne-myopathy 2018-09-14 09:15:04.198+00 https://www.pharmasalmanac.com/articles/novocure-and-us-oncology-research-announce-collaboration-on-panova-3-trial-for-patients-with-advanced-pancreatic-cancer 2018-09-14 09:15:03.747+00 https://www.pharmasalmanac.com/articles/oragenics-inc.-resumes-phase-2-clinical-trial-of-ag013-in-oral-mucositis-following-positive-routine-safety-review 2018-09-14 09:15:03.721+00 https://www.pharmasalmanac.com/articles/breakthrough-therapy-designation-for-new-asthma-drug 2018-09-13 18:58:44.458+00 https://www.pharmasalmanac.com/articles/sanofi-aventis-collaborates-with-dyadic-international-on-cl-gene-expression 2018-09-13 18:49:36.109+00 https://www.pharmasalmanac.com/articles/electromed-inc.-announces-results-of-an-independent-clinical-study-bronchiectasis-exacerbations-reduced-lung-function-stabilized-with-smartvest 2018-09-13 09:15:02.246+00 https://www.pharmasalmanac.com/articles/crescendo-biologics-reaches-technical-milestone-for-a-second-target-in-strategic-collaboration-with-takeda 2018-09-13 09:15:01.74+00 https://www.pharmasalmanac.com/articles/martin-pharmaceuticals-livantra-receives-fda-orphan-drug-designation-in-second-indication 2018-09-13 09:15:01.706+00 https://www.pharmasalmanac.com/articles/inova-diagnostics-receives-fda-clearance-for-test-to-detect-antibodies-to-hmgcr 2018-09-12 09:15:10.503+00 https://www.pharmasalmanac.com/articles/fda-grants-orphan-drug-designation-to-onspira-therapeutics-investigational-interleukin-1-receptor-antagonist-for-the-treatment-of-bronchiolitis-obliterans 2018-09-12 09:15:10.499+00 https://www.pharmasalmanac.com/articles/the-buck-institute-insilico-medicine-and-juvenescence-found-napa-therapeutics-to-develop-drugs-to-impede-age-related-disease 2018-09-12 09:15:10.002+00 https://www.pharmasalmanac.com/articles/aveo-announces-acceptance-of-canbridge-investigational-new-drug-application-for-can017-av-203-trial-in-esophageal-squamous-cell-cancer-escc-in-china 2018-09-12 09:15:09.468+00 https://www.pharmasalmanac.com/articles/kaneka-officially-starts-continuous-manufacturing-under-gmp 2018-09-11 14:43:22.314+00 https://www.pharmasalmanac.com/articles/moleculight-inc.s-first-of-its-kind-handheld-fluorescence-imaging-device-receives-fda-de-novo-clearance-for-us-wound-care-market 2018-09-11 09:15:12.301+00 https://www.pharmasalmanac.com/articles/synlogic-publishes-preclinical-data-supporting-development-of-synb1618-a-synthetic-biotic-medicine-as-a-potential-treatment-for-phenylketonuria 2018-09-11 09:15:12.223+00 https://www.pharmasalmanac.com/articles/medicure-announces-fda-approval-of-acute-care-cardiovascular-drug-sodium-nitroprusside-injection 2018-09-10 09:15:08.57+00 https://www.pharmasalmanac.com/articles/mylan-launches-first-generic-for-adcirca-tablets 2018-09-10 09:15:07.994+00 https://www.pharmasalmanac.com/articles/entasis-therapeutics-announces-results-from-patients-with-complicated-urinary-tract-infections 2018-09-10 09:15:07.993+00 https://www.pharmasalmanac.com/articles/funding-raised-for-development-of-drug-to-treat-symptoms-of-menopause 2018-09-07 16:35:38.009+00 https://www.pharmasalmanac.com/articles/patient-populations-with-cancer-associated-vte-treatment 2018-09-07 09:15:09.093+00 https://www.pharmasalmanac.com/articles/orsini-healthcare-specialty-pharmacy-selected-by-alnylam-pharmaceuticals-to-distribute-onpattro-patisiran 2018-09-07 09:15:08.634+00 https://www.pharmasalmanac.com/articles/bayer-gets-fda-approval-for-hemophilia-a-drug 2018-09-06 18:50:00.762+00 https://www.pharmasalmanac.com/articles/incorrect-dosing-cup-leads-to-recall-of-childrens-advil-suspension 2018-09-06 18:46:17.691+00 https://www.pharmasalmanac.com/articles/mercks-hiv-1-drugs-delstrigo-and-pifeltro-get-fda-approval 2018-09-06 18:38:54.445+00 https://www.pharmasalmanac.com/articles/new-lilly-oncology-president-selected 2018-09-06 18:35:53.104+00 https://www.pharmasalmanac.com/articles/grant-will-fund-workforce-development-program-for-biopharma-industry 2018-09-06 18:29:27.269+00 https://www.pharmasalmanac.com/articles/jhl-biotech-receives-positive-chmp-scientific-advice-for-global-phase-iii-clinical-trial-of-proposed-bevacizumab-biosimilar-to-treat-lung-cancer 2018-09-06 09:15:11.075+00 https://www.pharmasalmanac.com/articles/first-patient-dosed-in-phase-1/2-study-evaluating-sobi003-for-treatment-of-mucopolysaccharidosis-type-iiia-mps-iiia 2018-09-06 09:15:10.57+00 https://www.pharmasalmanac.com/articles/gi-dynamics-announces-fda-approval-for-endobarrier-pivotal-trial 2018-09-05 09:15:03.955+00 https://www.pharmasalmanac.com/articles/conavi-medical-announces-clinical-use-of-the-novasight-hybrid-system-with-simultaneous-intravascular-ultrasound-ivus-and-optical-coherence-tomography-oct-capabilities 2018-09-05 09:15:03.851+00 https://www.pharmasalmanac.com/articles/cancer-prevention-pharmaceuticals-completes-north-american-licensing-deal-with-mallinckrodt 2018-09-05 09:15:03.371+00 https://www.pharmasalmanac.com/articles/latam-cargo-opens-pharma-hub-in-denmark 2018-09-05 09:15:03.346+00 https://www.pharmasalmanac.com/articles/samsung-bioepis-to-initiate-phase-1-clinical-trial-of-sb26-ulinastatin-fc-fusion-protein 2018-09-05 09:15:03.337+00 https://www.pharmasalmanac.com/articles/gyros-protein-technologies-introduces-gyrolab-cho-hcp-e3g-kit-for-impurity-testing-of-biotherapeutics 2018-09-05 09:15:03.326+00 https://www.pharmasalmanac.com/articles/fda-grants-breakthrough-therapy-designation-for-xolairomalizumab-for-food-allergies 2018-09-04 09:15:08.153+00 https://www.pharmasalmanac.com/articles/accelerator-life-science-partners-launches-magnolia-neurosciences-corporation-with-31-million-series-a-to-develop-targeted-neuroprotective-therapies 2018-09-04 09:15:06.51+00 https://www.pharmasalmanac.com/articles/therapeuticsmd-announces-fda-approval-of-annovera-segesterone-acetate/ethinyl-estradiol-vaginal-system-for-birth-control 2018-09-04 09:15:05.622+00 https://www.pharmasalmanac.com/articles/protokinetix-enters-into-3rd-phase-of-retinal-cell-replacement-therapy-testing-at-ubc 2018-09-04 09:15:05.561+00 https://www.pharmasalmanac.com/articles/us-food-and-drug-administration-approves-arakoda-tafenoquine-tablets-for-oral-use-first-preventative-antimalarial-approved-in-almost-two-decades 2018-08-31 15:59:57.685+00 https://www.pharmasalmanac.com/articles/enrollment-passes-halfway-milestone-in-clinical-trial-evaluating-the-effect-of-an-exclusive-human-milk-diet 2018-08-31 09:15:08.556+00 https://www.pharmasalmanac.com/articles/gsk-ships-2018-19-seasonal-influenza-vaccines-for-us-market 2018-08-30 17:23:17.029+00 https://www.pharmasalmanac.com/articles/perrigo-expands-otc-growth-strategy-with-rx-to-otc-switch-licensing-for-nasonex 2018-08-30 09:15:05.617+00 https://www.pharmasalmanac.com/articles/beigene-initiates-new-phase-3-trial-of-anti-pd-1-antibody-tislelizumab 2018-08-30 09:15:05.059+00 https://www.pharmasalmanac.com/articles/relmada-therapeutics-allowed-patent-application-in-china-covering-nmda-receptor-antagonist-d-methadone-for-treatment-of-psychiatric-symptoms 2018-08-30 09:15:04.072+00 https://www.pharmasalmanac.com/articles/upm-pharmaceuticals-appoints-dr.-chi-chang-wung-as-director-of-analytical-development 2018-08-29 17:45:25.486+00 https://www.pharmasalmanac.com/articles/crispr-is-helping-dogs-with-muscular-dystrophy-and-young-boys-could-be-next 2018-08-29 16:24:20.564+00 https://www.pharmasalmanac.com/articles/fda-published-draft-guidance-on-use-of-placebo-control-groups 2018-08-29 16:21:20.613+00 https://www.pharmasalmanac.com/articles/novartis-reports-promising-results-for-its-new-alpha-specific-pi3k-inhibitor-byl719 2018-08-29 16:05:46.274+00 https://www.pharmasalmanac.com/articles/abbvie-receives-fda-approval-for-imbruvica-plus-rituximab-as-a-blood-cancer-treatment 2018-08-29 15:54:26.837+00 https://www.pharmasalmanac.com/articles/swri-to-host-2018-small-molecule-drug-development-workshop 2018-08-29 09:15:06.229+00 https://www.pharmasalmanac.com/articles/sangamo-announces-positive-preliminary-data-from-the-phase-1/2-alta-study-evaluating-sb-525-gene-therapy-for-hemophilia-a 2018-08-29 09:15:05.238+00 https://www.pharmasalmanac.com/articles/new-senate-bill-includes-amendment-on-drug-pricing-in-ads-for-prescription-meds 2018-08-28 19:27:35.223+00 https://www.pharmasalmanac.com/articles/researchers-make-discovery-about-leptin-resistance 2018-08-28 19:22:43.946+00 https://www.pharmasalmanac.com/articles/nucryo-vascular-announces-commercialization-agreement-with-lokai-medical-for-innovative-treatment-for-peripheral-arterial-disease 2018-08-28 09:15:08.693+00 https://www.pharmasalmanac.com/articles/trans-hit-bio-signs-an-exclusive-commercial-agreement-with-the-biobank-of-the-maricopa-integrated-health-system-mihs-to-support-industry-rd 2018-08-28 09:15:08.637+00 https://www.pharmasalmanac.com/articles/newly-published-independent-study-on-a-prospective-cohort-highlights-decisiondx-melanoma-prognostic-tests-ability-to-accurately-identify-high-risk-melanoma-patients 2018-08-28 09:15:07.676+00 https://www.pharmasalmanac.com/articles/ironshore-pharmaceuticals-announces-fda-approval-of-jornay-pmtmmethylphenidate-extended-release-capsules-cii-for-the-treatment-of-adhd 2018-08-27 09:15:02.87+00 https://www.pharmasalmanac.com/articles/ovascience-and-millendo-therapeutics-announce-merger-to-create-leading-rare-endocrine-disease-company 2018-08-27 09:15:00.949+00 https://www.pharmasalmanac.com/articles/synspiras-paag-therapy-demonstrates-persistence-against-pseudomonas-aeruginosa-persister-cells 2018-08-27 09:15:00.862+00